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SUMMARY 
 
DNA damage is chronic, inevitable and extensive. Damage caused by UV 
irradiation can cause bulky DNA lesions that block replication forks. Post-
replication repair (PRR) is a DNA damage tolerance mechanism, which enables 
the replication machinery to bypass DNA lesions. The PRR machinery is thought to 
be recruited by ubiquitination of the sliding clamp, PCNA. In human cells, the 
USP/UBP superfamily deubiquitinating enzyme (DUb) USP1 has been shown to 
remove ubiquitin from PCNA and hence acts as a PRR modulator.  
 
However, little is understood about the deubiquitination of PCNA or its regulation in 
yeast. The purpose of this study was to characterise the role of DUbs in yeast 
PRR. 24 DUbs were found to be encoded in the genome of Schizosaccharomyces 
pombe. No clear USP1 orthologue was found. A DUb deletion library was created 
and screened. A double mutant wherein two paralogous DUbs were deleted, 
ubp21∆ ubp22∆, was found to exhibit sensitivity to UVC and increased PCNA 
ubiquitination. The ubp21∆ ubp22∆ strain was also found to be sensitive to a 
variety of DNA damaging agents and some spindle poisons. The double delete 
was epistatic with a mutant strain in which PCNA cannot be ubiquitinated. 
However, the genetic relationship with the enzymes that ubiquitinate PCNA was 
not so clear and a reduction in PCNA ubiquitination was not detected when either 
Ubp21 or Ubp22 was exogenously expressed.  
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Ubp21 and Ubp22 also contain a meprin and TRAF homology (MATH) domain and 
a conserved DWGF motif in the MATH domain was found to be important for 
Ubp22 function. The human orthologue, HAUSPUSP7, stabilises the tumour 
suppressor p53 and is a highly characterised DUb. The Saccharomyces cerevisiae 
orthologue is Ubp15, but when this gene was deleted, only modest spindle poison 
sensitivity was detected. Determination of the precise functions of Ubp21 and 
Ubp22 in PRR requires further investigation. 
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Abbreviations 
 
 
Abbreviation 
 
 
Meaning 
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A adenine 
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Ade adenine 
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DSBR double strand break repair 
dsDNA double-stranded DNA 
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DTT dithiothreitol 
DUb deubiquitinating enzyme 
DUB deubiquitinating enzyme 
DUF domain of unknown function 
DUSP domain present in ubiquitin-specific 
proteases 
E. coli Escherichia coli 
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E2 ubiquitin conjugating enzyme 
E3 ubiquitin-protein ligase 
Ec Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
EGFR epidermal growth factor receptor 
FA Fanconi’s anaemia 
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G1  gap/growth phase 1 
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GGR global genome repair 
Gly glycine 
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terminus 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
HIRAN HIP116 Rad5 N-terminal domain 
HJ Holliday junction 
HR homologous recombination 
HU hydroxyurea 
INK cyclin-dependent kinase inhibitor 
IPTG isopropyl-β-D-thiogalactopyranoside 
IR ionising radiation 
ISG15 interferon-stimulated gene-15 (ubiquitin 
cross-reactive protein [UCRP]) 
JAMM Jab1/Pad1/MPN/Mov34 domain 
metalloenzyme 
kan kanamycin 
kb kilobases 
kDa kilodaltons 
KOD DNA Polymerase isolated from the 
extreme thermophile Thermococcus 
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kodakaraensis 
Leu leucine 
LOH loss of heterozygosity 
M phase mitosis 
MAPK mitogen-activated protein kinase 
MATH meprin and tumour necrosis factor 
receptor-associated factor homology 
MCM mini-chromosome maintenance 
MJD Machado-Joseph/Jakob disease 
protein/Josephin domain protease 
MMC mitomycin C 
MMR mismatch repair 
MMS methylmethane sulfonate 
mRNA messenger ribonucleic acid 
MVB multi-vesicular body 
NAT nourseothricin 
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NBS Nijmegen breakage syndrome 
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RAD radiation 
RF replication fork 
RFC replication factor C 
Rhp rad-homologue in S. pombe 
RING really interesting new gene 
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S. cerevisiae Saccharomyces cerevisiae 
S. pombe Schizosaccharomyces pombe 
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SBM signal transducing adapter molecule 
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Sc Saccharomyces cerevisiae 
SCF Skp1-Cullin-F-box 
SDS sodium dodecyl sulfate 
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SDS-PAGE sodium dodecylsulfate polyacrylamide gel 
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SIM SUMO interaction motif 
SMC structural maintenance of chromosomes 
Sp Schizosaccharomyces pombe 
ssDNA single-stranded DNA 
STAM signal transducing adapter molecule 
SUMO small ubiquitin-like modifier 
T thymine 
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TCR transcription coupled repair 
TEMED N,N,N',N'-tetramethylethylenediamine 
TF transcription factor 
TLS translesion synthesis 
Top1 topoisomerase 1 
TRAF tumour necrosis factor receptor associated 
factor 
tris tris(hydroxymethyl)aminomethane 
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Ub ubiquitin 
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UCH ubiquitin C-terminal hydrolase 
UDS unscheduled DNA synthesis 
UEV ubiquitin-enzyme variant 
UIM ubiquitin-interacting motif 
UPS ubiquitin proteasome system 
Ura uracil 
ura4 Gene encoding dihydroorotase (involved 
in the de novo biosynthesis of pyrimidines)  
USP ubiquitin-specific protease 
USP/UBP ubiquitin-specific protease superfamily 
USPV inactive ubiquitin-specific protease variant 
UV ultra-violet 
UVC UV of wavelength 280 nm –100 nm. 
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Nomenclature 
 
Protein names 
With the exception of the first half of the introduction, mammalian protein names 
are written in the format of SpeciesPROTEINAlias and yeast protein names in the 
format SpeciesProteinAlias. This format was found to be the most concise, and also 
clear when the literature is highly divided with regard to protein names. This 
nomenclature does not apply to viral proteins. Alias names, where given, may be 
capitalised or in lowercase depending upon literature conventions.  
 
Gene names 
Mammalian gene names are written in capital letters and italicised.  
Yeast gene names are written in lowercase in italics e.g. ubp21. A plus sign next to 
the gene name emphasises that it is an unmutated, wild-type version of the gene. 
ubp21∆ indicates a null mutant of ubp21, in other words, the ubp21 gene has been 
deleted, as indicated by the greek letter “∆”. ubp21∆::nat1 indicates a strain 
wherein the ubp21 gene has been deleted and replaced with the nourseothricin-
resistance gene, nat1 – this strain is able to grow in the presence of nourseothricin. 
Whereas, pcn1-K164R::ura4 indicates a strain where the pcn1 has not been 
deleted, but merely modified. This modification results in the mutation of lysine-164 
to an arginine in the translated protein. This mutation is marked (“::”) with the ura4 
gene – this strain is able to grow in the absence of uracil. lub1-1 means lub1 
mutant number 1, and indicates that the lub1 gene is present, but a mutation exists 
in the open reading frame of this gene. 
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Chapter 1: Introduction 
 
1.1.  The Function of DNA 
 
It can be argued that life has evolved entirely for its ability to continue life. That is, 
life has evolved to survive, reproduce, and aid the survival of its offspring.  Millions 
of years of selection for exceptional efficiency in these processes is neatly stored in 
the blueprint of an organism – its genome. Deoxyribonucleic acid (DNA) is the 
polymer within which the genetic information of the genome is stored. Efficient and 
accurate duplication of DNA is key to the production and survival of daughter cells. 
Hence, it can be concluded that the cellular processes involved in DNA duplication, 
repair and maintenance are of fundamental importance to the survival of the 
species.  
 
1.2.  The Cell Cycle and its Checkpoints 
 
The process undertaken by cells to grow, duplicate their cellular contents and 
subsequently divide into two daughter cells is known as the cell division cycle, or 
simply, cell cycle. This is due to the repeating pattern observed: following 
completion of one cycle of growth and division, a new cell results, which 
subsequently grows and divides in its own right. As biochemical research to date 
has outlined, the intracellular environment is very complicated, hence it follows that 
the preparation for and subsequent division of a cell into two daughter cells is also 
an incredibly complex procedure. As explained above, it is fundamental for survival 
that cell duplication must be highly controlled and co-ordinated.  
 
The fundamentals of the cell cycle are reviewed in chapter 21 of Lodish et al., 
2004. Figure 1.1 depicts the different phases of the mammalian cell cycle and their 
respective temporal control systems, known as the cell cycle checkpoints. In 
growth or gap phase 1 (G1), the diploid cell contains two copies of each 
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chromosome – a maternal and a paternal copy. At this stage, a chromosome is 
more commonly referred to as a chromatid, which is made up of one double strand 
of DNA. During synthesis or S-phase, each chromatid is duplicated resulting in an 
identical copy, known as its sister chromatid. Following gap or growth phase 2 
(G2), the cell enters mitosis (M), which is a very complicated and tightly regulated 
phase wherein the mother cell splits into two daughter cells. Of particular 
importance is the separation of each pair of sisters such that each sister is 
accurately segregated into one daughter cell. During metaphase, the chromatid 
pairs line up across the centre of the cell, and during anaphase, one sister 
chromatid is pulled to one pole, and the other sister to the opposite pole. The 
molecular motors that effect this process are associated with the spindle 
microtubules. Subsequently, the cytoplasm is divided into two (cytokinesis) and the 
nuclear envelope then reforms around the segregated chromatids. 
 
The cell cycle is driven by complexes made up of a cyclin and a cyclin-dependent 
kinase (CDK). The association of a particular cyclin with a particular CDK affects 
the kinase activity of the CDK, which in turn effects cell cycle progression. Still 
referring to mammalian cells, G1 is driven by cyclinD-CDK4 and cyclinD-CDK6, S-
phase entry by cyclinE-CDK2, progression through S-phase by cyclinA-CDK2, and 
G2 and M by cyclinA-CDK1 and cyclinB-CDK1. Levels of these complexes are 
tightly controlled by phosphorylation, which alters binding affinity, inhibition by CDK 
inhibitory proteins (CIPs and INKs), and degradation. As summarised in Figure 1.1, 
the cell cycle is controlled at important phases by checkpoints. There are four main 
types of checkpoint. DNA damage checkpoints prevent progression when genome 
integrity is found to be compromised (reviewed in Sancar et al., 2004). For 
example, lesions on the DNA can interfere with genome duplication during S-
phase, so p21CIP is activated to inhibit cyclin A and E and halt the cell cycle at this 
point. Cyclins A and B are sensitive to the inhibitory effect of proteins activated 
following the detection of unreplicated DNA prior to mitosis. Furthermore, the cell 
halts mitosis if incorrect assembly of the spindles or aberrant chromosome 
segregation occurs. It is much less catastrophic for the cell if these problems are 
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rectified before further progression. For example, both daughter cells may not have 
sufficient genetic information to survive if they are provided with an aberrant 
number of chromatids following cell division. However, despite these checkpoint 
mechanisms, of particular interest to this study is how the cell copes with DNA 
damage encountered during DNA replication. 
 
1.3.  DNA Replication 
 
DNA replication occurs during S-phase of the cell cycle. Here the entire genome of 
the cell is duplicated. Replication occurs at many different parts of the genome 
simultaneously – initiating from specific DNA origins upon which replication 
factories, made from colocalised replication machineries, form. At the heart of the 
factory is the DNA polymerase, an enzyme that covalently links DNA monomers in 
a specified order to create a polymeric copy of the parental template genome. 
Eukaryotic DNA polymerases are reviewed in detail in Hubscher et al., 2002.  
 
In addition to the DNA polymerase, a plethora of other proteins are required for the 
functioning of an effective replication factory. This is not just due to the importance 
of the procedure, but also a result of the format in which cellular DNA exists. A 
single strand of DNA has directionality, and the double helix is formed by the 
annealing of a second DNA strand with a complementary monomeric sequence of 
opposite polarity. That is a 5’ to 3’ single strand of DNA anneals to single-stranded 
DNA (ssDNA) that is complementary in a 3’ to 5’ direction. However, a daughter 
strand of DNA can only be polymerised in one direction. This has led to the semi-
discontinuous model of DNA replication, which is shown in Figure 1.2. Here, one 
strand, known as the leading strand, is synthesised continuously. However, for the 
strand that runs in the opposite direction, the lagging strand, new DNA must be 
synthesised in discrete segments. The daughter DNA segments, known as 
Okazaki fragments, are then joined up later. 
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Another important aspect of DNA replication is the inability of the DNA polymerase 
to synthesise DNA de novo. That is, when provided with naked, ssDNA and 
monomers for the production of a complementary strand, the DNA polymerase is 
unable to produce double-stranded DNA (dsDNA). The DNA polymerase can only 
extend a 3’ end – in other words, the polymerase requires a primer to get started. 
In leading strand synthesis, only one primer is needed, but lagging strand 
synthesis requires multiple priming events. To do this, the cell employs an RNA 
polymerase called a primase, which is capable of synthesising de novo. The DNA 
polymerase extends the RNA primers with DNA, and later the short stretches of 
RNA are replaced with DNA. 
 
Other core components of the replication factory include proteins for: separating 
the double helix (helicase), preventing reformation of the double helix and 
protecting the single strands (replication protein A, RPA), tethering the DNA 
polymerase to its template (clamp), loading the clamp (clamp loader), and ligating 
the Okazaki fragments (ligase). The positions of some of these core proteins are 
shown in Figure 1.3. For simplicity, the figure is based on replication in the 
eubacterium Escherichia coli and is adapted from Langston and O'Donnell, 2006, 
but as explained in the accompanying review, the model is equally relevant to 
eukaryotic DNA replication. The core components of the replication factory are 
reviewed in Johnson and O'Donnell, 2005. In addition to these key proteins, each 
are associated with a variety of other proteinaceous cofactors that aid and direct 
their function and assembly in the replication factory. Furthermore, when the 
replication machinery encounters problems, for example a damaged template that 
the DNA polymerase does not recognise, other important proteins associate with 
the factory to resolve the issue. Therefore, the replication factory is a complex and 
dynamic machine. 
 
There are two fundamental characteristics of DNA replication: fidelity and speed. 
Firstly, the DNA polymerase itself has evolved to be highly accurate – the active 
site of the DNA polymerase is very stringent. Only when a template monomer fits 
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perfectly is a complementary monomer inserted into the nascent, daughter strand. 
Factors most relevant to DNA replication fidelity are reviewed in Kunkel, 2004. 
Secondly, the DNA polymerase associates tightly with the doughnut-shaped sliding 
clamp protein to confer high speed replication. Prior to DNA polymerisation, a 
clamp loader cofactor loads the sliding clamp onto the ssDNA such that the strand 
passes through the hole in the centre of the doughnut. Binding of the polymerase 
to this sliding clamp confers high processivity to the polymerase – it dissociates 
from its template with low frequency due to mechanical association. 
 
This sliding clamp is conserved across all three domains of life, which implies 
fundamental importance to cells. In E. coli it is known as the β-clamp, and in 
archaea and eukaryotes, it is known as proliferating cell nuclear antigen, now 
subsequently referred to as PCNA. Eukaryotic PCNA is the subject of this thesis 
and so will be discussed extensively later in this introduction and in subsequent 
chapters. To further introduce and justify this study, the relevance of PCNA to 
genome integrity and research interest will be outlined in the following sections. 
 
1.4.  DNA Damage 
 
A fundamental factor in cell survival is its ability to withstand and repair insult to the 
genetic information. DNA damage is chronic, inevitable and extensive. Not only 
does DNA damage disrupt DNA replication, but persisting damage can result in 
DNA mutation, that is, a heritable change to the genetic information. Accumulation 
of mutations in the genome results in carcinogenesis and ageing (reviewed in 
Hoeijmakers, 2001b). 
 
DNA damage results from both exogenous and endogenous sources (for example, 
see Hillis, 1996, Lindahl, 1993; Halliwell and Aruoma, 1991). Deliberate or 
accidental exposure to chemicals, such as those found in smoke, chemotherapy 
drugs, and plant toxins, causes DNA damage. Radiation, particularly ultra-violet 
(UV) light and ionising radiation from radon in rocks, x-rays, radioactive decay, 
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cosmic rays and γ sources, induce reactions within DNA resulting in lesions. Free 
radicals, such as reactive oxygen species that result from normal intracellular 
metabolism, are also able to react with DNA. Furthermore, DNA replication is not 
100% accurate, hence replication errors are also an important endogenous source 
of mutation. Moreover, in the manipulation of their hosts, viral infection can cause 
DNA damage. Typical sources, effects and consequences of different types of 
DNA damage are summarised in Figure 1.4. 
 
The type and extent of damage caused depends on the source, its intensity and 
the format in which the DNA exists at the time. For example, benzo[a]pyrene, a 
bulky chemical constituent of cigarette smoke, typically reacts with the base 
component of a DNA monomer, whereas bifunctional chemicals may induce the 
formation of a covalent bond between two different DNA strands – known as an 
interstrand crosslink.  
 
1.5.  Cellular Responses to DNA Damage 
 
As alluded to in Figure 1.4, a plethora of responses to genetic insult have evolved 
in cells, which fall into two main categories – manipulation of the cell cycle and 
processing of the damage. The latter includes damage repair processes (reviewed 
in Friedberg, 2003; Lindahl and Wood, 1999; Hoeijmakers, 2001a; Friedberg et al., 
2004). Repair is carried out by simple, direct reversal of the lesion, or by excising 
the damage and filling in the gap. Which bonds are broken, and the means by 
which the correct bonds are formed, i.e. the pathway utilised, is dependent upon 
the type of lesion, where it occurs and its extent, along with temporal factors, such 
as when during the cell cycle the damage occurs and when it is detected. For 
example, sometimes only the damaged portion is removed and replaced, such as 
in a pathway called base excision repair, alternatively the lesion plus surrounding 
undamaged regions will also be removed and replaced, such as in nucleotide 
excision repair. Furthermore, there are differences in how healthy DNA is restored. 
When only one strand is affected, the opposite, undamaged strand can be used as 
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a template to fill in the missing information. However, when both strands are locally 
affected, the sister chromatid or homologous chromosome may be utilised if there 
is one available at the time. This decision is important as it may result in loss of 
heterozygosity, which may have lethal consequences in the longer term.  
 
Therefore, the choice of pathway utilised for the type of damage, where it occurs, 
and when is critical for the cell. Some pathways carry high risks, which may 
outweigh the benefits if used at the wrong cell cycle phase. Furthermore, some 
repair processes are simple and quick, and others are complex and lengthy. A 
focus of this study is a type of DNA damage tolerance pathway wherein the 
lesions, typically those that have occurred during S-phase, are directed down a 
pathway that provides a quick fix that is less disruptive to DNA replication. The 
tolerated damage can then be repaired more thoroughly once replication is 
complete. Before DNA damage tolerance is discussed more extensively, 
exemplary DNA repair mechanisms will be outlined. 
 
1.6.  Excision Repair 
 
Base excision and nucleotide excision repair, commonly known as BER and NER 
respectively, involve breaking the sugar-phosphate backbone of the DNA, 
removing the damaged section and then filling in the gap (reviewed in Friedberg et 
al., 2006; Sancar, 1996). In short patch mode, the former involves the extraction of 
a single, damaged base via the cleavage of the glycosidic bond between the sugar 
and base moieties. This process is catalysed by a glycosylase (reviewed in 
Friedberg et al., 2006; Seeberg et al., 1995). The resultant abasic site is then 
recognised by an endonuclease, which hydrolyses the sugar-phosphate backbone 
leaving what is referred to as a single-strand DNA break (SSB). This type of lesion 
is subsequently bound by DNA polymerase β (Polβ), which is capable of inserting 
the correct nucleotide across the gap and removing the 5’-terminal deoxyribose. 
Long patch BER occurs when Polβ-dependent activity alone is insufficient, so a 
variety of other enzymes are recruited to extend the gap, whereupon Polδ, Polε or 
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Polβ are utilised to polymerise across the gap using undamaged monomers, all in 
a PCNA-dependent manner (reviewed in Almeida and Sobol, 2007).  
 
NER is typically employed when the secondary structure of the double helix is 
distorted as a result of the lesion – a stretch of around 25 to 35 nucleotides is 
typically excised (reviewed in Friedberg, 2001; Wood, 1997; Costa et al., 2003; 
Mitchell et al., 2003). This process involves a cascade where different proteins 
detect the damage, and then recruit other proteins to instigate unwinding, excision, 
and removal of the damaged section, polymerisation of replacement, healthy DNA, 
and ligation to the sugar-phosphate backbone. This process is summarised in 
Figure 1.5, which is taken from Friedberg, 2001. 
 
NER has been particularly well characterised due to the existence of the condition 
xeroderma pigmentosum, which results when any one of the 7 proteins 
fundamental to NER, XPA to XPG, are mutant. XP patients have been found to 
demonstrate a markedly increased likelihood of developing sunlight-induced skin 
cancer. It can be concluded, therefore, that NER is very important in the repair of 
DNA damage caused by UV. The molecular mechanism of NER is classified into 
two pathways: transcription-coupled repair (TCR) and global genome repair 
(GGR). The former, as its name suggests, is linked to transcription and has been 
found to rapidly repair damage on the transcribed strand of active genes. Hence, it 
can be concluded that TCR acts to help prevent DNA damage from disrupting the 
action of RNA polymerases (reviewed in van Hoffen et al., 2003). GGR seems to 
have a more general role in the cell by acting on lesions that occur in non-specific 
locations in the genome. Later in this study, an eighth classification of XP, known 
as XP variant (XP-V), which is not linked to NER, will be discussed. 
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1.7.  Homologous Recombination 
 
Non-homologous end joining (NHEJ) and homologous recombination (HR) are two 
processes well characterised for their involvement in repairing double strand 
breaks (DSBs), and are commonly known as DSB repair (DSBR) pathways 
(reviewed in Friedberg et al., 2006; Karran, 2000; Pastink et al., 2001). DSBs can 
arise as a result of exposure to ionising radiation, specific chemicals, and blocked 
replication forks. NHEJ is generally thought to be the more prevalent DSBR 
pathway in mammalian cells and involves the direct ligation of the two pairs of 
ends. This pathway is reviewed in Barnes, 2001 and Doherty and Jackson, 2001, 
but will not be discussed further in this study. 
 
HR is an error-free mechanism of repair that requires a sister chromatid or 
homologous chromosome for use as a template. HR has been reviewed frequently 
(Liu and West, 2004, San Filippo et al., 2008; West, 2003; and Symington, 2002) 
and repair of DSB by HR is summarised in Figure 1.6. Upon detection of a DSB, 
nucleases perform a resection resulting in ssDNA overhangs. RAD51 has high 
affinity for ssDNA, and if RAD51 coats the ssDNA in this scenario (to form a 
RAD51 nucleoprotein filament) then it is able to induce strand invasion into 
complementary dsDNA. For this reason, HR activity cannot occur when a sister 
chromatid or homologous chromosome is absent, for example during S-phase, 
mitosis or G1 in haploid cells. How the RAD51 nucleoprotein filament is able to 
detect complementary DNA is not well understood. However, RAD52, which is not 
mentioned in Figure 1.6, has been found to be important for both nucleoprotein 
filament assembly and strand invasion (West, 2003), although this is a contentious 
point in the research community. The effect of strand invasion is that the DNA 
replication machinery is able to utilise the hydrogen-bonded complementary strand 
of the template to direct dNTP insertion and hence synthesise healthy DNA across 
the break. As Figure 1.6 depicts, there are many possible routes for the pathway to 
take depending upon which protein sets bind the DSB.  
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An important intermediate is a cruciform structure known as a Holliday junction, 
named after Robin Holliday who proposed a model in 1964, following work with 
smut fungi and budding yeast, to show how linked genes on the same 
chromosome could segregate away from each other (Liu and West, 2004; Stahl, 
1994). Due to the intertwined nature of the DNA strands, it is only possible to exit 
from a Holliday junction by nucleolytic cleavage of the DNA, untangling of two 
complementary pairs of dsDNA and resealing of the nicks. In the classical 
pathway, disassembly of the Holliday junction is known as resolution, and is 
typically catalysed by a resolvase protein, the paradigm of which is E. coli RuvC. In 
Figure 1.6, MUS81 is an example of a eukaryotic resolvase (reviewed in Whitby, 
2004; Heyer, 2004). The Holliday junction can also be branch migrated – ‘slid’ 
along to a different portion of the genome. RecQ-superfamily helicases, for 
example mammalian BLM, which is mutant in Bloom’s syndrome, have been 
ascribed such a role. In double Holliday junction dissolution, BLM is thought to 
branch migrate two Holliday junctions such that they become in close proximity. A 
topoisomerase enzyme, which functions to cleave DNA such to reduce torsional 
stress due to supercoiling of the helix, topoisomerase III in this case, can then 
cleave and hence dissolve the Holliday junctions.  
 
The orientation of resolution cleavage can result in what is referred to as either a 
‘crossover’ or a ‘non-crossover’ product. In the latter case, the damaged DNA is 
repaired and the two original pairs of dsDNA are restored after cleavage and 
separation. However, in the former situation, the pairs of dsDNA are hybrids of the 
original pairs. Using Figure 1.6 as an example, when a crossover has occurred, 
each new pair of dsDNA is half red and half blue. Crossovers, as you might expect 
from swapping one end of a homologous chromosome with the end of its partner, 
can have devastating consequences for the cell. Hence, crossovers are associated 
with gross chromosomal rearrangements and genome instability. Loss of 
heterozygosity (LOH) occurs when a cell, already deficient in one normal copy of a 
gene, is deprived of the second normal copy. LOH is closely associated with 
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oncogenesis. Therefore, crossovers are not normally associated with 
untransformed somatic cells. 
 
Important links between HR and breast cancer have been made. The genes 
encoding two tumour suppressor proteins, breast cancer 1 (BRCA1) and breast 
cancer 2 (BRCA2), have been found to be mutant in many familial breast and 
ovarian tumours. Cells from these tumours show genome instability – that is, large-
scale rearrangements of their chromosomes and evidence of truncated 
chromosomes. BRCA2, a huge protein of 3418 residues – a fact that has severely 
impaired research into this protein, binds RAD51 and mediates the loading of 
RAD51 onto RPA-coated ssDNA (reviewed in San Filippo et al., 2008). BRCA1, 
which is also a large protein, but approximately half the length of BRCA2, is an 
ubiquitin-protein ligase enzyme and will be discussed in the subsequent section on 
Fanconi anaemia. 
 
The recombinational pathways synthesis-dependent strand annealing (SDSA), 
which is also mentioned in Figure 1.6, and break-induced replication (BIR), are 
reviewed in Haber et al., 2004. HR has also been found to be employed in a wide 
variety of scenarios other than following a DSB, for example, SSBs and stalled 
replication forks can be repaired by recombination. A pathway for repair at a stalled 
replication fork is shown in Figure 1.7, which is adapted from Oakley and Hickson, 
2002. In this model, the replication machinery encounters localised DNA damage 
on the leading strand template, which, if the helicase is not blocked by the lesion, 
causes leading and lagging strand replication to become uncoupled – lagging 
strand synthesis can continue. This uncoupling is thought to induce fork regression 
and formation of a ‘chicken foot’ structure. The motor proteins that effect this 
regression are not known in eukaryotes, but a helicase called RecG has been 
identified in E. coli as a likely candidate (McGlynn and Lloyd, 2002a). This 
pathway, as shown in Figure 1.7, is thought to be RAD51-independent as no 
strand invasion or homology search is required. Also, it is an example of DNA 
damage tolerance, as the lesion has not been removed – it has been bypassed. 
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The replication fork has been prevented from collapsing and the lesion can be 
removed later, by NER for example. However, the chicken foot is thought to be 
pathological in yeast and an intermediate that may simply be a consequence of 
fork blockage (discussed in Atkinson and McGlynn, 2009).  
 
Also, the ssDNA ahead of the lesion due to continuation of lagging strand 
synthesis, can be a target for RAD51 and processed by more classical HR 
pathways. Alternatively, the ssDNA can act as a substrate for nucleases, resulting 
in a SSB or asymmetric DSB, which can also be processed by HR, for example by 
BIR. Li and Heyer, 2008, Atkinson and McGlynn, 2009, and McGlynn and Lloyd, 
2002b are reviews of the pathways thought to be important for restarting stalled or 
broken replication forks. 
 
1.8.  Fanconi’s Anaemia 
 
The condition Fanconi’s anaemia (FA) is associated with a deficiency in a cellular 
pathway that repairs DNA crosslinks (reviewed in Jacquemont and Taniguchi, 
2007). Crosslinks may occur between different strands of DNA, inter-strand 
crosslinks, or when a covalent bond is formed between different atoms from the 
same strand, an intra-strand crosslink. As you would expect, this damage blocks 
DNA replication and anaphase. Common crosslinking agents include cisplatin, 
mitomycin C and nitrogen mustards, and unsurprisingly, FA cells are 
hypersensitive to these agents. There are 13 genetic complementation groups 
associated with FA, known as FA-A, -B, -C, -D1, -D2, -E, -F, -G, -I, -J, -L, -M, and -
N. The protein products of eight of the responsible genes, FANCA, FANCB, 
FANCC, FANCE, FANCF, FANCG, FANCL and FANCM, are required to form a 
core complex with the capability of catalysing the ligation of the small modifying 
protein known as ubiquitin onto substrates. Enzymes with this catalytic activity are 
known as ubiquitin-protein ligases, or more commonly, E3s. Ubiquitin and E3s will 
be discussed more extensively below. FANCL is a RING finger protein and in 
collaboration with the FA core complex, modifies FANCD2 with one ubiquitin, 
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which causes it, with further aid from the core complex, to localise into nuclear foci 
with other DNA repair proteins – particularly those also involved in HR, for example 
BRCA1 and BRCA2 (which turned out to be the same gene as FANCD1). It is 
thought that the result of this cascade is RAD51-mediated DNA repair by HR. The 
gene linked to the FA-I complementation group was the most recent to be 
discovered (Dorsman et al., 2007) and also in 2007, the FANCI protein was 
identified and found to be a FANCD2 paralogue (Smogorzewska et al., 2007). In 
the latter study, the authors concluded that FANCI and FANCD2 form a complex, 
which is necessary for FANCD2 to become localised into damage-induced foci. 
Furthermore, FANCI is also mono-ubiquitinated, and this is dependent upon the 
presence of FANCA and an intact ubiquitination site on FANCD2. Interestingly, 
phosphorylation of FANCD2 and FANCI are also important precedents for the 
ubiquitination of these proteins, and this appears to be carried out by kinases 
involved in damage response signalling. Mono-ubiquitination of FA pathway 
proteins has been recently reviewed (Alpi and Patel, 2009). 
 
1.9.  p53 
 
A transcription factor called p53 is a central integration point for detection of DNA 
damage (reviewed in Riley et al., 2008). A variety of signalling pathways exist to 
detect and co-ordinate responses to DNA damage. Ataxia telangiectasia mutated 
(ATM), ATM and Rad3-related (ATR), DNA-dependent protein kinase (DNA-PK), 
checkpoint 1 (CHK1) and checkpoint 2 (CHK2) are all kinases activated by DNA 
damage. For example, ssDNA, such as that resultant from NER or from replication 
fork stall at a lesion, is thought to activate ATR, whereas DNA-PK and ATM are 
particularly important in the alerting the cell to DSBs. Prompted by this damage, 
these kinases phosphorylate p53 directly and indirectly, which initiates other types 
of modification of p53, such as methylation and acetylation. This results in p53 
stabilisation that allows binding to specific p53-responsive DNA response elements 
that control the expression of genes that control tumour suppression. The 
downstream effect of p53 stabilisation is the arrest of the proliferation of aberrant 
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cells by induction of senescence or programmed cell death. This pathway is 
summarised in Figure 1.8.  
 
The p53 protein, which is sometimes referred to as TP53, is encoded by a gene 
also called p53. In modulating the expression of particular genes important in 
preventing cancer, the p53 protein acts as a tumour suppressor (reviewed in Riley 
et al., 2008). In fact, p53 is commonly known as the “guardian of the genome”, due 
to the fact that its function has been abrogated in all known cancers, either due to 
mutation of p53, or via bypass of the p53 pathway altogether. An entire family of 
p53-like genes also exists, of which p63 and p73 are members (reviewed in 
Bourdon, 2007). Furthermore, p53 family genes each encode multiple different 
protein isoforms – the p53 gene encodes nine different isoforms. Moreover, p53 is 
mutant in Li-Fraumeni syndrome, which results in a dramatically increased risk of a 
wide variety of malignancies, which often strike at an early age. p53 also binds 
PCNA (Moldovan et al., 2007). 
 
1.10. The Importance of Understanding the DNA Damage 
Response: Carcinogenesis and Ageing 
 
As alluded to already, deficiencies in responses to DNA damage correlate with an 
increase in carcinogenesis and premature ageing. Hence, the study of DNA repair 
processes can be justified in many ways, which will be explained here in no 
particular order. Whilst the number of patients with inherited deficiencies in DNA 
repair pathways is relatively small, the exciting promise of gene therapy cures for 
these patients warrants research into the functional significance of their deficiency 
at the molecular level and the impact genetic intervention would play in this 
context. Secondly, cancer is an age-related condition – the repeated exposure to 
carcinogens over time causes and affects carcinogenesis. There are many steps 
that lead to a carcinogenic cell and the majority of these steps can result from 
unrepaired damage. It is important to understand this transformation in order to 
prevent cancer in the healthy population. Thirdly, recent evidence suggests that 
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reactions to DNA damage and ageing are inextricably linked – replication stress is 
thought to promote ageing (see, for example, Burhans and Weinberger, 2007), and 
of course there is massive public interest in delaying this. Finally, the DNA of 
cancer cells can be specifically targeted with DNA damaging agents, such as in 
chemotherapy. Whilst the vast majority of cells in the human body are in 
senescence, transformed cells are growing and dividing actively. This fact has 
been utilised for decades in order to kill malignant cells during the treatment of 
cancer patients. DNA repair pathways have been successfully used as targets for 
cancer therapy (reviewed in Helleday et al., 2008). 
 
The fundamentals of DNA damage and cellular responses have now been outlined 
from basic principles. Furthermore, the importance of research into damage 
tolerance and repair has been emphasised. Now, a more detailed introduction to 
the biochemistry of post-replication repair and deubiquitinating enzymes will follow. 
 
1.11.  An Introduction to Post-Replication Repair 
 
Post-replication repair (PRR) relates to processes that enable DNA damage to be 
tolerated by cells. UV irradiation of DNA typically induces adjacent DNA bases to 
react with each other. The principal, resulting chemical products when two 
pyrimidine bases are involved are cyclobutane pyrimidine dimers (CPDs) or, less 
commonly, a 6-4 photoproduct (6-4PP). It was found that when DNA containing 
these lesions is replicated, gaps form in the daughter strand opposite each lesion 
(Rupp and Howard-Flanders, 1968; Lehmann, 1972). From experiments in E. coli, 
it was hypothesised that a “post-replication repair” mechanism, that is, repair 
occurring after the replication fork has moved on, was responsible for the filling of 
these gaps i.e. the conversion from low molecular weight DNA (with gaps) to high 
molecular weight DNA (gaps filled; see Rupp and Howard-Flanders, 1968, which is 
reviewed in Bridges, 2005). It was also demonstrated in E. coli that PRR involved a 
HR mechanism between daughter DNA strands to restore the high-molecular 
weight DNA (Rupp and Howard-Flanders, 1968). In mammalian cells however, it 
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was also shown that the gaps opposite the CPDs are filled in by newly synthesised 
DNA, as opposed to DNA obtained from elsewhere such as occurs in HR 
(Lehmann, 1972). Interestingly, it was later discovered that dimer-free DNA is not 
likely to result from this gap-filling mechanism (Ganesan, 1974).  
 
1.12.  Xeroderma Pigmentosum Variant 
 
XP is a rare autosomal recessive disease and its name refers to the mottled, dry 
skin characteristic of XP patients. For a review see Gratchev et al., 2003. It is a 
very rare disease – an incidence of 2.3 cases per million live births in Western 
Europe has been calculated (Kleijer et al., 2008), and a higher frequency has been 
reported in Japan (Takebe et al., 1987). XP patients have a 2000-fold higher risk of 
developing skin cancer than the normal population (Kraemer et al., 1987). Other 
phenotypes include photophobia and other ocular pathologies, immunological skin 
abnormalities, premature ageing, neurological problems and premature death.  
 
In the early 1970s, patients were identified with XP symptoms but no defect in 
unscheduled DNA synthesis (UDS), which measures the amount 3H-thymidine 
incorporation in non-S-phase cells and correlates with the level of DNA repair by 
NER. This new form of XP was designated xeroderma pigmentosum variant, XP-V, 
and one fifth of XP patients fall into this category (Gratchev et al., 2003). However, 
it was not until 1999 that DNA polymerase η (Polη), the protein encoded by the 
gene that is mutant in XP-V, was finally identified (Masutani et al., 1999). 
 
In a seminal paper in 1975, it was found that subsequent to the UV-irradiation of 
XP-V cells, “the time taken for the newly synthesised DNA to attain a high 
molecular weight similar to that in unirradiated controls is much longer than in 
normal cells” (Lehmann et al., 1975). Hence it was concluded that XP-V cells are 
deficient in PRR and therefore this pathway is fundamentally important in the 
prevention of UV-induced carcinogenesis. 
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The current model for PRR is thus: lesions can be dealt with via two distinct 
pathways, a principally error-prone mechanism known as translesion synthesis 
(TLS), which can be error-free and error-prone, and an error-free mechanism 
referred to as a “template switch”.  
 
1.13.  DNA Polymerases and Translesion Synthesis 
 
Polη functions in the former pathway and is known as a specialised polymerase. 
Specialised polymerases are reviewed in Friedberg et al., 2002; Goodman, 2002; 
Prakash et al., 2005, and are named as such because they perform different, 
specialised functions compared to the high-fidelity replicative polymerases, such as 
DNA polymerases α (Polα), δ (Polδ), and ε (Polε) found in eukaryotes. There are 
nine specialised polymerases in human cells: DNA polymerases β, ζ, κ, η, ι, λ, µ, θ, 
and Rev1 (Friedberg et al., 2002). DNA polymerases can also be classified into 
seven distinct families, A, B, C, D, X, Y, and RT, based on sequence homology. 
The specialised polymerases Polη, Polι, Polκ and Rev1 are members of the Y-
family of DNA polymerases. There are six sub-classifications of Y-family 
polymerases (Ohmori et al., 2001). The UmuC Gram-positive and UmuC Gram-
negative groups relate to bacterial Y-family polymerases. The Rad30A group 
comprises Polη; the Rad30B group, Polι; the Rev1 group, Rev1; and the DinB 
group, Polκ. DNA polymerase ζ consists of a heterodimer comprising a B-family 
polymerase subunit, Rev3, and a cofactor protein called Rev7. The B-family also 
comprises Polα, Polδ and Polε, so as expected Rev3 has a greater fidelity than Y-
family polymerases, however it is missing the proofreading exonuclease domain 
found in these aforementioned replicative polymerases.  
 
Polη, Polι, Rev1, Polκ and Polζ have all been found to function in TLS. These Y-
family polymerases are characterised in that they comprise a more open active 
site, which can accommodate a damaged base. This structure has two important 
consequences, (1) these polymerases are able to bypass sites of DNA damage 
where a normal, replicative polymerase would stall, and (2) they have low-fidelity. 
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The TLS pathway is referred to as error-prone due to the latter. In the TLS model, 
the replicative polymerase encounters a damaged base and stalls, there is a 
“polymerase switch” to a TLS polymerase, which tries to bypass the damage, and 
then a switch back to the highly processive and accurate replicative polymerase 
occurs. However, Polη is actually very effective at inserting two consecutive 
adenine nucleotides, -A-A-, in the daughter strand opposite a -T-T- CPD, hence 
effectively bypassing this lesion (Johnson et al., 1999). For this reason, Polη-
mediated TLS is often referred to as an error-free sub-pathway of TLS. 
 
Recent research effort has tried to differentiate the functions of the different 
specialised polymerases (Lehmann, 2006) and how the polymerase switch occurs 
(Fischhaber and Friedberg, 2005). Rev1 is able to insert a dCTP, i.e. a “-C-“,  
opposite a template “-G-“ or abasic site. Rev1 has been found to interact with Polη, 
Polι, Polκ, and Rev7, and has been proposed to have a role in gap-filling during 
G2-M in S. cerevisiae (Waters and Walker, 2006) and to recruit Polζ to stalled 
replication forks and DSBs (reviewed in Kolas and Durocher, 2006). Furthermore, 
Polκ cannot carry out TLS past UV-induced dimers in vitro and has been found to 
function in NER (Ogi and Lehmann, 2006).  
 
1.14.  The Template Switch Mechanism 
 
Very little is known about the template switch sub-pathway of PRR, however 
epistasis analysis in S. cerevisiae has revealed that it is error-free (Prakash, 1981; 
Xiao et al., 2000). A template switch mechanism was actually first suggested in 
1976 (Higgins et al., 1976). The authors proposed that a chicken-foot structure 
could be formed in order to bypass damage encountered by replication forks 
(Figure 1.7), hence this was a “replication repair” mechanism rather than a post-
replication repair mechanism. However, recent evidence using electron microscopy 
with S. cerevisiae suggests that these four-way structures are rare in vivo (Lopes 
et al., 2006). Alternatively, HR machinery may be used in PRR gap-filling after the 
fork has moved on following its stall and reinitiation (reviewed in Friedberg, 2005). 
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Key work in E. coli has led to a plausible hypothesis for the reinitiation of replication 
on the leading strand beyond a blocked fork (Heller and Marians, 2006), the prior 
deficiency of such a model has always inhibited research progress in this area. In 
this model, the replicative helicase recruits multiple primase proteins to reprime 
both the leading and lagging strands. 
 
Taken together, there appears to be a role for PRR proteins to carry out TLS 
and/or recruit HR machinery in order to repair stalled replication forks, as well as in 
a truly post-replicative sense i.e. gap filling (Friedberg, 2005). In the latter mode, it 
is thought that the cell first tries to gap-fill using TLS, whereas persistent gaps are 
filled by a HR mechanism (discussed in Lehmann and Fuchs, 2006). 
 
Whilst the general principles of PRR are conserved in all three domains of life: 
archaea, eubacteria, and eukaryotes, differences exist between domains, and 
within domains. For example, DinB is absent from S. cerevisiae but found in other 
yeasts and Rad30B group polymerases are only found in higher eukaryotes. 
 
The modification of PCNA has been shown to be fundamental for PRR. Modulation 
of the biochemistry of the binding surfaces of PCNA, in particular by covalent 
modifications in eukaryotes, has been shown to be pivotal in PRR pathway 
decisions. The functions and binding partners of PCNA will now be discussed in 
greater detail. 
 
1.15.  PCNA: Functions and Binding Partners 
 
PCNA is the doughnut-shaped sliding clamp that encircles DNA and confers high-
processivity to bound DNA polymerases. Said sliding clamp in eukaryotes is 
actually a homotrimer of PCNA subunits that form a ring, which is loaded onto DNA 
in eukaryotes by the clamp-loader replication factor C (RFC). As previously 
discussed, PCNA is fundamentally important for ensuring processive DNA 
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synthesis, either during DNA replication or during many of the repair events that 
require polymerase activity.  
 
However, PCNA binds a variety of proteins other than polymerases and has been 
proposed to function as a sliding “toolbelt” that provides a binding platform for 
proteins requiring access to DNA (reviewed in Warbrick, 2000, Maga and 
Huebscher, 2003). The functions and binding partners of PCNA have been 
particularly eloquently reviewed in detail in Moldovan et al., 2007. For example, 
PCNA binds chromatin licensing and DNA replication factor 1 (Cdt1), which is 
important for correct replication origin firing (reviewed in Green, 2006). The wide 
variety of processes that PCNA is involved in is best illustrated by the variety of 
proteins that PCNA binds to: topoisomerases, endonucleases, DNA ligases, 
helicases, mismatch repair enzymes, BER enzymes, NER enzymes, histone and 
chromatin remodelers, poly-(ADP-ribose) polymerase (PARP), DNA 
methyltransferases, protein kinases e.g. CDK2, cell cycle regulators e.g. cyclin D1 
and p21CIP, sister-chromatid cohesion proteins, apoptotic factors, plus a variety of 
enzymes involved in post-replication repair and modification of proteins with 
ubiquitin and SUMO that will be discussed in the second half of this chapter 
(Moldovan et al., 2007). 
 
Known PCNA binding proteins contain a PCNA-interacting protein motif or PIP box. 
At the primary sequence level, this loosely comprises KAxQxxψxxθθ, wherein x is 
any residue, ψ is L, M or I, and θ is F or Y (Xu et al., 2001). The motif must also be 
found within an unstructured area of the PCNA-interacting protein in order to be a 
bona fide PIP box (Shell et al., 2007). For the PIP box sequences of a wide variety 
of PCNA interacting proteins, see supplementary figure S1 of Moldovan et al., 
2007. 
 
Each PCNA subunit comprises two globular domains connected by what is 
normally referred to as an interdomain connecting loop. Structure ‘A’ in Figure 1.9 
was solved in Gulbis et al., 1996, and here shows each subunit in a different 
 48 
colour. The structure is angled such that the division between the two domains can 
be clearly distinguished in the light purple subunit. The interdomain connecting 
loop is the unstructured portion on the outer surface of each subunit. The inner 
surface of the homotrimer comprises positively charged α-helices that interact with 
DNA. The remainder of each subunit forms β-sheets. The homotrimer has two 
distinct faces. The ‘C’ face (Figure 1.9, D), so-called because this is the side from 
which the C-terminus of each PCNA subunit protrudes, facings towards the 3’ end 
of the DNA i.e. forwards. RFC and the DNA polymerases bind the C face, and so 
PCNA is dragged along behind during DNA replication. 
 
Structural studies have shown that the PIP box of a PCNA interacting protein slots 
into a hydrophobic pocket underneath the interdomain connecting loop of one 
subunit. Only one PIP box can dock into this pocket, so interacting proteins must 
compete for one of the three docking sites on the PCNA homotrimer. 
 
Post-translational modifications of PCNA modulate the binding interfaces – of 
particular relevance to PRR is the modification of lysine residues in PCNA. Each 
human PCNA polypeptide is 261 amino acids long and contains 11 lysine residues. 
PCNA is ubiquitinated on lysine 164 (Figure 1.9, B) and modified with small 
ubiquitin-like modifier (SUMO) on lysine-164 and on lysine-127 (Figure 1.9, C).  
 
In order to further understand the roles of ubiquitination of PRR proteins and the 
functions of deubiquitinating enzymes, the following sections will introduce post-
translation modification of proteins, ubiquitin fold containing proteins and 
ubiquitination. 
 
1.16.  Post-Translational Modification of Proteins by Ubiquitination 
 
Following their synthesis, cellular proteins have been found to be covalently 
modified by a wide variety of modifiers. Proteins can be acetylated, 
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phosphorylated, biotinylated, hydroxylated, palmitoylated, farnesylated, and 
sulfated, to name but a few. Here we will discuss protein ubiquitination. 
 
The Nobel prize for chemistry in 2004 was won by Aaron Ciechanover, Avram 
Hershko, and Irwin Rose for their discovery of ubiquitin-mediated protein 
degradation (reviewed in Ciechanover, 2005 and Wilkinson, 2005). Ubiquitin is a 
small protein of only 76 amino acids that can be covalently attached to target 
proteins. Poly-ubiquitination of target proteins was found to induce their 
degradation, which is carried out by a large proteinaceous peptidase complex 
called the proteasome. In other words, the poly-ubiquitin tag is a death signal for 
the ubiquitinated protein. The ubiquitin-proteasome system is reviewed in 
Hochstrasser, 1996 and Voges et al., 1999. 
 
Post-translational modification of substrate proteins by ubiquitin requires a 
minimum of two enzymes, an E1 (ubiquitin-activating enzyme) and an E2 (ubiquitin 
conjugating enzyme). An E3 (ubiquitin-protein ligase) is also typically utilised. 
Ubiquitin is reversibly, covalently bonded to a target protein by the formation of an 
isopeptide bond between the C-terminal glycine-76 residue of ubiquitin, and the ε-
amino group on the side-chain of a lysine residue on the target. The E1 prepares 
the α-carboxyl group of glycine-76 on ubiquitin in an ATP-dependent step. This 
activation step results in an E1–ubiquitin conjugate. The E2 specifically recognises 
this conjugate, and ubiquitin is transferred to the E2 by transthiolation. The 
ubiquitin can then be transferred from the E2 to the target protein, and this is 
typically catalysed by an E3. E3s exist in two forms, HECT domain E3s become 
covalently bonded to the ubiquitin prior to its transferral to the target, and really 
interesting new gene (RING) finger E3s do not. The latter simply speeds up the 
process. E3s are thought to provide the most target specificity to the ubiquitination 
reaction. Furthermore, another enzyme class exists called the E4s, which are 
thought to be involved in chain elongation. Deubiquitinating enzymes catalyse the 
removal of ubiquitin from modified targets (discussed later). 
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Target proteins may be mono-ubiquitinated, in other words, modified by one 
ubiquitin tag. This single ubiquitin may be extended to form a poly-ubiquitin chain. 
Alternatively, a target may be ubiquitinated on multiple sites, which is known as 
multi-ubiquitination, and this can be multiple single ubiquitin tags or multiple poly-
ubiquitin chains.  
 
To direct a target to the proteasome for degradation, the poly-ubiquitin chain was 
found to be in a specific configuration. Following mono-ubiquitination of a target 
lysine, an ubiquitin chain is formed by bonding a second ubiquitin to a lysine 
residue on the first, followed by a third ubiquitin bonded to a lysine on the second, 
and so on as required. There are seven lysines in ubiquitin, lysine-6, -11, -27, -29, -
33, -48, and -63. These lysines are highlighted in pink in Figure 1.10, which is 
based on a structure solved in Vijay-Kumar et al., 1987. In order to direct the target 
to the proteasome, the mono-ubiquitin is extended with a lysine-48-linked poly-
ubiquitin chain. The position of lysine-48 is also shown in Figure 1.10, and lysine-
48-linked poly-ubiquitin chains form a compact chain. However, a different lysine 
on ubiquitin can be selected and this results in a different chain conformation that 
activates non-degradative pathways. 
 
1.17.  Ubiquitin-like Proteins and Non-Degradative Functions of 
the Ubiquitin Superfold 
 
Ubiquitin has been coined Darwin’s phosphate (Welchman et al., 2005). 
Phosphorylation is a very common type of post-translational modification and 
involves the addition of a single phosphate group onto a target, and quite often the 
target is phosphorylated in multiple places. Attachment with members of the 
ubiquitin system, on the other hand, is a more complex and “evolved” form of 
modification (Welchman et al., 2005). As alluded to already, mono-, multi- and 
poly-ubiquitination can occur. Furthermore, the poly-ubiquitination can occur in 
different configurations depending upon the lysine residue of ubiquitin that the 
chain is extended from, and chains with mixed linkages can occur (reviewed in 
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Ikeda and Dikic, 2008). These non-canonical ubiquitin modifications activate non-
degradative pathways. For example, as described above mono-ubiquitination of 
FANCD2 and FANCI induces colocalisation with DSBR proteins; also AMP-
activated protein kinase-related protein kinases are inhibited by modification with 
lysine-29/lysine-33-linked mixed poly-ubiquitin chains (Al-Hakim et al., 2008). 
 
Additionally, a variety of other ubiquitin-like proteins exist, one of which has been 
found to be involved in PRR. Known ubiquitin-like proteins (UBLs) include: small 
ubiquitin-like modifier (SUMO), ubiquitin cross-reactive protein (UCRP, also known 
as interferon-stimulated gene-15 [ISG15]), ubiquitin-related modifier-1 (URM1), 
neuronal-precursor-cell-expressed developmentally downregulated protein-8 
(NEDD8, but called Rub1 in S. cerevisiae), human leukocyte antigen F associated 
(FAT10), autophagy-8 (ATG8) and -12 (ATG12), Fau ubiquitin-like protein (FUB1), 
MUB (membrane-anchored UBL), ubiquitin fold-modifier-1 (UFM1) and ubiquitin-
like protein-5 (UBL5, which is also known as homologous to ubiquitin-1 [Hub1]). 
UBLs are reviewed in Welchman et al., 2005, Kerscher et al., 2006, and Grabbe 
and Dikic, 2009b. Whilst these proteins share only modest primary sequence 
identity with ubiquitin, they are closely related three-dimensionally. They all 
comprise an ubiquitin fold (often called an ubiquitin-like domain and sometimes an 
ubiquiton fold) – in fact, FAT10 and UCRP contain two. This compact globular β-
grasp fold is found in ubiquitin, UBLs, and proteins that comprise an ubiquitin-like 
domain. For example the S. cerevisiae spindle pole body duplication protein, Dsk2, 
and NER protein, Rad23, both contain N-terminal ubiquitin-like domains 
(Welchman et al., 2005).  
 
There are three SUMO proteins in H. sapiens, SUMO-1, -2, and -3. SUMO-1 is 
also known as Sentrin, suppressor of MIF2 mutations-3 (Smt3) and as Pmt3. A 
comparison of the structure of SUMO-1 and ubiquitin can be found in Figure 1.10 
(the structure of SUMO-1 shown was elucidated in Bayer et al., 1998). Despite 
sharing only 18% sequence identity and being over a third larger, SUMO folds to 
form the β-grasp domain found in ubiquitin. Modification of targets by SUMO is 
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known as sumoylation, which has been found to be important in a wide variety of 
cellular processes (reviewed in Zhao, 2007) such as transcription inhibition, the 
migration of the promyelocytic leukaemia protein (PML) into nuclear bodies, and 
genome stability (reviewed in Watts et al., 2007). SUMO has its own specific set of 
E1, E2 and E3 enzymes, as well as desumoylating enzymes (reviewed in Johnson, 
2004), and poly-SUMO chains can sometimes form (Vertegaal, 2007). 
 
PCNA ubiquitination and sumoylation influence the PRR pathway in a way that is 
independent of proteasomal degradation. 
 
1.18.  Post-Replication Repair in S. cerevisiae 
 
Key aspects of the molecular mechanisms of PRR in eukaryotes were first 
elucidated in the baker’s yeast S. cerevisiae. (For brevity and clarity hereon, 
protein names will be preceded by a two-letter prefix indicating the species from 
which it originates). In S. cerevisiae, ScPCNA was shown to be ubiquitinated in 
response to treatment with the damaging agent methyl methanosulfonate (MMS). 
This reaction was shown to be carried out by the E2 ScRad6 and the E3 ScRad18 
(Maga and Hubscher, 2003). These enzymes were found to catalyse the mono-
ubiquitination of ScPCNA on lysine-164 (Hoege et al., 2002), which is thought to 
activate the TLS branch of PRR.  
 
There are two Y-family polymerases in S. cerevisiae, ScRad30 (Rad30A group), 
ScRev1 (Rev1 group), plus the B-family polymerase, ScRev3 and its partner ScRev7. 
The mechanism for this activation is thought to be thus: upon encountering a 
lesion, PCNA is mono-ubiquitinated, which leads to a switch from the normal, 
replicative DNA polymerase to the TLS DNA polymerase (Friedberg et al., 2005).  
 
Alternatively, the mono-ubiquitination can be extended by a second set of 
enzymes, the ScUbc13-ScMms2 E2 heterodimer and the E3 ScRad5, to create a 
lysine-63-linked poly-ubiquitin chain (Hoege et al., 2002). ScUbc13 confers the E2 
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activity and ScMms2 is a cofactor containing a domain known as an ubiquitin-
enzyme variant (UEV), which is thought to be the product of an E2 pseudogene. 
ScMms2 has a similar structure to ScUbc13, but lacks the catalytic cysteine residue. 
This non-canonical, lysine-63-linked form of chain is thought to activate the 
template switch pathway proposed to use HR machinery to carry out the error-free 
method of lesion bypass. It has also been suggested that the HR proteins, such as 
ScRad51, ScRad52, ScRad54 and ScRad55, are involved (Pfander et al., 2005). 
Furthermore, a lysine-63-linked poly-ubiquitin chain has been found to adopt a 
more extended structure wherein, unlike ubiquitin in lysine-48-linked chains, there 
are no inter-ubiquitin interactions (Varadan et al., 2004, Tenno et al., 2004). Hence 
it is plausible that currently unidentified proteins with ubiquitin-binding domains 
capable of binding lysine-63-linked chains specifically can then recruit HR 
machinery to the stalled fork or gap. 
 
In the aforementioned, seminal paper by the Jentsch group in 2002 it was also 
shown that ScPCNA is sumoylated on lysine-164, and to a lesser extent, lysine-127 
(Hoege et al., 2002, and reviewed in Matunis, 2002). ScPCNA is sumoylated in 
undamaged cells during S-phase and this modification was proposed to antagonise 
PRR by sequestering lysine-164 from ubiquitin modification. A DNA helicase called 
ScSrs2 with 5’ to 3’ polarity that is known to be involved in HR had already been 
implicated in the template switch portion of PRR (Ulrich, 2001). In further papers by 
the Jentsch and Ulrich groups in 2005, ScSrs2 was found to bind SUMO-modified 
ScPCNA (Pfander et al., 2005, Papouli et al., 2005). ScSrs2 was proposed to inhibit 
HR induced by poly-ubiquitination of ScPCNA by disrupting ScRad51 nucleoprotein 
filaments (Veaute et al., 2003, Krejci et al., 2003). Systems where modification of 
the same site by ubiquitin or SUMO that result in different sometimes opposing 
downstream effects are known in the literature (reviewed in Ulrich, 2005). The 
modifications of ScPCNA are summarised in Figure 1.11 (Hoege et al., 2002).  
 
It has also been proposed that lysine-63-linked poly-ubiquitin chains on PCNA may 
simply sequester lysine-164 from activating normal replication or TLS, when in un-
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modified and mono-ubiquitinated form, respectively (Hofmann, 2009). This 
hypothesis primarily comes from (1) the complex domain architecture of ScRad5 
and its homologues in other organisms, and (2) work of the Prakash group in 2007 
who found a role for ScRad5 in replication fork regression (Blastyak et al., 2007). 
ScRad5 comprises a HIRAN (HIP116 Rad5 N-terminal) domain, the seven motifs (I, 
Ia, II, III, IV, V and VI) that make up a classical helicase domain, and a RING finger 
domain in the gap between the last few helicase motifs. The HIRAN domain is 
thought to bind DNA particularly in the context of damage or stalled replication 
forks (Iyer et al., 2006). Therefore, perhaps the lysine-63-linked poly-ubiquitination 
of ScPCNA promoted by the RING finger halts the activation of other pathways, in 
turn allowing ScRad5 to unwind the DNA helix, regress the fork, and generate the 
chicken-foot structure such as that seen in the template switch model shown in 
Figure 1.7. However, the function of the lysine-63-linked poly-ubiquitin as an inert 
chain in this way is merely speculation. 
 
1.19.  Post-Replication Repair in Higher Eukaryotes 
 
The literature reports that PRR occurs in a similar way in higher eukaryotes 
compared to budding yeast (reviewed in Lee and Myung, 2008; Lehmann et al., 
2007; Ulrich, 2009).  
 
Recent research using human cells has provided information about the damage 
that activates PRR. Specific types of DNA damage have been found to cause 
HsPCNA ubiquitination, particularly those that result in replication fork stall (Niimi et 
al., 2008). The hypothesis is that this results in ssDNA, which activates PRR. 
Knockdown with small interfering RNA (siRNA) targeted to the gene encoding 
HsRPA resulted in a reduction in HsPCNA ubiquitination (Niimi et al., 2008) and this 
agrees with evidence from mouse cells (Bi et al., 2006) and S. cerevisiae (Davies 
et al., 2008).  
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There are two E2s, HsRAD6A and HsRAD6B, and one E3, HsRAD18, thought to be 
involved in HsPCNA mono-ubiquitination on lysine-164 in human cells. HsRAD18 is 
495 residues long and contains five distinct binding domains: a RING finger that 
confers the E3 activity, a C2H2 zinc-finger, a SAP (SAF-A/B, Acinus, Pias) domain, 
a HsRAD6-binding domain, and a HsPolη-binding domain. In addition to 
HsPolη, HsRAD18 binds forked and ssDNA, HsRAD6B, ubiquitin and HsRPA, and is 
therefore thought to be a particularly fundamental control point in the activation of 
PRR (Notenboom et al., 2007, Tsuji et al., 2008). Evidence from S. cerevisiae 
corroborates this (Huttner and Ulrich, 2008). The HsPolη–HsRAD18 interaction is 
thought to act as a guide to bring HsPolη to mono-ubiquitinated HsPCNA (Watanabe 
et al., 2004). Moreover, HsRAD18 is capable of auto-ubiquitination, which is 
dependent upon HsRAD6 and is thought to function to control the subcellular 
localisation of HsRAD18 (Miyase et al., 2005). 
 
There are five known TLS polymerases in human cells: HsPolη (RAD30A group), 
HsPolι (RAD30B group), HsPolζ (B-family), HsRev1, and HsPolκ (DinB group). HsPolη, 
HsPolι, HsRev1 and HsPolκ have been shown to bind mono-ubiquitinated HsPCNA 
via novel ubiquitin-binding domains (Kannouche et al., 2004; Watanabe et al., 
2004; Bienko et al., 2005; Plosky et al., 2006; Guo et al., 2009). The accepted 
thinking is that mono-ubiquitination of HsPCNA increases its affinity for Y-family 
polymerases and induces a switch from a replicative to a TLS polymerase. Due to 
the homotrimeric nature of the PCNA doughnut, it is possible that the replicative 
polymerase binds a non-ubiquitinated subunit of HsPCNA, and one or more TLS 
polymerases bind ubiquitinated HsPCNA subunits. Hence, the “sliding toolbelt” 
model of the sliding clamp. A TLS polymerase is employed until the lesion is 
bypassed. It is not known whether or how specific TLS polymerases are selected 
for particular lesions. There is a theory proposed by Errol Friedberg that each TLS 
polymerase has cognate lesion(s), which it is able to bypass more accurately than 
non-cognate types, although this is not accepted in the majority of the research 
community.  
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Recent work clearly shows that HsPCNA mono-ubiquitination persists for some time 
following damage and repair of the damage (Niimi et al., 2008). In this study, a new 
model was proposed wherein each fork-blocking lesion results in an ubiquitinated 
HsPCNA molecule retained at that site. In other words, the replication machinery 
stalls, HsPCNA is mono-ubiquitinated, the replication fork is reloaded beyond the 
lesion using non-ubiquitinated HsPCNA and processive replication continues until 
the next lesion, whereupon the cycle repeats. The TLS machinery loads at each 
mono-ubiquitinated HsPCNA behind the fork to fill in the gaps. 
 
In human cells, recent, prominent work has finally provided substantiation that 
HsPCNA is poly-ubiquitinated, albeit at very low levels compared to yeast. Two 
ScRad5 homologues have now been identified in human cells – HsSHPRH (Motegi 
et al., 2006, Unk et al., 2006) and HsHLTF (Motegi et al., 2008) and there is 
evidence that lysine-63-linked poly-ubiquitination of HsPCNA is linked to the error-
free pathway – particularly due to its dependence upon the presence of HsUBC13 
(Chiu et al., 2006). By domain architecture, HsHLTF demonstrates the most 
similarity to ScRad5 in that it contains also the N-terminal HIRAN domain, and the 
seven helicase motifs with a zinc-finger before the final few C-terminal helicase 
motifs. HsSHPRH on the other hand is more dissimilar in this respect. Immediately 
following helicase motif I lies a linker histone domain, and a PHD-finger domain is 
found just before motif Ia. A PHD-finger is thought be involved in chromatin-
mediated transcriptional regulation processes, and is reminiscent of a RING finger 
(Aasland et al., 1995). A more divergent RING finger domain, compared to ScRad5 
and HsHLTF, is also found at the C-terminus of HsSHPRH. Although, there seems to 
be disagreement in the literature as to whether helicase motif IV comes after (Unk 
et al., 2006) or before (Motegi et al., 2006, Motegi et al., 2008) the RING finger in 
all three proteins. HsSHPRH is also approximately 50% longer than ScRad5 and 
HsHLTF.  
 
There are also findings to suggest that HsMMS2 is not the only UEV protein that 
can be used for poly-ubiquitination of HsPCNA. There are four UEV loci in human 
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cells and there appeared to be little difference in poly-ubiquitination of HsPCNA with 
or without siRNA-mediated depletion of only HsMMS2 (Brun et al., 2008). 
 
No HsPCNA sumoylation has been reported in human cells, although there is 
evidence in chicken cells and Xenopus laevis extracts (Arakawa et al., 2006, 
Goehler et al., 2008). However, the consequence of this modification on PRR has 
not been elucidated in these organisms, and no evidence for helicase involvement 
has been found. Therefore, it is plausible that this PRR antagonisation system is 
limited to S. cerevisiae (Ulrich, 2009). 
 
According to the polymerase switch model, once PRR has occurred, processive 
replication surely must be restored. TLS polymerases have poor fidelity on 
undamaged DNA, low processivity and excessive HR also has dangerous 
consequences for the cell. How such a switch is effected is not known. A potential 
mechanism was proposed in light of evidence that each TLS polymerase 
comprises a novel ubiquitin-binding domain and that the TLS polymerase itself is 
mono-ubiquitinated in undamaged cells (Bienko et al., 2005).  
 
HsPolη comprises one C-terminal ubiquitin-binding zinc finger 3 (UBZ3) domain, 
which is a C2H2 zinc-finger. HsPolκ contains an ubiquitin-binding zinc finger 4 
(UBZ4) domain, which is a C2HC zinc-finger. Interestingly, this domain is also 
found in HsRAD18, and has been postulated to bind to mono-ubiquitinated HsPCNA 
to block the extension to a poly-ubiquitin chain (Hofmann, 2009), thus inhibiting the 
template switch reaction. HsPolι and HsREV1 each contain an ubiquitin-binding 
motif, or UBM domain. These new ubiquitin-binding domains seem to be found in 
proteins with roles in the nucleus, particularly DNA damage responses (reviewed in 
Hofmann, 2009).  
 
The mechanism proposed by Bienko et al. is thus: polymerase mono-ubiquitination 
is thought to induce a conformational change within the polymerase enabling it to 
bind its own covalently attached ubiquitin via its ubiquitin-binding domain. This 
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intra-molecular interaction out-competes the inter-molecular interaction of the TLS 
polymerase with mono-ubiquitinated HsPCNA (Bienko et al., 2005). 
 
However, the obvious model for activation of a switch back to normal replication is 
the deubiquitination of HsPCNA. A deubiquitinating enzyme called HsUSP1 has 
been found to remove the mono-ubiquitination from HsPCNA in human cells (Huang 
et al., 2006). This enzyme will be discussed extensively later in this chapter. 
 
The fission yeast Schizosaccharomyces pombe was utilised as a model organism 
to study potential deubiquitinating enzymes that can act on SpPCNA. Before 
deubiquitinating enzymes and their roles in PRR are discussed in detail, the reason 
why S. pombe was used will be outlined.  
 
1.20. The Utilisation of Schizosaccharomyces pombe as a Model 
Organism 
 
Yeast are unicellular, eukaryotic micro-organisms of the fungi kingdom that can be 
cultured rapidly and easily in the lab. They offer a stripped down model system for 
the understanding of fundamental cellular processes, which can be directly 
applicable to more complicated, higher eukaryotes such as humans. S. pombe was 
the first species of fission yeast discovered, which as their name suggests, 
propagate by linear elongation and binary, medial fission (Sipiczki, 2000). S. 
pombe’s distant relative, S. cerevisiae, has been the yeast of choice due to its use 
for thousands of years in brewing and baking. The combination of popular use with 
the fact that baker’s yeast is generally more easily manipulated in the laboratory, 
has resulted in a more solid foundation of understanding of molecular processes in 
this organism. However, S. pombe is more comparable to humans from certain 
physiological perspectives, such as in the biochemistry of the cell cycle (Nurse, 
2002). S. pombe cells are rod-shaped and much larger than the small, round cells 
of S. cerevisiae. When blocked in cell cycle progression, the cells become 
progressively elongated, which can be recognisable by the naked eye and very 
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easily by light microscope. Upon medial fission, S. pombe produce two daughter 
cells of equal sizes. Baker’s yeast, on the other hand, divide by budding and do not 
demonstrate such an identifiable phenotype when blocked in the cell cycle. Sir 
Paul Nurse won the 2001 Nobel Prize in physiology and medicine, in combination 
with Tim Hunt and Lee Hartwell, for his ground-breaking work on the cell cycle 
using S. pombe. The full genome sequence of S. pombe was published in 2002 by 
the Sanger Institute in Cambridge, UK (Wood et al., 2002). A particularly germane 
advantage is the study of PRR is easier because the ubiquitination of PCNA occurs 
to a greater extent in S. pombe than in S. cerevisiae. Ubiquitinated forms of 
SpPCNA can be detected using anti-SpPCNA antibodies on whole cell extracts from 
fission yeast, rather than perform an α-ScPCNA immunoprecipitation as is 
necessary with baker’s yeast (compare Frampton et al., 2006 with Hoege et al., 
2002). Certainly, information about cellular biochemistry provided by both species 
of yeast provides, in combination, a powerful tool for biomedical research.  
 
1.21.  Post-Replication Repair in S. pombe 
 
In accordance with its distantly related cousin S. cerevisiae, S. pombe PRR utilises 
a similar system using orthologous genes. Lysine-164 of SpPCNA was found to be 
mono-ubiquitinated by SpRhp6 (E2) and SpRhp18 (E3, Frampton et al., 2006), 
where “Rhp” stands for Rad homologue in S. pombe. The proposed template 
switch is effected by lysine-63-linked poly-ubiquitination of SpPCNA by extending 
the mono-ubiquitin on lysine-164 via the SpUbc13-SpMms2 (E2 heterodimer) and 
the E3 SpRad8 (Frampton et al., 2006). There are three Y-family polymerases in S. 
pombe, SpEso1 (Rad30A group of Y family polymerases), SpRev1 (Rev1 group), 
and SpDinB (DinB group), as well as the B-family heterodimer, SpRev3-SpRev7, 
which forms the homologue of HsPolζ. A HsSUMO-1 homologue exists in S. pombe, 
which is known as SpPmt3, SpUbl2 or SpSmt3 (the nomenclature used hereafter: 
SpPmt3Ubl2/Smt3). However, no SpPCNA sumoylation has been detected in S. pombe 
(Frampton et al., 2006) and PRR in fission yeast is little studied.  
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Deubiquitination of PCNA in either budding or fission yeast has not been 
demonstrated. However, as alluded to already, deubiquitination of HsPCNA by 
HsUSP1 has been reported in human cells (Huang et al., 2006). Due to the 
pertinence of this protein to this project, before the work with HsUSP1 is discussed 
deubiquitinating enzymes will be introduced properly first. 
 
1.22.  An Introduction to Deubiquitinating Enzymes 
 
Deubiquitinating enzymes, deubiquitinating peptidases, deubiquitinating 
isopeptidases, deubiquitinases, ubiquitin proteases, ubiquitin hydrolases, ubiquitin-
protein hydrolases, ubiquitin isopeptidases, DUBs, or DUbs, are enzymes able to 
catalyse the removal of ubiquitin from ubiquitinated molecules. A key review of 
these enzymes is that written in 2004 by  Amerik and Hochstrasser (Amerik and 
Hochstrasser, 2004). However, a review of DUbs in the Annual Review of 
Biochemistry has been published this year, which was authored in part by Keith D. 
Wilkinson of the Emory University School of Medicine, Atlanta, USA, who has 
made extensive contributions to the understanding of DUb function in his career 
(Reyes-Turcu et al., 2009). DUbs and their functions have been reviewed: 
Johnston and Burrows, 2006; Rytkonen and Holden, 2007; Lindner, 2007; Wing, 
2003; Song and Rape, 2008; Chung and Baek, 1999; Ha and Kim, 2008; Kim et 
al., 2003; and Nijman et al., 2005b. DUbs function most commonly in either the 
removal of mono-ubiquitin from a modified cellular substrate, or the de-
polymerisation of a poly-ubiquitin chain into a shorter chain and/or individual 
ubiquitin monomers. In general, DUbs hydrolyse the covalent bond between the 
carboxy-terminus of the glycine-76 of an ubiquitin superfold, and the ε-amino group 
of a lysine side-chain on the modified target.  
 
DUbs are predominantly cysteine proteases, where the thiol group of the cysteine 
side chain within the active site performs a nucleophilic attack on the amide (or 
isopeptide) bond (Amerik and Hochstrasser, 2004). However, other known DUbs 
are metalloenzymes that are thought to utilise Zn2+ to activate water into a 
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nucleophilic hydroxyl. DUbs have four main functions in the cell: (1) They process 
inactive ubiquitin precursors as a quality control mechanism. Ubiquitin in most 
organisms is synthesised as fusions to ribosomal proteins, as head-to-tail repeats, 
and with other additional amino acids. Hence, DUbs provide a pool of useable 
ubiquitin. (2) They cleave ubiquitin–protein conjugates by removing ubiquitin from 
proteins inappropriately or mistakenly ubiquitinated. Alternatively the ubiquitination 
was appropriate, and the subsequent deubiquitination changes the binding 
partners of the previously ubiquitinated protein, which has downstream signalling 
effects. Also, a DUb may revert a poly-ubiquitinated protein into a mono-
ubiquitinated version. (3) DUbs maintain a sufficient pool of free ubiquitin in the cell 
by disassembling poly-ubiquitin chains. For example, a poly-ubiquitinated protein 
can be deubiquitinated by breaking the bond between the target protein and the 
first ubiquitin, which results in an unattached polyubiquitin chain. (4) DUbs also 
keep the 26S proteasome free from inhibitory ubiquitin chains. Only 
deubiquitinated and unfolded proteins can be cleaved by the proteasome. The 
proteasome lid subunits have deubiquitinating and unfolding functions (Amerik and 
Hochstrasser, 2004).  
 
1.23.  Superfamilies of Deubiquitinating Enzymes 
 
The proteinaceous fold that confers deubiquitinating activity is thought to have 
evolved in three independent ways: from a papain fold, from a metal-dependent 
deaminase fold, and from a retroviral aspartyl protease fold (Iyer et al., 2004). The 
papain-like domain, which has cysteine protease activity, confers the canonical, 
most highly characterised deubiquitinating activity, and has been highly expanded 
in eukaryotic organisms. DUbs containing DUb activity derived from the metal-
dependent deaminase fold, known as JAMM domain metalloenzymes (defined 
below), are less abundant, but have attained significant interest of late due to their 
important roles as essential proteasome subunits, and in endocytosis. The 
superfamilies of papain-like DUbs and the JAMM domain superfamily will be 
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discussed more extensively below. First, the aspartyl protease fold will be briefly 
discussed for completeness. 
 
A bioinformatical analysis, carried out by the group of Eugene Koonin at the 
National Center for Biotechnology Information, National Institute of Health in 
Bethesda, USA, predicted that a domain derived from retroviral aspartyl proteases 
may confer deubiquitinating activity (Krylov and Koonin, 2001). The protein DNA 
damage-inducible 1 (ScDdi1Vsm1), as its name suggests, was originally found to be 
upregulated in S. cerevisiae in response to genotoxic stress (Liu and Xiao, 1997), 
and has been shown to interact with ubiquitinated Pds1 and inhibit its proteasome-
dependent degradation (Bertolaet et al., 2001). ScPds1 is a checkpoint protein that 
is important for cell cycle arrest following detection of DNA damage during S-phase 
or incorrectly formed spindles during mitosis. Whilst no known orthologues of 
ScPds1 are known, all eukaryotes contain a highly-conserved ScDdi1Vsm1 orthologue 
(Sirkis et al., 2006). ScDdi1Vsm1 contains three domains, an N-terminal weakly 
ubiquitin-like domain, the aspartyl protease domain and a C-terminal ubiquitin-
binding domain known as an ubiquitin-associated domain (UBA). Two human 
orthologues exist, called HsDDI1 and HsDDI2, which do not contain the UBA 
domain, and there is an orthologue in S. pombe called SpMud1, which does not 
contain the N-terminal ubiquitin-like domain. Furthermore, the aspartyl protease 
domain is found in HsNIX1-like proteins, which are only found in mammals – there 
are three of this class in humans, HsNIX1, HsNRIP1 and HsNRIP2. Other proteins 
containing this aspartyl protease domain are found in bacteria and viruses (Krylov 
and Koonin, 2001). Whilst bioinformatics specialists suggest that this domain may 
confer deubiquitinating activity, significant research on ScDdi1Vsm1 and its 
orthologues has been carried out since Eugene Koonin’s prediction in 2001, and 
no studies have reported any bona fide ubiquitin protease function. Whilst the 
crystal structure of the aspartyl protease domain of S. cerevisiae ScDdi1Vsm1 could 
not rule out deubiquitinating activity (Sirkis et al., 2006), a recent study that 
determined the functional importance of the different domains in ScDdi1Vsm1, still 
referred to the protein as a “ubiquitin receptor” (Gabriely et al., 2008). Hence, whilst 
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this class of aspartyl protease may later be shown to possess deubiquitinating 
activity, they will not be discussed further.  
 
The six superfamilies of eukaryotic DUbs known in the literature will be considered 
in this thesis and these superfamilies are summarised in Table 1.1. All 
superfamilies are from the papain-like evolutionary tree, with the exception of the 
JAMM superfamily, which is derived from a metal-dependent deaminase fold. 
 
1.24. Cysteine Protease Superfamilies of Deubiquitinating 
Enzymes 
 
The catalytic triad of a cysteine protease is made up of cysteine, histidine, and 
aspartate side-chains in close three-dimensional proximity. The delocalised 
electrons of the aspartate side-chain polarise the pyrazole ring of a histidine side-
chain. The deprotonated nitrogen atom in the pyrazole ring then accepts a proton 
from the thiol group of the cysteine. In DUbs, the resulting nucleophilic sulfur reacts 
with the amide bond formed between the amino group of the lysine side-chain of 
the target protein and the carboxy-terminus of ubiquitin. The sulfur attacks the 
carbonyl carbon and the electrons of the amide bond are accepted by the 
electrophilic pyrazole of the histidine. At this stage, the target protein is released, 
and the DUb cysteine and ubiquitin carboxy-terminus form an intermediate. The 
intermediate is stabilised by additional residues that hydrogen bond with the 
oxyanion – that is, the oxyanion is stabilised by an oxyanion hole, typically created 
by proteins in glutamine, glutamate, or asparagine residues and the catalytic 
cysteine (Nijman et al., 2005b). Hydrolysis of the DUb—ubiquitin bond by the lone 
pair of the oxygen atom of water restores free DUb and free ubiquitin, hence 
completing the reaction. 
 
USP/UBP superfamily DUbs, the ubiquitin-specific proteases, which is by far the 
largest superfamily, all contain the C19 peptidase domain of clan CA of cysteine-
type peptidases. In general, USP/UBP family DUbs from mammals are most 
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commonly named numerically utilising a USP prefix e.g. USP1, and those from 
yeast almost always use a UBP prefix. USP/UBP DUbs have been found to be 
involved in DNA damage response processes. For example, HsUSP28 has been 
implicated in regulating the levels of p53-binding protein 1 (Hs53BP1), HsClaspin 
and mediator of DNA damage checkpoint 1 (HsMdc1), which are involved in 
transducing the presence of DSBs to the cell (Zhang et al., 2006). Furthermore, 
HsUSP11 has been shown to be involved in a pathway involving HsBRCA2 function 
in response to damage caused by the crosslinking agent mitomycin C (Schoenfeld 
et al., 2004). Moreover, HsUSP1 has been found to be involved in both the FA and 
PRR pathways, and these data will be discussed later.  
 
It is interesting to note that five HsUSP DUBs, HsUSP16, HsUSP30, HsUSP39, 
HsUSP45 and HsUSP52 were found to be missing catalytic residues (Nijman et al., 
2005b). The authors propose that as they are merely missing the catalytic 
aspartate, HsUSP16 and HsUSP30 likely utilise a different side-chain for catalysis. 
However, they suggest that the remainder, particularly HsUSP39, are inactive USP 
variants (USPVs) that are only able to bind ubiquitin, analogous to the UEV 
proteins thought to arise from E2 pseudogenes (Nijman et al., 2005b). 
 
The ubiquitin C-terminal hydrolase (UCH) superfamily of DUbs is one of the 
smallest superfamilies. Members contain the C12 peptidase domain of clan CA of 
cysteine-type peptidases. They were the first superfamily of DUbs to be 
characterised (Nijman et al., 2005b) and were originally identified as small proteins 
that were able to hydrolyse short amides and esters from the carboxy-terminus of 
ubiquitin (Amerik and Hochstrasser, 2004). Structural work showed that the active 
site of this superfamily is very similar to that of the USP/UBP superfamily. 
However, an active site crossover loop was also discovered, through which DUb 
substrates must pass through in order to access the active site cysteine. The 
diameter of the loop is only about 15 Å, which is thought to be the reason why most 
UCH DUbs only seem able to cleave small molecules from ubiquitin (Amerik and 
Hochstrasser, 2004). An important member of this family includes HsUCH-L1, which 
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is expressed in neurons and has been linked to Alzheimer’s and Parkinson’s 
diseases. This DUb is very interesting because it has also been found to have 
ATP-independent E3 activity dependent upon homo-dimerisation, and the ability to 
stabilise mono-ubiquitin, which is dependent upon its catalytic cysteine (reviewed 
in Setsuie and Wada, 2007). Another UCH DUb called HsBRCA1-associated 
protein 1 (HsBAP1) has been shown to bind the RING finger of HsBRCA1 to inhibit 
the E3 activity of the HsBRCA1/HsBARD1 complex, hence modulating the role of 
this protein in DNA repair (Nishikawa et al., 2009). It is interesting that HsBRCA1 
can also be associated with a JAMM superfamily (discussed in the next section) 
DUb called BRCA1/BRCA2-containing complex protein 36 or HsBRCC36 (Dong et 
al., 2003), and that the USP/UBP DUb HsUSP11 presumably also functions in the 
vicinity.  
 
It is worth noting here that the literature occasionally denotes C12 peptidases as 
ubiquitin C-terminal hydrolase (UCH) family 1 and C19 peptidases as UCH family 
2. Although USP/UBP superfamily DUbs may for this reason be denoted as 
containing a UCH domain, for example within the ExPASy, UniProt and Pfam 
databases, I do not know of an example where a UCH superfamily DUb has been 
described as containing a USP or UBP domain.  
 
The ovarian tumour protease (OTU) superfamily of DUbs was identified 
bioinformatically in 2000 using the OTU gene, which is involved in oocyte 
maturation in Drosophila, as a query (Makarova et al., 2000). Characterised OTU 
DUbs include HsDUBA, HsA20, HsOtubain-1 and -2, and HsCezanne. There is a 
particular bias for the involvement of OTU DUbs in the inhibition of cytokine 
inflammatory signalling cascades. For example, HsCezanne has been shown to 
deubiquitinate the signalling adaptor receptor-interacting protein 1, HsRIP1, which 
effects a negative feedback loop that inhibits nuclear factor-κB (HsNF-κB) activation 
(Enesa et al., 2008). HsDUBA has been found to deubiquitinate lysine-63-linked 
chains from tumour necrosis factor receptor associated factor 3 (HsTRAF3), which 
affects HsTRAF3 interactions and in turn results in the inhibition of type 1 interferon 
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(Kayagaki et al., 2007). Furthermore, in addition to its OTU domain, HsA20 also 
comprises seven zinc finger domains within its carboxy-terminus that fold up to 
form a domain with E3 activity. The result of HsA20 function is deubiquitination of 
lysine-63-linked chains from HsTRAF2, HsTRAF6 and HsRIP1, and subsequent 
replacement with lysine-48-linked chains (reviewed in Coornaert et al., 2009). 
 
Machado-Joseph disease aka Machado-Jakob disease aka Josephin protein 
domain proteases aka MJDs form one of the smallest DUb superfamilies. 
Machado-Joseph disease is also known as spinocerebellar ataxia type 3, and is 
caused by expanded poly-glutamine tracts in HsAtaxin-3, and results in 
neurodegeneration. MJD DUbs comprise a Josephin domain that imparts the DUb 
activity. HsAtaxin-3 is by far the most studied member of the superfamily. HsAtaxin-3 
can bind poly-ubiquitin chains via its ubiquitin interaction motifs (UIMs), and cleave 
the ubiquitin–target amide bond via its amino-terminal Josephin domain. 
Interestingly, HsAtaxin-3 was found able to bind lysine-63- and lysine-48-linked 
chains, but seemed particularly efficient at cleaving lysine-63-amide bonds in 
mixed linked chains (Winborn et al., 2008). HsAtaxin-3 is thought to be involved in 
the ubiquitin-proteasome pathway. 
 
The permutated papain fold peptidases of dsDNA viruses and eukaryotes (PPPDE) 
superfamily, is a small, entirely putative superfamily of DUbs predicted by 
bioinformatics analyses carried out by a collaboration of the groups of Eugene 
Koonin and L. Aravind in Bethesda, USA (Iyer et al., 2004). No members of this 
family have been experimentally confirmed as having bona fide DUb activity. 
Please note that the PPPDE domain is also commonly referred to as a DUF862 
domain (domain of unknown function), for example in the Pfam, ExPASy and 
EMBL databases.  
 
In the aforementioned paper, PPPDE DUbs were classified by similarity into three 
major families: eukaryotic family 1, eukaryotic family 2, and a more divergent viral 
family, which will not be discussed further. The viral counterparts of fungal family 2 
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PPPDE DUbs are also classified into eukaryotic family 2. No PPPDE DUbs were 
found in eubacteria or archaea. Eukaryotic family 1 consists of PPPDE DUbs from 
a variety of eukaryotes including plants, vertebrates and fungi, and contains one 
human protein known as HsFAM152B. Eukaryotic family 2 also contains proteins 
from various eukaryotes, which include plants, vertebrates and fungi, as well as 
fungal dsDNA viruses. Whereas Arabidopsis thaliana contains 7 paralogous family 
2 PPPDE DUbs, most eukaryotes contain one or two DUbs from this family, and 
there is one orthologue in humans, HsPNAS4FAM152A, and one in S. pombe, 
SpHag1Mug67. The authors of this study noted that there are distinct differences 
between residues near the catalytic site in family 1 and family 2 PPPDE DUbs, 
which indicates that they may differ in target specificity. Furthermore, they argue 
that all PPPDE DUbs are likely to deubiquitinate conserved targets, particularly 
family 1 members, which points towards targets relating to the cell cycle and 
genome manipulation, such as DNA replication. However, Iyer et al also point out 
that some organisms do not contain any PPPDE DUbs suggesting redundancy 
with other non-PPPDE superfamily DUbs (Iyer et al., 2004). 
 
This study actually identified both the PPPDE superfamily of predicted DUbs, but 
also the weak suppressor of ScSmt3 (ScWss1)-like metalloprotease (WLM) 
superfamily of putative desumoylating enzymes, which are found in plants, fungi, 
Trypanosoma and Plasmodium (Iyer et al., 2004). ScSmt3 is the S. cerevisiae 
SUMO-1 orthologue and a link between ScWss1 and PRR has been demonstrated 
– 
ScWss1 was found to physically interact with the replication fork stabiliser ScTof1 
and demonstrated genetic additivity with a variety of PRR components (O'Neill et 
al., 2004). Interestingly, there are two WLM members in S. pombe, SPAC521.02 
and SPCC1442.07c (Iyer et al., 2004), and the ScTof1 orthologue is SpSwi1, 
however these proteins do not fall within the remit of this study and so will not be 
discussed further.   
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1.25.  JAMM Superfamily Deubiquitinating Enzymes 
 
Jab1/Mov34/Mpr1, Pad1 N-terminal + (MPN+) (JAMM) domain superfamily of 
DUbs is found in a variety of cellular proteins, some of which have ubiquitin and 
ubiquitin-like isopeptidase activity. The JAMM superfamily is of medium size – with 
reference to mammals, it contains more members than the UCH, MJD and PPPDE 
superfamilies, but less than USP/UBP. HsRPN11POH1, HsAMSH and HsCSN5RRI1/JAB1 
are the most studied enzymes of the JAMM superfamily. HsRPN11 (regulatory 
particle non-ATPase 11), also known as HsPOH1, is a 19S proteasome lid 
component thought to remove ubiquitin from lysine-48-linked poly-ubiquitinated 
substrates committed for proteasomal degradation, and thus acts in ubiquitin 
recycling. HsAMSH (associated molecule of the SH3 domain of signal transducing 
adapter molecule [STAM]) is a DUb involved in the control of targeting membrane 
proteins for transport to the lysosome in endosomal vesicles (reviewed in Clague 
and Urbé, 2006). HsCSN5 (constitutive photomorphogenic gene 9 [COP9] 
signalosome 5), also known as HsRRI1 and HsJAB1, is thought to be the catalytic 
component of the COP9 signalosome (reviewed in Schwechheimer, 2004). SpCsn5 
has been shown to deneddylate Cullin 1 (SpCul1), a subunit of Skp1-Cullin-F-box 
(SCF) ubiquitin-protein ligases (Lyapina et al., 2001; Zhou et al., 2001; Cope et al., 
2002). 
 
During 2002, the JAMM superfamily received significant attention due to three 
important publications (reviewed in Hochstrasser, 2002, and Wilkinson, 2002). In 
September 2002, a seminal bioinformatics study, included within a paper 
discussing this domain, from a collaboration between the groups of Glickman and 
Hofmann (Maytal-Kivity et al., 2002). In this study, four main types of proteins were 
studied, proteasome lid components, CSN components, translation elongation 
factors type 3, and HsAMSH orthologues, all of which are known to contain the 
domain most commonly known as Jab1, MPN or Mov34. An alignment of the 
amino acid sequences of these proteins enabled classification into two distinct 
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groups: MPN+ or ‘plain’ MPN. In addition to the core MPN residues, the MPN+ 
group members, which includes HsRPN11POH1, HsAMSH and HsCSN5RRI1/JAB1 and 
their respective orthologues from selected eukaryotes, contain a further five 
specifically conserved residues within the motif, all of which have polar chemistry. 
The MPN domain of HsRPN8, HseIF3f, HseIF3h and HsCSN6, and their respective 
orthologues, contained, at the most, one of the extra conserved residues, so were 
classified as containing a plain MPN domain. MPN+ members were also found in 
archaea and eubacteria (Maytal-Kivity et al., 2002). An independent study also 
found antecedents in prokaryotes and bacteriophage (Iyer, Burroughs and Aravind, 
2006).  
 
The term JAMM is mainly used to refer to proteins classified as MPN+ by this 
study. Having said this, plain MPN proteins are frequently referred to as JAMM 
DUbs in the literature. Interestingly, recent evidence suggests that the plain MPN 
domain is a DUb pseudogene in that it can bind ubiquitin, but has lost its catalytic 
activity (Bellare et al., 2006) and hence this domain features in more 
comprehensive reviews of ubiquitin-binding motifs (Hurley et al., 2006). 
 
The crystal structure of an MPN+ JAMM domain, from a protein from the archaeon 
Archaeoglobus fulgidus was solved in 2003 (Tran et al., 2003). The function of this 
protein, known as AF2198, is not known. The structure revealed a fold very similar 
to that of cytidine deaminase, a member of the metal-dependent hydrolase 
superfamily, which binds zinc. The Zn2+ ion is utilised to activate water, forming a 
hydroxide ion that reacts with the carbon at the 4 position of the base of cytidine. 
The result of this nucleophilic attack is an amino group on this carbon becomes 
substituted with an oxygen atom from the water molecule forming a ketone moiety 
– hence the base of a cytosine nucleoside is converted into a uracil. The 
significance of this structure was revealed when it was found that the five MPN+ 
residues of AF2198 were found to co-ordinate the Zn2+ ion  (Tran et al., 2003).  
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In the Glickman and Hofmann 2002 paper, the bioinformatics study was combined 
with biochemistry using HsRPN11POH1, a component of the 19S proteasome lid  that 
is involved in removing poly-ubiquitin chains from proteins committed for 
proteasome-mediated degradation (Maytal-Kivity et al., 2002). Mutation of MPN+ 
residues in HsRPN11POH1 resulted in an accumulation of poly-ubiquitinated proteins 
(Maytal-Kivity et al., 2002). The following week, Yao and Cohen’s Nature paper 
demonstrated that the deubiquitination activity of S. cerevisiae ScRpn11 was 
dependent upon Zn2+ and single mutations of three MPN+ residues resulted in 
lethality (Yao and Cohen, 2002) – ScRpn11 is essential in S. cerevisiae. The 
following month the groups of Eugene Koonin, Raymond Deshaies, and 
collaborators published two papers in Science. One confirmed Yao and Cohen’s 
findings with ScRpn11 and proposed that the function of the proteasome lid is to 
effect tight coupling between lid DUb action to remove ubiquitin from ubiquitinated 
substrates and the degradation of deubiquitinated substrates mediated by the 
proteasome itself (Verma et al., 2002). The other paper described the importance 
of the JAMM motif in CSN function (Cope et al., 2002). Metal chelators allowed 
CSN assembly, but abrogated ScCsn5Rri1/Jab1 function in the removal of Nedd8 from 
ScCul1, and similar conclusions could be drawn about Csn5 function in S. pombe 
and D. melanogaster (Cope et al., 2002).  
 
More recently, the structure of the human MPN+ JAMM domain DUb, HsAMSH-LP, 
has been solved (Sato et al., 2008). HsAMSH-LP and its paralogue, HsAMSH, as 
well as its S. pombe orthologue, SpAmsh. will be discussed further in Chapter 3. 
 
1.26.  Deubiquitinating Enzymes Encoded within the Human 
Genome 
 
According to a recent review, there are 95 DUbs in human cells, and 58 are 
UBP/USP superfamily DUbs, 4 are UCH DUbs, 5 are MJD DUbs, 14 are OTU 
DUbs and 14 are JAMM DUbs (Nijman et al., 2005b). However, this review, whilst 
very informative, can be misleading. Firstly, two UBP/USP superfamily DUbs were 
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found to be absent from this study, HsUSP27USP22L and HsUSPL1. Furthermore, the 
aspartyl proteases and, more importantly, the PPPDE superfamily are not even 
mentioned in this review. As described above, there are two human PPPDE 
members, HsPNAS4FAM152A and HsFAM152B, that were identified in the Koonin and 
Aravind study (Iyer et al., 2004). Moreover, when the JAMM superfamily was 
analysed, proteins containing a plain MPN domain as well as those with an MPN+ 
were included in the Nijman et al. review. Only half of the 14 cited appear to be 
bona fide MPN+.  
 
1.27.  Deubiquitinating Enzymes in Post-Replication Repair 
 
HsUSP1 is a 785 amino acid DUb of the USP/UBP superfamily. Close orthologues 
can be found in Xenopus laevis, Mus musculus, Rattus norvegicus, Danio rerio 
(zebrafish), and Gallus gallus. HsUSP1 has been found to only contain the 
USP/UBP catalytic domain – the section comprising the first 75 residues that are 
not part of this domain is only highly conserved in DUbs of the aforementioned 
species. However, buried in the catalytic domain is an ubiquitin fold (Huang et al., 
2006), which is a common structural element in USP/UBP DUbs (Zhu et al., 2007). 
HsUSP1 is localised in the nucleus, expressed highly during S-phase, and can be 
ubiquitinated and degraded by the proteasome (Nijman et al., 2005a). It is also 
thought to be phosphorylated by HsATM or HsATR on serine-42 (Matsuoka et al., 
2007).  
 
In 2005, the function of HsUSP1 in FA was studied by a collaboration between the 
Bernards laboratory and the D’Andrea laboratory. HsUSP1 was found to 
deubiquitinate FANCD2 (Nijman et al., 2005a). As described in section 1.8 above, 
this has the effect of preventing FANCD2 from localising in DNA repair foci and 
thus aid crosslink repair. In fact, it was shown that knockdown of HsUSP1 had the 
effect of reducing the number of chromosomal aberrations compared to control 
cells (Nijman et al., 2005a). However, recent work in murine cells has shown that 
knocking out USP1 resulted in an FA phenotype and  increased levels of mono-
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ubiquitinated MmFANCD2, and that a double knockout of USP1 and FANCD2 
demonstrated a more severe phenotype (Kim et al., 2009). This implies that 
MmUSP1 function in the FA pathway is complex in this organism. It is not known 
whether the findings in mice can also be attributed to the FA pathway in other 
organisms. 
 
In 2006, D’Andrea’s laboratory and collaborators showed that HsUSP1 
deubiquitinates HsPCNA (Huang et al., 2006). Knockdown of HsUSP1 levels 
resulted in an increase in mono-ubiquitinated HsPCNA, and overexpression of 
wildtype HsUSP1 reduced mono-ubiquitinated HsPCNA levels whereas a mutant 
HsUSP1 in which the catalytic cysteine had been mutated to a serine could not. 
Interestingly, UV irradiation induced cleavage of the HsUSP1 protein into two 
discrete parts. This cleavage was dependent upon the catalytic activity of HsUSP1. 
The cleavage was found to occur carboxy-terminal to two consecutive glycine 
residues. Mutation of the di-glycines to di-alanines inhibited autocleavage. 
Furthermore, the authors also showed that knockdown of HsUSP1 resulted in an 
increased mutation frequency compared to control siRNA. The authors conclude 
that the role of HsUSP1 is to maintain low levels of mono-ubiquitinated HsPCNA in 
unchallenged cells to prevent error-prone PRR. However, in the presence of UV 
damage, HsUSP1 autocleaves and is degraded by the proteasome, activating PRR. 
More specifically, they propose that “in the presence of UV damage, USP1 
switches its substrate target from ubiquitinated PCNA to its own C-terminal Gly-Gly 
motif, resulting in an increase in mono-ubiquitinated PCNA levels and TLS” (Huang 
et al., 2006). This work is reviewed in Friedberg, 2006 and Ulrich, 2006. Figure 
1.12, which is adapted from Ulrich, 2006, summarises the pathway. 
 
There is also preliminary evidence to suggest that HsUSP1 can remove poly-
ubiquitin chains from HsPCNA – HsUSP1 knockdown resulted in an increase in the 
intensity of bands of higher molecular weight than mono-ubiquitinated HsPCNA 
(Motegi et al., 2008). However, this effect may be indirect.  
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1.28. An Introduction to This Study 
 
The aim of this study is to investigate the roles of DUbs in S. pombe PRR. Is there 
a HsUSP1 orthologue in yeast? Or does a different DUb deubiquitinate SpPCNA, 
and if so, which one performs this task? 
 
This project is divided into five main parts. Firstly, DUbs encoded within the S. 
pombe genome will be identified. The literature surrounding each DUb (and/or its 
orthologues in humans and budding yeast) will be discussed, its superfamily and 
likely importance in the cell outlined, if known. Here, its potential for involvement in 
PRR or SpPCNA deubiquitination will also be summarised. This first part 
corresponds to Chapter 3. Secondly, the assembly of an S. pombe DUb deletion 
library will be discussed, along with how this library was screened and the results 
(Chapter 4). In the third part, the literature surrounding the positive hit resulting 
from the screen will be summarised, along with the rationale behind the decision to 
investigate the role of these proteins in PRR further (Chapter 5). In the fourth 
section, the function of these proteins in S. pombe will be investigated further 
(Chapters 5, 7 and 8), along with the identification of, introduction to, and 
investigation into the role of the likely S. cerevisiae counterparts (Chapter 6). In the 
fifth and final section (Chapter 9), the significance of these data will be discussed.  
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Chapter 2: Materials and Methods 
Many of the methods described below are taken or adapted from Sambrook et al., 
1989. 
2.1. Chemicals and Buffers 
 
Materials were typically obtained from Sigma and were of the highest purity 
available unless otherwise stated.  
 
10x Blue Juice: 0.25% bromophenol blue, 0.25% xylene cyanol, 30% glycerol, 
water. 
Coomassie Stain: 450 ml methanol, 100 ml glacial acetic acid, 1 g Coomassie 
blue, water qsp 1 l. 
Destain Solution: 10% methanol, 10% acetic acid, water. 
10x Gel Running Buffer (GRB): 30 g tris base, 144 g glycine, 10 g SDS, water 
qsp 1 l. 
Elution Buffer (EB): 10 mM tris, pH 8.5, water.  
3x Laemmli Buffer: 2 ml glycerol, 1.5 ml β-mercaptoethanol, 4.5 ml 20% SDS, 
1.875 ml 1 M tris HCl pH 6.8, 125 µl 1% bromophenol blue. 
Phosphate Buffered Saline (PBS): 8 g NaCl, 0.3 g KCl, 1.44 g Na2HPO4, 0.24 g 
KH2PO4, pH 7.4 (using HCl), water qsp 1 l. 
Ponceau S Stain: 1 g Ponceau S, 15 g trichloroacetic acid, 15 g sulphosalicylic 
acid, water qsp 500 ml.  
TE Buffer: 10 mM tris HCl pH 8.0, 1 mM EDTA pH 8.0, water. 
TAE (50x): 242 g tris base, 57.1 ml glacial acetic acid, 100 ml 0.5 M Na2 EDTA 
(pH 8.0), water qsp 1 l. 
TBE (5x): 54 g tris base, 27.5 g boric acid, 20 ml 0.5 M EDTA pH8.0, water qsp 1 l. 
Semi-Dry Transfer Buffer: 5.82 g tris base, 2.93 g glycine, 1.875 ml 20% SDS, 
200 ml ethanol, water qsp 1 l. 
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Antibody Elution Solution: 800 µl 1M glycine pH 2.3, water qsp 4 ml. 
Antibody Storage Buffer: 1 ml 1M KCl, 200 µl 1M HEPES pH 7.7, water qsp 2 ml. 
 
 
2.2. Routine Bacterial and DNA Methods 
2.2.1. E. coli Culture 
 
E. coli cells grow optimally in liquid culture in LB broth at 37 °C with agitation and 
on standard Luria Bertani (LB) agar plates in a plate incubator at the same 
temperature, hence all culture was performed using these conditions unless 
otherwise stated. Cell density was measured as absorbance at 600 nm using a 
spectrophotometer.  
 
2.2.2. Plasmid Transformation of DH5α  
Competent DH5α E. coli cells were thawed on ice for 30 min and added to 0.5-2 µl 
(typically 400 to 1600 ng) of cooled plasmid or ligated DNA in buffer “EB” (as 
supplied in Qiagen kits). The E. coli-DNA mixture was incubated on ice for 30 
minutes, heat shocked at 42°C for 30 seconds and incubated on ice for a further 2 
minutes. Pre-warmed LB broth (250-500 µl) was added and the cells were 
incubated at 37 °C with agitation for 1 h to allow for the expression of the antibiotic 
resistance gene. The cells were then plated onto LB agar plus the relevant 
antibiotic and grown overnight 37°C.  
 
2.2.3. Creation of E. coli Glycerol Stocks 
 
700 µl of late log E. coli culture in LB broth was added to 300 µl of 50% glycerol in 
a screw topped tube and stored at –80°C.  
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2.2.4. Plasmid DNA Preparation 
 
A single DH5α colony was picked and used to inoculate 5 ml of LB broth plus 
relevant antibiotic and grown for approximately 5 h during the day. In the evening, 
this was added to 100 ml of fresh LB broth plus appropriate antibiotic and grown 
overnight. The following morning, plasmid DNA was isolated using a QIAfilter® 
Midiprep kit (Qiagen) according to the manufacturer’s instructions, with the final 
DNA pellet resuspended in up to 200 µl of EB. The quantity of plasmid DNA 
prepared was elucidated by analysing a 1 µl sample in 99 µl of water using a 
spectrophotometer at 260 nm. Typically between 500 and 1000 ng/µl of DNA was 
isolated. For smaller quantities of plasmid DNA, a QIAprep® Miniprep kit (Qiagen) 
was utilised. In this case, 2 ml of LB plus pertinent antibiotic was innoculated with a 
single colony and grown overnight. Plasmid DNA was then isolated according the 
manufacturer’s instructions. DNA was typically eluted in 30 µl EB, which was 
typically ~200 ng/µl.  
 
2.2.5. DNA Enzymatic Reactions 
 
Restriction digests, dephosphorylations and ligations were performed according to 
the manufacturers instructions with the buffers supplied. Restriction 
endonucleases, Antarctic phosphatase and Quick T4 DNA ligase were from New 
England Biolabs (NEB), and calf intestinal alkaline phosphatase was from 
Invitrogen.  
 
2.2.6. Agarose Gel Electrophoresis 
 
DNA from restriction digests or polymerase chain reaction (PCR) was fractionated 
using a 0.8–1.5% (w/v) agarose gel in 1x TAE or 1x TBE depending on 
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requirements. Ethidium bromide was added to the gel to a final concentration of 0.5 
µg/ml. Blue juice was used as a loading buffer to a final dilution of 2x and “1 kb 
Plus” molecular weight marker (Invitrogen) was used as a DNA ladder. DNA 
samples were run at 120-130 V until the desired fractionation was achieved. Gels 
were visualized with a UV transilluminator and photographed. DNA bands required 
for further cloning were quickly cut out of the gel using a scalpel blade. Where 
ligation of DNA extracted from agarose gels had failed previously, the DNA for 
extraction was shielded from UV damage using aluminium foil and then relevant 
part of the gel excised using DNA (5% of the total DNA) in flanking lanes as a 
guide. 
 
2.2.7. DNA Extraction from Agarose Gels 
 
DNA fragments were excised and purified from agarose gels using QIAquick gel 
extraction kit (Qiagen) according to the manufacturer’s instructions, with the DNA 
eluted into typically 30 µl of EB buffer.  
 
2.2.8. Purification of Polymerase Chain Reactions 
 
PCR products were purified from PCR reaction components using a PCR 
purification kit (Qiagen) according to the manufacturer’s instructions. Typically the 
DNA was eluted into 30-50 µl of EB buffer. 
 
2.2.9. Oligonucleotide Preparation 
 
Standard oligonucleotides were designed and obtained from the Invitrogen custom 
primer synthesis service. Without exception, primers were dissolved in TE to 100 
pM and diluted 1/10 or 1/100 as necessary.  
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2.2.10. DNA Sequencing 
 
Plasmid DNA or PCR reaction products were sent for sequencing at GATC 
Biotech, according to their instructions. Plasmid DNA was sent diluted in water at a 
concentration of 30-100 ng/µl and PCR products 10-50 ng/µl. 
2.2.11. DH5α Colony Polymerase Chain Reaction 
 
Correct plasmids transformed into DH5α were identified using colony PCR. A 
single colony of DH5α was added to 20 µl of EB and vortexed. Half of this mixture 
was then boiled for 10 minutes and then incubated on ice. Taq DNA polymerase 
(NEB) or KOD HotStart DNA polymerase (Novagen), primers for amplifying the 
appropriate gene and appropriate remaining PCR reagents were then added to a 
final volume of 50 µl and the PCR carried out according to the manufacturer’s 
instructions. Completed reactions were then analyzed by agarose gel 
electrophoresis.  
 
2.2.12. Gateway System “LR” Clonase Reaction 
 
DUb genes incorporated into pDONR201 entry vector were purchased from RIKEN 
Bioresource Center, Japan (Matsuyama et al., 2006). Genes were shuttled 
between Gateway System (Invitrogen) compatible vectors using the site-specific 
recombinase, Clonase II (Invitrogen). The pDUAL destination vectors were 
prepped using DB3.1 competent cells (Ivitrogen), which are resistant to the ccdB 
gene (Ken Sawin; Matsuyama et al., 2004). To set up this reaction, 50 ng of 
pDONR201-dub plasmid, 75 ng of pDUAL destination vector and TE buffer to a 
total of 4 µl was added to a 1.5 ml microfuge tube, which was then vortexed briefly. 
The LR Clonase II (Invitrogen) enzyme was thawed on ice for two minutes, 
vortexed briefly and 1 µl was added to the DNA mix. Mixed and spun down 
reactions were then incubated overnight in a 25 °C plate incubator. The following 
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day, the reactions were incubated with 0.5 µl of proteinase K solution (Invitrogen) 
for 10 minutes in a 37 °C water bath to terminate the reaction. The reaction was 
then transformed into DH5α as described above. The pDUAL destination vectors 
contained the ampicillin-resistance gene and ura4 marker.  
 
2.2.13. Site-Directed Mutagenesis 
 
Site-directed mutagensis was carried out using the QuikChange® II XL Site-
Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s 
instructions. These instructions were carried out with high stringency, except the 
total reaction mixture was halved. Primers designed using the QuikChange® 
primer design program (see section 2.6.2 for website link) were found to be more 
reliable than without. For the DWGF-AAAA mutation described in Chapter 7, the 
mutation was carried out in two steps. Furthermore, an elongation time of 20 min 
for each cycle was typically used. Initially, the supplied XL10-Gold® ultracompetent 
cells were utilised, but it was found that DH5α cells prepared in-house resulted in 
significantly higher frequency of success. 
 
2.2.14. BL21 E. coli Transformation 
 
Competent BL21 (DE3, Stratagene) E. coli expression strain cells, β-
mercaptoethanol and transformation tubes were pre-cooled on ice. Then 50 µl of 
cells were mixed with 0.85 µl of β-mercaptoethanol and incubated on ice for a 
further 10 minutes, with periodic mixing by flicking the tube. After the addition of 1 
µl of plasmid DNA, the mixture was incubated on ice for another 30 minutes. The 
mixture was then heat shocked at 42°C for exactly 45 seconds, and then chilled on 
ice for 2 minutes. Then 400 µl of pre-warmed LB broth was added, the tube 
incubated at 37°C for 1 h and 100 µl spread onto LB agar plates with the 
appropriate antibiotic at 37°C overnight.  
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2.3. Routine Protein Methods 
2.3.1. Expression and Native Purification of S. pombe His6-SpPCNA 
for Antibody Production 
 
S. pombe pcn1+ was subcloned into pET16b (Novagen) from pREP41HA via 
BamHI and NdeI sites and the correctly ligated plasmids checked by colony PCR 
using primers complementary to the pcn1+ gene and pET16b plasmid and 
sequencing. Hence, 1 µl of a pET16b-pcn1+ plasmid Midiprep was used to 
transform competent BL21 (DE3) cells and a single colony was picked and used to 
inoculate 5 ml of LB Amp broth, which was cultured overnight. In the morning, this 
was added to 1 l of fresh LB Amp broth in a 2 l flask and cultured to mid-log phase. 
At this point, 1 ml was removed, harvested by centrifugation and resuspended in 
Laemmli buffer to 0.01A600/µl for use as an uninduced control for SDS-PAGE 
analysis. The remaining culture was induced with isopropyl-β-D-galactopyranoside 
(IPTG) at 50 mM and incubated at 30 °C for 4 h. The culture was then harvested 
by centrifugation and resuspended in native lysis buffer and lysozyme to 1 mg/ml. 
After thorough sonication, the supernatant was spun multiple times until completely 
clear, whereupon Ni-NTA slurry (Qiagen) was added and used according to the 
manufacturers instructions. Purified SpPCNA was eluted using 250 mM imidazole 
and samples analysed by SDS-PAGE, Western blotting and immunodetection. 
Adequately pure elutions were then pooled and quantified, before sending 2 mg to 
Eurogentec for injection into two rabbits as part of an immunisation program. 
Unfortunately, the resultant antibodies were not able to detect ubiqitinated SpPCNA 
despite affinity purification. 
 
2.3.2. Protein Quantitation 
 
BioRad protein assay dye reagent concentrate was diluted 1 in 5 and 1 ml added 
to 6 µl of protein. The absorbance at 600 nm was determined using a 
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spectrophotometer and the concentration estimated using a standard curve from 
known concentrations of bovine serum albumin.  
 
2.3.3. SDS-PAGE Analysis  
 
10% SDS-PAGE protein gels were run using either the BioRad protean mini gel 
system (up to 15 lanes) or the Scie-Plas TV200 system (up to 36 lanes) in 1x GRB. 
Table 2.1 depicts typical recipes for the resolving and stacking gel. Gels were run 
for about 1.5 h at 100-200V. To calibrate the molecular weight of fractionated 
proteins, NEB broad-range prestained protein markers were run on the gel. 
SpPCNA typically runs in the region of the 32.5 kDa marker and a 10% resolving 
gel was utilised. In order to resolve ubiquitinated SpPCNA multiplet bands, a longer 
SDS-PAGE gel system (28 cm plates) was utilised, which was of an unknown 
brand. In this case, gels were run at 240 V for 4-5 h and ColorPlus prestained 
markers (NEB) were also used to aid differentiation of marker bands. 
 
2.3.4. Coomassie Staining of Gels 
 
Gels were stained in Coomassie stain for 40 min with agitation, and immediately 
destained using 3x 10 minute washes of destain solution until the contrast was 
sufficient. The gel was then dried in cling film onto blotting paper using a gel drier.  
 
2.3.5. Semi-Dry Western Blotting 
 
The SDS-PAGE gel, two sheets of extra thick blotting paper and Hybond C-extra 
supported nitrocellulose membrane (Amersham) of the same size were soaked in 
semi-dry transfer buffer. Later unsupported nitrocellulose membrane, Hybond ECL 
(Amersham), was utilised as it provides much greater band resolution. One side of 
the membrane was marked with a pencil and placed on the anode side of the gel to 
mark the protein-bound face of the membrane. These were then placed on the 
semi-dry transfer apparatus (BioRad) as a paper–gel–membrane–paper sandwich 
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from top to bottom, air bubbles were rolled out with a glass test tube and the 
cathode lid secured on top. A voltage of between 15-20 V for 30-40 minutes was 
applied depending upon the size of the gel. Transfer and loading was checked by 
staining the blot with Ponceau S for 5 minutes, rinsing off in water and 
photographing. The remaining stain was removed by washing a plurality of times, 
typically four times, in PBST. 
 
2.3.6. Immunodetection 
 
Western blots were immunodetected as outlined in Table 2.2. After the final wash 
in PBS, the bound antibodies were detected by the addition of enhanced 
chemiluminescence (ECL) Western Lighting kit (PerkinElmer) reagents at a 1:1 
ratio for 1 min with agitation. Excess ECL reagent was then blotted off with tissue 
and the blot wrapped in cling film. However, it was later found that sandwiching the 
blot with two pieces of transparent over-head projector film provided a clearer 
image as it was free from creases. The blot was then exposed to light-sensitive 
hyperfilm (Amersham) in the dark room and developed using a mechanical 
developer. 
 
2.3.7. Affinity Purification of Antibodies 
 
Pure SpPCNA (see 2.3.1 above) was run on a 10% SDS-PAGE gel, transferred 
onto Hybond ECL and stained with Ponceau S in order to identify the SpPCNA 
band. This band was cut out and into small squares and the stain was washed off 
using 0.1% PBST three times. The antigen squares were incubated in 5% milk 
0.1% PBST for 30 minutes and then the excess milk was washed off using PBS. A 
tube was then prepared containing 5 ml α-SpPCNA antibody serum plus 500 µl 
PBS and the antigen squares. This mixture was incubated overnight at 4°C on a 
roller. Subsequently, the antigen squares were removed from the serum using 
tweezers and put them into a clean 1.5 ml Eppendorf tube. The antigen squares 
were washed via the addition of 1 ml PBS, vortexing for 10 s and then removing 
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the PBS. This process was repeated four times. Then, four clean 1.5 ml 
Eppendorfs each containing 100 µl 1.5M Tris pH 8.8 and 220 µl antibody storage 
buffer was prepared. This neutralises and buffers the antibodies following elution. 1 
ml of elution solution was then added to the antigen squares, which was vortexed 
for 10 s. The elution solution was removed and pipetted directly into one of the 
prepared Eppendorfs. This was repeated three times. The pooled elutions were 
added to a Sartorius Vivaspin 6 column with a 32 kDa molecular weight cut-off and 
spun in a Heraus benchtop centrifuge at 3000 g for 20 min at 4°C. The flow-
through was emptied from the lower chamber. Then, 300 ml of 2 mg/ml BSA in 
PBS was added to the upper chamber and then the upper chamber filled to the top 
(6 ml mark) with PBS. The BSA helps to stop the antibody from sticking to the 
membrane. Spin in the Heraus benchtop centrifuge at 3000 g for 20 min at 4°C. 
The purified antibody was then removed from the upper chamber, NaN3 added to 
0.025% to inhibit microbe growth, aliquotted and stored at -80°C. 
 
2.4. Schizosaccharomyces pombe Methods  
 
Particularly helpful resources for S. pombe culture and experimentation was the 
Nurse laboratory manual (see section 2.6 below for a link to a copy of this) and the 
“Basic Methods for Fission Yeast” review by Susan Forsburg (Forsburg and Rhind, 
2006). 
 
2.4.1. S. pombe Culture 
 
S. pombe cells were grown in liquid culture in complete media, YEP (yeast extract, 
peptone, and nutritional supplements) in sterile glass tubes at 30 °C with light 
agitation and on YEA plates in a plate incubator at the same temperature, hence all 
culture was performed using these conditions unless otherwise stated. However, it 
is important to note here that a shift from YEP to YE (without peptone) occurred 
within my research institute approximately half-way through this project. Peptone 
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helps to prevent cells from clumping together (particulary seen in certain mutants), 
which makes them difficult to count or perform fluorescence activated cell sorting 
(FACS) analysis on. No difference in cell growth or experimental outcomes was 
found following the switch from YEP to YE. 
 
Cell density of liquid culture was measured by counting the number of cells in a set 
volume using a haemocytometer. Simultaneously, the culture was checked for 
phenotype, cell cycle progression and infection by foreign microbes.  
 
2.4.2. Generation of Transforming DNA for DUb Gene Disruptions 
 
The disruptions were performed by integrating DNA containing the nat1 gene, 
which encodes resistance to nourseothricin (NAT), in place of the DUb gene 
(Hentges et al., 2005). Hence, cells with successfully disrupted DUb genes were 
selected for by plating on YEA containing NAT. The knockout strategy utilised has 
previously been described (Baehler et al., 1998). Long primers were designed with 
approximately 20 bp homology to the nat1 gene at the 3’ end and 80 bp to the 
flanking regions outside the relevant DUb gene at the 5’ end. The resultant PCR 
product consisted, therefore, of the entire nat1 gene with 80 bp of homology to the 
flanking sequences of the DUb gene at either end. The strategy is also depicted in 
Figure 3.5.  
 
The amplification was initially performed using PicoMaxx high-fidelity PCR system 
(Stratagene) according to the manufacturer’s instructions. Later in the study, it was 
found that KOD HotStart (Novagen) was a much faster, higher fidelity and more 
reliable PCR polymerase for this purpose. To synthesise enough DNA for the 
highly inefficient transformation, 16 x 50 µl PCR reactions were set up. Due to the 
long, bulky primers utilised, two-stage cycling conditions were used to aid primer 
annealing and hence successful amplification (Table 2.3). In the first stage, a low 
annealing temperature increased the likelihood of primers annealing successfully. 
In the second stage, a higher, more stringent annealing temperature was used to 
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amplify only PCR products where the primers had annealed to the correct site of 
the plasmid. 
 
Reactions were then pooled, a small aliquot checked by agarose gel 
electrophoresis and cleaned up by phenol-chloroform extraction and ethanol 
precipitation, finally resuspending in 10 µl of 1x TE. The quantity of DNA was 
elucidated by analysing a 1 µl sample in 99 µl of water using a spectrophotometer 
at 260 nm. Typically 30-100 µg of transformable DNA was generated. 
 
2.4.3. Transformation using Lithium Acetate 
 
After growth overnight in YE, approximately 1 x 108 wild type 501 cells at mid-log 
phase were harvested by centrifugation at 2500 rpm for five minutes. The cells 
were washed once with 1 ml of 1x LiAc/TE and resuspended in 100 µl of the same 
buffer and added to transforming DNA (9 µl) plus 2 µl of salmon sperm carrier 
DNA. After ten minutes incubation at room temperature, 260 µl of 40% PEG in 1x 
LiAc/TE was added and the mixture incubated for 1 h at 30 °C with gentle agitation. 
Subsequently, 43 µl of dimethyl sulfoxide (DMSO) was added and the cells were 
heat shocked at 42 °C for five minutes and spun down. After washing with 1 ml of 
water, the cells were resuspended in 500 µl of water and plated onto YEA plates, 
which were incubated at 30 °C. After 18 h, the yeast were replica plated onto YEA 
NAT agar to select for NAT-resistant cells. After three days at 30°C, large colonies 
were restreaked onto fresh YEA NAT plates. Resultant single colonies were grown 
in YEP NAT broth until late log from which glycerol stocks were taken for long-term 
storage at -80 °C and genomic DNA isolated for PCR analysis. 
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2.4.4. Creation of Glycerol Stocks 
 
800 µl of late log S. pombe culture in YE plus appropriate selection was added to 
500 µl of 80% glycerol plus 300 µl of YE in a screw topped tube and stored at –80 
°C. 
 
2.4.5. Isolation of Haploids from Heterozygous Diploids 
 
The pON177 plasmid, which carries the h- mating type information (mat1-M) 
required to sporulate h+/h+ hererozygous diploids, was a gift from Olaf Nielsen and 
has already been described (Styrkarsdottir et al., 1993). This plasmid was 
transformed into a dipoid strain and positive ura4+ clones were spread onto agar 
extremely low in nitrogen for 2 days at 25°C to induce sporulation. The presence of 
tetrads was then verified using the light microscope. An enzyme called helicase, 
which comes from the juice of the snail Helix pomatia was used to digest the ascus 
wall. 1 ml of water was inoculated with a loopful of cells from the plate, 20 µl of a 1 
in 10 dilution of helicase was added and the mixture incubated overnight at 25°C in 
a plate incubator. The following day, the haploid spores were plated out onto media 
containing the appropriate supplements. Correctly disrupted haploids were verified 
by PCR and sequencing. 
 
2.4.6. Isolation of Genomic DNA  
 
1 ml of late log cells was harvested by centrifugation at 13 krpm for 2 minutes and 
the cells lysed and the genomic DNA isolated using the Wizard Genomic DNA 
purification kit (Promega) according to the manufacturers instructions, except using 
20 mg/ml Zymolyase®-20T (β-1,3-glucan laminaripentanohydrolase from 
Seikagaku Corporation) to digest the cell wall. However, it was later found that 
using a small amount of neat zymolyase powder resulted in more efficient cell wall 
digestion. Cell wall digestion was deemed complete by the observation of very high 
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proportion of “ghost” S. pombe cells that lacked a cell wall under the light 
microscope. Isolated DNA was resuspended in 50 µl of the supplied DNA 
rehydration solution and allowed to rehydrate overnight at 4°C. The quantity of 
DNA was elucidated by analysing a 1 µl sample in 99 µl of water in a suitable 
cuvette using a spectrophotometer at 260 nm.  
 
2.4.7. DUb Gene Disruption Verification by PCR 
 
A quick, preliminary screen for genomic DNA containing a disrupted DUb gene was 
devised utilising a Multiplex PCR kit (Qiagen) according to the manufacturer s` 
instructions. Primers were designed to anneal to sequences flanking either side of 
the DUb gene as well as within the nat1 gene. For correctly disrupted DUb genes, 
this favours the amplification of two short products of typically 400–700 bp 
depending upon the DUb gene in question.  
 
The disrupted DUb gene in genomic DNA that resulted in correctly amplified 
integration sites by multiplex were then analysed in detail by PCR using 
HotStarTaq (Qiagen) according to the manufacturers instructions. Later in the 
study, it was found that KOD HotStart (Novagen) was a much faster, higher fidelity 
and more reliable PCR polymerase for this purpose. Cycles that can correctly 
amplify the ~2 kb successfully disrupted gene were utilised as well as cycles that 
can amplify the wild type gene (2-4.6 kb, depending upon the DUb in question), 
using flanking (“checkKO”) primers on potentially disrupted genomic DNA or wild 
type genomic DNA, respectively. This strategy is illustrated in Chapter 3, Figure 
3.6. All PCR reactions were checked by agarose gel electrophoresis. Following the 
identification of a correctly-sized product, the PCR reaction was repeated on a 
larger scale and the purified product sent for sequencing using appropriate 
primers, including a negative control primer designed to anneal to the wild-type 
DUb gene. 
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2.4.8. DUb Gene Disruption Verification by Southern Analysis 
 
Chromosomal DNA was prepared on a large scale – 100 ml of YE late-log culture 
was harvested by centrifugation and resuspended in 5 ml of resuspension buffer 
(20 mM citrate-phosphate buffer pH 5.6, 1.2 M sorbitol, 40 mM EDTA) plus 
zymolyase. The cells were incubated for 1 h or until the cells were lysed. The cells 
were then harvested at 5 krpm for 5 min using a benchtop centrifuge (Heraus) and 
the pellet resuspended in 10 ml of 5x TE pH 7.5 and one tenth of the subsequent 
volume of 10% SDS to disrupt the cell membrane. Then 3.7 ml of 5M potassium 
acetate was added and the lysate put on ice for 30 min. The lysate was then 
centrifuged at 4600 rpm for 10 min and the supernatant decanted into 2 volumes of 
ethanol and incubated at room temperature for 5 min. Following centrifugation at 
4600 rpm for 10 mins, the pellet was washed with 70% ethanol. The resulting pellet 
of nucleic acids was then redissolved in 3 ml of 5x TE pH 7.5 and RNAse (Sigma) 
was added to a concentration of 20 µg/ml. To digest the RNA, the solution was 
incubated at 37°C for 2 h. The remaining genomic DNA was then further purified 
from contaminants with 4x phenol extractions and 2x chloroform extractions using 
phase-lock tubes (Eppendorf). A final ethanol precipitation was then carried out 
and the DNA resuspended in water at 37°C. 
 
The chromosomal DNA was digested overnight with appropriate enzymes 
according to the availability of restriction sites in the vicinity of the locus to be 
checked. Digestion and DNA concentration was checked on a mini agarose gel 
before running overnight at 60-70 V on a large 1% agarose gel with markers and 
digested wild-type control genomic DNA. A picture of the gel was taken using the 
transilluminator and then gel then cut to size. The gel was then washed for 20 min 
in denaturing solution (1.5 M NaCl, 0.5 M NaOH) to denature the DNA double helix 
and then 20 min in neutralising solution (1 M tris pH 7.5, 1.5 M NaCl). The DNA 
was transferred onto a GeneScreen nylon membrane by capilliary action. A plastic 
tray was filled with 10x saline-sodium citrate (SSC) buffer and the agarose gel 
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placed onto a Whatmann paper bridge pre-soaked in 10x SSC, which dipped into 
the tray solution at either end. The nylon blotting membrane was placed onto the 
gel, followed by one piece of Whatmann paper. These layers above the gel were 
pre-soaked in 10x SSC and rollered carefully to remove air bubbles. A piece of dry 
Whatmann paper, 2 stacks of green paper towels and finally a heavy weight were 
then placed onto. The Southern blotting was carried out overnight at room 
temperature. The following morning, the DNA was crosslinked to the membrane by 
irradiating both sides with UV (Stratalinker). Southern blots were left at 4°C 
wrapped in cling film and Whatman paper and sandwiched between glass plates 
prior to detection. 
 
A 400-600 bp probe template was generated by designing primers that annealed to 
flanking regions of the gene to be verified and performing PCR. The template DNA 
was purified from the PCR components and diluted to 2.5–25 ng/µl in 45 µl TE, 
boiled for 5 min to denature and then cooled on ice for 5 min. Then, 5 µl of α32P 
dCTP (GE Healthcare) and the 45 µl DNA was added to a tube containing the 
Klenow reaction mix (Ready-To-Go DNA Labelling Beads, Amersham) and mixed 
in by pipetting. The mixture was incubated at 37°C for 10 min. The reaction was 
stopped using 5 µl of 0.2 M EDTA, the probe purified with a Sephadex G-50 
column (Roche) and then boiled (5 min) and cooled on ice (5 min). The Southern 
blot was prehybridised in 30 ml hybridisation solution (1.5 ml 10% SDS, 20x SSC, 
100x Denhardts reagent, water qsp 1 l) at 65°C for 1 h, whereupon the probe was 
added to 15 ml fresh, pre-heated hybridisation solution. Hybridisation took place 
overnight in a hybridisation tube with gentle agitation (wheel) in the hybridisation 
oven (65°C). The hybridisation solution was discarded appropriately and the 
membrane washed twice for 30 min at 65°C using half the hybridisation tube full of 
washing solution (5 ml 20x SSC, 10 ml 10% SDS, water qsp 1 l). The membrane 
was then air dried on Whatmann paper for 10 min and wrapped in cling film. The 
counts per minute were measured with the Geiger counter and the pattern of 
hybridization was visualised by overnight exposure to X-ray film by 
autoradiography.  
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2.4.9. DNA Damage of S. pombe Deletion Strains 
 
For HU experiments, a single colony from a plated dub strain (along with wild-
type “501” and pcn1-K164R as controls) was used to inoculate 4 ml of YE media 
and grown for approximately 8-10 h, then diluted to 5 x 104 cells/ml in 10 ml of YE 
and incubated overnight. The following morning, the cells were diluted to between 
1 x 106 and 1 x 107 cells/ml (mid-log phase) in 5 ml YE in duplicate and treated (or 
left untreated) with 50 mM HU for 3 h at 30 °C. It was later decided to reduce the 
amount of HU to 10 mM due to reports from colleagues that some cells were 
unable to recover from incubation in 50 mM HU. 1 x 107 – 1 x 108 cells were 
harvested and prepared for analysis by trichloroacetic acid (TCA) extraction. 
 
UV damage experiments were performed as above, except between 5 x 106 and 1 
x 108 mid-log cells were transferred to a 0.45 µm PVDF membrane with a 47 mm 
diameter (Millipore) in duplicate using a vacuum pump. The cells were irradiated 
with typically 50 or 100 J/m2 UVC (254 nm, dose rate ~0.54 Jm-2s-1) and 
resuspended in 10 ml of YE for 30 minutes at 30°C. Mock treatment for control 
samples involved transferring the cells onto the membrane, but not irradiating with 
UV. 
 
The approximate two-dimensional area of a wild-type haploid S. pombe cell is 
between 36 and 75 mm2 and of the PVDF membrane is 1735 mm2. These 
quantities were found to be limiting – if too many cells were transferred to one 
membrane, cells may shield each other and hence receive different UV doses. 
Whilst multiple membranes could be used per sample when more than 1 x 108 cells 
were required, the cells would dry out if left on the membrane for too long. 
Therefore, a different method was devised and employed when irradiating 
significantly more cells. In this situation, a liquid culture of cells was spun down and 
spread onto a large (20 cm) YEA agar plate using a spreader and spreading wheel. 
Then, the plate was irradiated, 10 ml of YE was added to the plate, the cells were 
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resuspended using a spreader, and decanted into a culture tube. Mock treatment 
for control samples involved transferring the cells onto the agar plate, but not 
irradiating it with UV. 
 
2.4.10. HU Block and Release 
 
Cells were grown in 10 ml YE to mid-log phase and normalised to the same 
concentration (typically ~6 x 106 cells/ml). 1 M hydroxyurea was made up fresh in 
water and added to the cultures to 10 mM. After 2.5-3 hours growth in HU, the cells 
were spun down gently (2 krpm), the media discarded, the pellet washed, and 10 
ml fresh YE added. 1 ml samples were taken at various time points following 
release from HU, typically every 15, 30 or 60 min. Sometimes a sample was also 
taken prior to the additon of HU and before HU was washed out. Samples were 
spun down, washed, frozen in liquid nitrogen in TCA extracted. 
 
2.4.11. Fluorescence Activated Cell Sorting (FACS) 
 
Cells for FACS analysis were spun down, the media removed, washed once in 
water and 1 ml of 4°C 70% ethanol added and stored at 4°C until ready for 
analysis. At that stage, the cells were washed in ethanol and then resuspended in 
500 µl 50 mM sodium citrate pH 7.0 and 50 µl of 10 mg/ml RNAse A was added. 
RNA was digested for 3 h at 37°C. To 200 µl of cells, 10 µl of 500 µg/ml propidium 
iodide, and 1 ml of FACS buffer was added to special FACS tubes. A FACSCaliber 
(BD Biosciences) machine was used to measure the DNA content of the cells. 
 
2.4.12. Fluorescence Microscopy  
 
Cells were prepared for microscopy by fixing in methanol. The cells were then 
placed on glass microscope slide and the methanol allowed to evaporate. A 
solution containing 1 µg/ml 4',6-diamidino-2-phenylindole (DAPI), 50 µg/ml 
calcofluor, 1 mg/ml p-phenylenediamine (anti-fade), and 50% glycerol. DAPI binds 
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strongly to DNA and is excited by UV light and emits as a blue colour. Calcofluor 
binds chitin and cellulose and is used for visualised septating cells, which is seen 
as a bright white bar. 
 
2.4.13. Trichloroacetic Acid (TCA) Extraction  
 
Whole cell extracts were prepared using TCA. This technique adequately 
preserved the ubiquitinated forms of SpPCNA. 1 x 107 – 2 x 108 cells were 
harvested by centrifugation at 4.5 krpm for 10 min in 15 ml falcon tubes and the 
supernatant discarded. The cell pellet was then resuspended in 1 ml water and 
transferred to 2 ml screw-top ribolyser tubes. The washed cells were then spun 
down for 10 min at 13.5 krpm in a microfuge and the supernatant discarded. The 
cell pellet was then snap frozen in liquid nitrogen and stored at –80 °C. To 
complete the extraction, the tubes were transferred from the –80 °C freezer to 
liquid nitrogen and then batches of eight tubes maximum were transferred to ice. 
Immediately, one microfuge tube lid full of glass beads (acid washed, Sigma) and 
200 µl of 20% TCA was added. Ensuring the lids were tightly closed and the cells 
were kept at 4°C at all times, the tubes were then vortexed for one second (Vortex 
Genie 2, full speed), bead-beaten for 2 x 30 seconds in the ribolyser at 6.5 krpm 
and then vortexed again as before. Each tube was then placed upside-down in a 
metal tube rack (for safety) and the base pierced using a clean, sharp needle. The 
lysed cell contents were recovered by spinning through the hole at 4.6 krpm for 10 
min at 4°C into a clean 1.5 ml screw-top microfuge tube containing 400 µl of 5% 
TCA using a 15 ml falcon tube with the base cut off as a support. The ribolyser 
tubes containing only glass beads were discarded. The precipitated protein was 
then spun down for 20-30 min at 13 krpm at 4°C. The supernatant was completely 
removed and the protein resuspended in a volume of Laemmli buffer proportional 
to the number of cells originally harvested. The tubes were stored at room 
temperature (RT) for up to a few hours, or -20°C for longer periods, prior to 
fractionation by SDS-PAGE and analysis by Western blotting and 
immunodetection.  
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2.4.14. Drop Test Colony Forming Assay 
 
A high throughput “drop test” assay for measuring sensitivity of mutant strains to 
UV radiation was devised. This method has been previously used in assays for 
sensitivity of mutant strains to MMS treatment in S. cerevisiae (Xiao et al., 2000) 
and S. pombe (Memisoglu and Samson, 2000). It involves the creation of a linear 
array of cells of one particular strain down an agar plate, where the cells are at 
approximately uniform concentration along the extent of the array. To do this, 
suitable agar was poured into 12 cm x 12 cm square, sterile petri dishes and dried 
in a laminar flow hood. Each dried plate was then set at a ~45° angle. Mid-log cells 
were normalised to 4 x 106 cells/ml in YE and 45 µl was pipetted onto a labelled 
point at the top of the angled plate. The cells would flow down the agar at a 
constant speed. The liquid media was then allowed to dry off. Different strains 
could be added to the same plate – about 9 different arrays could be created on 
one square plate before there was a risk of arrays cross-contaminating. To create 
a UV dose gradient, the agar was subsequently irradiated in lateral strips, for 
example a 0-200 Jm-2 gradient was created in 40 Jm-2 increments. To irradiate in 
strips, 6 dish lids were cut into different sizes, such that that difference between 
each lid size was approximately constant. Using the flow rate of the UVC source, 
the number of seconds required to deliver the incremental dose, in this example 40 
Jm-2, was calculated and every 40 Jm-2 timed, the previous lid was replaced by a 
slightly smaller lid. The lowest section of each plate was not exposed to any UV. 
Cell death due to unrepaired UV damage was measured qualitatively by the 
density of colonies compared to controls. An entirely unirradiated agar plate was 
also utilised as a further control.  
 
2.4.15. UV Survival Colony Forming Assay 
 
Mid-log cells originating from a single colony were grown to a suitable 
concentration in YE and serially diluted such that when 100 µl was spread on a 
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plate, 100-200 cells would survive. For example, for wild-type cells the 
concentrations used were as follows: 0 and 40 J/m2: 2 x 103 cells/ml; 60 J/m2: 2 x 
103 cells/ml; 100 J/m2: 1 x 104 cells/ml. YEA plates were prepared beforehand and 
dried in a laminar flow hood. The cells were then spread on the plates and in at 
least triplicate i.e. in one experiment there was at least three identical plates for 
each strain at each dose. Spreading using glass beads was tried, but it was found 
that it was necessary for the plates to be over-dried in order to prevent the glass 
beads from retaining too many cells once they were discarded after being used to 
spread the cells. The optimum spreading means was found to be a wedge-shaped 
spreader and a rotating wheel. The cells were allowed a minimum amount of time 
on the plates before irradiation, which was carried out by placing an individual plate 
into the UVC box. Plates were irradiated one at a time. Following irradiation, the 
cells were incubated at 30°C. Following an appropriate growth period, the number 
of colonies on each plate was counted.  
 
2.4.16. Spot Test Colony Forming Assay 
 
Mid-log cells originating from a single colony were grown to ~1 x 107 cells/ml 
concentration in YE, 1 x 107 cells were spun down and resuspended in 240 µl, 
which was added to the first well in a 96 well plate. Cells for each strain were then 
diluted serially 1 in 6 across each row of the 96 well plate. Plates containing 
specific concentrations of various DNA damaging agents were prepared earlier the 
same day (the stock concentrations and diluents for these agents are shown in 
Table 2.4). The agar was cooled to 50°C before adding the genotoxin in order to 
prevent heat damage to it. The plates were then dried in a laminar flow hood or 
fume hood, depending upon the toxicity of the genotoxin. Various spotting 
techniques were tried e.g. a “frogger” was used, which comprises 96 metal rods. 
Following sterilisation using a flame, the frogger was simply dipped into the 96 well 
plate and the cells applied to the agar. This method was found to be less reliable 
and the plate was prone to becoming host to contaminant microbes, especially 
when highly toxic chemicals e.g. MMS, cisplatin etc required the use of a fume 
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hood throughout. Most reliable was an electronic repeating multi-channel pipette – 
4 µl from each well was added to the plate to make each spot. It was found that it 
was important to mix the cells in each well regularly or else the cells would sink to 
the bottom of the well. The plates were allowed to dry in the hood, put in a plastic 
bag for safety, and then allowed to grow in the plate incubator until photographed. 
 
2.4.17. DUb Expression  
 
DUbs were expressed by cloning the gene into an S. pombe compatible Gateway 
system destination vector of the pDUAL series, such that expression was 
controlled by the nmt1 promoter. This promoter is repressed by the addition of 
thiamine into growth media although repression is not 100% efficient and low-
levels of protein will be expressed in the presence of thiamine. Also, complete 
recovery from repression i.e. removal of thiamine, requires 18-24 h. pDUAL-dub 
constructs were transformed into S. pombe cells and plated onto minimal agar 
lacking uracil in order to select for ura4+ cells comprising the plasmid. For each 
transformation, half the cells were plated onto plates also comprising 15 µM 
thiamine and maintained in/on +thiamine –uracil media at all times. The remaining 
half were plated/maintained on/in –uracil media. When processing the blot 
resultant from running the samples from SpUbp21/SpUbp22 expression 
experiments, the blot was first probed with α-SpPCNA antibodies. Following 
detection, the blot was washed once in 1% sodium azide in 0.1% PBST to 
denature the horseradish peroxidase (HRP) enzyme, then ten times in 0.1% PBST, 
then cut longitudinally at the 62.5 kDa marker, and reblocked. The high molecular 
weight section of the blot was probed with α-FLAG to detect the tagged DUbs and 
the lower portion with α-tubulin. In order to optimalise loading, either the Ponceau 
S stained blot or the tubulin bands were quantified using Adobe Photoshop and the 
loading recalculated. 
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2.5. Saccharomyces cerevisiae Methods  
 
S. cerevisiae was used in Chapter 6 and the S. pombe methods above were 
utilised unless otherwise specified. Standard YPD-based media, which comprises 
yeast extract, peptone and dextrose, was utilised. All strains were a kind gift from 
Eva Hofmann, but originated from the European Saccharoymces Cerevisiae 
Archive for Functinal Analysis (EUROSCARF; see website link below; Brachmann 
et al., 1998). All strains were based on wild type “BY405” and the deleted genes 
were replaced by the kanMX4 cassette. The mutant strains were found to be able 
to grow on media containing G418, whereas the wild-type strain could not. 
Deletions were verified by isolating genomic DNA and amplifying the relevant 
locus, which was then sequenced. Also prior to counting with a haemocytometer, 
the cells were sonicated briefly.  
 
2.6. Computational Methods  
2.6.1. Thesis Production  
 
This thesis was created using Microsoft Word, Microsoft PowerPoint and Microsoft 
Excel on a Windows XP operating system. 
 
2.6.2. Useful Websites  
 
Literature searching:  
http://www.ncbi.nlm.nih.gov/sites/entrez 
 
S. pombe genome annotations: 
http://www.genedb.org/genedb/pombe/ 
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S. pombe information: 
http://www-rcf.usc.edu/~forsburg/index.html 
http://www.ebi.ac.uk/2can/genomes/eukaryotes/Schizosaccharomyces_pombe.htm
lhttp://www.biotwiki.org/twiki/bin/view 
 
Paul Nurse laboratory manual: 
http://www.biotwiki.org/bin/view/Pombe/NurseLabManual 
 
S. pombe genome BLAST software: 
http://www.genedb.org/genedb/pombe/blast.jsp 
 
RIKEN Chemical Genetics Laboratory: 
http://www.riken.jp/SPD/index.html 
 
S. cerevisiae genome annotations: 
http://www.yeastgenome.org/ 
http://www.genedb.org/genedb/cerevisiae/ 
 
S. cerevisiae EUROSCARF project: 
http://web.uni-frankfurt.de/fb15/mikro/euroscarf/index.html 
 
Genome annotations: 
http://www.uniprot.org/ 
http://www.genecards.org/index.shtml 
 
Protein structure information: 
http://www.rcsb.org/pdb/home/home.do 
 
Protein domain information: 
http://pfam.sanger.ac.uk/ 
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Protein structure analysis: 
http://www.umass.edu/microbio/chime/pe_beta/pe/protexpl/frntdoo2.htm 
 
Protein structure prediction: 
http://www.sbg.bio.ic.ac.uk/phyre/ 
 
Alignments: 
http://www.ebi.ac.uk/Tools/clustalw2/index.html 
 
BLASTs: 
http://www.ebi.ac.uk/Tools/psiblast/ 
 
Molecular biology: 
http://tools.neb.com/NEBcutter2/index.php 
 
Primer design: 
http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www_slow.cgi 
http://www.stratagene.com/qcprimerdesign 
 
Primer properties analysis: 
http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/Default.aspx 
 
Reverse complementation tool: 
http://www.bioinformatics.org/sms/rev_comp.html 
 
DNA sequencing: 
http://www.gatc-biotech.com/en/index.html 
 
Translation tool: 
http://us.expasy.org/tools/dna.html 
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Chapter 3: Identification and Disruption of 
Deubiquitinating Enzyme Genes in S. pombe 
 
3.1. Introduction 
 
There are many open questions with regard to the mechanism and employment of 
PRR. This study concentrates on an investigation of the role of deubiquitination in 
PRR. The species of fission yeast, S. pombe, was utilised. The main aim of this 
project is to identify a DUb enzyme capable of removing ubiquitin or ubiquitin 
chains from SpPCNA. This chapter discusses, firstly, evidence for ubiquitination and 
subsequent deubiquitination of SpPCNA. Secondly, DUb genes were identified in 
the S. pombe genome and the literature searched for roles of the encoded 
enzymes. Thirdly, the assembly of a DUb deletion library is explained. 
 
3.2. Evidence for PCNA Deubiquitination in S. pombe  
 
SpPCNA ubiquitination has already been described (Frampton et al., 2006). Figure 
3.1 depicts the cycle of appearance, persistence and subsequent disappearance of 
ubiquitinated species of SpPCNA following UVC irradiation. In this experiment, 
asynchronous wild-type S. pombe cells were grown to mid-log phase, irradiated 
with 100 J/m2 of UVC, and then allowed to recover. Samples were taken at the 
time points indicated. Each sample was TCA extracted and the whole cell extracts 
were fractionated by SDS-PAGE. Western blotting was then preformed and the 
blot probed with an anti-SpPCNA antibody, which was a kind gift from Dr. Felicity 
Watts.  
 
Following 100 J/m2 UVC, ubiquitinated forms of SpPCNA are apparent after 1 h. A 
single subunit of SpPCNA, which is encoded by the pcn1+ gene, is 260 amino acids 
long or 28.9 kDa. On a denaturing gel, a SpPCNA monomer runs at around the 32.5 
kDa marker. Two controls were also employed in this experiment, mock-irradiated 
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wild-type cells (not treated, NT), and a strain called pcn1-K164R (also a kind gift 
from Dr. Felicity Watts) where the ubiquitinated lysine of SpPCNA (lysine-164) has 
been mutated to an arginine. Low levels of ubiquitinated SpPCNA are seen in the 
mock treated, wild-type samples – it has previously been shown that SpPCNA is 
ubiquitinated at low levels every S-phase in unchallenged cells (Frampton et al., 
2006). No ubiquitinated forms of SpPCNA are seen in the pcn1-K164R strain 
following UVC irradiation. 
 
This experiment shows that following a high dose of UVC, ubiquitination of SpPCNA 
persists for many hours. Persistence of SpPCNA ubiquitination correlated with 
increased cell length (data not shown) implying the cells were blocked in G2 
repairing the damage – the cells were at their longest 11 h after irradiation. The 
following morning, a final sample was taken (24 h after irradiation), no SpPCNA 
ubiquitination was found, the cells had returned to normal cytology and were 
actively growing. Following lower doses of UVC, un-ubiquitinated SpPCNA was 
restored more quickly (data not shown). 
 
It is thought that SpPCNA is ubiquitinated in response to the occurrence of ssDNA 
following to replication fork blockage due to, for example, polymerase-blocking 
lesions resulting from UV irradiation. It is hypothesised that SpPCNA is 
deubiquitinated once cells have recovered from this crisis in order to prevent 
untimely PRR. 
 
Whilst there are other explanations for the disappearance of ubiquitinated forms of 
SpPCNA, proteasomal degradation for example, it is important to understand 
whether DUbs play a role in PRR in lower eukaryotes as has been shown for 
HsUSP1 in human cells.  
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3.3. Identification of Deubiquitinating Enzyme Genes in S. pombe 
 
S. pombe DUb genes were identified by database searching DUb catalytic and 
additional protein domain names and aliases. Table 3.1-4 depicts all the S. pombe 
DUbs experimentally considered in this study. The Table is arranged such that the 
DUbs are divided according to superfamily – the relevant rows are shaded in 
different colours, and the large UBP/USP superfamily is further divided according 
to any extra, well-known domains.  
 
The subsequent sections will summarise the literature surrounding each identified 
S. pombe DUb. Orthologues in humans and S. cerevisiae will be identified and 
their functions discussed, particularly when there is little or no information on the S. 
pombe version. The information provided is biased towards potential functions of 
additional domains, roles in carcinogenesis, and type of poly-ubiquitin chain 
disassembled. Alignments between orthologues were also performed in most 
cases, but only those alignments are shown herein where orthology has not 
previously been shown before.  
 
3.4. USP/UBP S. pombe DUbs Containing a DUSP Domain 
 
SpUbp1 and SpUbp12 share 32% sequence identity at the amino acid level, and are 
likely paralogous. In addition to the UBP/USP domain that confers catalytic 
function, SpUbp1 and SpUbp12 also contain an N-terminal DUSP (domain present in 
ubiquitin-specific proteases) domain, which, as its name suggests, is common in 
USP/UBP DUbs. The function of this domain, which is typically around 120 
residues in length, is not known. However, functions for DUSP domain-containing 
DUbs have been ascribed.  
 
Seven human UBP/USP superfamily DUbs contain this domain (de Jong et al., 
2006). HsUSP15, HsUSP4UNP and HsUSP11 all contain a DUSP domain N-terminal 
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to the catalytic domain, are a similar length, and are the likely orthologues of 
SpUbp1 and SpUbp12 (Kay Hofmann, personal communication). The DUSP domain 
of HsUSP15 has been solved, which revealed a novel α/β tripod structure, known 
as an AB3 fold, and the authors propose that it is involved in mediating protein-
protein interactions or direct substrate recognition (de Jong et al., 2006).  
 
A functional role of SpUbp12 was ascribed in 2003 by the Wolf group (Zhou et al., 
2003). The COP9 (constitutive photomorphogenic gene 9) -signalosome (CSN) is a 
multi-subunit complex with deneddylating activity. Cullins are a family of proteins 
important for the formation of Skp1-Cullin-F-box (SCF) complexes, which function 
as E3s. Deneddylation of cullins is inactivating because neddylated cullins have an 
enhanced affinity for E2s (Kawakami et al., 2001), hence the CSN functions to 
downregulate the E3 activity of SCF complexes. E3s able to ligate lysine-48-linked 
poly-ubiquitin chains are known to control their activity by auto-ubiquitination, which 
directs them for proteasome-mediated degradation. The Wolf group proposed that 
the CSN recruits SpUbp12 to F-box proteins for deubiquitination, which prevents 
degradation by their E3 neighbours, and hence, the CSN functions as a stabiliser 
of SCF assembly (Zhou et al., 2003; Wee et al., 2005). Furthermore, HsUSP15 was 
found to co-purify with the human CSN, and the ability of exogenously expressed 
HsUSP15 to stabilise HsRBX1, an SCF component containing the RING domain that 
confers the E3 activity to the SCF, was dependent upon a zinc finger domain found 
in the UBP/USP domain (Hetfeld et al., 2005).  
 
The authors found that many other UBP/USP DUbs also comprised this zinc finger 
integrated into the catalytic domain (Hetfeld et al., 2005). The same domain in the 
same position was found in another UBP/USP DUb called HsHAUSPUSP7 (Herpes-
associated ubiquitin-specific protease), but this was found to be “circularly 
permuted” and had lost its capacity to bind zinc (Krishna and Grishin, 2004; Hetfeld 
et al., 2005). However, the authors noted that the circularly permuted version was 
also found in other UBP/USP DUbs (Hetfeld et al., 2005). 
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The DUSP domain DUb HsUSP11, as mentioned in the Introduction, interacts with 
and, when overexpressed, can deubiquitinate HsBRCA2 (Schoenfeld et al., 2004). 
In this study, they also showed, as a control, that HsUSP11 cannot deubiquitinate 
mono-ubiquitinated HsFANCD2. HsUSP11 was found to be important in cellular 
survival following MMC treatment – knockdown of HsUSP11 resulted in sensitivity 
to MMC. However, the authors also found that MMC treatment up-regulated the 
poly-ubiquitination of HsBRCA2, which caused its degradation, in a HsUSP11-
independent manner. It was concluded that the “USP11 prosurvival functions, 
although shown to be BRCA2 dependent, appear to be mediated through a USP11 
substrate other than BRCA2” (Schoenfeld et al., 2004).   
 
Furthermore, levels of the alpha subunit of IκB kinase (HsIKKα) and Hsp53 are 
controlled by HsUSP11 (Yamaguchi et al., 2007a). In this study, it was shown that 
HsUSP11 knockdown resulted in decreased HsIKKα mRNA levels as measured by 
the real-time polymerase chain reaction (RT-PCR) technique. The mechanism of 
this transcriptional control is not known (Yamaguchi et al., 2007a). It had been 
previously shown that HsIKKα forms part of a pathway that stabilises and activates 
Hsp53 in response to reactive oxygen species (Yamaguchi et al., 2007b). HsUSP11 
also affects Hsp53 levels – it was demonstrated that HsUSP11 knockdown also 
resulted in reduced Hsp53 levels, whereas Hsp53 mRNA levels were unaffected 
(Yamaguchi et al., 2007a). 
 
The remaining SpUbp1 and SpUbp12 orthologue in humans, HsUSP4UNP, has been 
found to have altered levels in lung cancer cells (Gray et al., 1995; Frederick et al., 
1998). It has additionally been shown to interact with the important tumour 
suppressor protein HspRB (DeSalle et al., 2001). HsUSP4UNP comprises both a 
nuclear export signal and a nuclear localisation signal, and has been shown to 
have nucleo-cytoplasmic shuttling properties (Soboleva et al., 2005).  
 
HsUSP4UNP targets have also been identified. Tripartite motif containing protein 21, 
HsTRIM21Ro52, is a ribonucleoprotein particle with unknown function, and it has 
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been shown to interact with and be deubiquitinated by HsUSP4UNP (Wada et al., 
2006). HsTRIM21Ro52 comprises the tripartite RING-B-box-Coiled coil (RBCC) 
domain (this domain is also discussed in Chapter 5, section 5.5) and hence is an 
E3. The same group also showed in 2006 that HsTRIM21Ro52 ubiquitinates 
HsUSP4UNP and that HsUSP4UNP can auto-deubiquitinate (Wada and Kamitani, 
2006).  
 
3.5. S. pombe USP/UBP DUbs Containing a UBP-type Zinc Finger 
Domain 
 
There are four UBP/USP DUbs in S. pombe, SpUbp7, SpUbp8, SpUbp10 and 
SpUbp14Ucp2, that contain a UBP-type zinc finger domain, which is simply a zinc 
finger as found in many UBP/USP DUbs. It is not the same as the zinc finger found 
in the catalytic domain mentioned in section 3.3 above. The UBP-type zinc finger 
domain is also found in the human DUbs HsUSP3, HsUSP5IsoT1 (and the likely 
paralogous HsUSP13IsoT2), HsUSP16 (and the likely paralogous HsUSP45), 
HsUSP20VDU2 (and the likely paralogous HsUSP33VDU1), HsUSP22USP3L (and the 
likely paralogous HsUSP27 and HsUSP51), and HsUSP44 (and the likely paralogous 
HsUSP49; Kay Hofmann, personal communication;  Bonnet et al., 2008). This 
domain is also found in HsUSP39SNUT2, which is involved in spliceosome formation.  
 
The UBP-type zinc finger domain is also found in some non-DUb proteins, for 
example the cytoplasmic deacetylase, HsHDAC6, and BRCA1-associated protein 2 
(HsBRAP2). The latter is an RING E3 and there is an uncharacterised orthologue in 
S. pombe (gene identifier: SPAC16E8.13). The UBP-type zinc finger domain is 
also known as a BUZ domain (binder of ubiquitin zinc-finger) domain, a DAUP 
(deacetylase and ubiquitin-specific protease) domain, and a PAZ (polyubiquitin-
associated zinc-finger) domain.  
 
The likely human orthologues of SpUbp14Ucp2 are HsUSP5IsoT1 and HsUSP13IsoT2 
(Kay Hofmann, personal communication). HsUSP5IsoT1, which is also known as 
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HsIsopeptidaseT, has been well characterised and has been found to deubiquitinate 
unattached poly-ubiquitin chains. The likely S. cerevisiae orthologue of these DUbs 
is ScUbp14, which appears to have the same function as HsUSP5IsoT1 (Kay 
Hofmann, personal communication; Amerik et al., 1997). Deletion of ScUbp14 leads 
to the accumulation of free poly-ubiquitin chains and inhibition of the proteasome 
(Amerik et al., 1997). HsUSP5IsoT1 and ScUbp14 each comprise an N-terminal UBP-
type zinc finger domain, followed by the catalytic domain, which features two 
integrated ubiquitin-associated (UBA) domains. The crystal structure of the N-
terminal UBP-type zinc finger domain has been solved alone and in complex with 
ubiquitin, which revealed that it binds the unanchored C-terminus of ubiquitin, and 
binds ubiquitin with high affinity compared to other ubiquitin binding domains 
(Reyes-Turcu et al., 2006).  
 
Furthermore, Reyes-Turcu et al showed that the ubiquitin binding in the UBP-type 
zinc finger domain activated deubiquitinating catalysis by the UBP/USP domain. 
UBP-type zinc finger domain residues important for this were those that co-
ordinate Zn2+ and those that interact with ubiquitin (Reyes-Turcu et al., 2006).  
 
More recently, the same group has investigated the role of the UBA domains in 
HsUSP5IsoT1 function (Reyes-Turcu et al., 2008). This work showed that the UBA 
domains interact with the distal ubiquitins in linear and lysine-48-linked poly-
ubiquitin chains. In other words, when binding to a free poly-ubiquitin chain, the 
UBP-type zinc finger domain interacts with the proximal ubiquitin (ubiquitin-1), the 
catalytic domain interacts with ubiquitin-2, and the UBA domains interact with 
ubiquitin-3 and ubiquitin-4 (Reyes-Turcu et al., 2008).  
 
The structure of the UBP-type zinc finger domain of HsUSP33VDU1 has also been 
solved (Allen and Bycroft, 2007). There appears to be no S. pombe orthologue of 
HsUSP33VDU and the paralogous HsUSP20VDU2. These DUbs comprise an N-
terminal UBP-type zinc finger domain, followed by a central USP/UBP catalytic 
domain, and two C-terminal DUSP domains. It is pertinent to note here that 
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HsUSP33VDU1 was utilised as negative control in the paper that linked HsUSP1 to 
deubiquitination of HsPCNA, that is, HsUSP33VDU1 could not deubiquitinate HsPCNA 
(Huang et al., 2006).  
 
The structure of the UBP-type zinc finger domain of HsUSP33VDU1 differed slightly 
from that of HsUSP5IsoT1 and the domain was not found to bind ubiquitin (Allen and 
Bycroft, 2007). This was found to be intriguing by Bonnet et al because the 
ubiquitin-binding pocket and many ubiquitin-binding residues found to be important 
in the HsUSP5IsoT1 UBP-type zinc finger were conserved. So, Bonnet et al 
investigated the matter further by bioinformatically comparing the sequence of 
HsUSP5IsoT1 and HsUSP33VDU1 in addition to the UBP-type zinc finger domain of 
other proteins. They found a crucial ubiquitin-binding aspartate and arginine were 
serine and glutamate residues in HsUSP33VDU1. This would be incompatible with 
ubiquitin-binding. From this analysis, they were able to draw conclusions about the 
ubiquitin-binding capacity of UBP-type zinc finger domains in other DUbs. In 
particular, they concluded that the UBP-type zinc finger domain of HsUSP16UBP-M, 
HsUSP44, HsUSP45, and HsUSP49 can interact with ubiquitin, whereas that of 
ScUbp8, HsUSP22, and HsUSP20 cannot. Also, the authors imply it is unlikely that 
HsUSP13IsoT2 and HsUSP39 are able to bind ubiquitin (Bonnet et al., 2008). 
 
Interestingly, SpUbp14Ucp2 comprises two N-terminal UBP-type zinc finger domains, 
followed by the catalytic domain that also contains two UBA domains. The 
functional significance of two N-terminal UBP-type zinc finger domains is not 
known, and it would be interesting to see whether both domains are able to bind 
ubiquitin and the effect of ubiquitin-binding to one or both of the domains on 
catalytic activity. Only three other species, Aspergillus niger, Aspergillus oryzae, 
Chaetomium globosum (soil fungus), have SpUbp14Ucp2-like DUbs encoded within 
their genome with two N-terminal UBP-type zinc finger domains followed by a 
catalytic domain that also contains two UBA domains. No work on SpUbp14Ucp2 
itself has been published to date. 
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HsUSP13IsoT2 shows 55% identity at the protein level with HsUSP5IsoT1 and 
comprises the same domain structure (Timms et al., 1998). However, despite the 
extensive characterisation of its paralogue, HsUSP13IsoT2 is much less studied. 
Interestingly, a study showed that HsUSP13IsoT2 is expressed highly in the ovary 
and testes, whereas HsUSP5IsoT1 is highly expressed in brain cells and was not 
detected in the ovary (Timms et al., 1998). Also, both HsUSP5IsoT1 and HsUSP13IsoT2 
have been shown to be able to react with a suicide substrate of the HsISG15UCRP 
ubiquitin-like protein (Catic et al., 2007). In this study HsUSP2 and HsUSP14 were 
also identified, in addition to the HsISG15UCRP-specific protein HsUSP18.  
 
The likely human orthologues of SpUbp7 are HsUSP16UBP-M and HsUSP45 (Kay 
Hofmann, personal communication). A cellular function of HsUSP45 has not been 
described in the literature. However, the UBP-type zinc finger of HsUSP16UBP-M has 
also been shown to bind the C-terminus of unanchored ubiquitin and the authors 
conclude that the function of the UBP-type zinc finger is as a sensor for free 
ubiquitin in the cell (Pai et al., 2007). Based on the above studies, it seems likely 
that the UBP-type zinc finger of SpUbp7 is also able to bind ubiquitin. So far, 
HsUSP16UBP-M has been found to comprise only the UBP-type zinc finger and 
catalytic domains. HsUSP16UBP-M deubiquitinates mono-ubiquitinated histone H2A 
(but not H2B), which is important for mitotic chromosome condensation and 
caspase-induced apoptosis (Mimnaugh et al., 2001; Joo et al., 2007). HsUSP16UBP-
M is regulated by phosphorylation – the phosphorylated form is active, and siRNA 
knockdown results in cell cycle delay (Joo et al., 2007).  
 
It has been proposed that structural and sequence similarities between HsUSP27, 
HsUSP16UBP-M and HsUSP3 suggest similar activating functions for the UBP-type 
zinc finger in these proteins (Bonnet et al., 2008). The authors suggest that this 
domain in HsUSP16UBP-M and HsUSP3 functions as a free ubiquitin pool sensor, that 
is, their targets are only deubiquitinated when free ubiquitin levels are high enough 
– for example during particularly cell cycle phases (Bonnet et al., 2008). Congruent 
to HsUSP16UBP-M, HsUSP3 also deubiquitinates mono-ubiquitinated H2A, but also 
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H2B. It has also been shown that depletion of HsUSP3 causes S-phase delay, 
accumulation of DNA breaks in unchallenged cells as measured by comet assay, 
and checkpoint activation. Furthermore, HsUSP3 accumulates in γH2AX foci 
(Nicassio et al., 2007). No additional domains, other than the catalytic and UBP-
type zinc finger domains, have been ascribed to HsUSP3, and there is no likely 
orthologue of this enzyme in S. pombe.  However, it would be interesting to see 
whether SpUbp7 is able to undertake the functions of both HsUSP16UBP-M and 
HsUSP3, i.e. deubiquitinate histones in S. pombe, and whether SpUbp7 has any 
other roles in the DNA damage response. Furthermore, there is no SpUbp7 
orthologue in S. cerevisiae. H2A is not ubiquitinated in S. cerevisiae (Weake and 
Workman, 2008; Osley, 2006). No work on SpUbp7 has been published so far. 
 
The likely orthologues of SpUbp8 are ScUbp8, HsUSP22, HsUSP27 and HsUSP51 
(Kay Hofmann, personal communication). However, HsUSP27 and HsUSP51, whilst 
very similar to HsUSP22, are encoded by intronless genes and hence have 
questionable functionality (Bonnet et al., 2008). The Bonnet et al study also 
suggested that ScUbp8 and HsUSP22 cannot bind ubiquitin in their UBP-type zinc 
finger, which implies the same for SpUbp8.  
 
ScUbp8 and HsUSP22 are components of the Spt-Ada-Gcn5-acetyl transferase 
(SAGA) transcriptional co-activator complex, which links gene transcription with 
chromatin modifications (reviewed in Baker and Grant, 2007; Pijnappel and 
Timmers, 2008). HsUSP22 and ScUbp8 have been shown to deubiquitinate mono-
ubiquitinated H2B (Zhang et al., 2008c; Henry et al., 2003), and HsUSP22 has been 
shown to also deubiquitinate mono-ubiquitinated H2A (Zhang et al., 2008b). 
Interestingly, the ScPCNA ubiquitinator ScRad6 is also the E2 that catalyses H2B 
mono-ubiquitination, but in combination with a different E3 (reviewed in Game and 
Chernikova, 2009). The same function has been ascribed to SpRhp6 (Zofall and 
Grewal, 2007). No work on SpUbp8 has been published. 
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HsUSP39SNUT2 also comprises an N-terminal UBP-type zinc finger, although the 
catalytic domain is inactive (Makarova et al., 2001; van Leuken et al., 2008). 
HsUSP39SNUT2 is involved in spliceosome maturation. The likely orthologues of 
HsUSP39SNUT2 are snRNP (small nuclear ribonucleoprotein particle) assembly-
defective protein 1 (ScSad1) and SpUbp10 (Makarova et al., 2001; Kay Hofmann, 
personal communication). ScSad1 has also been implicated in spliceosome 
maturation, and is essential in S. cerevisiae (Lygerou et al., 1999). ScSad1 was 
found to be involved in the de novo assembly of one of the particles required for 
splicing, and in splicing itself (Lygerou et al., 1999). It is important to note here that 
ScSad1 is a different protein from ScRad53Sad1 (gene identifier: YPL153C). 
However, HsUSP39SNUT2 has also been found to be necessary for spindle 
checkpoint maintenance and for cytokinesis (van Leuken et al., 2008). The authors 
found a dramatic reduction in the mRNA levels of HsAuroraB when HsUSP39SNUT2 
was knocked down, and they suggested that HsUSP39SNUT2 has a role in splicing of 
HsAurora B mRNA and maybe the mRNA of other spindle checkpoint proteins (van 
Leuken et al., 2008). There no publications studying SpUbp10 in the literature. Also, 
SpUbp10 is not an alias for the spindle pole body protein, SpSad1 (SPBC16H5.01c).  
 
3.6. S. pombe USP/UBP DUbs Containing Ubiquitin-like Domains 
 
SpUbp6 comprises an N-terminal ubiquitin-like domain. The S. cerevisiae and H. 
sapiens orthologues, ScUbp6 and HsUSP14, respectively, have been well     
characterised due to their important role in the ubiquitin-proteasome system (UPS; 
reviewed in Reyes-Turcu et al., 2009; Reyes-Turcu and Wilkinson, 2009). Before 
entering the 20S proteolytic proteasome cylinder, proteins to be degraded must be 
deubiquitinated and unfolded by the lid portion of the 19S regulatory particle that 
associates with the 20S proteasome. Hence, the lid comprises subunits with DUb 
activity. Additionally, free DUbs associate with the proteasome to aid 
deubiquitination. The resulting free ubiquitin is recycled by the cell. ScUbp6 and its 
human counterpart HsUSP14 are the latter – free, proteasome-associated DUbs. 
The N-terminal ubiquitin fold of ScUbp6 and HsUSP14 is used to dock with the 
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proteasome lid, and this docking strongly stimulates the DUb activity (Leggett et 
al., 2002; Hu et al., 2005). In other words, the proteasome acts as a cofactor to 
these DUbs. It has also been shown that HsUSP14 trims poly-ubiquitin chains from 
the distal end (Hu et al., 2005; Reyes-Turcu and Wilkinson, 2009). 
 
ScUbp6 deletion results in reduced cellular pools of free ubiquitin and severely 
impinges upon growth in stress conditions (Leggett et al., 2002). Congruent to this, 
MmUSP14 mutation resulted in reduced ubiquitin levels in mouse brain and ataxia 
(Wilson et al., 2002; Crimmins et al., 2006). 
 
SpUbp6 has been studied during a research project on proteasome-associated 
fission yeast DUbs (Stone et al., 2004). Most SpUbp6 was found to be bound to 
26S proteasome, and to co-operate with different proteasome subunits to those 
found in humans and budding yeast. However, unlike ScUbp6 (Leggett et al., 2002), 
SpUbp6 seems to have more of a structural role rather than functioning as the 
principal proteasome-associated DUb as is found in budding yeast (Stone et al., 
2004). 
 
An important, recent bioinformatics study identified ubiquitin-like domains in 
numerous UBP/USP DUbs (Zhu et al., 2007). In fact, the authors concluded that 
“[this] domain can be regarded as the most frequently occurring domain in the 
human USP family, after the characteristic protease core domain”. An N-terminal 
ubiquitin fold was found inbetween the DUSP and catalytic domains of HsUSP4UNP, 
HsUSP11, HsUSP15 (orthologous to SpUbp1 and SpUbp12) and HsUSP32 (Zhu et al., 
2007). An ubiquitin fold was also found embedded in the catalytic core (within the 
zinc finger) of these four DUbs, and also in HsUSP6, HsUSP19, HsUSP21, and 
HsUSP43. One N-terminal ubiquitin fold was found in each of HsUSP9XFAFX, 
HsUSP9YFAFY, HsUSP24, HsUSP34, and HsUSP47. Finally, multiple C-terminal 
ubiquitin folds were found in HsUSP47, HsUSP40 and also HsHAUSPUSP7, which is 
the human orthologue of SpUbp21 and SpUbp22.  
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The authors of this study discuss the functional significance of the ubiquitin fold in 
UBP/USP superfamily DUbs. They propose two main roles: firstly, to modulate the 
deubiquitination of targets, and secondly, for binding to cofactors (Zhu et al., 2007). 
With respect to the first role, they suggest that the domain may function to auto-
inhibit DUb function by competing directly with ubiquitinated targets. They also 
propose that when integrated into the catalytic domain, the ubiquitin fold modulates 
the specificity of the DUb toward particular types of ubiquitination. They note that 
work with HsUSP15 showed that the cysteine residue that co-ordinated zinc in the 
catalytic domain abrogated poly-ubiquitin chain deubiquitination but not the 
deubiquitination of a ubiquitin-GFP fusion (Hetfeld et al., 2005; Zhu et al., 2007). 
Zhu et al imply that the ubiquitin fold that nests in the middle of the zinc finger likely 
has a role in target specificity as well – presumably guilt by association. With 
regard to the latter role, they suggest that the ubiquitin-like domain in a DUb may 
be used to dock with the proteasome akin to ScUbp6/HsUSP14. They further 
propose, due to the discovery of an ubiquitin fold in the N-terminus of HsUSP15, 
that the mechanism by which HsUSP15 associates with the CSN may be analogous 
to the docking of ScUbp6/HsUSP14 with the proteasome (Zhu et al., 2007).  
 
SpUbp21 and SpUbp22 both comprise an N-terminal meprin and tumour necrosis 
factor receptor associated factor (MATH) domain, in addition to a UBP/USP 
catalytic domain with a circularly permuted zinc finger. Published work on SpUbp21 
and SpUbp22 links them to pre-mRNA splicing (Richert et al., 2002). The human 
orthologue of these DUbs is the highly characterised HsHAUSPUSP7, which has a 
role in responses to DNA damage (reviewed in Brooks and Gu, 2006). In addition – 
as alluded to briefly above – four ubiquitin-like domains were found in the C-
terminus of HsHAUSPUSP7 (Zhu et al., 2007). Furthermore, Zhu et al mention the 
existence of other ubiquitin-like domains within HsHAUSPUSP7 that were not 
reported in the study due to scores below the significance threshold. SpUbp21, 
SpUbp22 and orthologues will be discussed extensively from Chapter 5 onwards. 
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3.7. Other S. pombe UBP/USP DUbs  
 
SpUbp13 is the likely orthologue of ScPan2 and HsUSP52 (Kay Hofmann, personal 
communication). No work characterising SpUbp13 has been published. SpUbp13, 
ScPan2, and HsUSP52 share very similar domain structures – no domains have 
been identified within the N-terminus, but their C-termini each comprise a 
UBP/USP catalytic domain followed by an exonuclease domain, which is found in 
ribonucleases and replicative DNA polymerases. ScPan2 and HsUSP52 have both 
found to have roles in mRNA poly(A) tail editing (Boeck et al., 1996). 
 
However, more recently, a link between ScPan2 and the DNA damage response 
has been reported (Hammet et al., 2002). DNA-damage Un-inducible 1 (ScDun1) is 
a serine/threonine protein kinase activated by DNA damage. It is important in the 
DNA damage response because it transcriptionally upregulates genes whose 
protein products are important in the response. Hammet et al showed that ScDun1 
collaborates with the PAN to stabilise rad5 mRNA, and that this was an important 
post-transcriptional mechanism action for DNA damage checkpoint effectors 
(Hammet et al., 2002).  
 
SpUbp11 comprises the UBP/USP catalytic motif from residues 36 to 341, plus a 
predicted transmembrane helix between residues 20 and 39. ScUbp1 is the likely 
orthologue of SpUbp11, despite the former being double the size of the latter (Kay 
Hofmann, personal communication). ScUbp1 comprises the UBP/USP catalytic 
motif from residues 98 to 735, plus a predicted transmembrane helix between 
residues 34 and 51. No work characterising SpUbp11 has been published, however 
ScUbp1 has been implicated in endocytosis (Schmitz et al., 2005). In this study, 
they found that two independent myc-tagged forms of ScUbp1 were expressed from 
an integrated ubp1-13myc gene: a membrane-anchored form (ScmUbp1) and a 
soluble version (ScsUbp1). They found that ScmUbp1 behaved like an integral 
membrane protein, and was most likely localised to the ER. The majority of 
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ScsUbp1 was found in the soluble fraction, but a small triton-resistant fraction was 
also likely localised to membrane rafts or a large protein complex.  
 
Overexpression of ScUbp1 stabilised the ATP-binding cassette (ABC) transporter 
ScSte6 (Schmitz et al., 2005). ScSte6 is a multi-membrane spanning protein, is the 
yeast orthologue of HsP-glycoprotein (encoded by the multi-drug resistance 1 
[MDR1] gene) and transports the S. cerevisiae mating pheromone α-factor 
(Raymond et al., 1992). When degraded, ScSte6 is ubiquitinated and carried to the 
vacuole by the multi-vesicular body (MVB) system. Hence, the authors propose 
that ScUbp1 regulates this (Schmitz et al., 2005).  
 
No clear orthologue of either ScUbp1 or SpUbp11 is present in humans (Kay 
Hofmann, personal communication). However, evidence has been put forward 
suggesting that the human orthologue of ScUbp1, which is not identified, processes 
HsISG15UCRP precursors (Potter et al., 1999). The authors purified the HsISG15UCRP 
precursor processing enzyme and sequenced a fragment of it, which was found to 
have “significant” homology with only ScUbp1 and a putative E3 called HsRNF144A. 
However, there is no HsISG15UCRP ubiquitin-like protein in yeast and ScUbp1 cannot 
process HsISG15UCRP precursors in vitro (Potter et al., 1999). 
 
Aside of their catalytic motifs, five DUbs in S. pombe, SpUbp2, SpUbp3, SpUbp4, 
SpUbp9, SpUbp16, contain no other domains that are clearly defined in databases. 
However, research of the literature indicates that other domains are present in the 
budding yeast and human counterparts of some of these DUbs.  
 
With 1141 amino acids (130.2 kDa), SpUbp2 is the largest DUb in S. pombe.  
SpUbp2 is the likely orthologue of ScUbp2, HsUSP25 and HsUSP28 (Kay Hofmann, 
personal communication). ScUbp2 is slightly larger at 1272 residues and shares 
significant homology with SpUbp2, and the UBP/USP catalytic domain occupies the 
entire C-terminal half of these proteins. HsUSP28 and HsUSP25 are slightly smaller 
than SpUbp2. Unlike SpUbp2 and ScUbp2, the catalytic domain takes a central 
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position in the primary sequence of HsUSP28 and HsUSP25. However, HsUSP25 
and HsUSP28 share homology in their C-termini. The Pfam database also states 
that HsUSP25 comprises two ubiquitin-interacting motifs (UIM domains) in its 
amino-terminus.  
 
ScRsp5 is an essential HECT E3 with pleiotropic functions. For example, it 
regulates fatty acid biosynthesis pathway components (Kaliszewski and Zoladek, 
2008), and has been shown to ubiquitinate an RNA polymerase II subunit, directing 
it for proteasome-mediated degradation (Huibregtse et al., 1997). ScUbp2, in 
combination with the UBA domain containing cofactor ScRup1, regulates ScRsp5 
activity. Furthermore, ScRsp5 assembles lysine-63-linked poly-ubiquitin chains and 
ScUbp2–ScRup1 can disassemble them (Kee et al., 2005). In another study, a rsp5-
1 mutant was found to be sensitive to hydroxyurea (HU), an agent that stalls 
replication forks (Lu et al., 2008). HU inhibits ribonucleotide reductase (RNR) – the 
enzyme that converts ribonucleotides into deoxyribonucleotides for use by DNA 
polymerases. The authors explain this phenotype with evidence that ScRsp5 
ubiquitinates the RNR subunit ScRnr2 (Lu et al., 2008). The ScRsp5–ScUbp2–
ScRup1 E3–DUb complex is involved in MVB pathway, and has been shown to 
control the endocytosis of an uracil permease called ScFur4 (Lam et al., 2009). 
 
As alluded to in Chapter 1, HsUSP28 has a role in signalling the presence of DNA 
damage. HsUSP28 interacts with Hs53BP1, HsClaspin and HsMdc1, which react to 
the presence of DSBs, particularly caused by IR, in the genome and transduce the 
signal to checkpoint kinases (Zhang et al., 2006). The function of this interaction is 
thought to protect these important proteins from unscheduled direction to the 
proteasome (Zhang et al., 2006). The yeast orthologues of Hs53BP1 are ScRad9 
and SpCrb2Rhp9, and of HsClaspin are ScMrc1 and SpMrc1. HsUSP28 has also been 
shown to be phosphorylated by the checkpoint kinases HsATM and HsATR 
(Matsuoka et al., 2007), the yeast equivalents of which are known as ScTel1 and 
SpTel1, and ScMec1 and SpRad3, respectively.  
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Hsc-MYC is a transcription factor involved in promoting cell cycle progression. 
Following DNA damage, levels of Hsc-MYC reduce in the cell, which correlates with 
the responses to genetic insult that halt the cell cycle to allow repair. F-box WD 
repeat-containing protein 7 (HsFBW7) is an F-box protein that forms a SCF E3 
which ubiquitinates Hsc-MYC causing it to be degraded. HsFBW7 is the substrate 
recognition portion of its SCF E3. HsUSP28 deubiquitinates nucleolar Hsc-MYC in 
the nucleolus by binding to the isoform of HsFBW7 that is expressed in the 
nucleolus, HsFBW7α (Popov et al., 2007). Hence, HsUSP28 stabilises Hsc-MYC by 
antagonising the Hsc-MYC–HsFBW7α interaction. HsUSP28 has also been shown to 
be a proto-oncogene – it is upregulated in colon and breast cancer cells (Popov et 
al., 2007). 
 
Little work has been published on HsUSP25 and its cellular function is not known. 
However, the UIM domains of HsUSP25 have recently shown to be sumoylated by 
multiple SUMO modifiers (Meulmeester et al., 2008). In this interesting study, the 
authors state that the domain structure (from N- to C-termini) of HsUSP25 is as 
follows: UBA; UIM-1; UIM-2; UBP/USP; predicted coiled-coil domain. It was shown 
that HsUSP25 is able to efficiently hydrolyse both lysine-48-linked and lysine-63-
linked tetra-ubiquitin. Furthermore, the UIM domains but not the UBA domain, were 
found to be important for efficient poly-ubiquitin chain hydrolysis, of either linkage. 
The authors found that HsUSP25 interacts more efficiently with SUMO-3 than 
SUMO-1, and a SUMO interaction motif (SIM) was found in UIM-1. Moreover, 
sumoylation of HsUSP25 was found to be dependent upon its SIM, and sumoylation 
of HsUSP25 by SUMO-3 is 2-3x more efficient than with SUMO-1. The sites of 
sumoylation were found to be lysine-99 and -141, which are within UIM-1 and next 
to UIM-2, respectively, and these sites do not fall within the canonical KxE 
context known for sites of sumoylation. Taken together, the authors predicted that 
sumoylation of the UIM would negatively affect the DUb activity of HsUSP25, and 
this was found to be true with regard to tetra-ubiquitin. Hence, the authors 
conclude that sumoylation of HsUSP25 acts to control its DUb activity on poly-
ubiquitin chains (Meulmeester et al., 2008). 
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No investigations into SpUbp3 function have been published. The likely orthologues 
of this DUb are ScUbp3Blm3 and HsUSP10 (Kay Hofmann, personal communication). 
ScUbp3Blm3 is a 912 amino acid protein wherein the catalytic domain occupies the 
C-terminal half of the protein. Its function in autophagy has been investigated. 
ScUbp3Blm3 binds its cofactor brefeldin A sensitivity 5 (ScBre5) – brefeldin A is a 
lactone-based antibiotic that inhibits GTPase proteins involved in particular 
autophagy pathways. The interaction between ScUbp3Blm3 and ScBre5 was first 
shown to be important in stabilising ScSec23, which is important in the transport 
between the ER and the Golgi apparatus, from proteasomal degradation (Cohen et 
al., 2003a). The ScUbp3Blm3–ScBre5 complex has also been shown to be important 
in NHEJ in response to a DSB-inducing agent called phleomycin (Bilsland et al., 
2007). Indeed, ScUbp3Blm3 was originally identified because mutants were sensitive 
to the similar DSB-causing agent bleomycin (Moore, 1991). A crystal structure of 
the ScUbp3Blm3–ScBre5 complex has confirmed that it is the nuclear transport factor 
2 (NTF2)-like domain of ScBre5 mediated the interaction with ScUbp3Blm3 and that 
ScUbp3Blm3 residues 208 to 211 were particularly important for this – mutation of 
these residues severely abrogated ScSec23 deubiquitination (Li et al., 2007). 
Interestingly, the Pfam database suggests that the N-terminus of ScUbp3Blm3 
resembles the N-terminus of HsUSP21. ScUbp3Blm3 has also been implicated in 
inhibiting silencing of transcription at silent mating type loci and telomeres (Moazed 
and Johnson, 1996). 
 
HsUSP10 has not been well characterised. HsUSP10 is a 798 amino acid protein 
where, like ScUbp3Blm3, the catalytic domain occupies the C-terminal half of the 
protein. However, a poly(A)-binding protein (PABP)-interacting motif 2 (PAM2) has 
been found between residues 78 and 95 in the N-terminus of HsUSP10 (Albrecht 
and Lengauer, 2004). The function of this domain is not known, but it is particularly 
found in eukaryotic proteins that are involved in RNA metabolism processes 
(Albrecht and Lengauer, 2004).  
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The N-terminus of HsUSP10 has been shown to interact with HsRAS GTPase 
activating protein (HsRAS-GAP) SH3 domain binding protein 1 (HsG3BP1), which 
was found to inhibit the DUb activity of  HsUSP10 (Soncini et al., 2001). HsG3BP is 
thought to be important in HsRAS signalling when HsRAS is in its active 
conformation (Parker et al., 1996). Residues 52 to 280 of HsUSP10 mediated the 
interaction with HsG3BP1, but the molecular basis for the inhibition of HsUSP10 is 
not known (Soncini et al., 2001). Interestingly, the human orthologues of ScBre5 are 
thought to be HsG3BP1 and HsG3BP2, and HsUSP10 has also been shown to 
interact with the latter (Cohen et al., 2003b). Despite the inhibitory effect of 
HsG3BP1 on HsUSP10, it has been proposed that HsUSP10 acts in an evolutionary 
conserved way to ScUbp3Blm3 in regulating transport between the Golgi apparatus 
and the ER (Cohen et al., 2003b).  
 
The rhodanese domain is a sulfur-binding motif that has sulfurtransferase activity. 
Three UBP/USP DUbs in S. cerevisiae, ScDoa4Ubp4, ScUbp5, and ScUbp7, possess 
this additional domain, whereas it is not represented in S. pombe. Having said this, 
bioinformatics suggest that SpUbp4 is the true orthologue despite the fact that it has 
lost its rhodanese domain (Kay Hofmann, personal communication). A human 
orthologue also exists, HsUSP8UBPY (Kay Hofmann, personal communication), 
which is important in the inhibition of endocytotic internalisation of EGFRs (Mizuno 
et al., 2005). The crystal structure of the rhodanese domain of HsUSP8UBPY in 
combination with an E3 called neuregulin receptor degradation protein-1 
(HsNRDP1) has been solved (Avvakumov et al., 2006). HsUSP8UBPY also harbours a 
microtubule interaction and transport (MIT) domain, as does the JAMM domain 
DUb HsAMSH (Row et al., 2007), which is discussed below. Both HsUSP8UBPY and 
HsAMSH, compete for the same binding site on HsSTAM via their respective SBMs 
(HsSTAM-binding motifs), which has been investigated by a collaboration between 
the Urbé, Clague and Prior laboratories (Row et al., 2006). SpUbp4 is significantly 
shorter then its human and budding yeast counterparts and an alignment suggests 
that there is no MIT domain present (data not shown). There are no SpUbp4 studies 
published in the literature. 
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The S. cerevisiae and H. sapiens orthologues of SpUbp9 are ScUbp9 and ScUbp13, 
and HsUSP12UBH1 and HsUSP46 (Kay Hofmann, personal communication). The 
orthology of ScUbp9 and ScUbp13 with HsUSP12UBH1 has also been demonstrated 
independently (Hansen-Hagge et al., 1998). The S. cerevisiae orthologues are 
~750 residues, SpUbp9 is 583 residues, and the human orthologues are ~370 
residues. No cellular function has been ascribed to any of these proteins.  
 
SpUbp16 has no clear S. cerevisiae orthologues, but is orthologous to HsUSP17, 
HsUSP36 and HsUSP42 (Kay Hofmann, personal communication). HsUSP17 is 
encoded by one member of a family of USP17-like genes that share over 95% 
homology (Burrows et al., 2005). The USP17 gene is found in a highly 
polymorphic, megasatellite repeat found on chromosomes 4 and 8, and the copy 
number varies between 20 and ~100. Thirteen HsUSP17-like proteins have been 
indentified HsUSP17A-J and HsDUB1-3 (Burrows et al., 2005). Recently, the 
localisation of HsRAS has been shown to be controlled by the deubiquitinating 
activity of HsUSP17 (Burrows et al., 2009). Other DUbs in this family have been 
shown to be involved in cytokine signalling. For example, cells overexpressing 
HsDUB-1 became blocked in G1 (Zhu et al., 1996a), and HsDUB-1 mRNA was 
shown to be induced by the cytokines interleukin-3 and -5 (Zhu et al., 1996b).  
 
Little is known about the other SpUbp16 orthologues HsUSP36 and HsUSP42. 
HsUSP36 has been shown to be important in regulating the nucleolus (Endo et al., 
2009). HsUSP42 has been implicated in acute myeloid leukemia (AML). The runt-
related transcription factor 1 (HsRUNX1AML1) is important for normal haematopoiesis 
and is known to be mutant in various leukaemias (reviewed in Wang et al., 2009). 
A study has shown that a mutation found in AML involves the fusion of 
HsRUNX1AML1 with HsUSP42 (Paulsson et al., 2006).  
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3.8. S. pombe UCH DUbs  
 
Two UCH DUbs are encoded in the S. pombe genome, SpUch1 and SpUch2 (Li et 
al., 2000). The larger, latter DUb has a C-terminal extension in addition to the 
catalytic domain and hence is the orthologue of the proteasome-associated 
HsUCH37UCH-L5 (Li et al., 2000). It has been shown that whilst a uch2∆ strain was 
found to be viable, SpUch2 was responsible for the majority of DUb activity at the 
proteasome (Li et al., 2000; Stone et al., 2004). Stone et al concluded that, in vivo, 
other DUb enzymes compensate for the lack of SpUch2. This was found to be 
different to budding yeast, which has no HsUCH37UCH-L5 orthologue, where it has 
been shown that ScUbp6 confers the majority of proteasomal DUb activity (Leggett 
et al., 2002). It has also recently been shown that HsUCH37UCH-L5 is a component of 
the INO80 chromatin remodelling complex and that this complex and the 
proteasome may act in concert to modulate DNA repair and transcription (Yao et 
al., 2008b). 
 
SpUch1 appears more similar to ScYuh1, HsUCH-L1 and HsUCH-L3 (Johnston et al., 
1997; Li et al., 2000). HsUCH-L3 HsUCH-L1 is exclusively expressed in neurons 
(Wilson et al., 1988), and has been found to be mutant in Parkinson’s disease (PD) 
and altered in Alzheimer’s disease (AD; reviewed in Setsuie and Wada, 2007).  
 
In summary, increased amounts of oxidatively modified HsUCH-L1 has been found 
in the brains of PD and AD patients, and decreased levels of soluble HsUCH-L1 
correlate with increased neurofibrillary tangles, within which HsUCH-L1 is known to 
be present, have been found in AD. A toxic gain of function mutation, whereby 
isoleucine-93 is mutated to methionine in HsUCH-L1, has been found in German 
family with PD. This mutation was shown to reduce the DUb activity by nearly half 
and caused the protein to be found in more cellular aggregates (Setsuie and 
Wada, 2007).  
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Interestingly, E3 functionality has also been ascribed to homo-dimerised HsUCH-L1 
(Liu et al., 2002). Furthermore, a S18Y polymorphism is responsible for a reduced 
risk for PD and is dependent upon the E3 activity – HsUCH-L1 with the S18Y 
mutation were less likely to from dimers compared to wild-type (Liu et al., 2002). 
 
A control mechanism for HsUCH-L1 has been reported whereby lysines near the 
active site of HsUCH-L1 are mono-ubiquitinated, which inhibits ubiquitin binding 
(Meray and Lansbury, 2007). The modification can be removed by auto-
deubiquitination (Meray and Lansbury, 2007).  
 
The remaining H. sapiens, and important BRCA1-associated, UCH DUb, HsBAP1, 
is not thought to be orthologous to either SpUch1 or SpUch2. 
 
3.9. S. pombe PPPDE DUbs  
 
There is one PPPDE superfamily DUb known in S. pombe called SpHag1Mug67, 
which is the smallest DUb in S. pombe at only 201 amino acids (21.9 kDa). 
SpHag1Mug67 is the orthologue of HsPNAS4FAM152A, which was originally identified as 
a pro-apoptotic protein in the human acute PML cell line NB4 (Iyer et al., 2004). It 
has been reported that the gene encoding HsPNAS4FAM152A is activated early in 
response DNA damage (Zhang et al., 2008a). There have been reports that it is 
important in development, and recent work using the zebrafish orthologue have 
confirmed this (Yao et al., 2008a). Both SpHag1Mug67 and HsPNAS4FAM152A are very 
small and consist almost entirely of the papain-like PPPDE fold. 
 
It is important to mention here that the S. pombe protein SpLub1 was also included 
in this study. With the benefit of hindsight, this inclusion was in error. Confusion in 
the literature implied that SpLub1, which has the orthologues HsPLAPPLAA and 
ScUfd3Doa1, was a divergent PPPDE member. This was later found to be not the 
case.  
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In the study that identified the PPPDE superfamily, certain PPPDE eukaryotic 
family 1 members from fungi were found to have the PPPDE domain fused to a N-
terminal thioredoxin domain followed by an uncharacterised C-terminal domain 
(Iyer et al., 2004). The authors searched for other proteins that contained this 
domain and found the proteins human phospholipase A2-activating protein 
(HsPLAPPLAA), ScUfd3Doa1 and SpLub1, and named it a PUL domain. These three 
proteins contain an N-terminal WD40 β-propeller domain, an HsPLAPPLAA family 
ubiquitin binding (PFU) domain, followed by the C-terminal PUL domain. They do 
not contain the PPPDE papain-like motif that confers DUb activity to the true 
PPPDE members SpHag1, HsPNAS4FAM152A and HsFAM152B. Proteins with a 
conserved (WD40)n—PFU—PUL structure are found in most eukaryotes, although 
the number of WD40 repeats (n) varies. Work in S. cerevisiae revealed that the 
PFU and PUL domains of ScUfd3Doa1 were required for the formation of a ternary 
complex with ScCdc48p97/VCP (discussed below) and ubiquitin, and the PFU and 
PUL domains were purported to be novel ubiquitin-binding motifs (Mullally et al., 
2006). ScUfd3Doa1 was originally found to be associated with the ubiquitin-fusion 
degradation pathway, and when ScUfd3Doa1 is absent, a depletion in cellular mono- 
and poly-ubiquitin results (Johnson et al., 1995).  
 
3.10. S. pombe OTU DUbs  
 
No work on either SpOtu1 or SpOtu2 has been published. ScOtu1, the S. cerevisiae 
orthologue of the former, however, has been found to interact with ScCdc48p97/VCP 
and be involved in the OLE pathway of fatty acid biosynthesis (reviewed in Jentsch 
and Rumpf, 2006). ScCdc48p97/VCP is a chaperone-like protein that binds and 
escorts poly-ubiquitinated proteins to the proteasome for degradation, particularly 
in the ER-associated protein degradation (ERAD) pathway. ScCdc48p97/VCP is a 
barrel-shaped, hexameric, AAA ATPase (reviewed in Halawani and Latterich, 
2006). ScUfd3Doa1 has been shown to interact with ScCdc48p97/VCP and ScOtu1, and 
ScUfd3Doa1 inhibits the function of ScCdc48p97/VCP – it acts as a negative regulator of 
protein degradation (Rumpf and Jentsch, 2006). The same study showed that 
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ScOtu1 was able to deubiquitinate lysine-48-linked poly-ubiquitin chains and 
interacts with ScCdc48p97/VCP via its N-terminus, which is alleged to comprise an 
UBX-like domain (Rumpf and Jentsch, 2006; Messick et al., 2008). The UBX 
domain has been said to be similar to the UBA domain and an important binding 
module in the ERAD pathway (reviewed in Grabbe and Dikic, 2009a; Buchberger 
et al., 2001). The UBX domain actually comprises an ubiquitin fold. ScOtu1 has also 
been found to contain a C2H2 zinc finger at its C-terminus (Bohm et al., 1997). 
 
Figure 3.2 depicts an alignment between ScOtu1 and its orthologues in S. pombe, 
SpOtu1, and H. sapiens, HsOTU1YOD1, which share about 30% identity with each 
other. This alignment is included here because no mention of the orthology 
between these DUbs was found in the literature. The cysteine and histidine 
residues in the C2H2 zinc finger are completely conserved between these 
organisms. Only weak homology was found at the N-terminus – the UBX domain is 
thought to occupy the first 86 residues of ScOtu1 (Messick et al., 2008).  
 
The crystal structure of the C-terminus (residues 87 to 301) of ScOtu1 has also 
recently been solved (Messick et al., 2008), which, as expected, was found to be 
analogous to the crystal structure of its fellow OTU DUb HsOtubain 2 (Nanao et al., 
2004). This study also showed that ScOtu1 had very little activity on lysine-63 and -
29-linked poly-ubiquitin chains and preferred to bind lysine-48-linked poly-ubiquitin 
chains over mono-ubiquitin.  
 
SpOtu2 and ScOtu2 share 31% sequence identity, no work on either has been 
published. No mention of the human counterpart of these DUbs was found in the 
literature. A PSI-BLAST using the amino acid sequence of ScOtu2 as a query 
revealed the closest human homologues to be HsOTUD6B and HsOTUD6A, which 
had E-values of 4e-35 and 3e-24 (very high significance), respectively, and share 
56% identity with each other. Between the yeast and human proteins, SpOtu2 and 
HsOTUD6B were most similar with an identity of 32%, and ScOtu2 and HsOTUD6A 
were least similar at 25% identity. An alignment between with these four DUbs is 
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shown in Figure 3.3. Cellular roles for these DUbs have not been ascribed, 
although ScOtu2 has been identified as a weak interactor of ribosomal complexes 
(Fleischer et al., 2006). 
 
3.11. S. pombe JAMM DUbs  
 
Seven JAMM domain-containing proteins were found in S. pombe, two proteasome 
lid subunit DUbs, SpRpn11Pad1 and SpRpn8; two translation elongation factors 
SpeIF3f and SpeIF3h; the CSN component SpCsn5; and SpAmshSst2. Like in S. 
cerevisiae, there is no known HsCSN6 orthologue in S. pombe. According to the 
Hofmann and Glickman study, SpRpn11Pad1, SpCsn5 and SpAmshSst2 contain the 
Zn2+ co-ordinating MPN+ residues, whereas SpRpn8, SpeIF3f and SpeIF3h do not 
(Maytal-Kivity et al., 2002). From the structural study outlined in Chapter 1, it is 
unlikely that the latter proteins function as active DUbs (Tran et al., 2003).  
 
An HsAMSH paralogue called HsAMSH-LP also exists – these proteins share 56% 
amino acid sequence identity (Kikuchi et al., 2003). However, HsAMSH-LP was 
found to be unable to interact with HsSTAM – the authors concluded that this was 
because a key residue in its SBM was a threonine, whereas it is a lysine in 
HsAMSH. The consensus for interactions with HsSTAM, as exists in the SBM of 
HsAMSH and HsUSP8UBPY, has been shown to be Px(V/I)(D/N)RxxKP (Kato et al., 
2000). Like HsAMSH (McCullough et al., 2004), HsAMSH-LP has also been shown 
to be active on lysine-63-linked poly-ubiquitin chains (Nakamura et al., 2006). 
Furthermore, a crystal structure of HsAMSH-LP in complex with lysine-63-linked di-
ubiquitin has been solved (Sato et al., 2008). 
 
SpAmshSst2 has been shown, congruent to its human counterpart, to function in the 
MVB pathway (Iwaki et al., 2007). The authors found 31% identity between 
SpAmshSst2 and HsAMSH at the amino acid level, but did not find the correct SBM 
required for HsAMSH to interact with its substrate HsSTAM. An alignment shows that 
the SBM of SpAmshSst2 reads PxYTRxxEP (Figure 3.4). The S. pombe orthologue of 
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HsSTAM is SpHse1 (Iwaki et al., 2007). Figure 3.4 also shows that SpAmshSst2 only 
contains two of the key residues found to be conserved in MIT domain-containing 
proteins (Row et al., 2007), and the bi-partite nuclear localisation signal (NLS) and 
clathrin-binding site (CBS) are also not conserved (Kikuchi et al., 2003; Nakamura 
et al., 2006). However, the crystal structure of HsAMSH-LP revealed two important 
inserts into the catalytic domain, which were thought to confer the specificity of this 
JAMM DUb to lysine-63-linked poly-ubiquitin chains, were said to be conserved in 
the S. pombe protein (Sato et al., 2008). The inserts are boxed in Figure 3.4.  
 
The seventh JAMM domain protein found in S. pombe is SpSsp42Cwf6/Prp8, which 
contains a further seven different domains. In the Hofmann and Glickman study, 
the Prp8 kinases also featured in their analyses as a more divergent class of 
JAMM domain-containing proteins. Some of the MPN+ residues were also 
conserved and Hofmann and Glickman could not decide whether to classify them 
as MPN+ or plain MPN. However, a study of S. cerevisiae suggests that Zn2+ co-
ordination by the JAMM domain in ScPrp8 is not necessary for function, and 
attempts to demonstrate deubiquitinating activity were not successful (Bellare et 
al., 2006). Whilst SpSsp42Cwf6/Prp8 contains three out of the five MPN+ residues – 
ScPrp8 only contains one – the upstream glutamate residue, thought to be involved 
in water de-protonation in the catalytic cascade, is conserved as a glutamine in all 
eukaryotic Prp8 orthologues aligned in the Hofmann and Glickman study, which 
includes SpSsp42Cwf6/Prp8 (Maytal-Kivity et al., 2002). It is worth noting here that the 
S. pombe protein SpCdc28Prp8, which is a DEAH-box RNA helicase involved in pre-
mRNA splicing and cell cycle control, is not a Prp8-like kinase and does not 
contain a JAMM domain.  
 
3.12. Summary of S. pombe DUbs  
 
All superfamilies of DUbs are represented in S. pombe, with the exception of the 
MJD superfamily. However, the above review revealed that very little is known 
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about S. pombe DUbs. No DUbs have been implicated in PRR and no HsUSP1 
orthologue was elucidated.  
 
However, in almost all cases, a function has been assigned for a S. cerevisiae or 
H. sapiens orthologue. Out of these orthologues, none have been implicated 
directly in PRR, however some have involvement in DNA repair or responses to 
DNA damage. Furthermore, some have the ability to disassemble lysine-63-linked 
poly-ubiquitin chains. Specifically, ScUbp2 (Kee et al., 2005), HsAMSH (McCullough 
et al., 2004; McCullough et al., 2006), and HsAMSH-LP (Nakamura et al., 2006; 
Sato et al., 2008) have been shown to have activity on this variety of chain. 
 
3.13. Exclusion of S. pombe DUb Genes from this Study 
 
Using bioinformatics and a literature review of S. pombe DUbs summarised above, 
the DUbs targeted in this study were chosen. The reasons for the choices were to 
create an optimal balance between the breadth of the screen and ability to follow 
up screen results. In other words, given the finite time frame of this research 
project, if too many proteins were targeted – even those that are unlikely to have 
functional ubiquitin isopeptidase activity – there may not be time to investigate the 
role of positive hits, i.e. candidate PCNA deubiquitinases, in PRR.  
 
With regard to the UBP/USP, UCH, and OTU superfamily DUbs, all known 
members of these superfamilies in S. pombe were included. The likely non-
functional UBP/USP superfamily DUb SpUbp13Pan2, was included because of a 
tenuous link to PRR. A study using S. cerevisiae showed that the levels of ScRad5 
were higher in a dun1∆ pan2∆ double mutant, than in wild-type cells (Hammet et 
al., 2002).  
 
Of the JAMM domain DUbs, only SpAmshSst2 was included in this project. Many of 
the proteasome lid components are essential in baker’s yeast (Giaever et al., 2002) 
and are highly conserved between S. cerevisiae and S. pombe at the amino acid 
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level, hence it is highly likely that rpn11∆ S. pombe strains would not be viable. 
Hence, SpRpn11 was excluded from this project. Whilst, SpUch2 is also a 
proteasome lid component, it was decided to study this DUb because the null 
mutant was already known to be viable (Li et al., 2000; Stone et al., 2004), and due 
to the tenuous link to DNA repair mentioned above (Yao et al., 2008b). 
 
Whilst its MPN+ motif is very similar to that of the DUb ScRpn11, the S. pombe 
MPN+ protein SpCsn5 has been shown to possess deneddylating activity (Cope et 
al., 2002). Whilst a wide variety of functions for the CSN have been ascribed 
(reviewed in Schwechheimer, 2004), S. pombe csn5∆ cells have previously been 
investigated from a DNA damage response perspective in my laboratory and no 
interesting phenotypes have been noted (Mundt et al., 2002). Therefore, SpCsn5 
was not included in this project.  
 
Moreover, none of the ubiquitin-like proteases known to be encoded in the S. 
pombe genome, e.g. SpUlp1, a SUMO protease (Taylor et al., 2002), and SpNep1, a 
deneddylase (Zhou and Watts, 2005), were included in this project.  
 
As a result of these decisions, 22 S. pombe DUbs were included in this study. 
These proteins are listed in Tables 3.1 to 3.3, which detail important information for 
each DUb in addition to marking those DUbs that are not included in this project 
and those that are unlikely to be functional.  
 
3.14. Assembly of a S. pombe DUb Deletion Library 
 
It was planned to find PRR involved DUbs by using reverse genetics. The 
hypothesis was that a strain deficient in a DUb involved in PRR may show 
increased SpPCNA ubiquitination, and may show sensitivity to UV due to 
upregulated, error-prone PRR. As a result, it was decided to assemble of a S. 
pombe DUb deletion library. Therefore, S. pombe strains singly deleted for each of 
the 22 selected DUb enzymes were collected. The strains were either created by 
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replacing the DUb gene with the gene that encodes nourseothricin-resistance, 
nat1, or obtained from collaborators. In the latter case, some double deletes were 
also added to the library.  
 
3.15. Disruption of S. pombe DUb Genes by Integration of the 
Nourseothricin-Resistance Gene 
 
The wild-type haploid h- S. pombe strain “501” was transformed with DNA 
designed to disrupt ubp7+, ubp8+, ubp11+, ubp13+, ubp14+, ubp16+, uch2+ or 
ubp22+ genes by the integration of a gene encoding nourseothricin resistance 
(nat1). The nat1 gene encodes nourseothricin acetyltransferase. The antibiotic 
nourseothricin (hereafter NAT) inhibits eukaryotic translation, and is produced 
naturally by certain bacteria. NAT acetyltransferase mono-acetylates NAT, which is 
inactivating. The construction of the nat1 antibiotic cassette for use with S. pombe 
has been described (Hentges et al., 2005).  
 
Figure 3.5 depicts the strategy for amplification of an approximately 1200 bp PCR 
product containing the nat1 gene flanked by 80 bp sequences with homology to the 
flanking chromosomal regions of the DUb gene to be disrupted. The strategy has 
previously been described (Baehler et al., 1998). 
 
3.16. Verification of Disrupted S. pombe DUb Genes by 
Polymerase Chain Reaction and Sequencing 
 
Correct disruption of DUb genes was verified by PCR at the DUb gene locus using 
isolated genomic DNA (gDNA) of each NAT-resistant strain. gDNA was isolated on 
a small scale, and primers were designed to anneal to flanking DNA of each DUb 
gene, in addition to oligonucleotides complementary to the nat1 gene. The PCR 
strategy is depicted in Figure 3.6.  
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Figure 3.7 shows the successful verification results for strains ubp13∆::nat1, 
ubp7∆::nat1, ubp22∆::nat1, and ubp16∆::nat1. For each DUb, lanes from left to 
right, the first lane shows a multiplex PCR using all four primers described in 
Figure 3.6 in one reaction. A correctly disrupted strain revealed a distinctive pair of 
bands with 100-200 bp size difference. The multiplex PCR kit (Qiagen®) was found 
to be very quick and reliable. The second and third lanes show the products 
amplified using primers a and b on gDNA from disrupted and wild-type strains, 
respectively. With a congruent lane arrangement, Figure 3.8 shows the successful 
verification results for strains ubp8∆::nat1, ubp14∆::nat1, and ubp11∆::nat1 and 
Figure 3.9 for strains ubp4∆::nat1, ubp9∆::nat1, uch2∆::nat1, and amsh∆::nat1. 
 
Correctly sized PCR products resultant from an a+b reaction on gDNA from a NAT-
resistant strain were also sent for sequencing. A primer with homology to the 
undisrupted DUb gene was also tested.  
 
3.17. Verification of Disrupted S. pombe DUb Genes by Southern 
Analysis 
 
In order to completely verify the disruption of DUb genes, gDNA was examined by 
Southern analysis. Disrupted haploids were grown on a large scale and 
chromosomal DNA was isolated and digested with selected restriction 
endonucleases, which was then run on an agarose gel and a Southern blot was 
performed. In all cases, wild-type genomic DNA was used digested with the same 
enzymes and used as a control. Blots were probed with radioactively-labelled DNA 
designed to specifically hybridise to chromosomal regions flanking a DUb gene. 
 
Figures 3.10, 3.11 and 3.12 show the successfully verified knockout strains 
ubp13∆::nat1, ubp7∆::nat1 and ubp22∆::nat1, respectively. In each figure, part A 
shows the digestion strategy and the complementary site to which the probe was 
designed to hybridise. In part B, the results of the Southern analysis are shown – 
correctly-sized fragments of DNA resulted.  
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It was planned to also check for integration of the nat1 gene into other loci. The 
blots probed with the gene flanking probe were to be stripped and re-probed with a 
probe complementary to a portion of the nat1 gene. Despite repeated attempts, 
this proved to be unsuccessful, and unfortunately no further time for Southern 
analysis was available. It was decided that verification by PCR and sequencing 
was sufficient for this project.  
 
3.18. Verification of S. pombe DUb Gene Disrupted Strains 
Obtained from Collaborators 
 
Strains disrupted for the DUb genes ubp1, ubp2, ubp3, ubp12, otu1, otu2, and 
uch1 by integration of the ura4 gene were kind gifts from Dieter Wolf. The strain 
ubp12∆::ura4 has been previously described (Zhou et al., 2003; Wee et al., 2005). 
Figures 3.13, 3.14 and 3.15 depict the successful verification of the deletion of the 
aforementioned DUb genes by PCR using a and b primers. These strains were 
also checked for independence from uracil for growth. 
 
The strains ubp21∆::ura4, ubp22∆::ura4 and a double delete resulting from a cross 
of these strains were obtained from Norbert Käufer, and have been previously 
described (Richert et al., 2002). The ubp21 and ubp22 loci of these strains were 
also checked by PCR (Figure 3.16) and sequencing. 
 
3.19. Sporulation of S. pombe Diploids Obtained from Bioneer 
 
For the following DUb genes: ubp6+, ubp10+, ubp21+, lub1+ and hag1+ disrupted 
strains were purchased from Bioneer in the form of h+/h+ heterozygous, 
kanamycin-resistance gene (kan) disrupted diploids. Transformation of a plasmid 
called pON177, which contains the h- mating type information, was performed to 
allow sporulation. Resulting haploids were isolated by selection with the addition of 
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geneticin to growth media. Figures 3.17 to 3.18 depict the products from PCR 
using a and b primers.  
 
3.20. Conclusions 
 
With the exception of the MJD superfamily, the genome of S. pombe encodes 24 
DUb enzymes. None of these DUbs nor orthologues in humans or budding yeast 
have been shown to be involved in PRR. It was decided to concentrate on 22 
DUbs in this study via the exclusion of the deneddylase SpCsn5 and the 
proteasome subunit SpRpn11Pad1.  
 
The strategy for discovering PRR involved DUbs was via analysing the effects of 
DUb deficiency. It was hypothesised that increased SpPCNA ubiquitination and/or 
UV sensitivity may result when a PRR DUb was not present in the cell. Hence a 
DUb deletion library was assembled. DUbs were disrupted or deletion strains 
collected from collaborators. All strains were succesfully verified. 
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Chapter 4: Screening of Deubiquitinating Enzyme Gene 
Disrupted S. pombe Strains 
 
4.1. Introduction 
 
Once a library of S. pombe strains containing single disruptions of selected DUb 
genes was assembled, a strategy for screening each of these strains for 
involvement in PRR, specifically the deubiquitination of SpPCNA, was developed. 
At this particular point in the project, there were significant concerns about 
redundancy among deubiquitinating enzymes. It was thought likely that multiple 
DUbs may be able to remove ubiquitin from SpPCNA; hence no phenotype may be 
observed when one DUb is removed from the cell because a second compensates. 
Hence, there was a high-throughput emphasis on these screening experiments 
with the expectation that double and triple deletes would be required. Every singly 
deleted strain was tested for sensitivity to UV as well as an increased level of 
ubiquitinated SpPCNA. The rationale for choosing these particular experiments will 
be explained here. 
 
In order to test the S. pombe strains deleted for specific DUb genes for potential 
involvement in PRR, it was decided to assay for sensitivity to UV irradiation. It was 
hypothesised that when a DUb with the ability to deubiquitinate SpPCNA is absent 
from the cell, PRR may be constitutively active or at least over-promoted. In such a 
situation where PRR is poorly controlled, the frequency of error-prone PRR of DNA 
damage may increase. This could lead to an increase in the number of cells dying 
as a result of high levels of mutation or chromosomal damage. Thus a strain 
deleted for a DUb that is involved in SpPCNA deubiquitination may show increased 
sensitivity to UV irradiation compared to wild-type. 
 
It was hypothesised that when a deubiquitinating enzyme that can act on SpPCNA 
is not present in the cell, an increase in SpPCNA ubiquitination would be observed. 
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Increased levels of mono-ubiquitinated HsPCNA was clearly observed in human 
cells when HsUSP1 was depleted by siRNA-mediated knockdown (Huang et al., 
2006). Hence, using the knockout strains utilised in this study, the levels of 
SpPCNA ubiquitination were analysed in a variety of scenarios. The levels of 
SpPCNA ubiquitination were measured in asynchronous, actively growing cells, in 
asynchronous cells treated with UV, and in cells treated with hydroxyurea. Levels 
found throughout the cell cycle were also measured by blocking the cells in S-
phase and then releasing to allow progression into the subsequent G2 and beyond.  
 
4.2. Screen for Sensitivity to UVC Radiation 
 
A high throughput “drop test” assay for measuring sensitivity of mutant strains to 
UV radiation was used (see section 2.4.14). This qualitative assay was verified 
using a quantitative colony-forming assay. A known number of cells from each 
strain were spread evenly onto agar, which was subsequently subjected to a 
specific dose of UV. Surviving colonies were counted after three days growth, the 
percentage survival at that dose was calculated and a graph of percentage survival 
versus UV dose was plotted for each strain.  
 
The results of the qualitative UV sensitivity assay for S. pombe strains deleted for 
the OTU superfamily DUbs are shown in Figure 4.1. The density of cells of strain 
otu1∆ following different doses of UV was similar to that shown by wild-type cells. 
The strain otu2∆ demonstrates a slightly reduced density of cells following UV 
irradiation compared to wild-type, which is particularly evident in the 0-200 Jm-2 
gradient. However, the pcn1-K164R strain demonstrates a dramatically more UV-
sensitive phenotype in comparison. Hence, it is likely that the cell concentration in 
the otu2∆ culture used in this assay was slightly lower than that of the other strains 
and that this strain is not UV-sensitive at all. Furthermore, a double deletion strain 
resulting from a cross of the two aforementioned OTU DUb deleted strains, otu1∆ 
otu2∆, showed the same UV-sensitivity as wild-type cells. These observations 
were verified by the quantitative assay, shown in Figure 4.8.  
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The results of the qualitative UV sensitivity assay for strains deleted for the UCH 
superfamily DUbs are shown in Figures 4.2 and 4.6. The strains uch1∆ (Figure 4.2) 
and uch2∆ (Figure 4.6) were not sensitive to UV. This observation was verified by 
the quantitative assay, shown in Figures 4.8 and 4.10, respectively. 
 
When the gene encoding the PPPDE superfamily DUb SpHag1 was deleted, the 
qualitative assay did not reveal any clear UV sensitivity (Figure 4.3). S. pombe 
cells deficient in SpLub1, lub1∆::kan, also did not show any significant UV-
sensitivity (Figure 4.3). A strain containing a point mutant in the lub1+ gene, 
hereafter lub1-1, which was obtained from Tokayoshi Kuno and has already been 
described (Ogiso et al., 2004), was also tested and found not to have any UV 
sensitivity (Figure 4.3). These findings were verified by UV-survival (Figure 4.11).  
 
The qualitative UV sensitivity assay results for the strain deleted for the JAMM 
superfamily DUb, SpAmsh, are shown in Figure 4.4. The strain amsh∆ was not 
found to be sensitive to UV. This observation was verified by the quantitative 
assay, shown in Figure 4.11. 
 
The results of the qualitative UV sensitivity assay for S. pombe strains deleted for 
the UBP/USP family DUbs are shown in Figures 4.1, 4.2, 4.3, 4.4, 4.5 and 4.6. 
Strains ubp1∆, ubp2∆, ubp3∆, ubp4∆, ubp6∆, ubp8∆, ubp9∆, ubp10∆, ubp11∆, 
ubp12∆, ubp13∆, and ubp14∆ did not demonstrate any detectable sensitivity to UV. 
This observation was verified by the quantitative assay, shown in Figures 4.7, 4.9, 
4.10 and 4.11. The doubly deleted strain, ubp1∆ ubp12∆, was also not sensitive to 
UV (Figures 4.2 and 4.7). However, results for ubp16∆ strains are discussed in 
section 4.4. Furthermore, screen results for strains deficient in the MATH-domain 
containing UBP/USP superfamily DUbs SpUbp21 and/or SpUbp22 can be found in 
chapter 5.  
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4.3. Screen for an Increase in SpPCNA Ubiquitination 
 
It was expected that in a strain deficient in a DUb with an ability to deubiquitinate 
SpPCNA, an increase in SpPCNA ubiquitination beyond that seen in wild-type cells 
would be observed. It was not certain whether this expected increase would be 
found in untreated cells or those treated with agents that induced SpPCNA 
ubiquitination or both, as observed in human cells (Huang et al., 2006). 
Unfortunately, as the aim of the project is to find a DUb that can act on SpPCNA, no 
positive control for this assay could be employed. However, SpPCNA ubiquitination 
cannot occur in the pcn1-K164R strain, hence allowing differentiation between 
bands on a Western blot that demonstrate real ubiquitinated species of SpPCNA, as 
opposed to other types of covalent modification of SpPCNA or proteins that the anti-
SpPCNA antibodies cross react with in certain circumstances.  
 
Figures 4.12 and 4.13 depict the levels of SpPCNA ubiquitination prior to and 
following treatment with hydroxyurea. HU is an inhibitor of ribonucleotide 
reductase, an enzyme that processes ribonucleotides into deoxyribonucleotides 
(dNTPs). DNA is a polymer of dNTPs, and hence in the presence of a sufficient 
concentration of HU, the cell exhausts dNTPs before S-phase is complete. It is 
thought that HU induces SpPCNA ubiquitination because replication forks stall 
when dNTP pools are drained, thus mimicking the effect of a DNA polymerase 
stalling as a result of a lesion. The cell tries to activate PRR, which is likely to be a 
futile event because both TLS and the proposed template switch pathways require 
DNA synthesis steps and hence dNTPs. After 2.5 h in the presence of HU, all S. 
pombe cells within a culture become synchronised in S-phase, and more slowly-
migrating bands representing mono-, di-, and tri-ubiquitinated SpPCNA are evident. 
As shown in Figure 4.12 and 4.13, the strains otu1∆, otu2∆, otu1∆ otu2∆, ubp1∆, 
ubp2∆, ubp3∆, ubp12∆, ubp1∆ ubp12∆ and uch1∆ do not show significant or 
reproducibly increased levels of ubiquitinated SpPCNA in asynchronous cells prior 
to treatment (-) or following 2.5 h in HU (+).  
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At this point there were concerns about bleed-through of ubiquitinated SpPCNA 
species from the samples where ubiquitination had been induced, into the 
neighbouring untreated samples. Due to very high levels of ubiquitination in the 
treated lane, even very small amount of contamination into an untreated lane may 
result in a greater level of SpPCNA ubiquitination compared to wild-type. Therefore 
treated and untreated samples were kept separate henceforth, as is demonstrated 
in Figure 4.14.  Here, the same strains as described above were mock treated 
(Figure 4.14 A) or treated with 100 Jm-2 of UV (Figure 4.14 B) to induce SpPCNA 
ubiquitination. No increase in SpPCNA ubiquitination relative to wild-type was seen, 
consistent with the data obtained with HU.  
 
Figure 4.15 shows the levels of SpPCNA ubiquitination in ubp10∆ prior to and 
following treatment with 10 mM of HU. There were reports that 50 mM HU is quite 
a high dose for S. pombe, hence this lower dose is used henceforth. For some 
reason, high background levels of SpPCNA ubiquitination were seen in the wild-
type and ubp10∆ cells prior to treatment. Variability in the levels of SpPCNA 
ubiquitination is seen in unchallenged, asynchronous cells and seems to depend 
upon various factors, for example the exact state of the cells, type of experiment 
and the length of exposure to light-sensitive film. In repeat experiments, ubp10∆ 
has only shown wild-type levels of SpPCNA ubiquitination. As expected, after the 
addition of HU, an increase in the levels of SpPCNA ubiquitination is seen, but once 
again, at wild-type levels.  
 
Figure 4.16 shows the levels of SpPCNA ubiquitination in the strains ubp8∆ and 
ubp14∆ in untreated cells and following HU treatment. Here, the lower panel shows 
a lower exposure of the Western blot to more clearly demonstrate the relative 
levels of unmodified SpPCNA between lanes. This additional blot was added as a 
result of concerns that poorly normalised lanes will significantly impact on the 
interpretation of data. Normalisation between strains was performed by utilisation 
of the same number cells for each sample. However, often a few cells were lost in 
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the TCA extraction procedure, and the extracts could not be further normalised by 
protein amount due to the incompatibility of the sample buffer in which the 
extracted protein was finally resuspended, most notably the presence of sodium 
dodecyl sulfate. Furthermore, mutant cells with a large cell phenotype may contain 
more SpPCNA and possibly more ubiquitinated SpPCNA. The usefulness of this 
lower exposure of unmodified SpPCNA can be seen in Figure 4.16, with reference 
to the ubp14∆ lanes. At first glance, there appears to be an increase in SpPCNA 
ubiquitination following HU damage compared to wild-type. However, there is 
clearly more unmodified SpPCNA in this lane, compared to the ubp8∆ and wild-type 
lanes, and there is no increased SpPCNA ubiquitination seen in the untreated 
ubp14∆ lane compared to wild-type where the loading is more even. Certainly, 
there is no apparent increase in SpPCNA ubiquitination in the ubp8∆ samples 
compared to wild-type. 
 
Another important observation from Figure 4.16 is that the ubiquitinated species of 
SpPCNA appear as doublets. This is very interesting because prior to this point, a 
supported nitrocellulose membrane had been utilised for Western blotting. This 
type of membrane is more robust than unsupported nitrocellulose, but provides 
less resolution. Certainly unsupported nitrocellulose was utilised in the study that 
previously characterised SpPCNA ubiquitination in S. pombe (Frampton et al., 
2006). Unsupported nitrocellulose was utilised for the first time in Figure 4.16, and 
hence this is the most likely reason for the resolution of the ubiquitinated species 
into doublets. There are reports in the literature that human HsPCNA is 
phosphorylated (Wang et al., 2006) and acetylated (Naryzhny and Lee, 2004), 
hence these other types of modification of S. pombe SpPCNA seem most likely. 
Certainly, Nedd8 and SUMO, other important cellular ubiquitin-like proteins that 
contain the ubiquiton superfold and are known protein modifiers, are too large to 
cause such a subtle shift in molecular weight. In Figure 4.16, the upper band in 
each doublet appears approximately 50% less intense than the lower band of the 
pair. With the assumption that SpPCNA firstly exists as either an entirely unmodified 
protein, or as a phosphorylated or acetylated (or modified by some other small 
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modifier) version, the latter is ubiquitinated 50% less often than unmodified 
SpPCNA. However, there is no difference between the relative levels of each band 
in the doublet between untreated and HU treated samples, implying that this other 
form of SpPCNA modification does not occur in response to replication fork stall. 
Experiments undertaken to make native extracts of ubiquitinated SpPCNA doublets 
failed. The TCA extraction procedure is optimal for retaining labile covalent bonds, 
such as ubiquitination, however treatment with alkaline phosphatase, for example, 
is incompatible with this type of extract. Ubiquitinated forms of SpPCNA are not 
successfully retained in native extracts, particularly following incubation on ice, 
which is required for phosphatase or acetylase treatment. Hence, it was not 
possible to identify this other, smaller type of SpPCNA modifier due to the instability 
of this modification.  
 
Interestingly, human mono-ubiquitinated HsPCNA cannot be resolved into a 
plurality of bands (Simone Sabbioneda, personal communication). This may imply 
that phosphorylated or acetylated human HsPCNA cannot be ubiquitinated or that 
the phosphorylation or acetylation of HsPCNA occurs at low levels such that it 
cannot be detected as a molecular weight shift on a Western blot. 
 
In Figure 4.17, the strains ubp4∆, ubp7∆, ubp8∆, ubp11∆, ubp13∆, ubp14∆ were 
tested for an increase in SpPCNA ubiquitination compared to wild-type following UV 
irradiation, and these strains were found to be indistinguishable from wild-type. The 
strains amsh∆, lub1∆, lub1-1, hag1∆, ubp6∆ and uch2∆ were also tested for PCNA 
ubiquitination levels after UV in Figure 4.18. The strains entirely deficient in SpLub1 
seemed to show slightly lower levels of SpPCNA ubiquitination, which fits with the 
proposition that the SpLub1 homologue in S. cerevisiae provides ubiquitin required 
for SpPCNA ubiquitination (Lis and Romesberg, 2006). However, this effect was not 
seen following HU treatment of the mutant S. pombe cells. 
 
It has been previously shown that in S. pombe, SpPCNA becomes ubiquitinated 
every S-phase in unchallenged cells synchronised by elutriation (Figure 4.19, 
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Frampton et al., 2006). It is not known why this occurs. However, it was decided to 
utilise this effect for the identification of DUbs with the ability to deubiquitinate 
SpPCNA. Very low levels of SpPCNA ubiquitination are seen in the intervening cell 
cycle phases implying active deubiquitination of SpPCNA in these phases. Hence, it 
could be hypothesised that when a DUb with the ability to deubiquitinate SpPCNA is 
absent from the cell, ubiquitination of SpPCNA may persist outside of S-phase. In 
this experiment, cells were blocked for 2.5 h in hydroxyurea, which is sufficient time 
for all cells to become synchronised in S-phase. The cells were then spun down 
gently, washed, and resuspended in fresh growth media. Samples to assay for the 
levels of SpPCNA ubiquitination were taken immediately and every fifteen minutes 
following release. Figure 4.20 shows the profile of SpPCNA ubiquitination seen for 
wild-type cells following HU block and release. High levels of ubiquitination are 
immediately evident after the HU treatment. On release, the cells are now able to 
synthesise dNTPs and finish replicating their DNA, the levels of ubiquitinated 
SpPCNA soon decrease in the subsequent cell cycle phases. After 60-90 minutes, 
an increase in ubiquitination is seen again, which represents the following S-phase. 
These timings are significantly different from those that occur when the cells are 
synchronised by elutriation. This is because the cells are chemically blocked in S-
phase when HU is utilised, but the cells are still alive and they can still grow but the 
S-phase checkpoint prevents cell division, hence they elongate. When released 
into fresh media, these elongated cells rush through the cell cycle more quickly, 
sometimes without dividing completely. The morphology of wild-type cells when 
released from HU block is depicted in Figure 4.21. At 0 and 15 minutes, the cells 
are elongated. The fuzzy nuclei indicative of DNA replication can be seen in cells 
after 75 minutes, and segregation of DNA can be seen in some cells after 90 
minutes. After 210 minutes, the cells are clearly back to normal morphology. 
However, the variation in morphology between cells at each time point in this 
Figure shows that there is significant variation in each cell’s ability to recover from 
this block.  
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When a population of cells is synchronised by elutriation, the cells are simply 
sorted into cell cycle phases by cell size. Although this would be a significantly less 
invasive method for synchronising cells, it is not appropriate and too time-
consuming for this screening assay. The addition of HU strongly activates PRR, 
whereas it is not known if the complete PRR machinery is recruited in unperturbed 
cells every S-phase, and deubiquitination activities may be affected.  
 
Figure 4.22 depicts the results of the HU block and release assay for ubp13∆::nat1 
and ubp8∆::nat1. Firstly, it is worth noting that a slightly different profile is displayed 
by the wild-type control in this Figure, the loading of protein across this gel is not 
highly uniform and there is smearing where the gel has been over-loaded. 
However, all three strains show an increase in SpPCNA ubiquitination following HU 
treatment, and high levels of ubiquitination exist after 0 and 30 minutes (although 
the ubp13∆::nat1 0 minutes sample is clearly erroneously under-loaded), these 
levels decrease after 45 minutes, and decrease further after 60 and 75 minutes. At 
120 minutes, the levels of SpPCNA ubiquitination are high again, which represents 
the following S-phase, although clearly there has been a gel running and transfer 
problem on the far right-hand side of this blot that has affected the clarity of the 
ubp8∆::nat1 120 minute lane. In general though, it is concluded that all three 
strains behave similarly and neither SpUbp13- or SpUbp8-deficient cells 
demonstrate unusual levels of SpPCNA ubiquitination. 
 
The strains lub1-1, lub1∆::kan, hag1∆::kan and ubp6∆::kan were compared with 
wild-type following HU block and release (Figure 4.23). This blot is difficult to 
interpret due to loading and transfer problems. However, the kinetics of the general 
trend where SpPCNA ubiquitination levels are high, reduce and then increase 
again, is similar to that of wild-type cells. Figure 4.24 depicts samples taken from 
amsh∆ cells following HU block and release. Here, in order to make the blot less 
smeary, less protein has been loaded, so the blot is much cleaner. Once again, 
amsh∆ cells seem to exhibit wild-type kinetics of SpPCNA ubiquitination. The strain 
ubp3∆, shown in Figure 4.25, also shows wild-type levels of SpPCNA ubiquitination 
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following HU block and release. Following 2.5 h after the addition of HU (lanes 
labelled “HU”), ubp3∆ cells appear to shown increased SpPCNA ubiquitination 
compared to wild-type, however the lower panel, which shows a low exposure of 
unmodified SpPCNA, suggests that the wild-type lanes HU and 0 minutes are 
under-loaded.  
 
4.4. ubp16+ Deleted S. pombe Cells 
 
Two different ubp16∆ strains were utilised in this study. The first strain was 
constructed by integration of the nat1+ gene into haploid wild-type cells as 
described in Chapter 3. The second was a gift from a colleague in the Genome 
Damage and Stability Centre, Edgar Hartsuiker. The latter was derived from the 
Bioneer deletion library (described in Chapter 3). Hence this strain was derived 
from an h+/h+ diploid where one allele of ubp16+ had been replaced with a 
kanamycin-resistance gene. However, the ubp16∆::kan was not acquired from 
Bioneer directly. The entire Bioneer deletion library of heterozygous diploids was 
gifted to the laboratory of Prof. Paul Nurse and, as part of a global study, all of the 
diploids were transformed with the pON177 plasmid (which contains the h- genetic 
information) and sporulated into haploids in a high-throughput fashion. This 
resultant haploid deletion library was then obtained by Dr. Hartsuiker. 
 
Figure 4.26 depicts the UV sensitivity of ubp16∆::kan and ubp16∆::nat1 measured 
by qualitative assay. Confusingly, the kan-marked deletion strain shows a dramatic 
UV sensitivity, whereas the nat1-marked strain is significantly more UV-resistant – 
up to nearly wild-type levels. The ubp16∆::kan strain was also highly growth 
defective (data not shown). The two strains were also tested in parallel for PCNA 
ubiquitination following HU block and release, which is shown in Figure 4.27. The 
kan-marked strain demonstrated an ubiquitination profile following release from HU 
that is very similar to that of wild-type cells. The nat1-marked strain showed 
considerably and consistently higher levels of both unmodified and ubiquitinated 
SpPCNA. The levels do decrease after 60 and 75 minutes in this strain, and the 
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levels of ubiquitination are very low in the non-HU treated sample (NT). However, 
the reasons for the dramatic difference between these strains were not known, and 
therefore the status of the ubp16 locus in these strains was investigated. 
 
The source of the problem appears to be the size of the ubp16+ gene. PCR 
amplification of the wild-type gene with flanking primers revealed a product that 
was almost exactly the same size as the product expected for either the kan- or 
nat1-marked deletion strain (Chapter 3, Figure 3.7). However, for ubp16∆::nat1 
gDNA, the multiplex PCR amplification suggests that the nat1 gene is positioned 
within the context of a ubp16∆ locus (Chapter 3, Figure 3.7). However, resolution 
of the PCR product from an amplification across the ubp16 locus of ubp16∆::nat1 
gDNA with flanking primers revealed a doublet (Figure 4.28), implying that two 
different types of ubp16 locus are found in this strain.  
 
To help elucidate this the PCR products from wild-type, ubp16∆::nat1, and 
ubp16∆::nat1 gDNA amplification depicted in Figure 4.28 were digested with either 
NcoI or BglII. The restriction endonuclease NcoI, which cuts at the sequence 
CCATGG, was expected to digest the start codon of the kanamycin- and 
nourseothricin-resistance genes. Whereas BglII was expected to cut within flanking 
DNA found at the ubp16 locus in a ubp16∆::nat1 strain, but would not cut the 
product obtained from the wild-type ubp16+ locus. However, Bioneer were not 
prepared to explain how their strains were originally created, so the sequences 
flanking the kan+ gene at the ubp16 locus were not known in the ubp16∆::kan 
strain. Therefore, the expected sizes of DNA fragments resulting from digestion of 
the kan+ product with NcoI were unknown and it was not known whether BglII 
would cut at all. However, for the ubp16∆::nat1 product, ~1100 bp and ~800 bp 
fragments were expected following NcoI digestion, and ~1500 bp and ~400 bp 
fragments following BglII digestion. The wild-type ubp16 locus was expected to 
resist digestion. The results of the digests are shown in Figure 4.29. Both the wild-
type and ubp16∆::kan products resisted digestion. The DNA fragment sizes 
resulting from NcoI digestion of the ubp16∆::nat1 product were as expected, 
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although the ~400 bp fragment of BglII digestion was not detected, but it may be 
hidden under the bromophenol blue dye front. However, more notably, a large 
proportion of the ubp16∆::nat1 product was resistant to digestion. As a positive 
control digest was not performed in parallel, partial digestion may explain these 
results, but the likelihood is that the lower of the doublet bands seen from Figure 
4.28 is ubp16∆::nat1 at the ubp16 locus and was successfully digested with NcoI 
and BglII, whereas the upper band results from amplification of a ubp16+ locus, 
which is resistant to digestion.  
 
In addition to these experiments, the ubp16∆::nat1 strain was also found to exhibit 
a larger cell size that is associated with diploids. Hence, it is presumed that 
following transformation and the application of these cells onto nourseothricin-
containing agar, the cells diploidised. This is presumably achieved by replicating 
both a wild-type copy of genomic DNA in addition to a mutant version, hence the 
cells become heterozygous h-/h- diploids for ubp16∆::nat1. Interestingly, when the 
ubp10∆::kan diploids purchased from Bioneer were sporulated, a high-percentage 
of the kanamycin-resistant ‘haploids’ isolated actually turned out to be diploids. 
Both the ubp10+ and ubp16+ genes are about 2 kb in size when amplified with 
flanking PCR primers, which is about the same size of the kan+ and nat1+ genes. 
Hence, it is possible that homologous recombination is more efficient when the 
homologous fragment to be recombined is a similar size to that found in the 
genome, and means that the probability of the cell retaining both a wild-type copy 
of the gene, plus an integrated copy of the antibiotic-resistance gene to be retained 
by the cell simultaneously, is much higher.  
 
Amplification of the ubp16 locus of genomic DNA from the ubp16∆::kan strain 
using flanking primers revealed a 2 kb band that could not be resolved into 
doublets (Figure 4.28) and was resistant to digestion (Figure 4.29). The 
morphology of this strain was a haploid-like size. However, sequencing of this 
product revealed that this strain had a wild-type ubp16+ copy at the ubp16 locus. 
Hence, it is likely that the kanamycin-resistance of this strain is resultant from 
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integration of the kan+ gene elsewhere in the genome. For this reason, the 
ubp16∆::kan strain was discarded.  
 
With hindsight, it may have been more appropriate to create the deletion strains by 
transforming DNA into a diploid wild-type strain, selecting for nourseothricin-
resistance heterozygotes, and then dissecting tetrads to recover ubp16∆::nat1 
haploids. Certainly this method is known to be more efficient in isolating haploid 
deletion mutants without error. However, it is much more time-consuming, which 
makes it less relevant when an important aim of the study was to allow time for 
investigating positive hits following screening.  
 
However, not all of the isolated nourseothricin-resistant ubp16∆::nat1 colonies that 
showed a correct multiplex PCR doublet were found to be diploids, in the region of 
50% were haploids, and six of these haploids were tested for UV-sensitivity. The 
qualitative result of this is shown in Figures 4.30 and 4.31. The haploids are 
numbered clone 26, 28, 34, 39, 42 and 43, and the diploid labelled as 
ubp16∆::nat1 in Figures 4.26 to 4.29, which is used as a comparison, is now 
labelled as “ubp16∆::nat1 diploid”. Haploids 39, 42 and 43 demonstrated very 
subtle UV-sensitive phenotype, as verified in the quantitative assay shown in 
Figure 4.33, whereas the other three haploids were not found to be UV-sensitive 
(Figure 4.32). The haploids were found to be correctly knocked out (Figure 4.34). 
 
4.5. Discussion 
 
It can be concluded from the experiments completed in this chapter that deletion of 
a gene encoding a deubiquitinating enzyme, in general, has little effect on S. 
pombe cells. A very slight growth defect was found in ubp2∆ cells, but otherwise 
the strains grew normally and no obvious cytological defects were observed. The 
double deletions ubp1∆ ubp12∆ and otu1∆ otu2∆ also showed no phenotypes.  
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It is important to note that the qualitative assay for measuring the sensitivity of 
strains to UV irradiation was verified in all cases by quantitative survival curves, 
hence this assay is reliable for further use as a high throughput method.  
 
DUbs have multiple roles in the cell, from maintaining pools of free ubiquitin in the 
cell, removing ubiquitin modifications from ubiquitinated proteins, and removing 
inhibitory ubiquitin chains from the proteasome (Amerik and Hochstrasser, 2004). 
Numerous examples of DUbs working in concert with E3s exist in the literature and 
given that 46 E3s were found in the S. pombe genome, it is tempting to 
hypothesise that DUbs have more redundant roles that E3s. It is plausible that 
SpPCNA may be deubiquitinated by different DUbs in different cell cycle phases. 
Furthermore, certain DUbs may be responsible for deubiquitinating the lysine-63-
linked poly-ubiquitin chain from mono-ubiquitinated SpPCNA, and another set may 
be responsible for removing the mono-ubiquitin from lysine-164 of SpPCNA. 
Moreover, it is possible that different DUbs may be associated with deubiquitinating 
SpPCNA following the bypass of different types of DNA lesions, or whether other 
DNA damage response pathways are activated concurrently, for example, other 
DNA repair pathways or cell cycle checkpoints. 
 
Creation of double and triple DUb knockout strains may aid the elucidation of DUbs 
that have the ability to deubiquitinate SpPCNA. However, one strain, ubp21∆ 
ubp22∆ displayed both UV sensitivity and increased SpPCNA ubiquitination. As a 
result of this it was decided to prioritise investigations into the role of SpUbp21 and 
SpUbp22 in PRR over any further screening experiments of S. pombe DUbs. The 
screen results, plus further experiments performed on ubp21∆ ubp22∆, are 
discussed in the following chapter.  
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Chapter 5: Characterisation of S. pombe Strains Deficient 
in SpUbp21 and/or SpUbp22 
 
5.1. Introduction 
 
Chapter 4 explains the screening process utilised for detecting potential PRR 
phenotypes of S. pombe strains deficient in specific DUb genes. The majority of 
these strains did not display any interesting phenotypes and hence it was decided 
not to study these further. However, a double deletion strain with the genotype 
ubp21∆ ubp22∆ demonstrated positive results for both types of screen assay – it 
showed both UV sensitivity and increased SpPCNA ubiquitination and the data for 
this immediately follows. SpUbp21 and SpUbp22 share 40% amino acid identity and 
are likely to be paralogous. In addition to a UBP/USP superfamily catalytic domain, 
they both also contain a little-studied meprin and tumour necrosis factor associated 
factor homology (MATH) domain. The potential function of the MATH domain is 
then discussed, followed by analysis of the literature with respect to DUbs from 
other species that contain the MATH domain. Finally, phenotypes of the singly 
deleted strains ubp21∆ and ubp22∆, as well as the double delete ubp21∆ ubp22∆ 
are investigated more thoroughly. 
 
5.2. Screening Results for the Strains ubp21∆::ura4, ubp22∆::ura4 
and ubp21∆::ura4 ubp22∆::ura4  
 
Qualitative assays for UV sensitivity of the strains ubp21∆::ura4, ubp22∆::ura4 and 
ubp21∆::ura4 ubp22∆::ura4, as shown in Figure 5.1, revealed a redundant 
relationship between SpUbp21 and SpUbp22 in S. pombe. The double delete, 
resultant from a cross between the two aforementioned singly deleted strains, was 
UV sensitive, but the two singles were not. This implies that in the absence of one, 
the other can efficiently restore UV resistance up to wild-type levels. Interestingly, 
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the double delete was found not to be as UV-sensitive as the pcn1-K164R strain 
where the entire PRR pathway is nullified. This is to be expected, however, as 
constitutively active PRR, such as may occur when a SpPCNA DUb is absent from 
the cell, is unlikely to cause UV sensitivity beyond that of when PRR cannot be 
carried out at all.  
 
Figure 5.2 shows SpPCNA ubiquitination in the three aforementioned ura4 
disrupted strains prior to and following HU treatment. The double delete clearly 
shows SpPCNA ubiquitination in unchallenged cells, and this level seems to 
increase further after exposure to HU for 2.5 h. This implies that a deficiency in 
both SpUbp21 and SpUbp22 results in high levels of SpPCNA ubiquitination and this 
basal level increases further upon active ubiquitination of SpPCNA to induce PRR, 
such as in the presence of HU. The ubp22∆::ura4 strain also seems to show higher 
levels of SpPCNA ubiquitination after HU treatment. However, the panel depicting a 
low exposure of unmodified SpPCNA shows more SpPCNA loaded in this lane 
compared to wild-type, which may explain this observation. 
 
However, it may be that only a sub-population of the cells demonstrate SpPCNA 
ubiquitination – perhaps only cells in a particular cell cycle phase. Therefore the 
HU block and release experiment was performed, and SpPCNA ubiquitination levels 
in various cell cycle phases analysed. This experiment is depicted in Figure 5.3. 
Very clearly, the doubly deleted strain shows a distinctly different SpPCNA 
ubiquitination profile compared to that of wild-type cells. The untreated lane shows 
the background level of SpPCNA ubiquitination characteristic of this strain. 
Following HU treatment, SpPCNA ubiquitination levels are as bold and strong as 
seen in Figure 5.2. This high level decreases, but the ubiquitination seems to 
persist for a much greater length of time than in wild-type cells. Most interestingly, 
however, 75 minutes after release from HU, there is little or no SpPCNA 
ubiquitination. There are a variety of plausible explanations for this. Given that the 
levels of SpPCNA ubiquitination do not persist at a constant high level and there is 
some decrease, it is likely that another, unknown DUb can effect SpPCNA 
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deubiquitination, and may even be upregulated in response to a deficiency in 
SpUbp21 and SpUbp22. It is plausible that different DUbs control SpPCNA 
ubiquitination during different cell cycle phases. SpUbp21 and SpUbp22 may 
maintain pools of deubiquitinated SpPCNA during S-phase, whereas during G2, for 
example, a broader cohort of enzymes capable of deubiquitinating SpPCNA may be 
employed. Alternatively, the disappearance of ubiquitinated SpPCNA may be the 
result of degradation. However, it is important to note here that the lower exposure 
of unmodified SpPCNA suggests that there is less SpPCNA loaded into this lane.  
 
The singly deleted strains show less easily interpretable SpPCNA ubiquitination 
levels following HU block and release. There appears to be a higher background 
level of SpPCNA ubiquitination than in the wild-type lanes, and the blot is generally 
less clean. One of the reasons for this is smearing, which can be most clearly seen 
in the pcn1-K164R lanes, and is thought to be the result of over-loading of the gel 
with protein. However, the general pattern seen for the ubp21∆::ura4 and 
ubp22∆::ura4  strains is most similar to that of the wild-type profile. There is little or 
no SpPCNA ubiquitination in the untreated lanes, ubiquitination increases 
dramatically following HU treatment and this is most evident after 30 minutes. 
However, this level of ubiquitination is significantly reduced after 45 minutes. These 
lanes alone, when contrasted with the SpPCNA ubiquitination levels demonstrated 
in the double delete, clarify the significance of the persistence and increased levels 
of SpPCNA ubiquitination seen in the double delete. They also agree with the UV 
sensitivity data that implies that SpUbp21 and SpUbp22 can act redundantly, in that 
there is little observable phenotype when either SpUbp21 or SpUbp22 is absent.  
 
Upon reflection at this point in the project, it was decided to exclusively investigate 
further the potential involvement of SpUbp21 and SpUbp22 in PRR. Some very 
interesting data emerged from these experiments, which will be presented and 
discussed in this and the following chapters. Therefore, an analysis of what is 
already known about SpUbp21 and SpUbp22, the human homologue of these DUbs 
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and the MATH domain will be provided at this point in order to properly introduce 
the remainder of this thesis.   
 
 
5.3. Previous Studies, Homology and Domains of SpUbp21 and 
SpUbp22 
 
SpUbp21 and SpUbp22 are discussed in one publication in the scientific literature 
(Richert et al., 2002), which links these DUbs to pre-mRNA splicing, the process 
whereby intron sequences are removed and the remaining exons spliced together 
to generate mature mRNA. This process is carried out by a large complex called 
the spliceosome, which, in S. pombe, consists of RNA and more than 80 proteins 
(reviewed in Kuhn and Kaufer, 2003). Richert et al found that SpUbp21 is able to 
deubiquitinate a mutant version of an important kinase involved in pre-mRNA 
splicing, called SpPrp4. The residues ALKHP in SpPrp4 are conserved in cyclin-
dependent and mitogen-activated protein kinases (MAPKs), and mutation of these 
residues to SSKLP resulted in loss of function of this kinase and sensitivity to 
growth at 36°C. Transformation with a plasmid containing ubp21+ was found to 
suppress this. The deubiquitinating activity of SpUbp21 was found to stabilise the 
mutant version of SpPrp4. It is thought that the growth defect of the SpPrp4 mutant is 
caused by abnormally low levels of SpPrp4, and that overexpression of SpUbp21 
prevents proteasomal degradation of mutant SpPrp4. Hence, they conclude that 
SpUbp21 is likely to stabilise wild-type SpPrp4 in vivo. This implies that SpUbp21 has 
the capability for deubiquitinating lysine-48-linked poly-ubiquitin chains, but, of 
course, this does not preclude an ability to deubiquitinate poly-ubiquitin with 
different linkages. The authors also show that the double deletion, ubp21∆::ura4 
ubp22∆::ura4, which is the same doubly deleted strain utilised in this study, is 
temperature sensitive (Richert et al., 2002). Unfortunately, confusing wording in the 
text of this publication implies that deleting both ubp21+ and ubp22+ in S. pombe is 
lethal. However, it is clear that what the author actually meant is that the double 
delete cannot grow at 20°C and 36°C – the corresponding Figure clearly depicts 
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growth at the standard S. pombe growth temperature, 30°C. This 
misunderstanding has led to most public sequence databases stating that the 
double delete is lethal.  
 
SpUbp21 and SpUbp22 are large DUb enzymes and are both UBP/USP superfamily 
members. They are also very occasionally referred to as SpUbp15 and SpUbp5 and 
are 1129 and 1108 amino acids in length, which corresponds to a molecular weight 
of approximately 130.8 and 128.6 kDa, respectively. They both contain two known 
protein domains in their N-terminal halves: a MATH domain, and a UBP/USP 
superfamily catalytic domain C-terminal to this. No clear protein domains have 
been assigned to the C-terminal half of these DUbs. The domains in SpUbp21 and 
SpUbp22 are positioned very similarly (Figure 5.4) and Ubp21 is only 1.9% bigger 
(21 amino acids). An alignment of the amino acid sequence of these two DUbs 
revealed 40% sequence identity (Figures 5.5 and 5.6), which is very high and, in 
agreement, most public sequence databases state that SpUbp21 andSpUbp22 are 
likely to be paralogues of each other. 
 
The catalytic domain of SpUbp21 and SpUbp22 is boxed in red in Figures 5.5 and 
5.6. UBP/USP DUbs are cysteine proteases wherein cysteine, histidine and 
aspartate residues form a catalytic triad, which are highlighted in blue in the 
alignment shown in Figures 5.5 and 5.6. The yellow highlighted residues in this 
Figure are other important amino acids for catalysis that are conserved in 
UBP/USP superfamily DUbs (Amerik and Hochstrasser, 2004).  
 
The meprin and tumour necrosis factor receptor associated factor homology 
(MATH) domain, as its name suggests, was originally found in a class of 
mammalian metalloproteases called meprins, which are involved in development, 
as well as tumour necrosis factor receptor associated factors (TRAFs) that are 
involved in cellular signal transduction. Later, the MATH domain was also found in 
other protein classes, most of which contain domains that are involved in 
ubiquitination or deubiquitination. Bioinformatical analyses reveal that most 
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organisms contain one UBP/USP superfamily DUb with a MATH domain at the N-
terminus, although a few organisms, like S. pombe, contain two. In published 
MATH domain structures, eight anti-parallel β-sheets come together to form a 
distinctive, partially twisted β-sandwich structure. The function of the MATH domain 
is not well understood, however in meprins and TRAFs it is proposed to be 
involved in oligomerisation – TRAFs and meprins are fundamentally dependent on 
oligomerisation for their activity. Having said this, it has been reported that the 
residues known to be interfacial in other MATH domain proteins are not conserved 
among MATH domain DUbs (Sunnerhagen et al., 2002). The MATH domains of 
SpUbp21 and SpUbp22 are boxed in green in Figure 5.5. Interestingly, compared to 
SpUbp22, SpUbp21 has an extra 22 residues in the middle of the MATH domain 
sequence (Figure 5.5), whereas these DUbs align almost exactly throughout the 
rest of the amino acid sequence. Therefore this extra section accounts for the 
slightly bigger size of SpUbp21. The functional significance of this is not known, but 
will be discussed further in Chapter 7 when the structure of the MATH domains 
found in SpUbp21 and SpUbp22 are predicted. First, the MATH domain, and the 
proteins within which it is found, will be discussed more thoroughly. 
 
5.4. Meprin and Tumour Necrosis Factor Receptor Associated 
Factor (MATH) Domain  
 
The MATH (meprin and tumour necrosis factor [TNF] receptor [TNFR] associated 
factor [TRAF]) domain, was first coined in 1996 and is thought to be involved in 
protein-protein interactions between other MATH domain containing proteins (Uren 
and Vaux, 1996) to allow hetero- or homo-oligomerisation.  
 
Meprins are zinc-dependent metalloendopeptidases comprising homo- or hetero-
oligomers of α and β subunits. Each subunit contains an astacin family 
metalloprotease domain, meprin/A5 protein/protein-tyrosine phosphatase µ (MAM) 
domain, MATH domain and an “after MATH” (AM) domain (Bertenshaw et al., 
 151 
2003). Meprins are directed to the endoplasmic reticulum following biosynthesis, 
can either be in membrane-bound form or secreted extracellularly, cleave a wide 
variety of polypeptides such as growth factors and hormones, and are highly 
expressed in microvillar membranes of mammalian kidney and intestine (Johnson 
and Bond, 1997). The MAM and MATH domains are particularly important for 
oligomerisation and it has been demonstrated that rat α and β subunits oligomerise 
quite differently, as shown in Figure 5.7 (Bertenshaw et al., 2003).  
 
TNFRs are membrane bound receptors that bind the extracellular growth factor 
TNFα. The majority of TNFRs transduce their signal to downstream signalling 
cascades via TRAF proteins and this results in activation of nuclear factor kappa B 
(NF-κB) transcription factors, mitogen-activated protein kinases (MAPKs) and pro-
apoptotic death signalling. The interleukin-1 receptor and Toll-like receptors, which 
are important for the immune and inflammatory systems, also use TRAFs for signal 
transduction. In mammals, six TRAFs have been identified so far (reviewed in Arch 
et al., 1998) and all TRAFs contain a MATH domain at their C-terminus. With the 
exception of TRAF1, all TRAFs contain a RING finger domain at their N-terminus 
and a stretch of zinc fingers that varies in length. TRAFs seem to function by 
recruiting other proteins, and each other, to signalling complexes (Arch et al., 
1998). TRAF oligomerisation via the MATH domain affects TRAF localisation and 
function, and many TRAF signalling functions are mediated through the RING 
domain (Au and Yeh, 2007). TRAF autoubiquitination has been reported (Petroski 
et al., 2007), but how the ubiquitin-protein ligase activity of TRAF proteins effect 
TRAF function is not well understood.  
 
5.5. Other MATH Domain Containing Proteins 
 
In 1996 the MATH domain was first identified (Uren and Vaux, 1996). However, the 
MATH domain was only found in proteins other than TRAFs and meprins in 2001 
(Zapata et al., 2001). Using the position-specific iterative basic local alignment 
search tool (PSI-BLAST) bioinformatics program at the National Center for 
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Biotechnology Information, the Reed group and collaborators found novel MATH 
domain-containing proteins using the MATH domain of human HsTRAF2 as a 
query. Three human cDNAs were selected as containing significant homology, 
which encoded the proteins HsMUL, HsSPOP and HsHAUSPUSP7.  
 
The MUL gene was identified in 2000 as being mutant in mulibrey (muscle-liver-
brain-eye) nanism, an autosomal recessive disorder with the typical characteristics; 
severe growth failure, hepatomegaly, muscle hypotonia, skull abnormality, yellow 
dots in the eyes, endocrine gland hypoplasia that results in hormone deficiency 
and, occasionally, kidney tumours (Avela et al., 2000). It is thought that the HsMUL 
protein has highly pleiotropic functions because several tissues of mesodermal 
origin are affected in mulibrey nanism (Perheentupa et al., 1973). HsMUL, more 
commonly known as tripartite motif-containing protein 37 (HsTRIM37), contains 
three domains at the N-terminus that are known collectively as the RING-B-box-
Coiled-coil (RBCC) domain, a MATH domain, and two Asp-Glu-Ser-rich sequences 
that have homology to several transcription factors (Avela et al., 2000). Whilst the 
RING portion of the RBCC domain of HsMUL has been shown to function as a bona 
fide E3 that is capable of auto-ubiquitination, substrates of MUL are yet to be 
identified (Kallijarvi et al., 2002). The RBCC family of proteins have been reviewed 
(Meroni and Diez-Roux, 2005; Torok and Etkin, 2001).  
 
The SKP1/CUL1/F-box (SCF) complex is the canonical RING finger E3, wherein 
CUL1 is utilised as a scaffold subunit to interact with the RING finger subunit, 
ROC1 (reviewed in Willems et al., 2004). A variety of other cullins exist, including 
CUL3, which is thought to be involved in regulating cell cycle checkpoints, but the 
other subunits of this E3 complex are not yet well understood. Human speckle-type 
poxvirus and zinc finger (POZ) protein (HsSPOP) contains an N-terminal MATH 
domain followed by a Bric-a-brac/Tramtrack/Broad complex (BTB) domain, which 
is also known as a POZ domain. The BTB domain is thought to inhibit DNA binding 
and aid specific protein-protein interactions (Bardwell and Treisman, 1994). 
HsSPOP has been shown to promote the ubiquitination of the anti-apoptosis protein 
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HsDAXX (death domain-associated protein) by recruiting HsDAXX to HsCUL3 (Kwon 
et al., 2006). Poly-ubiquitinated HsDAXX is directed to the proteasome for 
degradation, and low-levels of HsDAXX trigger apoptosis and repressed Hsp53-
dependent transcription (Kwon et al., 2006). An N-terminally truncated HsSPOP 
mutant with an intact BTB domain and C-terminus, but no MATH domain, could still 
interact with HsCUL3 (Kwon et al., 2006), but as HsSPOP has been shown to 
interact with HsDAXX via its MATH domain (La et al., 2004), HsDAXX degradation 
was abrogated (Kwon et al., 2006). Hence, HsSPOP acts as an adaptor protein – 
the BTB domain recruits the E3 functionality, and the MATH domain selects 
appropriate targets for degradation.  
 
5.6. The Human Meprin and Tumour Necrosis Factor Receptor 
Associated Factor (MATH) Domain Deubiquitinating Enzyme 
 
Herpes virus-associated ubiquitin-specific protease or ubiquitin-specific protease 7 
(HsHAUSPUSP7) is a UBP/USP superfamily DUb with a MATH domain at the N-
terminus and is the human orthologue of SpUbp21 and SpUbp22. It is 1102 amino 
acids in size, corresponding to a molecular weight of 128.3 kDa, and shares 31% 
identity to SpUbp21 and 29% identity to SpUbp22. An alignment of HsHAUSPUSP7 
with SpUbp21 and SpUbp22 is shown in Figure 5.8 and 5.9. HsHAUSPUSP7 is the 
most highly characterised MATH domain DUb known and has been assigned to 
several interesting cellular functions related to cell cycle control, DNA damage 
responses and carcinogenesis.  
 
The most characterised function of HsHAUSPUSP7 is its ability to stabilise the key 
tumour suppressing gatekeeper protein, Hsp53, which was introduced in Chapter 1. 
Following DNA damage, Hsp53 becomes phosphorylated preventing interaction 
with a RING finger E3 called mouse double minute 2 (HsMDM2), also known as 
HsHDM2 in human cells, which poly-ubiquitinates Hsp53 directing it for proteasomal 
degradation. Stabilisation of Hsp53 has a fundamental impact on DNA damage 
signalling. After DNA damage, Hsp53 is able to effect cell cycle halt to enable repair 
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before the lesions are replicated into mutations, or damaged genetic material is 
transferred into daughter cells. However, in other cell types, DNA damage causes 
Hsp53 to direct the cell into apoptosis, which also avoids tumourigenesis. Clearly 
regulation of the activity of Hsp53 is fundamental, so the cell employs a variety of 
methods to control the levels of this tumour suppressor – Hsp53 levels are also 
modulated by its acetylation. Deubiquitination by HsHAUSPUSP7 appears to be 
another method of stabilising Hsp53. However, confusingly, HsHAUSPUSP7 has also 
been shown to stabilise HsMDM2. 
 
The potential role of HsHAUSPUSP7 in the Hsp53 pathway was first noted by the Gu 
research group when HsHAUSPUSP7 was found, by affinity-purification and mass 
spectrometry, to interact with Hsp53 (Li et al., 2002). The overexpression of 
HsHAUSPUSP7 was clearly found, both in vitro and in vivo, to abolish higher-
molecular weight ladders of Hsp53 and to increase unmodified Hsp53 levels, even in 
the presence of cycloheximide. However, Hsp53 levels were unchanged when the 
catalytic cysteine of HsHAUSPUSP7 was mutated to a serine. Due to the highly 
stable interaction between HAUSPUSP7 and Hsp53, the authors imply that 
HAUSPUSP7 not only deubiquitinates Hsp53, but maintains Hsp53 in deubiquitinated 
form. This hypothesis results from the finding that the expression of catalytically 
dead HsHAUSPUSP7 in the presence of the wild-type, endogenous DUb, leads to 
increased Hsp53 ubiquitination. Hence, it was suggested that catalytically dead 
HsHAUSPUSP7 prevents wild-type HsHAUSPUSP7 from gaining access to the modified 
lysine on Hsp53. The group also found that the Hsp53–HsHAUSPUSP7 interaction is 
enhanced in response to DNA damage (Li et al., 2002). Taken together, the Gu 
group proposed from this study that HsHAUSPUSP7 acts in vivo as a tumour 
suppressor, and clearly this has important implications for clinical research in the 
treatment of tumours where Hsp53 levels have been compromised. However, a 
second study by the Gu group revealed that HsMDM2 is also a Hsp53-independent 
substrate for the catalytic activity of HsHAUSPUSP7 (Li et al., 2004). RNAi-mediated 
knockdown of HsHAUSPUSP7 in the presence of cycloheximide resulted in 
destabilisation of HsMDM2 compared to a control knockdown. This reduction in the 
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levels of HsMDM2 also correlated with an increase in Hsp53 levels, presumably due 
to a reduction in HsMDM2-triggered proteolysis of Hsp53. The pathway is 
complicated because HsMDM2 is known to constitutively auto-ubiquitinate itself, 
leading to its own degradation – HsHAUSPUSP7 is thought to regulate this, which 
would of course have the knock-on effect of reducing Hsp53 levels. However, due 
to the pro-apoptotic and growth repressive effects of HsHAUSPUSP7 expression 
demonstrated in the first study (Li et al., 2002), the Gu group argue that Hsp53 is 
the preferential target of HsHAUSPUSP7 in vivo (Li et al., 2004). Interestingly, a 
second DUb, HsUSP2a, has been shown to stabilise HsMDM2 but not Hsp53 
(Stevenson et al., 2007), revealing another player in this complex regulatory 
network. Furthermore, it has been proposed that a group of proteins linked by 
HsDAXX regulate the switch of HsMDM2 from self-ubiquitination to substrate 
ubiquitination mode (Ronai, 2006). HsDAXX has been shown to be key in 
controlling the levels of HsMDM2, and can bind HsHAUSPUSP7 and HsMDM2 
concurrently. Furthermore, the DNA damage-inducing agent etoposide was shown 
to disrupt this association, which was partially dependent on HsATM (Tang et al., 
2006). From this it is proposed that HsDAXX acts as a scaffold to bring together 
HsHAUSPUSP7 and HsMDM2, and possibly the HsMDM2 E3 HsMDMX (Ronai, 2006), 
to act together to poly-ubiquitinate Hsp53. HsDAXX allows HsMDMX and 
HsHAUSPUSP7 to work opposingly to regulate the levels of HsMDM2, which is free to 
induce Hsp53 degradation. However, upon DNA damage, HsATM-mediated 
phosphorylation of HsMDM2, and probably other components, cause this complex 
to fall apart, dissociated HsMDM2 switches to auto-ubiquitination mode, and the 
levels of Hsp53 increase (Tang et al., 2006). The model summarised by Ronai, 
2006) is depicted in Figure 5.10. More recently, the tumour suppressor and cell 
cycle controller HsRASSF1A has also been proposed to aid the dissociation of this 
complex (Song et al., 2008b), and has also been shown to be ubiquitinated by 
HsSKP2, the F-box protein in SCF E3s, by the same group (Song et al., 2008a).  
 
HsHAUSPUSP7 has also been shown to deubiquitinate mono-ubiquitinated Forkhead 
box O (FOXO) transcription factors, which affects their cellular localisation. FOXO 
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transcription factors are involved in a diverse range of cellular processes, for 
example cell cycle progression, stress responses and differentiation, and are 
described as acting within a genetic pathway “at the interface between ageing and 
cancer” (reviewed in Greer and Brunet, 2008). Like Hsp53, FOXO transcription 
factors are post-translationally regulated by phosphorylation, acetylation and 
ubiquitination. Lysine-48-linked poly-ubiquitination of FOXOs is thought to be 
effected by HsSKP2 (Huang et al., 2005). However, HsFOXO3 and HsFOXO4 mono-
ubiquitination, as well as multi-ubiquitination with mono-ubiquitin, has also been 
found by the Burgering group and this modification seems to be induced by cellular 
stress, particularly oxidative stress induced by hydrogen peroxide (van der Horst et 
al., 2006). Cells co-transfected with HsFOXO4 tagged with the C-terminal half of 
YFP, and ubiquitin tagged with the N-terminal half of YFP, showed YFP staining in 
the nucleus indicating that ubiquitinated HsFOXO4 occurs in this cellular 
compartment. This technique is known as bimolecular fluorescence 
complementation. Following further confirming experiments, this group concluded 
that mono-ubiquitination of HsFOXO4 resulted in nuclear localisation, and mono-
ubiquitinated HsFOXO4 demonstrated a greater transcriptional activity than 
unmodified HsFOXO4. The authors cite a yeast two-hybrid screen that had shown 
that amino acids 884-1065 of the C-terminus of HsHAUSPUSP7 interacted with the C-
terminus of HsFOXO4 (Colland et al., 2004). The Burgering group confirmed this 
interaction by immunoprecipitation and went on to show that HsHAUSPUSP7 can 
deubiquitinate HsFOXO4, which appears to reduce the amount of HsFOXO4 present 
in the nucleus (van der Horst et al., 2006). Certainly, knockdown of HsHAUSPUSP7 
significantly reduced the proportion of cells with cytosolic HsFOXO4 staining. 
Furthermore, overexpression of wild-type, but not catalytically inactive 
HsHAUSPUSP7, reduced HsFOXO-responsive gene transcription. From this study, 
this group draw parallels between Hsp53 and HsFOXO functions, their functions in 
inducing cell cycle arrest and apoptosis, how they are regulated – by 
phosphorylation, acetylation and ubiquitination, and the proteins involved in these 
regulatory pathways (van der Horst et al., 2006).  
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HsHAUSPUSP7 was first named as herpes virus-associated ubiquitin-specific 
protease because it was originally found to interact with the herpes simplex virus 
type 1 regulatory protein ICP0, which is an E3 of the RING finger variety (Everett et 
al., 1997). Herpes infection in humans causes cold sores and skin lesions. ICP0 
ubiquitinates the promyeloytic leukaemia protein, HsPML, and sumoylated HsSp100, 
targeting them for proteasome-mediated degradation (reviewed in Hagglund and 
Roizman, 2004).  HsPML and HsSp100 are major components of nuclear PML 
bodies, which are observed in a wide variety of neurodegenerative disorders such 
as Parkinson’s and Alzheimer’s diseases. Interestingly, HsPML is also known as 
HsTRIM19 due to its RBCC motif. ICP0 also ubiquitinates the centromeric proteins 
HsCENP-A and -C, as well as HsDNA-PKcs, and also Hsp53 at low levels. However, 
most interestingly, ICP0 can ubiquitinate itself (auto-ubiquitination) leading to its 
degradation, but its strong interaction with HsHAUSPUSP7 prevents this (Canning et 
al., 2004). Furthermore, ICP0 ubiquitinates HsHAUSPUSP7 inducing its degradation, 
although it has been shown that the stabilising role of HsHAUSPUSP7 is dominant 
over its ICP0-induced degradation during virus infection (Boutell et al., 2005).   
 
HsHAUSPUSP7 has also been shown to interact with Epstein-Barr nuclear antigen 1 
(EBNA1; Holowaty et al., 2003b) and HsATAXIN1. Epstein-Barr virus causes 
cellular immortalisation by manipulating a variety of host cell pathways, which 
predisposes infected individuals to carcinogenesis. EBNA1 affects cellular DNA 
replication, segregation and transcriptional activation. It has been proposed that as 
an EBNA1 peptide binds HsHAUSPUSP7 with higher affinity than a Hsp53 peptide 
(Holowaty et al., 2003a), and can displace it, that EBNA1 promotes Hsp53 
degradation by preventing HsHAUSPUSP7 from removing lysine-48 linked poly-
ubiquitination of Hsp53 (Saridakis et al., 2005).  
 
HsATAXIN1 is the protein product of SCA1, which is mutant in the disorder 
spinocerebellar ataxia type 1 (SCA1). SCA1 is a neurodegenerative disorder 
known to cause ataxia and progressive motor deterioration, and it is associated 
with the expansion of CAG repeats in the SCA1 gene, which results in extended 
 158 
poly-glutamine tracts in HsATAXIN1. The C-terminus of HsATAXIN1 was found to 
interact with the C-terminus (amino acids 705-1102) of HsHAUSPUSP7 (Hong et al., 
2002).  Interaction of HsHAUSPUSP7 with full-length HsATAXIN1 was almost 
abrogated when the poly-glutamine tract length in the N-terminal region of 
HsATAXIN1 was increased significantly. The dominant negative function of mutant 
HsATAXIN1 is thought to manifest itself in the nucleus of neural Purkinje cells, and 
it has been shown to co-localise with HsPML (Skinner et al., 1997). Hence, it is 
thought that mutant HsATAXIN1 cannot be deubiquitinated by HsHAUSPUSP7, 
HsATAXIN1 degradation is accelerated (Hong et al., 2002), and thus presumably a 
reduction in HsATAXIN1 levels causes the phenotypes observed in SCA1. 
However, it has not been shown whether HsHAUSPUSP7 can stabilise the levels of 
HsATAXIN1, nor is any information given on the type of ubiquitination that 
HsHAUSPUSP7 is supposed to deubiquitinate. Hence, HAUSPUSP7 may not provide a 
link between SCA1 and the ubiquitin-proteasome system at all. Co-incidentally, 
CAG repeat expansion is also associated with Machado-Joseph disease (MJD), 
from which the superfamily of MJD DUbs are named.  
 
Checkpoint protein with Forkhead associated and RING domains (HsCHFR) is an 
early mitotic checkpoint protein and important tumour suppressor that has been 
receiving considerable research interest recently (reviewed in Baker et al., 2005). 
HsHAUSPUSP7, which was found by mass spectrometry to interact with HsCHFR, has 
been shown to control the stability and activity of HsCHFR by preventing its auto-
ubiquitination (Oh et al., 2007). Furthermore, an interesting link with PRR has also 
been revealed. HsCHFR has been shown to catalyse the formation of lysine-63-
linked poly-ubiquitin chains by functioning with an HsUBC13-HsMMS2 heterodimer 
(Bothos et al., 2003). Studies with the S. cerevisiae homologues ScChf1 and 
ScChf2, also known as ScDma1 and ScDma2, suggest that ScUbc4-dependent 
ubiquitination results in ScChf protein auto-ubiquitination and subsequent 
degradation, which is involved in G1 cell cycle delay, and this activity is 
independent of the ScUbc13-ScMms2-dependent lysine-63-linked ubiquitination 
activity of ScChf proteins that affect G2/M cycle arrest (Loring et al., 2008). The 
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involvement of HsHAUSPUSP7 in these two processes is yet to be defined, but there 
is an S. pombe HsCHFR homologue called SpDma1 that has been shown to be 
involved in the spindle checkpoint (Guertin et al., 2002).  
 
These elucidated roles have resulted in HsHAUSPUSP7 receiving growing research 
interest from a clinical perspective. A clinical study on HsHAUSPUSP7 expression in 
non-small cell lung carcinoma tumour cells revealed that 45% showed reduced 
HsHAUSPUSP7 mRNA levels, and the levels were significantly more likely to be 
reduced in adenocarcinoma cells (Masuya et al., 2006). The authors conclude that 
HsHAUSPUSP7 may have a role in the transformation of these cells in particular 
(Masuya et al., 2006), but it is not known whether a reduction in HsHAUSPUSP7 
levels induces transformation directly, or whether it is knock-on effect. However, to 
exploit the possible usefulness of targeting this deubiquitinating enzyme in the 
clinic, pharmaceutical companies have patented inhibitors of HsHAUSPUSP7 binding 
and catalysis, which result in Hsp53 stabilisation (presumably as a result of HsMDM2 
destabilisation) and the expected anti-carcinogenic effects of increased levels of 
Hsp53 function (Guedat and Colland, 2007). 
 
5.7. MATH Domain Containing DUbs in Other Species 
 
Most eukyarotic organisms, for example Mus musculus (mouse), Rattus 
norvegicus (rat), Xenopus laevis (frog), Anopheles gambiae (mosquito) and 
Dictyostelium discoideum (slime mould), all contain one MATH domain DUb. 
However, in addition to S. pombe, Arabidopsis thaliana and Neurospora crassa 
also contain two paralogous MATH DUbs. Why these organisms have retained two 
MATH domain DUbs, whereas the majority of eukaryotes only utilise one, is not 
known. Unfortunately, very little is known about the MATH domain DUbs in these 
and other eukaryotes – the vast majority of research has focused on the human 
homologue.  Although it is worth noting here that one HsHAUSPUSP7 homologue, 
ScUbp15, is found in the commonly utilised yeast model organism Saccharomyces 
cerevisiae. More attention has been devoted to ScUbp15 than its S. pombe 
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counterparts, but no definite functions for this enzyme have been elucidated. 
Analyses of this S. cerevisiae homologue will be discussed in Chapter 6. The 
considerable structural information available for HsHAUSPUSP7, and subsequently 
the implications for SpUbp21 and SpUbp22, will now be analysed. 
 
 
5.8. Structure of the Catalytic Core of HsHAUSPUSP7 
 
In 2002, the Gu group and collaborators published the first crystal structure of a 
UBP/USP superfamily DUb, HsHAUSPUSP7 (Hu et al., 2002). Preparatory work 
revealed that HsHAUSPUSP7 was monomeric, and limited proteolysis, DUb assays 
and bioinformatics concluded that residues 208-560 defined the catalytic domain. 
Only the structure of this 40 kDa catalytic core domain of HsHAUSPUSP7 was 
solved, alone and when covalently linked to ubiquitin aldehyde (Figure 5.11). The 
structure is akin to an extended right hand comprising three domains, palm, fingers 
and thumb. A catalytic cleft, where the Cys and His boxes are located, is formed at 
the interface between the palm and thumb domains (Hu et al., 2002). In the 
unbound HsHAUSPUSP7 structure, the catalytic triad side chains of residues 
cysteine-223, histidine-464 and aspartate-481 were misaligned such that hydrogen 
bonding between them was implausible. However, upon binding to ubiquitin, the 
structure of HsHAUSPUSP7 was found to switch into an active conformation with an 
effective catalytic triad. Ubiquitin was found to bind the concave pocket formed by 
the DUb ‘hand-like’ structure formed from its three domains. Ubiquitin is shaped 
like a “pear drop” – the bulkier N-terminus of ubiquitin was found to be held by the 
β-sheets in the finger domain of HsHAUSPUSP7 and the tapered C-terminus lay in 
the DUb catalytic cleft. The mutant ubiquitin utilised in this study was modified such 
that the C-terminal carboxylate was replaced with an aldehyde moiety. This mutant 
ubiquitin acts as a suicide substrate for DUbs – the catalytic cysteine, cysteine-223 
in the case of HsHAUSPUSP7, had been irreversibly reacted with the ubiquitin 
aldehyde group prior to crystallisation. Hence it is unsurprising that the C-terminus 
of ubiquitin lies in this cleft. However, it was also found that a layer of ordered 
water molecules was present at the interface between HsHAUSPUSP7 and ubiquitin, 
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and these were thought to cause the reduced affinity of HsHAUSPUSP7 for ubiquitin 
compared to other DUbs (Hu et al., 2002). Therefore, perhaps a free complex of 
these two proteins, without a covalent linkage, would not be stable enough for 
crystallisation. Of course, if the orientation of ubiquitin binding by HsHAUSPUSP7 
shown in this study is physiological, it could be easily imagined how HsHAUSPUSP7 
would cleave the covalent bond between the C-terminal glycine-76 of ubiquitin and 
the lysine on the modified protein, hence effecting a deubiquitinating reaction. 
Interestingly, the authors also propose that by reducing the affinity for ubiquitin, 
these water molecules aid the selectivity of HsHAUSPUSP7 for ubiquitinated Hsp53, 
rather than a different ubiquitinated protein (Hu et al., 2002). Presumably, it is 
meant here that in order for a deubiquitination event to be successful, a threshold 
of binding stability between DUb and ubiquitinated substrate must be achieved in 
order for the reaction to occur. The stability of protein-protein interactions is 
dependent upon affinity, which is modulated by the complementarities of charge 
and conformation shared by a pair of proteins. If a DUb has a high affinity for 
ubiquitin, then it may bind and deubiquitinate, sometimes fruitlessly, a variety of 
ubiquitinated proteins, in addition to free ubiquitin alone, whereas if a DUb has a 
modest affinity for ubiquitin and a modest affinity for particular ubiquitinated 
substrates, then both of these interactions must occur simultaneously in order for 
deubiquitination to be effected. Hence, it could be imagined that fewer futile 
interactions occur, and only cognate substrates are deubiquitinated.  
 
In this same study, the in vitro DUb activity of HsHAUSPUSP7 on lysine-48 linked di-
ubiquitin was investigated (Hu et al., 2002). Firstly, it was confirmed that the 
HsHAUSPUSP7 catalytic domain and full-length HsHAUSPUSP7 cleave this substrate 
with similar kinetics. Then mutagenesis of residues within the catalytic cleft 
revealed ten important amino acids, which when each mutated to alanine, 
abolished the ability of HsHAUSPUSP7 to cleave di-ubiquitin (Hu et al., 2002). All ten 
of these residues were completely conserved in S. pombe SpUbp21 and SpUbp22 
(Figure 5.8 and 5.9). Furthermore, it was shown that these residues were totally 
conserved amongst other UBP/USP superfamily DUbs selected by the authors in 
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this study, with the exception of S. cerevisiae ScUbp8 where two residues were 
slightly divergent (Hu et al., 2002). In this publication the authors also mapped the 
region of HsHAUSPUSP7 that interacts with Hsp53 to within the MATH domain amino 
acids 53-208. The Hsp53 protein contains three main domains, the N-terminal DNA-
binding domain, a central tetramerisation domain and a C-terminal regulatory 
domain. Eleven amino acids 357-367 within the regulatory domain of Hsp53 were 
shown to have a critical role in binding to HsHAUSPUSP7 – removal of this section 
abrogated the interaction (Hu et al., 2002).  
 
Recently, the crystal structure of the catalytic domain of the human UBP/USP 
superfamily DUb HsCYLD revealed some interesting information about 
HsHAUSPUSP7 (Komander et al., 2008). HsCYLD seems to specifically deubiquitinate 
lysine-63 linked poly-ubiquitin chains formed by the E3s HsTRAF2 and HsTRAF6 to 
activate HsNK-κB signalling pathways (reviewed in Courtois, 2008). These lysine-
63 linked chains provide a “molecular scaffold for the coassembly of” HsNK-κB 
pathway components (Komander et al., 2008). Mutations in CYLD result in a type 
of skin cancer called cylindromatosis. In this paper, the catalytic domain of 
HsHAUSPUSP7 was directly compared with that of HsCYLD, and two major 
differences were identified. Firstly, in addition to the palm, thumb and finger 
domains, HsCYLD was found to have an additional 60 amino acid zinc-binding 
domain, which was found to be most similar to a type 1 B-box domain. Deletion of 
this domain in HsCYLD was not found to have any effect on the DUb activity nor 
HsNK-κB suppression. This domain also could not function as an E3 and did not 
bind to ubiquitin or ubiquitin chains. This implies that the B-box does not confer the 
specificity of HsCYLD for lysine-63-linked poly-ubiquitin chains. However, this 
domain did appear to play a role in excluding HsCYLD from the nucleus (Komander 
et al., 2008). 
 
Secondly, HsCYLD was found to have an extended loop between β-sheets 12 and 
13 of the palm domain, which is near the vicinity of the catalytic cleft. If the N-
terminus of ubiquitin sites in the concave pocket of the DUb “hand” and the tapered 
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C-terminus lies in the catalytic cleft, this extended loop points towards the likely 
location of the ubiquitinated substrate, or modified ubiquitin in the case of a poly-
ubiquitin chain. In in vitro DUb assays where lysine-48 linked tetra-ubiquitin chains 
were used as a substrate, when the wild-type catalytic domain of HsCYLD was 
utilised, only around 50% of the tetra-ubiquitin was cleaved into smaller fragments 
after 5 h. Hence, HsCYLD certainly has some activity on lysine-48 linked poly-
ubiquitin. When the HsCYLD extended loop was decreased to the size of that found 
in the structure of HsHAUSPUSP7, even less tetra-ubiquitin was cleaved – less than 
50% of the levels of mono-ubiquitin were seen after 5 h compared with the wild-
type control. Furthermore, when a catalytically dead HsCYLD was used dramatically 
less tetra-ubiquitin was cleaved – no mono-ubiquitin was seen at all. However, 
when lysine-63 linked tetra-ubiquitin was utilised with the wild-type catalytic domain 
of HsCYLD, only mono-ubiquitin was seen after 5 h, hence deubiquitination had 
occurred to completion and when the truncated loop mutant of HsCYLD was 
utilised, no mono-ubiquitin at all was seen after 5 h (Komander et al., 2008).  
 
From this it can be argued that there are two main factors that determine the 
kinetics of DUb activity of different poly-ubiquitin linkages. To clarify these points, 
the nomenclature utilised in Figure 5.12 will be additionally referred to in square 
parentheses. With reference to how HsCYLD binds ubiquitin, position “a” of 
ubiquitin would indicate lysine-63 and position “b”, lysine-48. Firstly, the authors 
state that “modelling indicates that similar to HsHAUSP…, the Lys48 side chain of 
the distal ubiquitin [Ub-3] would be occluded and that a Lys48-linked chain could 
not be extended from a ubiquitin molecule [Ub-2] bound to the distal ubiquitin 
binding site of CYLD”; hence preventing endo-deubiquitinating activity on lysine-48 
linked chains because a more distal ubiquitin [Ub-3] cannot be attached by lysine-
48. This must dramatically increase the kinetics for deubiquitination of lysine-63 
linked poly-ubiquitin chains because only binding to the most proximal ubiquitin 
[Ub-1] would result in a futile cleavage attempt (where the poly-ubiquitin chain is 
not attached to a modified protein).  
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Secondly, the data implies that this extended loop dramatically increases the 
kinetics of the HsCYLD DUb activity of lysine-63-linked chains specifically. Whether 
this loop has a stabilising effect on lysine-63-linked chains (a positive function), or 
whether it acts to exclude chains linked by a different lysine on the proximal 
ubiquitin [Ub-1] (a negative function), or both, is not discussed by Komander et al., 
2008. In the stabilising hypothesis, the extended loop somehow aids the binding of 
the proximal ubiquitin [Ub-1] if it is linked to the bound, distal ubiquitin [Ub-2] by 
lysine-63. The conformation of the proximal ubiquitin [Ub-1] in a lysine-63-linked 
mode could be not only complementary to the extended loop, but the extended 
loop amino acids (ADRGGQNGFNIP) could interact and bond non-covalently with 
ubiquitin [Ub-1] residues. Alternatively (or additionally), it could be imagined that 
HsCYLD can only properly bind a distal ubiquitin [Ub-2] in its hand if it is attached 
via lysine-63 of the proximal ubiquitin [Ub-1], and this is controlled by the extended 
loop. Perhaps the extended loop sterically hinders the proximal ubiquitin [Ub-1] if it 
is attached via any lysine other than lysine-63, and the effect of this is that the 
distal ubiquitin [Ub-2] cannot bind the hand optimally and therefore the ubiquitin-
ubiquitin bond can only be cleaved with slow kinetics. However, the negative, 
excluding hypothesis does not fit with the observation that truncation of the 
extended loop reduces the ability of HsCYLD to deubiquitinate lysine-48-linked 
chains. Perhaps, also, the active site of HsCYLD has evolved to require the 
extended loop for proper functionality as well as to select for lysine-63-linked 
ubiquitin-ubiquitin [Ub-2—Ub-1] bond. It is also worth noting that full length HsCYLD 
has other domains that may interact with this extended loop modulating its 
function. The N-terminal residue of the catalytic domain used in this study is found 
in very close proximity to the extended loop, and the N-terminus of the full length 
protein accounts for a further 582 amino acids. At no point in Komander et al., 
2008 is the activity of the full length protein tested. 
 
The impact of this data on the specificity of HsHAUSPUSP7 for particular poly-
ubiquitin linkages will now be explained. Komander et al., 2008 argue that HsCYLD 
is a DUb specific for lysine-63-linked chains and that other UBP/USP superfamily 
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DUbs that have published structures of their catalytic domains, are not. Contrary to 
what Komander et al., 2008 incorrectly cite, in the seminal 2002 Cell paper by Hu 
et al that reported the structure of the catalytic domain of HsHAUSPUSP7 in complex 
with ubiquitin-aldehyde (Ubal), the authors actually state: 
 
“Both Lys29 and Lys63 are largely solvent accessible in the ubiquitin moiety 
of the HAUSP-Ubal complex, but the Lys48 side chain [of Ub-2] is involved 
in hydrogen bonds to residues in helix α5 of HAUSP and is only partially 
exposed to solvent. Examination of the local structure indicates that the side 
chain of Lys48 can be linked to the C-terminal carboxylate of another 
ubiquitin [Ub-3] without disruption of the HAUSP-Ubal interface. 
Nevertheless, Lys48 is not as freely available as the other ubiquitin lysine 
residues. Moreover, the HAUSP residues Asp305 and Glu308 that co-
ordinate ubiquitin [Ub-2] Lys48 are conserved as acidic amino acids in other 
UBPs…A possible function of these residues is to promote binding of a 
ubiquitin moiety [Ub-2] that contains a free Lys48 side chain. Thus, cleavage 
by HAUSP might be biased toward the ubiquitin at the distal end of a K48-
linked chain [Ub-3] or toward conjugates with either monoubiquitin or non-
K48-linked polyubiquitin.” 
 
Therefore, this does not preclude HsHAUSPUSP7 from deubiquitinating a lysine-63-
linked poly-ubiquitin chain. Certainly, the data on HsCYLD seem to imply that the 
extended loop is a gained function that has made the enzyme more able to 
deubiquitinate lysine-63-linked chains in particular, and less able to deubiquitinate 
a broader range of ubiquitin modifications. Hence, HsCYLD is a more specialised 
DUb. Furthermore, HsCYLD is known for deubiquitinating unattached (free) lysine-
63-linked poly-ubiquitin chains, the extended loop may prevent HsCYLD from 
deubiquitinating ubiquitinated substrates other than ubiquitin, for example removing 
the most proximal ubiquitin [Ub-1] from a lysine-63-linked poly-ubiquitinated 
protein.  
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5.9. Structure of the MATH Domain of HsHAUSPUSP7 
 
The N-terminal MATH domain, sometimes referred to as the TRAF, TRAF-like, or 
simply N-terminal domain, of HsHAUSPUSP7 has been demonstrated to be very 
important for the ascribed roles of this DUb. HsHAUSPUSP7 was found to be nuclear, 
and although no nuclear localisation motif was found, the MATH domain was 
required for nuclear localisation (Fernandez-Montalvan et al., 2007). The authors of 
this study propose that HsHAUSPUSP7 utilises its MATH domain to bind unknown 
factors that are transported to the nucleus, allowing HsHAUSPUSP7 to ‘piggy-back a 
ride’ to this cellular compartment (Fernandez-Montalvan et al., 2007). Furthermore, 
it is the MATH domain that mediates interactions with Hsp53, HsMDM2 and EBNA1, 
and crystal structures of the MATH domain in complex with peptides from each of 
these three proteins have been published (Hu et al., 2006; Sheng et al., 2006; 
Saridakis et al., 2005).  
 
The first HsHAUSPUSP7 MATH domain structure published revealed an eight-
stranded, partially twisted β-sandwich domain very similar to that seen in TRAFs. It 
was solved in complex with an EBNA1 peptide, which was found to bind laterally 
across the β-sheets and important residues in HsHAUSPUSP7 for this interaction 
were defined (Saridakis et al., 2005). Later structures of the HsHAUSPUSP7 MATH 
domain in complex with Hsp53 and HsMDM2 peptides were in agreement (Hu et al., 
2006; Sheng et al., 2006). Due to the same binding position of these peptides, 
EBNA1, Hsp53, and HsMDM2 must compete for the same binding site in the 
HsHAUSPUSP7 MATH domain. The structure of the MATH domain in complex with a 
Hsp53 peptide elucidated in the Hu et al., 2006 PLoS Biology paper is depicted in 
Figure 5.13.  
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5.10. Further Investigation of the Phenotypes of S. pombe Strains 
Deficient in MATH Domain DUbs 
 
Based on analyses of the literature, mostly with respect to HsHAUSPUSP7, the 
experimental direction of further investigations into the role of SpUbp21 and 
SpUbp22 in responses to DNA damage were as follows. Firstly, the phenotypes 
demonstrated by the double delete seen in the screening assays were verified. The 
growth defect of this strain was analysed, in addition to verification of the 
temperature sensitivity previously reported. Due to the established involvement of 
HsHAUSPUSP7 in responses to DNA damage in general, as well as to oxidative 
stress, spot test assays were utilised to measure the sensitivity of the doubly 
deleted strain to a wide variety of DNA damaging agents.  
 
Firstly, the striking UV-sensitivity of the ubp21∆::ura4 ubp22∆::ura4 was measured 
quantitatively by the colony-forming assay described in Chapter 4. As depicted in 
Figure 5.14, the two ura4-marked single deletes were found to demonstrate 
approximately the same UV-sensitivity as wild-type, and the double delete was 
found to have an intermediate sensitivity compared to these strains and the more 
sensitive pcn1-K164R. It is interesting to note here that double delete had a colony 
forming growth defect: when untreated cells were spread onto agar, colonies would 
form more slowly than wild-type, the singly deleted strains, or pcn1-K164R, which, 
incidentally, forms colonies slightly more quickly than wild-type. Where wild-type 
cells would take two days at 30°C, the double delete would take three days to 
reach approximately the same colony size. Furthermore, when ubp21∆::ura4 
ubp22∆::ura4 colonies were added to liquid media, they took significantly longer to 
recover from the stationary phase state within which cells in colonies exist. The 
reasons for these observations are unknown – it appears that these cells have 
difficulties exiting from G0 or quiescence. These observations were tested by 
growth curve assays. Firstly, the exponential growth rates of the three ura4-marked 
strains, compared with wild-type and pcn1-K164R, was assayed, which is shown in 
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Figure 5.15. By observing the gradient of a graph measuring the absorbance of a 
culture versus time, the double delete was found to grow at a slightly slower rate. 
Absorbance at 600 nm measures the mass of cells present within a particular 
volume, hence a million cells doubling in size would result in the same change in 
optical density as a million cells dividing to make two million cells. Hence, this 
assay was verified by physically counting the cells over a time period, and the 
same result was obtained (data not shown). The growth defect was more evident 
when exponentially growing cultures were grown to stationary phase, and then re-
diluted, to approximately the same density, in fresh, liquid media (Figure 5.16). The 
double delete was barely able to recover, grow and divide over a 10 h period. 
Although when a sample was taken the following day, after 20 h growth, it had 
clearly recovered from stationary phase during the night. Moreover, following 
irradiation the double delete was found to form colonies much more slowly, and 
this correlated with UV dose. This effect is seen in wild-type colonies at very high 
doses, but to a much lower extent. However, if ubp21∆::ura4 ubp22∆::ura4 
colonies were counted after six days at 30°C, the strain appeared more UV 
resistant than if they were counted after the usual 2-3 days. This is because some 
colonies were too small to be observed, and thus counted, after only a couple of 
day’s growth. As this assay is designed to measure the percentage of cells that do 
not die after specified UV doses, the colonies were counted when they stopped 
increasing in number, and five days growth was deemed appropriate in this 
respect. Hence, Figure 5.14 shows data collected from all five strains following five 
days growth.  
 
Before further studies of the phenotypes of the double delete were assayed, an 
important discrepancy between the UV sensitivity of two different ubp22∆ strains 
was investigated. Confusingly, Figure 5.17, which is an uncropped version of 
Figure 4.5 from Chapter 4, shows that the ubp22∆::nat1 strain has a subtle UV 
sensitive phenotype, whereas it was previously shown in Figure 5.1 that the 
ubp22∆::ura4 strain was not UV sensitive. The reason for this difference is 
unknown. PCR and sequencing results revealed the expected DNA sequences at 
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the ubp22 locus, and there was no evidence of diploidisation. The ubp21∆::ura4 
ubp22∆::ura4 strain was created by a cross between the ubp21∆::ura4 and 
ubp22∆::ura4. An important concern was that ubp22∆::ura4 may originally have 
been UV-sensitive, but subsequent to being crossed with the ubp21∆::ura4 strain, 
the single may have obtained suppressors of this phenotype. Furthermore, the UV-
sensitivity and/or other interesting phenotypes of the ubp21∆::ura4 ubp22∆::ura4 
strain may, as a result, be entirely related to a lack of SpUbp22 in the cell. However, 
when an HU block and release experiment was performed on ubp22∆::nat1, which 
is shown in Figure 5.18, an uncropped version of Figure 4.22 from Chapter 4, this 
strain demonstrated a similar profile to that of wild-type, and contrasts significantly 
with the profile of the ubp21∆::ura4 ubp22∆::ura4 strain depicted in Figure 5.3. An 
alternative, less plausible explanation for the differences in UV-sensitivity between 
these strains is that the ura4 marker somehow alleviates the phenotype of the 
strain, or that perhaps the nat1 marker sensitises the strain. Certainly there is 
anecdotal evidence from the S. pombe research community that ura4-marked 
strains can behave differently to deletions marked with a different marker. Perhaps 
when placed within certain genomic DNA contexts, the ura4 gene affects 
nucleotide pools. Alternatively, variation in UV-sensitivity may exist between 
different clones with an ubp22∆ genotype, irrespective of the marker utilised. To 
check for this, different clones of the nat1 marked strain resultant from when this 
strain was originally made, and positive for multiplex PCR products, were checked 
for sensitivity to UV by qualitative assay. The results of this are shown in Figure 
5.19. Clone number 19 is the ubp22∆::nat1 strain utilised previously in this study, 
and clones 20 and 21 are isogenic strains not previously tested for their sensitivity 
to UV. When these strains were compared with the ubp22∆::ura4 strain, wild-type 
and pcn1-K164R, all the nat1-marked strains demonstrated a very similar UV-
sensitive phenotype. However, in the 0-200 Jm-2 gradient, there is still evidence of 
smaller colonies in the arrays of the nat1-marked strains at the top of the agar 
plate, indicating that perhaps a more subtle UV-sensitive phenotype might be 
resultant if the colonies were left to grow for longer. To check for this, the 
quantitative assay was employed. A different ubp22∆ strain was created, 
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ubp22∆::hph (verification shown in Figure 5.20), and a second ubp21∆ strain, this 
time marked with a kanamycin-resistance gene (verified in Chapter 3), was also 
tested. Figure 5.21 depicts the five different singly deleted strains compared to 
wild-type, ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. After six days growth, the 
five singly deleted strains demonstrate a very similar phenotype to that of wild-type. 
Furthermore, the double delete is clearly far more sensitive than the singles, hence 
the redundancy between SpUbp21 and SpUbp22 can be confirmed. However, when 
the y-axis of this graph was altered in order to resolve the singly deleted strains 
(Figure 5.22) and the sensitivities of the strains are analysed at the 100 Jm-2 dose 
in particular, the ubp22∆ strains are marginally more sensitive to UV compared to 
the ubp21∆ strains, and notably the ubp22∆::hph strain appears intermediate. A 
ubp22∆::hph strain was found to be UV sensitive to a similar level as ubp22∆::nat1. 
It is important to note here that these conclusions are speculative without detailed 
statistical analysis However, it is likely that either the ura4 marked strain has 
picked up suppressors of its UV sensitivity or that somehow the ura4 marker 
rescues the sensitivity of this strain. However, it is also possible that the strains 
marked with genes that confer antibiotic resistance function slightly differently from 
an auxotrophic marker, when placed at this locus. In general, it is concluded that 
there is little significant difference between ubp22∆ strains. However, it was 
decided to use the ubp21∆::ura4, ubp22∆::ura4 and ubp21∆::ura4 ubp22∆::ura4 
strains for further investigations of the phenotypes of ubp21∆, ubp22∆ and ubp21∆ 
ubp22∆. This is because all three of these strains have the same genetic 
background in that they were made from the same wild-type strain.  
 
In Figure 5.2, an increase in PCNA ubiquitination was seen in unchallenged 
ubp21∆::ura4 ubp22∆::ura4 cells, and this basal level increased further when the 
cells were treated with HU. This experiment was repeated, except UV was utilised 
instead in order to analyse whether this effect was HU-specific. Furthermore, the 
kinetics of SpPCNA ubiquitination following mock, or UV treatment was also 
analysed. This experiment is shown in Figure 5.23. As expected, the double delete 
shows an increase in SpPCNA ubiquitination in the mock-treated samples. The lack 
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of SpPCNA ubiquitination after 180 minutes following mock treatment is the result of 
a Western transfer problem that also affected the pcn1-K164R unmodified SpPCNA 
bands. After UV treatment, the levels of SpPCNA ubiquitination increase, but 
beyond that seen in wild-type cells, and these levels persisted for 180 minutes after 
irradiation. Hence, this experiment verifies the finding of Figure 5.3.  
 
In Chapter 4, when an unsupported nitrocellulose membrane was utilised and the 
ubiquitinated species of PCNA were run on a gel for a sufficiently long period of 
time, the ubiquitinated bands could be resolved into doublets. In case SpUbp21 
and/or SpUbp22 are only involved in removing one variant of this ubiquitinated 
species, the levels of the doublets were checked in ubp21∆::ura4, ubp22∆::ura4 
and ubp21∆::ura4 ubp22∆::ura4 after UV treatment, which is shown in Figure 5.24. 
An extra-long SDS-PAGE gel was utilised in order to resolve the ubiquitinated 
bands to a greater extent. This experiment shows that both bands in each doublet 
are present at approximately the same level in all strains used in this experiment, 
except for the pcn1-K164R strain where no ubiquitinated forms of SpPCNA at all 
were observed.  
 
A possible explanation for the persistence of SpPCNA ubiquitination seen in the 
double delete following release from HU block, as shown in Figure 5.3, is that S-
phase is delayed in this strain. This would be consistent with the slightly reduced 
exponential growth rate seen in Figure 5.15. In order to check this, the HU block 
and release was repeated, but with just wild-type cells and the double delete this 
time. The levels of SpPCNA ubiquitination observed at each time point, which were 
similar to that seen previously, are shown in Figure 5.25, but more importantly the 
DNA content of a duplicate set of samples was measured by DAPI staining and 
fluorescence activated cell sorting (FACS), which is shown in Figure 5.26. S. 
pombe cells spend 75% of their time in G2, and because cytokinesis occurs at 
almost the same time as DNA replication, S. pombe does not have a proper G1 
phase and so when wild-type asynchronous cells are analysed by FACS, only one 
peak is seen, which represents 2C DNA content. Following block in HU for 2.5 h, 
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this peak moved dramatically to the left, indicating that all the cells were blocked in 
S-phase. This peak was denoted 1C DNA content. When the cells were released in 
to fresh media, the 1C peak gradually moved towards a 2C peak position as the 
cells quickly replicated their DNA and divided. After 210 minutes, the position of the 
peak was similar to that seen in the NT sample. The FACS profiles of wild-type and 
ubp21∆::ura4 ubp22∆::ura4 cells were indistinguishable from each other. Hence, 
the persistence of SpPCNA modification seen in the double delete cannot be 
explained by an elongated or delayed S-phase.  
 
5.11. Sensitivity of S. pombe Strains Deficient in MATH Domain 
DUbs to Variety of Genotoxic Agents and Other Stresses 
 
In order to check for a role of MATH domain DUbs in a DNA damage responses in 
general, the double delete was exposed to wide variety of agents. For speed, it 
was decided to use an assay that was qualitative – spot tests are colony-forming 
assays that are more accurate than the UV drop tests assays employed previously 
because the effect of the agent on serial dilutions spotted onto agar containing the 
agent are assessed independently. Each set of experiments was repeated, and the 
most representative data are presented here.  
 
Firstly, the sensitivity of ubp21∆::ura4, ubp22∆::ura4, and ubp21∆::ura4 
ubp22∆::ura4 cells to 4-nitroquinoline-1-oxide (4NQO) was compared with wild-
type and pcn1-K164R. 4NQO is a UV-mimetic genotoxic agent in that it produces 
bulky DNA base adducts. As expected 4NQO treatment causes SpPCNA poly-
ubiquitination in S. pombe (Frampton et al., 2006) and pcn1-K164R is sensitive to 
this agent (Figure 5.27). The double delete is less sensitive to this agent than 
expected from the UVC sensitivity data previously shown, but there still appears to 
be a subtle phenotype.  
 
Many agents utilised in this study, including 4NQO, were dissolved in the organic 
solvent dimethylsulfoxide (DMSO). Whilst an appropriate DMSO control was 
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always used, it was deemed appropriate to check the sensitivity of the strains to 
higher doses of DMSO, which is shown in Figure 5.28. The double delete in 
particular was found to be sensitive to DMSO at doses above 4% (v/v). Previously, 
it had been shown that the double delete is sensitive to cold and hot temperatures 
– it did not grow at 20°C or 36°C (Richert et al., 2002) and these data are 
reproduced in Figure 5.29 (although RT was used instead of 20°C). The sensitivity 
of this strain to DMSO correlates well with these findings. Strains sensitive to 
temperature also tend to be sensitive to DMSO because the solvent alters protein 
structure in the same way that temperature can.  
 
The effect of HU on cells has been explained previously in this study. Interestingly, 
although it is well characterised that HU induces ubiquitination of SpPCNA, the 
pcn1-K164R strain was not HU-sensitive (Figure 5.30). However, there is a simple 
explanation for this. Whilst the cell attempts to utilise PRR to bypass the replication 
fork block, it is futile. Without a dNTP pool, DNA cannot be replicated. In other 
words, PRR is not required by the cell to bypass ‘damage’ caused by HU, hence it 
is unsurprising that the pcn1-K164R strain was not found to be sensitive to this 
agent. However, the double delete was sensitive to HU.  
 
The effect of the genotoxic agent methyl methanesulfonate (MMS) on colony 
formation was analysed and is shown in Figure 5.31. MMS is an methylating agent 
known to react with and methylate DNA bases, and indirectly this causes both 
SSBs and DSBs. NER and HR are thought to be the main processes in S. pombe  
that repair MMS damage (Memisoglu and Samson, 2000). However, MMS-induced 
PCNA ubiquitination in human cells (Niimi et al., 2008) and S. pombe cells 
(Frampton et al., 2006), and a role for PRR in repairing MMS damage has also 
been demonstrated in chicken DT40 cells – a PCNA-K164R mutant cell line was 
sensitive to MMS (Arakawa et al., 2006) as well as in human cells (Niimi et al., 
2008). As expected from these studies, the S. pombe pcn1-K164R strain was very 
MMS-sensitive implying that SpPCNA ubiquitination is required for bypass of this 
type of damage. However, for the ubp21∆::ura4 ubp22∆::ura4 strain, only a subtle 
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sensitivity may exist if at all. The spot tests can be difficult to interpret due to the 
growth defect of the double delete, which is evident in the control plate (YEA). 
 
Camptothecin (CPT) is a suicide substrate for DNA topoisomerase I (Hsiang et al., 
1985). Topoisomerase activity is required during S-phase to prevent supercoils 
from inhibiting DNA replication, hence treatment with camptothecin causes S-
phases specific DSBs due to replication fork collapse. HR is thought to be the main 
process that repairs CPT damage in S. pombe, however mono-ubiquitination of 
SpPCNA is seen in S. pombe cells following CPT treatment (Frampton et al., 2006). 
Furthermore, a role for GgRAD18, albeit independently of GgPCNA, in controlling 
CPT repair has been elucidated in chicken DT40 cells (Saberi et al., 2007). 
However, a stable human cell line expressing exogenous HsPCNA-K164R where 
endogenous HsPCNA has been knocked down did not display any sensitivity to 
CPT (Niimi et al., 2008). Interestingly, a subtle CPT-sensitivity may exist in the 
pcn1-K164R S. pombe strain, but the ubp21∆::ura4 ubp22∆::ura4 strain was found 
to be more CPT sensitive (Figure 5.32).  
 
The cross-linking agent cis-diamminedichloridoplatinum (II), also commonly known 
as cisplatin, can cause DNA inter- and intra-strand cross-links in addition to DNA-
protein adducts. The S. cerevisiae strain pol30-K164R (pol30 is the homologue of 
the S. pombe pcn1+ gene) was found to be sensitive to nitrogen mustard (a 
different cross-linking agent) and subsequently a model of repair of DNA inter-
strand cross-links has been proposed where the lesion is first ‘unhooked’ by the 
NER machinery, leaving a gap opposite the unhooked cross-link that is repaired by 
translesion synthesis (Sarkar et al., 2006). PRR has also been demonstrated to be 
involved in the repair of cisplatin damage in chicken DT40 cells – a PCNA-K164R 
mutant cell line was sensitive to cisplatin (Arakawa et al., 2006). In S. pombe, the 
pcn1-K164R strain was also found to be sensitive to cisplatin, and the double 
delete demonstrated the same, or slightly less sensitivity (Figure 5.33).  
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When the sensitivity of cells to cisplatin was assayed, a variety of diluents were 
utilised in order to dissolve the cisplatin. It was advised that dimethylsulfoxide 
(DMSO) should not be utilised as a cisplatin diluent because it is capable of 
chelating the platinum ion (Sigma). The stability of cisplatin in water is 
questionable, but cisplatin would not dissolve in the advised 0.9% saline solution. 
Dimethylformamide (DMF), which does not chelate platinum, was tried, but as 
cisplatin would only dissolve at low concentrations and DMF is a known 
carcinogenic agent in itself, the sensitivity of the five strains to DMF was assayed. 
Interestingly, there are also reports that hydrogen peroxide is released when DMF 
is broken down by cells (Midorikawa et al., 2000). The results of these spot test 
assays are shown in Figure 5.34. In 2% DMF, the double delete did not appear to 
be more sensitive than the other strains and certainly pcn1-K164R was not 
sensitive. However, at 4% DMF, the strains exhibited some very strange 
resistances to DMF. The ubp21∆ and pcn1-K164R appeared more resistant than 
the other strains to DMF. The reasons for this are unknown and were not 
investigated. It is important to note here, however, that in the end no cisplatin 
diluent was utilised, appropriate masses of cisplatin powder was weighed out neat 
and then dissolved directly in the warm agar.  
 
Hydrogen peroxide (H2O2) causes oxidative damage to DNA, mostly to DNA 
bases. There are also reports that hydrogen peroxide has a similar effect on 
topoisomerase I as CPT (Daroui et al., 2004). The main repair pathway that deals 
with oxidative damage is thought to be BER. It has been shown that hydrogen 
peroxide induces SpPCNA ubiquitination (Montaner et al., 2007). The S. pombe 
pcn1-K164R strain was not found to be sensitive to this type of oxidative damaging 
agent, but the ubp21∆::ura4 ubp22∆::ura4 strain was (Figure 5.35).  
 
Bleomycin is a large glycopeptide antibiotic that reacts with iron producing 
superoxide and hydroxyl radicals that subsequently react with DNA to produce 
SSB and DSBs. Approximately 10% of strand breaks are DSBs (Friedberg et al., 
2006). Furthermore, as bleomycin is an oxidising agent, base modifications are 
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also produced (Friedberg et al., 2006). Bleomycin does not induce HsPCNA 
ubiquitination in human cells, but it has been shown that γ radiation causes 
SpPCNA poly-ubiquitination in S. pombe and pcn1-K164R cells were sensitive to 
irradiation (Frampton et al., 2006). Bleomycin is thought to be an ionising radiation 
mimetic, so it would be expected that pcn1-K164R cells would be sensitive to this 
genotoxin. However, this was not found to be the case (Figure 5.36). Furthermore, 
a very similar glycopeptide antibiotic called phleomycin, which is often used instead 
of bleomycin because it is available more cheaply, also had no effect on the pcn1-
K164R strain (Figure 5.37). Higher doses of bleomycin and phleomycin were used, 
and this also did not affect the ability of pcn1-K164R to grow. Moreover, because 
the effects of bleomycin and phleomycin are the result of the generation of oxygen 
free radicals, it would be expected that the ubp21∆::ura4 ubp22∆::ura4 strain would 
also be sensitive to these agents, and this was found to be the case (Figures 5.36 
and 5.37) – the double delete demonstrated a strong sensitivity to these agents.   
 
As previously described (Frampton et al., 2006), the pcn1-K164R strain was found 
to be sensitive to irradiation with γ radiation (Figure 5.38). Why this strain is 
sensitive to ionising radiation (IR), but not to bleomycin or phleomycin, which are 
often used as mimetics of this treatment, is not understood. It is plausible however, 
that IR causes non-specific, or “dirty” breaks in the DNA, which PRR is required to 
repair. Whereas the breaks caused by bleomycin and phleomycin are more 
specific to certain DNA bases, for example. Interestingly, the double delete was 
found to be sensitive to all types of DNA strand break inducing agents – bleomycin, 
phleomycin and IR. Interestingly, whilst the sensitivity of the double delete was 
evident at 800 Grays, the growth of this strain was not noticeably different at 1200 
Grays, whereas there was a significant difference in the pcn1-K164R strain 
between these two doses. Why this occurs is not known, but perhaps there is a 
resistant fraction of cells e.g. those in a particular cell cycle stage.  
 
The sensitivity of ubp21∆::ura4, ubp22∆::ura4, and ubp21∆::ura4 ubp22∆::ura4 
cells compared with wild-type and pcn1-K164R to microtubule poisons was also 
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assayed. Cells with a defective spindle checkpoint are sensitive to microtubule 
poisons. Spindles, which comprise filament-like microtubules, are used in 
chromosome segregation during mitosis, and the checkpoint blocks mitosis 
progression if not all chromosomes are properly attached to their respective 
spindles. Hence, cells with a defective spindle checkpoint are sensitive to 
microtubule poisons because either mitosis cannot occur properly, or resultant 
daughter cells do not have an adequate complement of genetic information. A 
homologue of HsCHFR, which has been shown to be deubiquitinated by 
HsHAUSPUSP7 (described above), called SpDma1 exists in S. pombe, hence it was 
worth investigating whether any of the MATH DUb deficient strains had spindle 
checkpoint defects. Nocodazole, which is typically used in mammalian and S. 
cerevisiae for this purpose, cannot traverse the cell wall of S. pombe cells, hence 
thiabendazole (TBZ) and the very similar drug carbendazim (CBZ), were utilised 
instead. The results of these experiments are depicted in Figure 5.39 and 5.40. 
The results for both TBZ and CBZ were consistent with each other, the double 
delete shows strong sensitivity to both of these microtubule destabilisers. A very 
subtle sensitivity was also seen reproducibly for the ubp21∆::ura4 strain.  
 
In summary, the ubp21∆::ura4 ubp22∆::ura4 strain demonstrated clear sensitivity 
to UVC, HU, DMSO, temperature, CPT, cisplatin, bleomycin and phleomycin, and 
thiabendazole and carbendazim. Intermediate sensitivity to 4NQO, IR and 
hydrogen peroxide, and very slight or no sensitivity to MMS and DMF was 
observed. The pcn1-K164R strain was found to be highly sensitive to UVC, 4NQO, 
MMS, cisplatin and IR, and was sensitive to high doses of CPT. 
 
In order to eliminate any effect of the growth defect of the double delete, growth in 
the presence of some of these agents was observed after a week. Figure 5.41 
depicts growth after one week in the presence of 4NQO; Figure 5.42, DMSO; 
Figure 5.43, cisplatin; Figure 5.44, DMF; Figure 5.45, bleomycin; Figure 5.46, 
phleomycin; and Figure 5.47, CBZ. All results were in agreement with the 
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observations described above except that a more subtle cisplatin-sensitive 
phenotype was also seen for ubp21∆::ura4 cells (Figure 5.43).   
 
As a final summary, the sensitivities of the double delete relative to pcn1-K164R 
tested are depicted in Table 5.1. 
 
 
5.12. Discussion 
 
The MATH domain USP/UBP superfamily DUb HsHAUSPUSP7 has a wide variety of 
roles in human cells, particularly in stabilising key signalling proteins and directing 
E3s towards non-self substrates. The MATH domain appears to be important for 
substrate binding in the case of Hsp53, HsMDM2 and EBNA1. However, HsFOXOs 
and ICP0 interact with the C-terminus of HsHAUSPUSP7. The important role of 
HsHAUSPUSP7 in the DNA damage response is consistent with the observed role of 
Ubp21 and Ubp22 in the DNA damage response in S. pombe. Furthermore, the 
ubp21∆::ura4 ubp22∆::ura4 strain was shown to be sensitive to hydrogen peroxide, 
and in human cells, HsFOXO4 mono-ubiquitination in response to this stress is 
deubiquitinated by HsHAUSPUSP7. Confusingly however, many of the known 
substrates of HsHAUSPUSP7 are not found in S. pombe, for example Hsp53, 
HsMDM2, HsFOXOs and HsATAXIN1.  
 
Consistent with the known pleiotopic roles of HsHAUSPUSP7, ubp21∆::ura4 
ubp22∆::ura4 strain demonstrates sensitivity to a wide variety of stresses, 
genotoxic agents, microtubule poisons, and agents that alter protein structure. The 
sensitivity of the double delete overlaps with the sensitivity of a strain where all 
PRR has been abolished i.e. pcn1-K164R. However, where both aforementioned  
strains showed sensitivity, the double delete generally exhibited less extreme 
sensitivity than pcn1-K164R, with the exception of CPT treatment, (summarised in 
Table 5.1).  
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Although SpUbp21 can optimally take over the functions of SpUbp22 when the cell is 
deficient in SpUbp22, and vice versa, the subtle UV-sensitivity of ubp22∆ strains, 
and the subtle sensitivity of the ubp21∆ strain to spindle poisons may hint towards 
a segregation of roles of these DUbs in wild-type cells.  
 
HsHAUSPUSP7 has not been shown to have a role in PRR in human cells. However, 
there is emerging evidence that other human DUbs, in addition to HsUSP1, can 
deubiquitinate HsPCNA (Martin Cohn, personal communication), but these data are 
yet to be published. Furthermore, PCNA ubiquitination occurs at much higher 
levels in S. pombe than in mammalian cells and S. cerevisiae, and HsPCNA poly-
ubiquitination is barely detectable in human cells. Moreover, there is no known 
HsUSP1 homologue in yeast (Kay Hoffmann, personal communication). Hence, it 
seems likely that SpPCNA deubiquitination in S. pombe will be significantly different 
to that in other more highly characterised systems.  
 
Based on these data, further work on SpUbp21 and SpUbp22 is justified and two 
main lines of experimental work were decided upon. Firstly, does overexpression 
of SpUbp21 or SpUbp22 result in a decrease in SpPCNA ubiquitination? Secondly, 
how do SpUbp21 and SpUbp22 interact genetically with other PRR components? 
However, before these data are discussed, the S. cerevisiae orthologue ScUbp15 
will be analysed along with the phenotypes of cells deficient in ScUbp15.  
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Chapter 6: S. cerevisiae DUbs and the MATH Domain-
Containing DUb ScUbp15 
 
6.1. Introduction 
 
Saccharomyces cerevisiae is a widely utilised species of budding yeast. As a result 
there is a much greater understanding of cell biochemistry in S. cerevisiae than in 
S. pombe. S. cerevisiae has been the yeast model organism of choice to date due 
to its easy availability as a result of its popular use in baking and brewing, hence a 
lot more is known about S. cerevisiae DNA repair mechanisms and, more 
importantly, there are more sophisticated experimental tools available. In fact, as 
detailed in the Introduction, the molecular details of PRR were first elucidated in S. 
cerevisiae. However, there are many aspects of S. pombe biochemistry that are 
more similar to that of human cells, for example cell cycle control. Taken together, 
study of the S. cerevisiae literature for researchers utilising S. pombe is very 
informative. Furthermore, demonstrating that a particular enzyme functions 
similarly or that a deletion strain is sensitive to the same genotoxin in both species 
of yeast is a powerful statement.  
 
This chapter summarises DUbs in S. cerevisiae and their likely S. pombe and 
mammalian homologues. The representation of DUb superfamilies in these two 
species of yeast are compared and contrasted. As in human cells, only one MATH 
domain-containing DUb, ScUbp15, was found in this organism. Due to the fact that 
colleagues had assembled strains from a global deletion project of S. cerevisiae 
genes, and hence these strains were easily available, it was decided to assay for a 
DNA damage phenotype in ScUbp15-deficient cells. The results of this are 
presented. 
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6.2. Deubiquitinating Enzymes in S. cerevisiae  
 
All the known DUb enzymes encoded in S. cerevisiae genome are displayed in 
Tables 6.1 to 6.3. Many of the S. cerevisiae DUbs that have orthologues in S. 
pombe have already been discussed in Chapter 3. However, the remainder and 
other differences will now be briefly outlined. 
 
Unlike S. pombe only four out of the six known superfamilies of DUbs are 
represented in S. cerevisiae, no members of the MJD or PPPDE superfamilies 
have been identified. However, whilst there are three more members of the 
USP/UBP superfamily, the UCH and JAMM superfamilies are under-represented in 
S. cerevisiae.  
 
The extra USP/UBP superfamily are accounted for as follows: Firstly, DUbs are 
represented differently in this organism. There are three rhodanese domain-
containing DUbs, whereas the only likely orthologue in S. pombe has lost this 
domain. Also, there is only one DUSP domain DUb, one MATH domain DUb, but 
two SpUbp9 orthologues.   
 
Secondly, there are three additional USP/UBP DUbs that do not have orthologues 
in S. pombe. ScUbp10Dot4 also contains no additional domains and does not have 
any clear orthologues in humans or S. pombe (Kay Hofmann, personal 
communication). However, there are opinions within the research community that 
SpUbp16 is the orthologue of ScUbp10Dot4 (Edgar Hartsuiker, personal 
communication), despite the fact that the domain structure is different (Kay 
Hofmann, personal communication). Hence, this is a contentious area in the 
research community. ScUbp10Dot4 was original shown to interact with various “Sir” 
proteins and be important in silencing (Kahana and Gottschling, 1999). Later, this 
DUb has been shown to deubiquitinate histones H2B and H3 and have some 
overlapping functions with ScUbp8 (Emre et al., 2005).  
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ScUbp11 also does not have any obvious orthologues in humans or S. pombe (Kay 
Hofmann, personal communication). However, very weak orthology was found with 
HsUSP20VDU2 and HsUSP33VDU1 (Kay Hofmann, personal communication), but 
ScUbp11 lacks the UBP-type zinc finger and DUSP domains. Overexpression of 
ScUbp11 (in addition to ScUbp5) in vivo was found to confer growth resistance to 
treatment with an immunosuppressive drug fingolimod (Welsch et al., 2003). 
Otherwise, very little is known about this 717 amino acid DUb.  
 
ScUbp16 is an entirely membrane-associated DUb found to be localised to the 
outer mitochondrial membrane (Kinner and Kolling, 2003; Schmitz et al., 2005). 
There is no clear orthologue of ScUbp16 in S. pombe or H. sapiens (Kay Hofmann, 
personal communication).  
 
The remaining USP/UBP DUbs in S. cerevisiae seem to have similar counterparts 
in S. pombe.  
 
Only one UCH DUb is present in S. cerevisiae, ScYuh1. A HsUCH37/SpUch2 
orthologue is not present, hence this organism appears to be missing this 
important proteasome subunit and DUb activity at the proteasome lid is thought to 
work differently in S. cerevisiae compared to S. pombe and human cells (Stone et 
al., 2004). 
 
A highly conserved orthologue of the SpRpn11Pad1 and HsRPN11 JAMM DUbs exists 
in S. cerevisiae. However, the likely SpAmshSst2/HsAMSH orthologue in baker’s 
yeast, YLR073C, has lost its JAMM domain (reviewed in Clague and Urbé, 2006). 
 
6.3. ScUbp15  
 
As mentioned in Chapter 5, the HsHAUSPUSP7, SpUbp21 and SpUbp22 orthologue in 
budding yeast is ScUbp15. ScUbp15 is a 1230 amino acid protein with a very similar 
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domain structure to its S. pombe and human counterparts. Figure 6.1 to 6.3 depict 
an alignment between these four DUbs. This reveals that ScUbp15 appears to be a 
more divergent member of the MATH USP/UBP family. Whilst the catalytic triad 
residues (CHY, highlighted in blue), the residues found to be important for DUb 
activity (blue squares; Hu et al., 2002), and the majority of Cys and His box 
residues (highlighted in yellow) are completely conserved in ScUbp15, the C-
terminus contains inserts not found in any of the human or S. pombe proteins. 
 
A previous study of DUbs in S. cerevisiae revealed that cells deficient in ScUbp15 
were temperature sensitive (Amerik et al., 2000). This study also found that the 
ubp15∆ strain was not sensitive to UV light, but only a very low dose of 1.3 Jm-2 
was utilised and the wavelength of UV used was not stated (Amerik et al., 2000).  
 
6.4. Verification of the ubp15∆::kan and rad5∆::kan Strains  
 
The S. cerevisiae strains ubp15∆::kan and rad5∆::kan, as well as an isogenic wild-
type strain (“BY405”) were a kind gift from Eva Hofmann. The deletion strains 
originated from the European Saccharoymces Cerevisiae Archive for Functinal 
Analysis (EUROSCARF) global deletion project (see Materials and Methods). The 
function of the ScRad5-deficient strain in this study was as a positive control for UV 
sensitivity – a pol30-K164R strain was not available (pol30 encodes ScPCNA). 
ScRad5 is the 1169 amino acid E3 and helicase found to poly-ubiquitinate ScPCNA 
with lysine-63-linked poly-ubiquitin chains – ScRad5 and orthologues were 
discussed in section 1.18 of the Introduction. The UV sensitivity of rad5∆ is widely 
reported in the literature (Torres-Ramos et al., 2002, for example). The status of 
the ubp15 and rad5 loci were checked by PCR amplification of genomic DNA, and 
were found to be correctly deleted (Figure 6.4) and both strains grew on rich media 
supplemented with G418, whereas wild-type cells did not.  
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6.5. Phenotypes of ubp15∆::kan Cells  
 
Firstly, the UVC sensitivity of ubp15∆ cells was considered. The UV drop test was 
utilised. The results are shown in Figure 6.5. The ubp15∆ cells were not found to 
be sensitive to UVC compared to wild-type. The rad5∆ cells were found to be very 
sensitive as expected – less than 10% survival has been reported following 10 Jm-2 
UV (Torres-Ramos et al., 2002) – indicating that the experiment was successful. 
Furthermore, using the spot test assay, the ubp15∆ cells were not found to be 
sensitive to hydrogen peroxide (Figure 6.6), phleomycin (Figure 6.7), or DMSO 
(Figure 6.8). However, modest sensitivity to thiabendazole was detected (Figures 
6.9 and 6.10). 
 
6.6. Discussion  
 
Assuming that there are 99 DUbs in human cells, the proportional representations 
of each superfamily are thus 61% UBP/USP, 4% UCH, 5% MJD, 14% OTU, 2% 
PPPDE and 14% JAMM. Whilst both species of yeast lack the MJD superfamily, 
the S. pombe DUbs present appear more similar to those found in human cells. 
Most significantly, there is no HsPNAS4/SpHag1 orthologue in S. cerevisiae and the 
SpAmsh/HsAMSH orthologue, YLR073C, is missing its JAMM domain altogether. 
The proportional representations of each superfamily in S. cerevisiae are thus: 
78% UBP/USP, 4% UCH, 9% OTU, and 9% JAMM. The proportional 
representations of each superfamily in S. pombe are thus: 67% UBP/USP, 8% 
UCH, 8% OTU, 4% PPPDE, and 13% JAMM. Hence, the representations of each 
superfamily are more similar to human cells in S. pombe than in baker’s yeast. 
Most notably, there are three S. cerevisiae DUbs, ScUbp11, ScUbp11 and ScUbp16, 
which do not contain any clear human or S. pombe orthologues (Kay Hofmann, 
personal communication). Furthermore, there is only one known DUb that contains 
a rhodanese domain in humans, HsUSP8UBPY, but three in S. cerevisiae.   
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The lack of a sensitivity of baker’s yeast cells deficient in ScUbp15 to genotoxic 
agents does not preclude a role of SpUbp21 and SpUbp22 in deubiquitinating 
SpPCNA. Recent work on PCNA modification in other organisms has revealed 
distinct differences between species (see, for example, Frampton et al., 2006; 
Andersen et al., 2008; Ulrich, 2009). Following exposure genotoxic agents, a 
higher proportion of PCNA is mono-ubiquitinated in S. pombe than in human cells. 
Furthermore, PCNA poly-ubiquitination has only recently been detected in human 
cells, whereas it occurs strongly in S. pombe. Unlike in S. pombe, α-PCNA 
antibodies are not sufficient to detect PCNA ubiquitination in S. cerevisiae on a 
Western blot – immunoprecipitation and the utilisation of tagged ubiquitin is normal 
procedure. Despite extensive investigation by the group of Felicity Watts, who 
performed lysine codon mutagenesis of pcn1, sumoylation of SpPCNA was very 
difficult to detect, and there are no reports of HsPCNA sumoylation. Clearly, due to 
the lack of an obvious HsUSP1 homologue in yeast, deubiquitination of PCNA 
occurs differently in yeast compared to humans. Therefore, it would not be 
surprising if SpPCNA deubiquitination occurred differently in S. pombe compared to 
S. cerevisiae. The thiabendazole data may indicate that ScUbp15 is more involved 
in regulating the mitotic checkpoint in baker’s yeast? Or perhaps more than one 
DUb can deubiquitinate ScPCNA in S. cerevisiae, and hence no phenotype is seen 
in ScUbp15-deficient cells due to redundancy.  
 
The above considered, it was decided not to investigate the role of ScUbp15 further, 
but to concentrate on further characterising the S. pombe orthologues.  
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Chapter 7: Expression of SpUbp21 and SpUbp22 
 
7.1. Introduction 
 
If SpUbp21 and SpUbp22 can deubiquitinate SpPCNA one might predict that a 
reduction in SpPCNA ubiquitination levels would be seen when SpUbp21 or SpUbp22 
were overexpressed in wild-type cells. HsUSP1 knockdown was shown to increase 
HsPCNA mono-ubiquitination in human cells, and HsPCNA mono-ubiquitination 
levels decreased when HsUSP1 was overexpressed (Huang et al., 2006). Hence, 
verification of the whether SpUbp21 and SpUbp22 can deubiquitinate SpPCNA 
specifically could be achieved by overexpressing each of these DUbs in wild-type 
cells. Unfortunately, no antibody against either DUb was available therefore the 
endogenous levels of the proteins are not known. Hence, it is not known whether 
the exogenous expression, as described below, constitutes overexpression. In this 
Chapter, investigations were carried out to ask whether exogenously expressed 
SpUbp21 and SpUbp22 were functional by expressing the proteins in ubp21∆::kan 
ubp22∆::nat1 strain and analysing the rescue of UV sensitivity of this strain. 
Furthermore, a conserved DWGF motif was found in the MATH domain – the 
importance of this was investigated, in addition to the relevance of two potential 
PIP boxes. 
 
7.2. Construction of Gateway System-Based Plasmids for the 
Expression of SpUbp21 and SpUbp22  
 
The Gateway System (Invitrogen) was utilised in order to clone SpUbp21 and 
SpUbp22 into a suitable expression vector. All S. pombe DUb genes already cloned 
into the pDONR201 entry vector were purchased from RIKEN Bioresource Center, 
Japan (Matsuyama et al., 2006). Unfortunately, a large proportion of the DUb 
genes, including ubp21 and ubp22, contained missense mutations. Furthermore, in 
all genes the last base of the stop codon had been mutated, which would have 
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resulted in an additional C-terminal amino acid tail on all non-C-terminally tagged 
expressed protein. Hence, it was necessary to create four plasmids pDONR201-
ubp21+, pDONR201-ubp21+-STOP, pDONR201-ubp22+, pDONR201-ubp22+-
STOP by site-directed mutagenesis. Then each DUb gene was transferred via the 
“LR” reaction into Gateway System compatible pDUAL destination vectors, which 
were a kind gift from Ken Sawin (Matsuyama et al., 2004). These vectors allowed 
His6FLAG2 tagging of S. pombe proteins where protein expression was under the 
control of the nmt1 (no message in thiamine 1) promoter. A summary of the protein 
contructs resulting from this cloning strategy to be expressed in vivo are depicted 
in Figure 7.1. 
 
7.3. Exogenous Expression of SpUbp21 and SpUbp22 in Wild-Type 
Cells 
 
For each DUb, the four different pDUAL constructs were transformed into wild-type 
S. pombe cells and positive clones selected by plating onto minimal media without 
uracil. Growth in the absence of uracil is required in order to force the cells to keep 
the plasmid. The nmt1 is the strongest promoter of its type and is not 100% 
repressable. This is useful. Repression of the promoter via the addition of thiamine 
results in low protein expression levels, whereas growth in the absence of thiamine 
results in very high expression levels.  
 
Figure 7.2 depicts the ubiquitination status of SpPCNA in cells expressing SpUbp21 
following HU treatment. No reproducible reduction in ubiquitinated forms were 
observed relative to the vector only control. The αFLAG Western shows FLAG-
tagged species that correspond with the molecular weight of SpUbp21. As 
expected, greater quantities of FLAG-tagged SpUbp21 were detected in the 
absence of thiamine. Interestingly, higher levels of C-terminally tagged SpUbp21 
were found compared to the N-terminally tagged version. Tubulin proteins were 
detected as a loading control. Two forms of tubulin alpha are detected in S. pombe 
– 
SpAtb2Tub1 and SpNda2, which are 50.5 kDa and 51.1 kDa, respectively. The 
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loading is relatively equal across the gel, except at the edges where presumably 
the α-tubulin antibody appears not to have bound properly. However, the amount 
of unmodified SpPCNA in the far left lanes does not appear significantly lower than 
the others.  
 
Figure 7.3 depicts the ubiquitination status of SpPCNA in cells expressing SpUbp22 
following HU treatment. Similar to the previous figure, no reproducible reduction in 
ubiquitinated forms were observed relative to the vector only control. As with 
SpUbp21, higher levels of C-terminally tagged SpUbp22 were found compared to the 
N-terminally tagged version.  
 
Using the same samples as depicted in Figure 7.3, in Figure 7.4 the Western blot 
was probed with α−Ubiquitin antibodies. The question asked by this experiment 
was: Does SpUbp22 have a promiscuous role in its deubiquitination of cellular 
proteins? Whilst this is not a very precise experiment, this experiment is routinely 
utilised in the study of DUbs. However, no significant, reproducible reduction in 
ubiquitinated forms of cellular proteins was detected when SpUbp22 was 
expressed. Having said this, no antibody raised against S. pombe ubiquitin is 
commercially available. This experiment was carried out using a commercial 
antibody raised against human ubiquitin, which is only 3 amino acids different from 
S. pombe and S. cerevisiae versions. However, this antibody was found to be very 
sensitive to immunodetection conditions and Figure 7.4 was the cleanest, most 
reliable blot generated using this antibody. 
 189 
 
7.4. Expression of SpUbp21 and SpUbp22 in ubp21∆::kan 
ubp22∆::nat1 Cells 
 
Was the lack of reduction in SpPCNA ubiquitination when either SpUbp21 or 
SpUbp22 are expressed because the expressed forms of the DUbs are non-
functional? To test this, each DUb was expressed in the doubly deleted strain and 
assessed for rescue of UVC sensitivity.  
 
In order to express SpUbp21 and SpUbp22 in cells deficient in both of these DUbs, 
which is required for assessment of the functionality of these expressed DUbs, the 
construction of a doubly deleted, but ura4- strain was necessary. This is because 
the expression plasmids were marked with ura4+ and hence this marker is 
necessary for retention of the expression plasmids by growth on/in media deficient 
in uracil. Therefore, the strains ubp21∆::kan and ubp22∆::nat1 previously 
characterised in this thesis were crossed and the ubp21 and ubp22 loci in the 
resulting G418 and NAT resistant haploids were verified by PCR. Figure 7.5 shows 
the successful verification of this new double delete.  
 
Furthermore, the UVC sensitivity of this new strain was found to be the same as 
that of the ubp21∆::ura4 ubp22∆::ura4 strain. These data are depicted in Figure 
7.6, where three different clones (both mating types) of ubp21∆::kan ubp22∆::nat1 
were tested for UVC sensitivity by drop test and compared with controls. Moreover, 
the ubp21∆::kan ubp22∆::nat1 strain was also found to be temperature sensitive 
(Figure 7.7). Thus the phenotype of the double delete was similar irrespective of 
the marker used to generate the deletions. 
 
Next, the ability of expressed SpUbp21 and SpUbp22 to rescue the UV sensitivity of 
the double delete was checked. These experiments are shown in Figure 7.8 and 
7.9, respectively. Figure 7.8 shows that SpUbp21 cannot rescue the UVC sensitivity 
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of ubp21∆::kan ubp22∆::nat1 strain up to wild-type levels. This result was 
confirmed by spot test (data not shown). This was not entirely unexpected given 
that ubp22∆::nat1 was shown in previous Chapters to be UVC sensitive compared 
to the ura4-marked version. Rescue was better in the absence of thiamine and 
above that of the vector only control. Hence, it can be concluded that expressed 
SpUbp21 can, to some extent, rescue the UVC sensitivity and hence at least a 
proportion of expressed SpUbp21 must be functional in terms of negating the 
effects of UV.  
 
Figure 7.9 shows that expressed SpUbp22 can fully rescue the UVC sensitivity of 
the double delete up to wild-type levels. This indicates that expressed SpUbp22 is 
functional in terms of negating the effects of UV. However, rescue was only 
complete in the presence of thiamine i.e. low-level expression – only partial rescue 
was observed in the absence of thiamine. This suggests that high levels of 
SpUbp22 were deleterious in its role in negating UVC sensitivity.  
 
7.5. An Important DWGF Motif in the MATH domain  
 
In Chapter 5, the literature surrounding the MATH domain was discussed. In 
HsHAUSPUSP7, it appears to act as a binding module and a nuclear locator. An 
alignment of the primary sequence of the MATH domain of MATH domain-
containing UBP/USP DUbs from a wide variety of eukaryotic organisms (including 
S. pombe) is depicted in Figure 7.10. Strikingly, four adjacent residues, DWGF, 
were 100% conserved in all organisms, even in the most divergent slime mould 
DUb. An upstream phenylalanine was also found to be 100% conserved.  
 
Analyses of the structure of HsHAUSPUSP7, revealed that this DWGF motif is the 
binding site for the EBNA1, Hsp53, and HsMDM2 peptides (Hu et al., 2006; Sheng et 
al., 2006; Saridakis et al., 2005). Figure 7.11 shows the structure of of the MATH 
domain of HsHAUSPUSP7 in complex with the HsMDM2 peptide (Sheng et al., 2006). 
Using Protein Explorer (website link in Chapter 2), all aspartate, tryptophan, glycine 
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and phenyalanine residues were shaded (see legend for the colours). Important 
residues are labelled with their one-letter code and residue number. DWGF 
represents residues 164 to 167. The HsMDM2 peptide is shown in this Figure to sit 
neatly on top of this motif. The conserved upstream phenylalanine previously 
alluded to is F158, which is positioned higher and presumably interacts with a 
different part of the HsHAUSPUSP7 interacting proteins. Some other phenylalanines 
were also found to be in the vicinity of the DWGF motif: F117 and F150 are only 
conserved in higher eukaryotes (the first six from the top of the alignment); and 
F169 is conserved in all organisms except S. cerevisiae.  
 
In order to assess the importance of the DWGF motif in SpUbp22, it was mutated to 
AAAA. The mutant protein was expressed as before in the double delete cells and 
assayed for its ability to rescue the UVC sensitivity phenotype of this strain. The 
results are shown in Figure 7.12. In the furthest lefthand lane (lane 1), the 
ubp21∆::kan ubp22∆::nat1 cells have been transformed with the vector only as a 
control. The rescue of the UVC sensitivity of the double delete is shown in lane 2 
with the expression of untagged wild-type SpUbp22. Lane 2 shows the ability of 
mutant SpUbp22 to rescue when untagged. No live colonies resulted when when N- 
or C-terminally tagged mutant SpUbp22 was transformed into S. pombe 
ubp21∆::kan ubp22∆::nat1 cells. Under thiamine repression, mutant SpUbp22 is not 
able to rescue. Without thiamine repression, the mutant of SpUbp22 is able to 
rescue a little more, but this rescue is not complete. Therefore, the DWGF motif is 
important in SpUbp22 function to protect the cell from UVC. Furthermore, the 
difference between rescue with and without thiamine implies that mutant SpUbp22 
can carry out some of its UV protective function, but with very low efficiency. 
However, perhaps when there is a high abundance of mutant SpUbp22 in the cell, 
random collisions with interaction partners occur sufficiently often to suppress the 
mutation.  
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7.6. Structure of Prediction of SpUbp21 and SpUbp22 
 
Two potential PIP boxes were found in SpUbp21 and SpUbp22. As introduced, the 
PIP box comprises KAxQxxψxxθθ, wherein x is any residue, ψ is L, M or I, and θ is 
F or Y (Xu et al., 2001). Figure 7.13 shows their conservation in the budding yeast 
and human counterparts. In SpUbp22, the motif KVQLITPEFY was found a few 
amino acids downstream of the catalytic domain (PIP box A). In SpUbp21 the motif 
SHNQNVVMFY was found in the middle of the C-terminus (PIP box B).  
 
Recent work with HsMSH6 showed that for a PIP to function as such, it must occur 
in an unstructured region of a protein (Shell et al., 2007). Hence, in order to 
elucidate whether these motifs have the potential to be functioning PIP boxes, the 
structures of SpUbp21 and SpUbp22 were predicted using the protein 
homology/analogy recognition engine (PHYRE) program (Kelley and Sternberg, 
2009; see also section 2.6 for the website address). This program works by 
comparing a query amino acid sequence to a known structure, aligning with that 
structure and matching them with algorithms.  
 
As expected, the structures were very similar to that of HsHAUSPUSP7. As depicted 
in Figure 7.14, the two potential PIP boxes were found to occur in ordered regions 
of the proteins. Furthermore, the poor conservation of these sequences between 
organisms implies that they are unlikely to be functionally important.  
 
7.7. Discussion 
 
Expression of SpUbp21 and SpUbp22 does not result in reduced SpPCNA 
ubiquitination. The result does not appear to be explained by non-functionality of 
these proteins when expressed or tagging. As a result of this, the following chapter 
uses a different approach in order to clarify the involvement of these DUbs in PRR.  
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Given the 100% conservation of the DWGF motif in the aligned species in Figure 
7.10 and the fact that the reported crystal structures of HsHAUSPUSP7 in 
combination with peptides from its binding partners show the peptides binding 
across the DWGF motif, it is not surprising that this motif is important for SpUbp22 
function. It seems likely, therefore, for the DWGF motif to act as a binding 
interface, or important part thereof, with SpUbp22 targets or cofactors. With a 
mutant MATH domain, SpUbp22 cannot bind these partners so efficiently, and 
therefore cannot deubiquitinate its targets so efficiently.  
 
The amino acid sequences of both DUbs were checked for PIP boxes and any 
potentials were checked for likelihood of functionality. SpUbp21 and SpUbp22 do not 
contain any likely PIP boxes. However, no PIP box has been found in HsUSP1 
either.  
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Chapter 8: Epistasis Analysis 
 
8.1. Introduction 
 
A method of attributing a protein to a cellular pathway can be deduced in yeast by 
epistasis analysis. This method involves crossing a knockout strain where the 
product of the disrupted gene(s) have known function(s) with a second knockout 
strain in order to test the involvement of the protein encoded by the latter disrupted 
gene in the pathway of the former. A dramatic increase in the UV sensitivity of 
strain x∆ y∆ compared to x∆ and y∆ singles implies protein X and protein Y function 
in different, parallel UV repair pathways – this effect is known as synergy. If the UV 
sensitivity of the x∆ y∆ is the same as to y∆, then this implies that Y is involved in 
the same pathway – an epistatic effect is observed. The paradigm for this effect in 
the DNA repair field is experiments with E. coli mutants of HR and NER 
components – a cross between two NER mutants, for example, would be epistatic 
to UV relative to its parental strains, whereas a cross between a HR and an NER 
deficient strain would show synergistic UV sensitivity. There is also an intermediate 
effect known as additivity where the sensitivity of x∆ y∆ is approximately the sum of 
the sensitivity of x∆ and y∆.  
 
The aim of this Chapter, therefore, is to perform epistasis analysis with cells 
deficient in SpUbp21 and SpUbp22 and crosses thereof with cells deficient in 
components of PRR. The aim is to further elucidate potential functions of these two 
DUbs, in particular, to confirm or exclude a role in PRR.  
 
8.2. Creation of Strains 
 
ubp21∆::kan ubp22∆::nat1 cells were crossed with the pcn1-K164R::ura4 strain, 
plus also rad8∆::ura4 (Doe et al., 1993) and rhp18∆::ura4 strains (Verkade et al., 
2001). Isolated triple mutants, which were NAT and G418 resistant and able to 
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grow with uracil independence, were verified by PCR (Figures 8.1-8.3). In Figure 
8.1 one primer was designed to anneal to the ura4 locus and the other within or 
flanking the PRR gene. Hence, no fragments result when wild-type genomic DNA 
is utilised.  
 
8.3. Epistasis with pcn1-K164R, rad8∆ and rhp18∆ 
 
ubp21∆::kan ubp22∆::nat1 appears epistatic with pcn1-K164R::ura4 (Figure 8.4). 
An epistatic relationship of the triple with pcn1-K164R suggests that these two 
DUbs and ubiquitination of SpPCNA at lysine-164 participate in the same pathway 
when it comes to protecting from cell death due to UV. Possible explanations for 
this include: (1) the DUbs directly deubiquitinate SpPCNA at lysine-63, thereby 
preventing PRR and hence resulting in UV sensitivity due to replication fork 
breakage and so forth; (2) the DUbs stabilise a protein involved in promoting, 
protecting or stabilising SpPCNA ubiquitination. The identity of this protein is not 
known.  
 
It seems unlikely that the DUbs could stabilise SpPCNA itself i.e. deubiquitinate 
lysine-48-linked poly-ubiquitin chains from SpPCNA, because this could result in 
decreased cellular levels of SpPCNA in the double DUb delete, which is not seen in 
the Westerns in Chapter 4 and 5. Furthermore, if the DUbs stabilised the levels of 
e.g. SpRhp6, SpRhp18, SpUbc13, ScMms2, or SpRad8 such that UV sensitivity was 
the result when the DUbs were absent, then in the double DUb delete a reduction 
in SpPCNA ubiquitination would also be expected. Of course, the DUbs could 
stabilise a different or yet to be identified PRR protein.  
 
Figure 8.5 shows the analysis with rad8∆::ura4. Comparing the red and purple 
lines, whilst the error bars are not very tight they do overlap at all doses, which 
suggests an epistatic relationship. However, epistasis cannot be clearly concluded. 
SpRad8, E3 an orthologue of ScRad5, extends the mono-ubiquitination of SpPCNA 
into a lysine-63-linked poly-ubiquitin chain (Frampton et al., 2006). However, 
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epistasis of these DUbs with SpRad8 and lysine-164 of SpPCNA points towards a 
role of SpUbp21/SpUbp22 in SpPCNA deubiquitination. The genetic relationship of 
SpUbp21/SpUbp22 with SpRad8 could be verified by performing epistasis with strains 
deficient in SpUbc13 or ScMms2. 
 
The relationship between ubp21∆::kan ubp22∆::nat1 and rhp18∆::ura4 is not clear 
(Figure 8.6). The error bars of the red and purple lines slightly overlap at 100 J/m-2 
and are very close at 40 J/m-2, but are clearly different at 60 J/m-2. The rescue of 
the UV sensitivity of a strain deficient in SpRhp18 by removing SpUbp21 and 
SpUbp22 was unexpected. If a lack of SpRhp18-mediated mono-ubiquitination of 
SpPCNA results in UV sensitivity, it is not obvious how also removing SpUbp21 and 
SpUbp22 could relieve the cell of the effects of UV. An explanation could be that 
SpUbp21/SpUbp22 action generates a toxic product that requires processing by 
SpRhp18. For example, the DUbs could over-deubiquitinate a target and require 
SpRhp18 to re-ubiquitinate it. In the absence of SpRhp18 the toxic product 
accumulates, but in the concurrent absence of SpUbp21/SpUbp22, it does not exist.  
 
Another explanation could be that somehow the presence of SpUbp21/SpUbp22 
stabilises a PRR promoter that commits the cell to bypass the damage via PRR. 
Therefore, when SpUbp21 and SpUbp22 are present, the cellular effects are worse 
than in the absence of SpRhp18 than in the presence of SpRhp18. An epistatic 
relationship would corroborate a role of SpUbp21/SpUbp22 in SpPCNA 
deubiquitination, but this cannot be concluded from Figure 8.6. A method to verify 
the genetic relationship of SpUbp21/SpUbp22 with SpRhp18 is to perform epistasis 
with strains deficient in SpRhp6, the E2 that participates in SpPCNA mono-
ubiquitination. 
 
It was attempted to create an ubp21∆ ubp22∆ rad13∆ uvde∆ strain. SpRad13 is 
fundamental to NER in fission yeast and uvde∆ strains are deficient in a CPD and 
64-PP exonuclease that effects the UV damage repair (UVDR) pathway. It would 
be expected that SpUbp21/SpUbp22 might be synergistic with SpRad13 and SpUvdE. 
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However, this strain could not be constructed. Tetrad analysis would elucidate 
clearly as to whether this quadruple delete is viable. 
 
8.4. Mutation Frequency Analysis 
 
In section 1.27 of Chapter 1, the phenotypes of HsUSP1 knockdown in human cells 
is discussed -- one of these was an increased mutation frequency (Huang et al., 
2006). To assay for an increased mutation frequency in the ubp21∆ ubp22∆, due to 
e.g. increased error-prone PRR or defective error-free PRR, a canavanine-
resistance assay was performed. Canavanine is a toxic arginine analogue because 
it is incorporated into proteins in the place of arginine – the chemistry of 
canavanine versus arginine is sufficiently different such that proteins do not fold 
and function normally. However, canavanine is taken up into the cell via an 
arginine permease and canavanine resistance results when the gene encoding this 
permease is mutant. Hence, mutation frequency following DNA damage e.g. by 
UVC, can be quantified by counting the number of cells that developed into 
canavanine-resistant colonies out of a known number of cells.  
 
Whilst the UV-induced mutation frequency for wild-type and the pcn1-K164R strain 
was as expected, the double DUb delete did not grow on media comprising 
canavanine. The reasons for this are unknown, but it is not an unusual finding for 
S. pombe mutant strains. 
 
8.5. Discussion 
 
This chapter described a genetic analysis of the role of SpUbp21 and SpUbp22 in 
PRR. SpUbp21/SpUbp22 seems to be epistatic with Sppcn1-K164R. The relationship 
with SpRad8 and SpRhp18 was less clear, however and the genetic relationship with 
these DUbs were rather complex, with suggestions of some suppression of the UV 
sensitivity of rad8∆ and rhp18∆. A shortcoming of the work was that there was no 
positive control with which synergistic effects have been demonstrated. Future 
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work, therefore, should be carried out using triple deletes with rad13∆ or uvde∆ 
alone, since quadruple may not be viable. 
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Chapter 9: Discussion 
 
9.1. Introduction 
 
This study has revealed that the S. pombe orthologue of one of the most highly-
characterised DUbs in H. sapiens has a role in the DNA damage response. This 
finding has significance because of the fundamental role of Hsp53 in mammalian 
cells in responding to DNA damage and yet there is no orthologue of Hsp53 in 
yeast. In this chapter the data elucidated in this study will be brought together, 
conclusions drawn, and important future research directions discussed. 
 
9.2. Deubiquitination of SpPCNA and Functions of SpUbp21 and 
SpUbp22 
 
Chapter 3 of this thesis discussed what is known about S. pombe DUbs and 
provided the basis for a strategy to elucidate potential DUb involvement in S. 
pombe PRR. Promisingly, DUbs with known roles in DNA repair have orthologues 
in S. pombe, for example HsUSP11, which functions in the HsBRCA2 pathway and 
in sensitivity to MMC. However, none of these DUbs have previously been 
implicated in PRR. It was very exciting, therefore, to discover that two paralogous 
DUbs with an orthologue in humans that has a fundamental role in the DNA 
damage response, were indirectly implicated in S. pombe PRR and were required 
for an efficient response to UV irradiation.  
 
In Chapter 4 and 5, an increase in SpPCNA ubiquitination was seen in the absence 
of both SpUbp21 and SpUbp22. It seems most likely that these are lysine-63-linked 
forms of ubiquitin, although this has not been directly proven and should be 
demonstrated in future experimentation. From this it was hypothesised that 
SpUbp21/SpUbp22 can remove mono- and lysine-63-linked ubiquitin from lysine-164 
of SpPCNA, which had the effect of sensitising the cells to UV due to lack of PRR. 
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However the data in Chapter 7 show that expression of either of these DUbs did 
not, as predicted from the above hypothesis, reduce the level of SpPCNA 
ubiquitination. Thus the nature of the role played by these DUbs in PRR remains 
unclear. 
 
Chapter 8 linked the UV-sensitivity of the double DUb delete with lysine-164 of 
SpPCNA. However, in Chapter 5, the pcn1-K164R strain was found to be highly IR 
sensitive, whereas the double DUb delete showed only intermediate sensitivity to 
this genotoxin. Furthermore, the pcn1-K164R strain was sensitive to MMS, but 
ubp21∆ ubp22∆ cells were not. Hence, the link between SpUbp21/SpUbp22 and 
lysine-164 of SpPCNA appears to be dependent upon the nature of the damage. 
Furthermore, the sensitivity of the double DUb delete to spindle poisons suggests 
roles for SpUbp21/SpUbp22 outside of DNA repair. 
 
Given what is known about HsHAUSPUSP7, it seems more likely that 
SpUbp21/SpUbp22 stabilise target(s) by dissassembling lysine-48-linked poly-
ubiquitin chains. Equally, for such a role on SpPCNA, a reduction in cellular SpPCNA 
could be expected in the double DUb delete, which is not observed. However, 
perhaps the proteasome is not able to degrade SpPCNA sufficiently quickly enough, 
which results in a build up of lysine-48-linked poly-ubiquitinated SpPCNA.  
 
Another explanation could be that SpUbp21/SpUbp22 stabilise the levels of a protein 
that specifically protects SpPCNA ubiquitination on lysine-164 or stabilises such 
forms of ubiquitinated SpPCNA. In ubp21∆ ubp22∆ cells, UV sensitivity is seen 
because this protein (protein X) is degraded more rapidly, lysine-164 ubiquitinated 
forms of SpPCNA are less prevalent, and therefore PRR is inhibited. In fact, 
SpUbp21/SpUbp22 could be said ‘protein X’. SpUbp21/SpUbp22 could bind lysine-164 
ubiquitinated SpPCNA and protect it from lysine-48-linked poly-ubiquitination. 
However, this does not explain why an increase in ubiquitinated SpPCNA is seen 
when the DUbs are absent. 
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Based on the findings of Chapter 7, it would be useful if an antibody against 
SpUbp21/SpUbp22 could be created in order to detect the endogenous levels of 
these proteins, which would enable true overexpression, and also to allow for 
expression experiments without the use of tags. Alternatively or additionally, the 
ubp21 and ubp22 genes could be tagged in situ in order to detect the endogenous 
levels of the protein products.  
 
Furthermore, purification of SpUbp21/SpUbp22 protein would also be very useful. It 
would enable in vitro deubiquitination experiments to be carried out e.g. to check 
for specificity for lysine-48- or lysine-63-linked polyubiquitin chains, as has been 
previously described (Frampton et al., 2006). However, this would take 
considerable time to be completed and commitment to such a direction should only 
occur once the importance of SpUbp21/SpUbp22 has been clarified with less time-
consuming methods. Also, as discussed below, these DUbs may require accessory 
proteins for catalytic function. 
 
The obvious direction from Chapter 8 is to repeat the epistasis experiments with 
other DNA damaging agents, for example 4-NQO. As discussed in Chapter 8, 
epistasis analysis with cells deficient in SpRhp6 and also SpUbc13 and/or SpMms2, 
would also be suitable directions. Furthermore, synergy with NER, UVDR and HR 
mutants would exclude roles in these pathways. 
 
9.3. S. cerevisiae ScPCNA Deubiquitination 
 
No ScPCNA-specific DUbs have been identified in budding yeast, despite research 
effort. The case in point, it has been stated: “In [budding] yeast, the reaction is 
clearly reversible, and although a dedicated isopeptidase has not been identified, 
the modification disappears after removal of the damaging agent within the time it 
takes the cells to recover from the damage and complete S phase (A.A. Davies 
and H.D. Ulrich, unpublished observations)” (Ulrich, 2009). These findings are 
commensurate with the findings described in section 3.2 of Chapter 3 and Figure 
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3.1, plus the findings in Chapter 6 wherein no DNA repair defects were found in 
cells deficient in ScUbp15. As has been already discussed, there are interesting 
differences between budding and fission yeast PRR. For example, SpPCNA 
sumoylation cannot be detected and ubiquitinated forms of SpPCNA are more 
abundant (Frampton et al., 2006). Different PRR regulation pathways may be 
supported or facilitated by duplication of the MATH domain DUb gene in fission 
yeast i.e. SpUbp21 and SpUbp22.  
 
9.4. HsHAUSPUSP7, HsUSP1 and HsUAF1WDR48 
 
Given the extensive characterisation of the roles of HsHAUSPUSP7, it seems unlikely 
that it could have a role in deubiquitination of HsPCNA in addition to HsUSP1. 
Certainly such a role would likely be less significant than in S. pombe. It is not 
known if HsHAUSPUSP7 knockdown results in UV sensitivity, for example.  
 
However, there is room for non-HsUSP1 DUbs in human PRR – whether 
deubiquitinating HsPCNA directly or another PRR component such as a HsPCNA E2 
or E3. HsUSP1 was discussed in section 1.27 of Chapter 1 where it was explained 
that the HsUSP1 protein auto-cleaves following UV irradiation, which correlates with 
an increase in ubiquitinated forms of SpPCNA. However, no such correlation has 
been elucidated following other types of genetic insult, such as HU, MMS or MMC 
treatment (Huang et al., 2006; Niimi et al., 2008). Hence, other DUbs may be 
involved in modulating PRR in human cells.  
 
Also, it has been shown that HsUSP1 mRNA levels are decreased following UV 
irradiation – the authors compared this with the inhibition of RNA polymerase II 
using actinomycin D and a found similar result, and subsequently concluded that 
transcription of USP1 is inhibited in response to UV (Cohn et al., 2007). Given that 
SpUbp21/SpUbp22 have been shown to play a role in splicing (Richert et al., 2002), 
it is possible that PRR is controlled by these enzymes at the RNA level in S. 
pombe.  
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At the time this project was being completed, there were rumours within the 
research community that other DUbs capable of deubiquitinating HsPCNA were in 
the process of being identified. So far, however, the identity of these DUbs has 
been concealed by referring to them as “DUb-X” and “DUb-Y”. It is assumed that 
this does not refer to HsUSP9X and HsUSP9Y, which are thought to control 
HsSMAD4 levels in HsTGFβ signalling pathways (Dupont et al., 2009).  
 
It has been shown by the D’Andrea laboratory that the activity of HsUSP1 is greatly 
enhanced in the presence of HsUSP1 associated factor 1 (HsUAF1; Cohn et al., 
2007), which is also known as WD repeat-containing protein 48 (HsWDR48). WD 
repeats form a β-propeller structure that is thought to create a rigid scaffold 
suitable for facilitating the assembly of protein complexes i.e. it is a stabilising 
interaction domain. Each repeat often ends in a tryptophan-aspartate dipeptide, 
hence the name. HsUAF1WDR48 comprises eight WD repeats, each of which are 
about 40 residues long, and hence are known as WD40 repeats. WD40 repeats 
are a very commonly found motif in cellular proteins. In this study, the authors 
analysed the literature concerning 19 budding yeast DUbs and found that 11 had 
been reported to interact with WD40 repeat proteins, which included ScUbp15 
(Cohn et al., 2007). However, the Saccharomyces Genome Database lists 73 
genetic and physical interactors of ScUbp15, hence it is not so surprising that some 
comprise WD40 repeats.   
 
In a recent follow-up study, the D’Andrea laboratory found that HsUAF1WDR48 also 
interacted with the paralogous HsUSP12 and HsUSP46 (Cohn et al., 2009). Neither 
the HsUSP12–HsUAF1WDR48 nor the HsUSP46–HsUAF1WDR48 complex are thought to 
deubiquitinate the HsUSP1 substrate HsUb-FANCD2. Any function in 
deubiquitinating HsPCNA was not discussed. As reported in the tables in Chapters 
3 and 6, the S. pombe and S. cerevisiae orthologues are SpUbp9 and the 
paralogous ScUbp9 and ScUbp13, respectively. The authors submit that the likely 
HsUAF1WDR48 orthologue in S. cerevisiae is YOL087C. The S. pombe orthologue of 
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YOL087C is the uncharacterised protein SPAC31A2.14, which, according to the 
Pfam database, comprise two and three WD40 repeats, respectively. It is also 
concluded in this study that perhaps a WD40 cofactor is required for optimal 
activity of HsHAUSPUSP7 due to its low catalytic activity when expressed 
recombinantly. Furthermore, the authors speculate that complexes “USPX–UAF2” 
and “USPY–UAF2” may exist (Cohn et al., 2009). It is not known if USPX and 
USPY are capable of deubiquitinating HsPCNA, but it is assumed that they are the 
“DUb-X” and “DUb-Y” referred to above.  
 
9.5. Functions of the MATH Domain 
 
The importance of the MATH domain in SpUbp22 function was demonstrated in 
Chapter 7. Here it was proposed that the highly conserved DWGF motif acts as a 
binding interface with targets of these DUbs. A suitable follow-on experiment would 
be to utilise the SpUbp22 MATH domain as bait in a yeast-2-hybrid experiment on 
the S. pombe proteome in order to search for potential SpUbp22 substrates and 
interactors.  
 
In some MATH domain-containing proteins, such as meprins, the MATH domain 
acts as an oligomerisation interface. Therefore, it is plausible that homo- or 
hetereo-oligomers of SpUbp21/SpUbp22 exist in vitro. For example, it is possible 
that the inability of DWGF-mutated SpUbp22 to rescue the UV sensitivity of the 
double delete is due to abrogated homo-oligomerisation, rather than binding its 
substrate. However, there is no evidence that HsHAUSPUSP7 forms homo-oligomers. 
Furthermore, given that only very mild phenotypes were observed in the single 
deletes, it is clear that hetero-oligomers are not a required or major species in the 
cell. However, it would interesting to see in such a yeast-2-hybrid experiment, 
whether e.g. the SpUbp22 MATH domain interacts with SpUbp22 or SpUbp21. 
 
Site-directed mutations could be carried out on the primary sequence of 
SpUbp21/SpUbp22. For example, rather than deleting the genes in their entirety, the 
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catalytic site in the USP/UBP domain could be disrupted e.g. by mutating the 
catalytic cysteine. The inability of such a mutant to rescue the UV sensitivity of the 
double delete would confirm that the DUb activity is responsible for the role in the 
response to UV. SpUbp21/SpUbp22 may merely act as scaffolding components. It 
would also be interesting to see the effects of further mutations in the MATH 
domain i.e. in addition to the DWGF/AAAA mutation, for example, mutation of other 
residues highly conserved in yeast or removing the MATH domain completely. 
Furthermore, mutation of potential ubiquitin domains in the C-terminus may also 
affect the catalytic activity of these DUbs and may provide pointers as to whether 
the DUbs bind poly-ubiquitin chains e.g. in the C-terminus, or whether binding to a 
single ubiquitin in the active site is sufficient. 
 
9.6. SpPCNA Deubiquitination in S. pombe 
 
The importance of HsPCNA deubiquitination is not well understood. In the model 
proposed by Niimi et al., 2008, which is discussed in section 1.19 of Chapter 1, it 
was suggested that a persistence of ubiquitinated HsPCNA is not inhibitory to the 
cell because it is the combined effect of: (1) the inability for normal replicative 
polymerases to bypass damage DNA, and (2) promotion of PRR e.g. by 
ubiquitinating HsPCNA, that results in PRR. Hence, ubiquitinated HsPCNA species 
in the absence of damage i.e. in the absence of (1), does not necessarily result in 
PRR. Having promoted PRR e.g. an abundance of ubiquitinated HsPCNA, is not 
likely to cause (1) to occur. Therefore, minimising HsPCNA ubiquitination in the 
absence of damage may not be as important as previously thought.  
 
It is also not known whether ubiquitinated PCNA is deposited on the DNA at every 
lesion, or whether deposition only occurs when the TLS machinery does not effect 
bypass sufficiently quickly. Hence PCNA ubiquitination may not be 
necessary/required for PRR to occur, but simply a PRR promoter. Afterall, 
HsRAD18 binds ssDNA and HsPolη via different domains, hence a TLS polymerase 
could be recruited to a stalled fork in the absence of an ubiquitinated HsPCNA. 
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The Niimi et al model also implies that in situ deubiquitination of HsPCNA is less 
important for the switch back to the normal replicative polymerase because the 
replicative machinery is simply reloaded. The pool of deubiquitinated HsPCNA may 
be maintained by (1) deubiquitination by one or more DUbs with particular 
specificity towards HsPCNA, and/or (2) deubiquitination events by numerous non-
HsPCNA-dedicated DUbs, and/or (3) degradation of ubiquitinated HsPCNA and 
synthesis of new HsPCNA. Whilst there is no hint of SpPCNA degradation (e.g. in 
Figure 5.3), which suggests that pathway (3) is not major in S. pombe, it is possible 
that pathway (1) is simply not found in yeast. 
 
9.7. A Role of SpUbp21 and SpUbp22 in the Spindle Checkpoint 
 
As discussed in Chapter 5, HsHAUSPUSP7 has been shown to control the stability 
and activity of HsCHFR by preventing its auto-ubiquitination (Oh et al., 2007). It 
would be interesting to investigate whether SpUbp21/SpUbp22 are capable of 
affecting the levels of SpDma1, the orthologue of HsCHFR. For example, whether 
exogenous expression of SpUbp21/SpUbp22 results in an increase in SpDma1 
levels, whether there is a decrease in the double DUb delete and whether these 
DUbs act redundantly in this function. Further experiments with 
thiabendazole/carbendazim treatment could also be carried out to check for a 
functioning spindle checkpoint.  
 
9.8. Final Conclusions 
 
This study has shown that SpUbp21 and SpUbp22 are important in DNA damage 
responses in S. pombe. This is an entirely novel finding, and hence is an important 
contribution for the understanding of DNA damage responses in fission yeast. 
Whilst a role for them in PRR has not been clearly demonstrated, the ground has 
been prepared for further research into this.  
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Figure 1.1. Summary of the Mammalian Cell Cycle and its 
Checkpoints. Following growth or gap phase 1 (G1), the cell duplicates 
its genome in the synthesis phase (S). Afterwards the cell contains two 
identical copies of each chromosome (only one chromosome is shown 
here for brevity). During mitosis (M), one copy of an identical pair is 
separated by the spindle network. Eventually, two identical daughter cells 
are resultant, whereupon the cycle starts again. However, most cells in 
the mammalian body are not cycling, but in a quiescent state known as 
G0. Cell cycle checkpoints act as quality control mechanisms throughout 
the process, and are explained in the text. Figure adapted from Lodish et 
al., 2004.
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Figure 1.2. The Semi-Discontinuous Model of DNA Replication: 
Leading and Lagging Strand DNA Synthesis. The DNA polymerase 
can only synthesise DNA in the 5’ to 3’ direction. The parental leading and 
lagging template strands are shown in burgundy and navy, respectively. 
Newly synthesised DNA from continuous replication is shown in red and 
Okazaki fragments are shown blue. RNA primers are shown in green.
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Figure 1.3. Core Components of the Replication Factory. This figure is 
oriented as in Figure 1.2 – the replication fork is proceeding towards the 
top of the page. dsDNA is unwound by the helicase, and a complementary 
daughter strand is synthesised by the DNA polymerases using the 
unwound ssDNA as a template. Replication protein A (RPA) protects and 
stabilises the ssDNA. The sliding clamp confers processivity to the DNA 
polymerase, and is loaded periodically onto newly unwound lagging 
strand by the clamp-loader complex. The primase synthesises a short 
RNA primer to allow the lagging strand polymerase to synthesise DNA de 
novo. Figure adapted from Langston and O’Donnell, 2006.
RPA
Figure 1.4. DNA Damage and its Consequences. a) Common DNA damaging 
agents (top); examples of DNA lesions induced by these agents (middle); and 
most the relevant DNA repair mechanism responsible for the removal of the 
lesions (bottom). b) The effects of DNA damage on cell-cycle progression, 
leading to transient arrest in G1, S, G2 and M phases (top), and on DNA 
metabolism (middle). Long-term consequences of DNA injury (bottom) include 
permanent changes in the DNA sequence and their biological effects. 
Abbreviations: cis-Pt and MMC, cisplatin and mitomycin C, respectively (both 
DNA crosslinking agents); (6–4)PP and CPD, 6–4 photoproduct and 
cyclobutane pyrimidine dimer, respectively (both induced by UV light); HR, 
homologous recombination; EJ, end joining. Figure and legend from 
Hoeijmakers, 2001.
Figure 1.5. Nucleotide Excision Repair (NER). a) Damage (red circle) 
that alters the secondary structure of the duplex, is, as shown in b), is 
detected and bound by a heterodimer of XPC and RAD23 (XPC-R23). c) 
and d) XPA, RPA, XPG, and TFIIH follow. TFIIH comprises the DNA 
helicases XPD and XPB, which unwind the DNA to form a bubble around 
the damage. ERCC1-XPF also binds. e) XPG cleaves the damaged 
strand at the 3’ end, and ERCC1-XPF cuts at the 5’ end. f) The damaged 
portion is excised and with the aid of clamp-loader RFC, PCNA, a DNA 
polymerase, healthy DNA is synthesised across the gap, and sealed in 
place with a DNA ligase. g) Undamaged dsDNA is restored. Figure and 
legend adapted from Friedberg, 2001.
Figure 1.5. Homolgous recombination at. Adapted from Oakley and 
Hickson, 2002.
Figure 1.6. A Summary of Homologous Recombination (HR) Pathways initiated 
by a DNA double-strand break (DSB) and which lead to gene conversion with or 
without crossover. First, the ends of the DSB are resected to produce single-stranded 
DNA that recruits the recombination protein RAD51. The RAD51 nucleoprotein 
filament leads to interactions with homologous duplex DNA and strand invasion. 
Intermediate structures might be stabilized by RAD54. In the central pathway, strand 
invasion is followed by capture of the second DNA end in reactions that are likely to 
involve RAD52. This intermediate can proceed to form double Holliday junctions, and 
any remaining gaps might be filled by new DNA synthesis. The resulting Holliday 
junctions might then serve as the substrate for classical Holliday-junction-resolution 
reaction, involving RAD51C, XRCC3, or be dissociated by the combined actions of 
BLM (Bloom's syndrome protein) and topoisomerase III (Topo III). The BLM–Topo-III 
reaction primarily leads to the formation of non-crossover products. Recombinants 
can also form by a MUS81-dependent pathway (right) that does not involve Holliday-
junction formation. Similarly, DSBs can be repaired by synthesis-dependent strand 
annealing (SDSA), a pathway that is dependent on the SRS2 helicase (left). Figure 
and legend adapted from Liu and West, 2004.
Figure 1.7. The “Chicken Foot” Model – Homologous Recombination 
at Replication Forks. (a) A lesion (yellow diamond) in the leading strand 
template blocks leading strand synthesis, (b) but lagging strand synthesis 
can continue for a short distance. (c) The fork regresses due to helical 
tension ahead of the fork, or it is thought that this reaction could be 
promoted by a specialised enzyme e.g. RecG in E. coli. (d) The nascent 
strands anneal, permitting leading strand synthesis using the nascent 
lagging strand as a template. The ‘chicken-foot’ structure (a Holliday 
junction) can be branch migrated to reset the fork. (e) The leading strand 
has been extended beyond the lesion. Figure and legend adapted from 
Oakley and Hickson, 2002.
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Figure 1.8. Summary of p53 Activation and the Resultant 
Downstream Effects. Adapted from Riley et al, 2008.
Figure 1.9. Structure of PCNA in Cartoon Format. (A) Each subunit of the 
homotrimer is in yellow, pink and light purple. (B) PCNA (yellow) modified on 
lysine 164 with ubiquitin (orange). (C) PCNA (yellow) modified on lysine 127 with 
small ubiquitin-like modifier (SUMO, blue). (D) PCNA (yellow) side-view. The 
symbol ‘C’ is found on the side of PCNA where the C-terminus protrudes. 
Structure (A) was prepared using Protein Explorer (see Chapter 2) using PDB ID: 
1AXC (PCNA, Gulbis et al. 1996). B to D are modified from Moldovan et al., 2007.
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Figure 1.10. Structures of Ubiquitin (light blue) and SUMO-1 (light green) in 
cartoon format (left) to show the secondary structure elements, and in spacefill
format (right). Lysine residues of ubiquitin and SUMO-1 are shown in pink and 
red, respectively. Structures were prepared using Protein Explorer (see Chapter 
2) using PDB ID: 1UBQ (ubiquitin, Vijay-Kumar et al, 1987) and 1A5R (SUMO-1, 
Bayer et al, 1998).
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Figure 1.11. Post-replication Repair in S. cerevisiae. Modified from Hoege et 
al, 2002.
Metallopeptidase, clan MP, family 
C67 A, B and C
Jab1/Pad1/MPN/Mov34 domain 
metalloenzymes (JAMMs)
Cysteine-type peptidase, 
classification not known
Permutated papain fold peptidases of 
dsDNA viruses and eukaryotes 
(PPPDEs)
Cysteine-type peptidase, 
classification not known
Machado-Joseph/Jakob disease 
protein/Josephin domain proteases 
(MJDs)
Cysteine-type peptidase, clan CA, 
C64 and C65 families
Ovarian tumour-like proteases 
(OTUs)
Cysteine-type peptidase, clan CA, 
C12 family
Ubiquitin C-terminal hydrolases 
(UCHs)
Cysteine-type peptidase, clan CA, 
C19 family
Ubiquitin-specific proteases 
(USP/UBPs)
Peptidase DomainName of DUb Superfamily
Table 1.1. Superfamilies of Deubiquitinating enzymes and their Peptidase 
Domains.
Figure 1.12. Function of HsUSP1 in the Deubiquitination of HsPCNA. The 
replication machinery encounters stalling damage on the DNA template (red star). 
HsRAD6 (light blue), aided by HsRAD18 (dark blue), mono-ubiquitinates the 
HsPCNA homotrimer (beige). At this point, a TLS polymerase (green) may bind to 
mono-ubiquitinated HsPCNA and bypass the damage. Alternatively, HsUSP1 may 
deubiquitinate HsPCNA. HsUSP1 autocleavage is induced by UV irradiation. Figure 
adapted from Ulrich, 2006.
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Table 2.1. SDS-PAGE Gel Preparation. Recipes for 8%, 10% and 12% 
resolving gels are shown for illustration. Quantities are in ml. * Protogel
(National Diagnostics) contains 30% acrylamide, 0.8% bisacrylamide. ** 
For the stacking gel, 0.5 M tris pH 6.8 was used.
10
0.01
0.1
0.1
1.25**
1.7
6.8
Stack
101010Total
0.0040.0040.006TEMED
0.10.10.110% AMPS
0.10.10.110% SDS
2.52.52.51.5 M tris pH 8.8
4.03.32.730% acrylamide 
mix*
3.34.04.6Water
12%10%8%Gel
Table 2.2. Immunodetection Methods. Milk powder was Marvel or a 
supermarket own-branded version and percentages are w/v. All other 
percentages are v/v. Room temperature (RT) was about 22°C. Water was 
double distilled. Secondary antibodies were from DAKO.
(a) 1x 5 mins
in water. 
(b) 3x 5 mins
in 0.1% PBST. 
(c) 1x 5 min in 
1x PBS.
Rabbit α-Mouse 
HRP 
1 in 5000 in 5% milk 
in 0.1% PBST for 1 
h
(a) 1x 3 mins
in water. 
(b) 3x 3 mins
in 0.1% PBST
1 in 500 in 5% 
milk in 0.1% 
PBST for 1 h
5% milk in 
0.1% 
PBST for 
30 min
Immunodection
using mouse α-
FLAG (Sigma)
(a) 1x 5 mins
in water. 
(b) 3x 5 mins
in 0.1% PBST. 
(c) 1x 5 min in 
1x PBS.
Rabbit α-Mouse 
HRP 
1 in 5000 in 5% milk 
in 0.1% PBST 
for 1 h
(a) 1x 3 mins
in water. 
(b) 3x 3 mins
in 0.1% PBST
1 in 500 in 5% 
milk in 0.1% 
PBST 
overnight at 
RT
5% milk in 
0.1% 
PBST for 
30 min
Immunodection
using rabbit α-
ubiquitin (DAKO)
(a) 1x 5 mins
in water. 
(b) 3x 5 mins
in 0.1% PBST. 
(c) 1x 5 min in 
1x PBS.
Rabbit α-Mouse 
HRP 
1 in 5000 in 5% milk 
in 0.1% PBST for 1 
h
(a) 1x 3 mins
in water. 
(b) 3x 3 mins
in 0.1% PBST
1 in 2000 in 5 
% milk in 0.1% 
PBST for 1 h
5% milk in 
0.1% 
PBST for 
30 min
Immunodection
using mouse α-
tubulin (Sigma)
(a) 1x 5 mins
in water. 
(b) 3x 5 mins
in 0.1% PBST. 
(c) 1x 5 mins
in 1x PBS.
Goat α-Rabbit HRP 
1 in 5000 in 5% milk 
in 0.1% PBST 
for 1 h
(a) 5 mins in 
water. 
(b) 3x 5 mins
in 0.1% PBST.
1 in 5000 in 
5% milk in 
0.1% PBST 
overnight
5% milk in 
0.1% 
PBST at 
RT for 30 
min 
Improved 
immunodection
using affinity 
purified rabbit α-
SpPCNA
(a) 1x 5 mins
in water. 
(b) 3x 5 mins
in 0.1% PBST. 
(c) 1x 5 min in 
1x PBS.
Rabbit α-Mouse 
HRP 
1 in 10 000 in 5% 
milk in 0.1% PBST 
for 1 h
(a) 1x 3 mins
in water. 
(b) 3x 3 mins
in 0.1% PBST
1 in 3000 in 
5% milk in 
0.1% PBST for 
1 hour
5% milk in 
0.1% 
PBST for 
1 h
Immunodection
using mouse α-
His6 (Amersham
Pharmacia 
Biotech)
(a) 1x 15 mins
in water. 
(b) 3x 15 mins
in 0.5% PBST. 
(c) 1x 15 mins
in 1x PBS.
Goat α-Rabbit HRP 
1 in 10000 in 5% 
milk in 0.5% PBST 
for 1 h
(a) 15 mins in 
water. 
(b) 3x 15 mins
in 0.5% PBST.
1 in 10000 in 
5% milk in 
0.5% PBST for 
1 hour
5% milk in 
0.5% 
PBST for 
1 h 
Immunodection
using rabbit α-
SpPCNA
Washes2° Antibody 
Incubation
Washes1° Antibody 
Incubation
BlockProtocol 
Table 2.3. PCR Cycling Conditions for Amplification of 
Transforming DNA.
6 °CHold
72 °C10 min
72 °C2.5 min
60 °C30 s
95 °C40 s
72 °C2.5 min
50 °C30 s
95 °C40 s
95 °C30 s
RepetitionsTemperatureTime
x 25
x 5
Table 2.4. Genotoxic Agent Stocks and Diluents.
SigmaWater9.8MHydrogen peroxide (H2O2)
SigmaNoneneat powdercis-platin
SigmaDMSO33.3 mg/mlThiabendazole (TBZ)
SigmaDMSO2.5 mg/mlCarbendazim (CBZ)
MelfordWater10 µg/mlBleomycin
MelfordWater10 µg/mlPhleomycin
SigmaDMSO5 mM4-nitroquinoline-1-oxide (4-
NQO)
SigmaWater1-2 MHydroxyurea (HU)
SigmaWater1% (v/v)Methylmethano sulfonate 
(MMS)
SigmaDMSO5 mMCamptothecin (CPT)
SourceDiluentBench Stock 
Concentration
Genotoxic Agent
Figure 3.1. Persistence of SpPCNA Ubiquitination after UVC 
Irradiation in wild-type and pcn1-K164R cells. The same number of 
cells of exponentially growing cultures were irradiated or mock irradiated 
(NT) with 100 J/m2 UVC and samples were taken at the indicated times. 
Size fractionated whole cell extracts were probed with anti-SpPCNA
antibodies. Mono-ubiquitinated (*), di-ubiquitinated (**) and tri-
ubiquitinated (***) forms of SpPCNA are labelled.
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*
**
***
HsCSN5.ScRri1Csn5/Jab1**SpCsn5
HsRPN11ScRpn11**SpRpn11Pad1
HsAMSH, HsAMSH-L1-SpAmshSst2
HsPNAS4FAM152A-SpHag1Mug67
HsOTUD6B and HsOTUD6AScOtu2SpOtu2
HsOTU1YOD1ScOtu1SpOtu1Mug141
HsUCH37UCH-L5-SpUch2
HsUCH-L1, HsUCH-L3ScYuh1SpUch1
HsUSP36, HsUSP42, HsUSP17-SpUbp16
HsUSP25, HsUSP28ScUbp2SpUbp2
HsUSP12, HsUSP46ScUbp9, ScUbp13SpUbp9
HsUSP10ScUbp3SpUbp3
HsUSP8UBPYScUbp5, ScUbp7, ScDoa4SpUbp4
sHAUSPUSP7ScUbp15SpUbp22Ubp5
sHAUSPUSP7ScUbp15SpUbp21Ubp15
-ScUbp1SpUbp11
HsUSP52ScPan2SpUbp13Pan2
HsUSP14ScUbp6SpUbp6
HsUSP5IsoT1, HsUSP13IsoT2
HsUSP39SNUT2*
-
HsUSP22, HsUSP27*, HsUSP51*
HsUSP16UBP-M, HsUSP45
HsUSP4, HsUSP11, HsUSP15
HsUSP4, HsUSP11, HsUSP15
H. sapiens
ScUbp14SpUbp14Ucp2
ScSad1SpUbp10
ScUbp8SpUbp8
-
SpUbp7
SpUbp12SpUbp12
ScUbp12SpUbp1
S. cerevisiaeS. pombe
Table 3.1. DUbs in Three Species. Table of DUbs in S. pombe and their 
likely orthologues in S. cerevisiae and H. sapiens. USP/UBP DUbs are 
shown in green, UCHs in blue, OTUs in pink, PPPDEs in yellow, and 
JAMMs in beige. A single asterisk indicates that the enzyme is unlikely to 
possess DUb activity. A double asterisk adjacent to a S. pombe DUb 
indicates it is not included in this study.
S. pombe Deubiquitinating EnzymeAdditional Domains
UBP/USP Superfamily DUbs
SpUbp6
-467 a.a.
-Ubiquitin-like domain.
-SPAC6G9.08
-Likely orthologues are ScUbp6, HsUSP14
Ubiquitin-like 
Domain
SpUbp14Ucp2
-775 a.a.
-Two UBP-type zinc finger domains.
-Two UBA domains within UBP/USP domain.
-SPBC6B1.06c
-Likely orthologues are ScUbp14, HsUSP5IsoT1, HsUSP13IsoT2
SpUbp10
-502 a.a.
-UBP-type zinc finger domain
-SPBC577.07
-Likely orthologues are ScSad1, HsUSP39SNUT2* 
SpUbp8
-449 a.a.
-UBP-type zinc finger domain
-SPAC13A11.04c
-Likely orthologues are ScUbp8, HsUSP22, HsUSP27*, HsUSP51*
SpUbp7
-875 a.a.
-UBP-type zinc finger domain
-SPAC23G3.08c
-Likely orthologues are HsUSP16UBP-M, HsUSP45
UBP-type Zinc 
Finger Domain
SpUbp12
-979 a.a.
-DUSP domain
-SPCC1494.05c
-Paralogue is SpUbp1
-Likely orthologues are ScUbp12, HsUSP4, HsUSP11, HsUSP15
SpUbp1
-849 a.a.
-DUSP domain
-SPCC16A11.12c
-Paralogue is SpUbp12
-Likely orthologues are ScUbp12, HsUSP4, HsUSP11, HsUSP15
DUSP domain
Table 3.2. DUbs in S. pombe. Important facts for each S. pombe DUb is 
provided. USP/UBP DUbs are shown in green, UCHs in blue, OTUs in 
pink, PPPDEs in yellow, and JAMMs in beige. USP/UBPs are further 
divided by additional domains. A single asterisk indicates that the enzyme 
is unlikely to possess DUb activity. A double asterisk adjacent to a S. 
pombe DUb indicates it is not included in this study.
SpUbp16
-457 a.a.
-SPCC1682.12c
-Likely orthologues are HsUSP36, HsUSP42, HsUSP17
SpUbp2
-1141 a.a.
-SPAC328.06
-Likely orthologues are ScUbp2, HsUSP25, HsUSP28
SpUbp9
-585 a.a.
-SPBC1703.12
-Likely orthologues are ScUbp9, ScUbp13, HsUSP12, HsUSP46
SpUbp3
-512 a.a.
-SPBP8B7.21
-Likely orthologues are ScUbp3, HsUSP10
SpUbp4
-438 a.a.
-SPBC18H10.08c
-Likely orthologues are ScUbp5, ScUbp7, ScDoa4, HsUSP8UBPY
No extra domains
SpUbp22Ubp5
-1108 a.a.
-MATH domain.
-SPCC188.08c
-Paralogue is SpUbp21
-Likely orthologues are ScUbp15, HsHAUSPUSP7
SpUbp21Ubp15
-1129 a.a.
-MATH domain.
-SPBC713.02c
-Paralogue is SpUbp22
-Likely orthologues are ScUbp15, HsHAUSPUSP7
MATH domain
SpUbp13Pan2
-1115 a.a.
-WD-40 repeat.
-Exonuclease domain.
-Ribonuclease H fold
-SPAC22G7.04
-Likely orthologues are ScPan2, HsUSP52
Exonuclease Domain
SpUbp11
-350 a.a.
-Probable transmembrane helix
-SPBC19C2.04c
-Likely orthologues are ScUbp1
Trans-membrane 
Helix
Table 3.3. DUbs in S. pombe. Legend as Table 3.1.
UCH Superfamily DUbs
SpUch2
-300 a.a.
-SPBC409.06
-Likely orthologue is HsUCH37UCH-L5.
SpUch1
-222 a.a.
-SPAC27F1.03c
-Likely orthologues are ScYuh1, HsUCH-L1, HsUCH-L3.
OTU Superfamily DUbs
SpOtu2
-324 a.a.
-SPAC1952.03
-Likely orthologues are ScOtu2, HsOTUD6B and HsOTUD6A.
SpOtu1Mug141
-329 a.a.
-C2H2 zinc finger
-SPAC24C9.14
-Likely orthologues are ScOtu1, HsOTU1YOD1.
PPPDE Superfamily DUbs
SpHag1Mug67
-201 a.a.
-PPPDE domain.
-SPAPYUG7.06
-Likely orthologue is HsPNAS4FAM152A.
JAMM Superfamily DUbs
SpAmshSst2
-435 a.a.
-SPAC19B12.10
-Likely orthologues are HsAMSH, HsAMSH-L1.
**
SpRpn11Pad1
-308 a.a.
-SPAC31G5.13
-Likely orthologues are ScRpn11, HsRPN11.
**
SpCsn5
-299 a.a.
-SPAC1687.13c
-Likely orthologues are ScRri1Csn5/Jab1, HsCSN5.
Table 3.4. DUbs in S. pombe. Legend as Table 3.1.
Figure 3.2. Alignment of Otu1 DUbs in Three Eukaryotic Species. The 
catalytic Cys and His boxes are boxed in red, the C2H2 in blue. Residue 
letters are coloured according to type. Acidic residues, Asp and Glu, are 
typed in blue; basic residues, Arg and Lys, pink; green residues, His, Asn, 
Gly, Tyr, Ser, Gln, Thr, are hydrophilic; and hydrophobic residues, Phe, 
Met, Ala, Leu, Iso, Pro, Trp, are typed in red. An asterisk indicates 
homologous residues; a colon indicates conservation with a highly similar 
residue; a dot, conservation with less similar residues; and no symbol 
indicates no conservation. The table underneath shows the percentage 
identity (score) of pairwise comparisons.
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Score
SpOtu1ScOtu1
SpOtu1HsOTU1YOD1
ScOtu1HsOTU1YOD1
DUb 2DUb 1
Figure 3.3. Alignment of Otu2 DUbs in Three Eukaryotic Species. 
Colour coding as previous figure. The table underneath shows the 
percentage identity (score) of pairwise comparisons.
25HsOTUD6AScOtu2
27HsOTUD6ASpOtu2
31ScOtu2SpOtu2
54
32
27
Score
HsOTUD6AHsOTUD6B
ScOtu2HsOTUD6B
SpOtu2HsOTUD6B
DUb 2DUb 1
Figure 3.4. Alignment of AMSH DUbs in S. pombe and H. sapiens. The MIT 
domain is boxed in green. Important MIT domain residues are highlighted in green. 
The bi-partite NLS is boxed in orange. The CBS is boxed in violet. The SBM domain 
is boxed in dark blue. The JAMM domain residues are boxed in red. MPN+ residues 
are highlighted in red. Residues that are invariant in over 50% of JAMM domain 
proteins are highlighted in yellow (Maytal-Kivity et al, 2002). The inserts conferring 
ubiquitin chain specificity are shown in light blue and light green (Sato et al, 2008). 
Other colour coding as Figure 3.1. The table underneath shows the percentage 
identity (score) of pairwise comparisons.
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Figure 3.5. DUb Gene Deletion-Insertion Approach Using the nat1 
Integration. Firstly, transforming DNA was synthesised by one-step PCR 
using long (100 bp) primers. The pFA6a_natMX6 plasmid comprises the 
NAT resistance gene. The nat1 gene is represented in turquoise, a dub 
gene in green, flanking sequences of the dub gene in pink, and an HR 
reaction is represented by a blue cross.
80
 bp homologous
 to
 DUb
 gene
 3’ flank
dub in chromosome
Transformation
Selection on NAT
nat1 in chromosome
Figure 3.6. PCR Primer Positions for Checking dub Knockout Status. 
PCR was performed on genomic DNA preparations of nourseothricin
(NAT) resistant strains. The gene encoding NAT resistance (nat1) is 
represented in turquoise, a dub gene in green, flanking sequences of the 
dub gene in pink.
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Figure 3.7. PCR Amplification of the ubp13, ubp7, ubp22, and ubp16
Loci Utilising Primers that Anneal to Flanking DNA and the nat1 
marker. Using genomic DNA from of the S. pombe strains wild-type,
ubp13∆::nat1, ubp7∆::nat1, ubp22∆::nat1, and ubp16∆::nat1. Lanes are 
marked with the primers utilised (as per figure 3.6).
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Figure 3.8. PCR Amplification of the ubp8, ubp14, and ubp11 Loci 
Utilising Primers that Anneal to Flanking DNA and the nat1 Marker. 
Using Genomic DNA from of the S. pombe Strains wild-type, ubp8∆::nat1,
ubp14∆::nat1, and ubp11∆::nat1. Lanes are marked with the primers 
utilised (as per figure 3.6).
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Figure 3.9. PCR Amplification of the ubp4, ubp9, uch2, and amsh
Loci Utilising Primers that Anneal to Flanking DNA and the nat1 
Marker. Using Genomic DNA from of the S. pombe Strains wild-type,
ubp4∆::nat1, ubp9∆::nat1, uch2∆::nat1, and amsh∆::nat1. Lanes are 
marked with the primers utilised (as per figure 3.6).
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Figure 3.10. Verification of ubp13∆::nat1 Genotype via Southern 
Analysis. (A) Genomic DNA from wild-type and a candidate ubp13∆::nat1
strain was digested overnight with the indicated endonucleases. 
Subsequently, the digested DNA was fractionated on an agarose gel and 
transferred onto a membrane, which was then probed with a small piece 
of radiolabelled dsDNA (grey) designed to anneal just downstream of the 
ubp13 locus. The expected sizes detected are shown. (B) The DNA 
fragments detected on the Southern blot.
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Figure 3.11. Verification of ubp7∆::nat1 Genotype via Southern 
Analysis. As figure 3.10. Blue arrows indicate the position of the bands 
on the Southern.
u
bp
7∆
::
n
at
1
gD
NA
w
ild
-
ty
pe
 
gD
NA
5000
2000
1650
4000
3000
6000
bp
7000
nat1
a
b
A
B
dubp7+
EcoRV
5643 bp
2022 bp
EcoRV
EcoRV EcoRV
EcoRV
Figure 3.12. Verification of ubp22∆::nat1 Genotype via Southern 
Analysis. As figure 3.10
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Figure 3.13. PCR Amplification of the ubp1 and ubp12 Loci Utilising 
Primers that Anneal to Flanking DNA. Using Genomic DNA from of the 
S. pombe Strains wild-type, ubp1∆::ura4, ubp12∆::ura4, and ubp1∆::ura4
ubp12∆::ura4. Expected size of deletions was not known because these 
strains were made by collaborators – the locus was checked by 
sequencing. The lower diagram shows the PCR strategy in wild-type 
gDNA and potentially dub-deleted gDNA. Primers that flank the DUb gene 
locus are depicted by arrows.
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Figure 3.14. PCR Amplification of the ubp2, ubp3, and uch1 Loci 
Utilising Primers that Anneal to Flanking DNA. Using Genomic DNA 
from of the S. pombe Strains wild-type, ubp2∆::ura4, ubp3∆::ura4 and 
uch1∆ ::ura4. Expected size of deletions was not known because these 
strains were made by collaborators – the locus was checked by 
sequencing. The lower diagram shows the PCR strategy in wild-type 
gDNA and potentially dub-deleted gDNA. Primers that flank the DUb gene 
locus are depicted by arrows.
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Figure 3.15. PCR Amplification of the otu1 and otu2 Loci Utilising 
Primers that Anneal to Flanking DNA. Using Genomic DNA from of the 
S. pombe Strains wild-type, otu1∆::ura4, otu2∆::ura4, and otu1∆::ura4
otu2∆::ura4. Expected size of deletions was not known because these 
strains were made by collaborators – the locus was checked by 
sequencing. The lower diagram shows the PCR strategy in wild-type 
gDNA and potentially dub-deleted gDNA. Primers that flank the DUb gene 
locus are depicted by arrows.
Expected Sizes (bp): 1309 1361
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Figure 3.16. PCR Amplification of the ubp21 and ubp22 Loci Utilising 
Primers that Anneal to Flanking DNA. Using Genomic DNA from of the 
S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4 and 
ubp21∆::ura4 ubp22∆::ura4. Sizes of PCR products from deletion strains 
was estimated from what was described of their knockout strategy
(Richert et al., 2002). The locus was further checked by sequencing. The 
lower diagram shows the PCR strategy in wild-type gDNA and potentially 
dub-deleted gDNA. Primers that flank the DUb gene locus are depicted by 
arrows.
5000
bp
2000
4000
3000
ubp21 locus primers ubp22 locus primers
w
ild
-
ty
pe
 
gD
NA
u
bp
21
∆:
:u
ra
4
gD
NA
u
bp
21
∆:
:u
ra
4
u
bp
22
∆:
:u
ra
4
gD
NA
w
ild
-
ty
pe
 
gD
NA
u
bp
22
∆:
:u
ra
4
gD
NA
u
bp
21
∆:
:u
ra
4
u
bp
22
∆:
:u
ra
4
gD
NA
n
o 
gD
NA
u
bp
22
∆:
:u
ra
4
gD
NA
u
bp
21
∆:
:u
ra
4
gD
NA
n
o 
gD
NA
4217Expected Sizes (bp): 45624217 4562>4217 >4217 ~3000 ~3000
dub+
marker? ??
5000
1000
bp
2000
1650
500
4000
3000
lub1 locus primers ubp6 locus primers
w
ild
-
ty
pe
 
gD
NA
lu
b1
∆:
:k
an
gD
NA
w
ild
-
ty
pe
 
gD
NA
ha
g1
∆:
:k
an
gD
NA
u
bp
6∆
::
ka
n
gD
NA
hag1 locus primers
w
ild
-
ty
pe
 
gD
NA
Figure 3.17. PCR Amplification of the lub1, hag1 and ubp6 Loci 
Utilising Primers that Anneal to Flanking DNA. Using genomic DNA 
from of the S. pombe Strains wild-type, lub1∆::kan, hag1∆::kan and 
ubp6∆::kan. Expected size of deletions was not known because these 
strains were purchased from Bioneer who refused to disclose the 
sequence information – the locus was checked later by sequencing. The 
lower diagram shows the PCR strategy in wild-type gDNA and potentially 
dub-deleted gDNA. Primers that flank the DUb gene locus are depicted by 
arrows.
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Figure 3.18. PCR Amplification of the ubp10 and ubp21 Loci Utilising 
Primers that Anneal to Flanking DNA. Using Genomic DNA from of the 
S. pombe Strains wild-type, ubp10∆::kan, and ubp21∆::kan. Expected size 
of deletions was not known because these strains were purchased from 
Bioneer who refused to disclose the sequence information – the locus was 
checked later by sequencing. The lower diagram shows the PCR strategy 
in wild-type gDNA and potentially dub-deleted gDNA. Primers that flank 
the DUb gene locus are depicted by arrows.
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Figure 4.1. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, otu1∆, otu2∆, otu1∆ otu2∆, ubp1∆, ubp2∆ 
and pcn1-K164R to Different Doses of UVC. Exponentially growing 
cultures were normalised by cell concentration and dropped down YEA  
agar plates, which were subsequently exposed to a UVC dose gradient as 
indicated. Plates were grown for three days at 30ºC before photographing.
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Figure 4.2. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, ubp3∆, ubp12∆, ubp1∆ ubp12∆, ubp10∆, 
uch1∆ and pcn1-K164R to Different Doses of UVC. This experiment 
was performed as described in figure 4.1.
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Figure 4.3. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, lub1-1, lub1∆, hag1∆, ubp6∆, and pcn1-
K164R to Different Doses of UVC. This experiment was performed as 
described in figure 4.1.
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Figure 4.4. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, ubp11∆, ubp14∆, amsh∆, and pcn1-
K164R to Different Doses of UVC. This experiment was performed as 
described in figure 4.1.
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Figure 4.5. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, ubp13∆, ubp7∆, ubp8∆, and pcn1-K164R 
to Different Doses of UVC. This experiment was performed as described 
in figure 4.1. The complete agar plates can be found in figure 5.17.
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Figure 4.6. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, uch2∆, ubp4∆, ubp9∆, and pcn1-K164R 
to Different Doses of UVC. This experiment was performed as described 
in figure 4.1.
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Figure 4.7. Colony Forming Assay Measuring the Percentage Survival 
Following UVC Irradiation. Strains ubp1∆, ubp2∆, ubp3∆, ubp12∆, and 
ubp1∆ ubp12∆ were compared with wild-type and pcn1-K164R. 
Exponentially growing cultures were plated onto YEA agar, which were 
exposed to the UVC doses indicated. Plates were grown for three days at 
30ºC before counting. The results represent the mean of two independent 
experiments and the error bars represent the standard deviation.
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Figure 4.8. Colony Forming Assay Measuring the Percentage Survival 
Following UVC Irradiation. Strains otu1∆, otu2∆, otu1∆ otu2∆, uch1∆
were compared with wild-type and pcn1-K164R. This experiment was 
performed as described in figure 4.7.
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Figure 4.9. Colony Forming Assay Measuring the Percentage Survival 
Following UVC Irradiation. Strains ubp13∆, ubp7∆, ubp8∆ were 
compared with wild-type and pcn1-K164R. This experiment was performed 
as described in figure 4.7.
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Figure 4.10. Colony Forming Assay Measuring the Percentage 
Survival Following UVC Irradiation. Strains uch2∆, ubp4∆, ubp9∆,
ubp14∆, ubp11∆ were compared with wild-type and pcn1-K164R. This 
experiment was performed as described in figure 4.7.
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Figure 4.11. Colony Forming Assay Measuring the Percentage Survival 
Following UVC Irradiation. Strains amsh∆, lub1∆, lub1-1, hag1∆, ubp6∆ were 
compared with wild-type and pcn1-K164R. This experiment was performed as 
described in figure 4.7.
Figure 4.12. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, pcn1-K164R, otu1∆, otu1∆, otu1∆ otu2∆, ubp1∆, ubp3∆,
ubp12∆, ubp1∆ ubp12∆ and uch1∆ Without Treatment (-) or Following 
50 mM Hydroxyurea Treatment (+). The same number of cells of 
exponentially growing cultures were left untreated or treated with 
hydroxyurea, then size-fractionated whole cell extracts were probed with 
anti-SpPCNA antibodies.
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Figure 4.13. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, pcn1-K164R, and ubp2∆ Without Treatment (-) or Following 
50 mM Hydroxyurea (+). This experiment was performed as described in 
figure 4.12.
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Figure 4.14. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, pcn1-K164R, otu1∆, otu1∆, otu1∆ otu2∆, ubp1∆, ubp2∆,
ubp3∆, ubp12∆, ubp1∆ ubp12∆ and uch1∆ Following Mock Treatment 
(A) or 100 Jm-2 UVC (B). The same number of cells of exponentially 
growing cultures were irradiated or mock irradiated with UVC, then size 
fractionated whole cell extracts were probed with anti-SpPCNA antibodies.
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Figure 4.15. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, ubp10∆ and pcn1-K164R Without Treatment (-) or 
Following 10 mM Hydroxyurea (+). This experiment was performed as 
described in figure 4.12.
w
ild
-
ty
pe
pc
n
1-
K1
64
R
u
bp
10
∆:
:k
an
w
ild
-
ty
pe
HU+- +-
u
bp
10
∆:
:k
an
pc
n
1-
K1
64
R
- +
32.5
47.5
62
kDa
w
ild
-
ty
pe
pc
n
1-
K1
64
R
u
bp
8∆
::
n
at
1
u
bp
14
∆:
:n
at
1
HU
- +- +- ++-
w
ild
-
ty
pe
pc
n
1-
K1
64
R
u
bp
8∆
::
n
at
1
u
bp
14
∆:
:n
at
1
32.5
Figure 4.16. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, ubp8∆, ubp14∆ and pcn1-K164R Without Treatment (-) or 
Following 10 mM Hydroxyurea Treatment (+). This experiment was 
performed as described in figure 4.12. A percentage value under a lane 
indicates the relative level of ubiquitinated SpPCNA when unmodified 
PCNA is set to 100%, which was measured by quantification of bands on 
a low exposure using ImageJ (http://rsb.info.nih.gov/ij/). The lower panel 
indicates a lower exposure of the  unmodifed SpPCNA band to indicate 
relative gel loading levels between lanes.
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Figure 4.17. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, ubp4∆, ubp7∆, ubp8∆, ubp11∆, ubp13∆, ubp14∆ and pcn1-
K164R Following Mock Treatment (-) or UVC Treatment (+). As Figure 
4.16.
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Figure 4.18. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, amsh∆, lub1∆, lub1-1, hag1∆, ubp6∆, uch2∆ and pcn1-
K164R Following Mock Treatment (-) or UVC Treatment (+). The same 
number of cells of exponentially growing cultures were irradiated or mock 
irradiated with 50 Jm-2 UVC, then size fractionated whole cell extracts 
were probed with anti-SpPCNA antibodies. The lower panel indicates a 
lower exposure of the  unmodifed SpPCNA band to indicate relative gel 
loading levels between lanes.
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Figure 4.19. Levels of SpPCNA Ubiquitination in Wild-type S. pombe 
Cells During the Cell Cycle. (A) shows samples from mock treated cells 
and (C) from UV irradiated cells (50 Jm-2). Cell cycle position was 
measured by mitotic or septation index. Septation occurs in early S-
phase. Figure from Frampton et al, 2006.
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Figure 4.20. Levels of SpPCNA Ubiquitination Prior to and Following 
Cell Cycle Block in S-phase in wild-type S. pombe cells. Exponentially 
growing cultures were treated with 10 mM hydroxyurea for 2.5 hrs and 
then released into fresh media. Samples were taken every 15 mins
following release from HU. Size fractionated whole cell extracts were 
probed with anti-SpPCNA antibodies. 
Figure 4.21. Cell Cytology Following Cell Cycle Block in S-phase in 
Wild-type S. pombe Cells. Exponentially growing cultures were treated 
with 10 mM hydroxyurea for 2.5 hrs and then released into fresh media. 
Samples were taken every 15 mins following release from HU as labels 
indicate. Cells were stained with DAPI and calcofluor and photographs 
taken under the fluorescent microscope. 
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Figure 4.22. Levels of SpPCNA Ubiquitination Following Cell Cycle Block in 
S-phase in the S. pombe Strains Wild-type, ubp13∆::nat1, ubp8∆::nat1,
and pcn1-K164R. The same number of cells of exponentially growing cultures 
were treated with 10 mM hydroxyurea for 2.5 hrs and then released into fresh 
media. Samples were taken after treatment (HU) and then approximately every 
15 mins following release from HU. Size fractionated whole cell extracts were 
probed with anti-SpPCNA antibodies. A percentage value under a lane indicates 
the relative level of ubiquitinated SpPCNA when unmodified PCNA is set to 
100%, which was measured by quantification of bands on a low exposure using 
ImageJ (http://rsb.info.nih.gov/ij/). The lower panel indicates a lower exposure 
of the unmodifed SpPCNA band to indicate relative gel loading levels between 
lanes. The complete version of this gel is shown in Figure 5.18.
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Figure 4.23. Levels of SpPCNA Ubiquitination Following Cell Cycle 
Block in S-phase in the S. pombe Strains wild-type, lub1-1,
lub1∆::kan, hag1∆::kan, ubp6∆::kan and pcn1-K164R. This experiment 
was carried out as described in figure 4.22.
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Figure 4.24. Levels of SpPCNA Ubiquitination Prior to and Following 
Cell Cycle Block in S-phase in the S. pombe Strains wild-type, 
amsh∆::nat1, and pcn1-K164R. This experiment was carried out as 
described in figure 4.22.
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Figure 4.25. Levels of SpPCNA Ubiquitination Prior to and Following 
Cell Cycle Block in S-phase in the S. pombe Strains wild-type, 
ubp3∆::ura4, and pcn1-K164R. This experiment was carried out as 
described in figure 4.22.
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Figure 4.26. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, ubp16∆::kan, ubp16∆::nat1, and pcn1-
K164R to Different Doses of UVC. Exponentially growing cultures were 
normalised by cell concentration and dropped down YEA agar plates, 
which were subsequently exposed to a UVC gradient as indicated. Plates 
were grown for three days at 30ºC before photographing.
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Figure 4.27. Levels of SpPCNA Ubiquitination Prior to and Following 
Cell Cycle Block in S-phase in the S. pombe Strains wild-type, 
ubp16∆::kan, ubp16∆::nat1, and pcn1-K164R. This experiment was 
carried out as described in figure 4.22.
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Figure 4.28. PCR Amplification of the ubp16 Locus Utilising Primers 
that Anneal to Flanking DNA. Using genomic DNA from of the S. pombe 
strains wild-type, ubp16∆::kan and ubp16∆::nat1. The control lanes 
indicate PCR reactions where water was added in place of genomic DNA. 
The lower diagram shows the PCR strategy in wild-type gDNA and dub-
deleted gDNA. Primers that flank the DUb gene locus are depicted by 
arrows.
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Figure 4.29. Digestion of PCR Products Obtained from Amplification 
of the ubp16 Locus. Using genomic DNA from of the S. pombe strains 
wild-type, ubp16∆::kan and ubp16∆::nat1. Digestion of PCR products 
shown in figure 4.28 with NcoI and BglII, the location of the restriction 
sites of which are shown in the lower diagram with blue and red arrows, 
respectively.
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Figure 4.30. Drop Test Assays Measuring the Relative Sensitivities to 
Different Doses of UVC of Different S. pombe ubp16∆::nat1 Haploid 
Clones Compared to wild-type, ubp16∆::nat1 Diploid and pcn1-
K164R. Exponentially growing cultures were normalised by cell 
concentration and dropped down YEA agar plates, which were 
subsequently exposed to a UVC dose gradient as indicated. Plates were 
grown for three days at 30ºC before photographing.
w
ild
-
ty
pe
pc
n
1-
K1
64
R
u
bp
16
∆:
:n
at
1 
di
pl
oi
d
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
26
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
28
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
34
w
ild
-
ty
pe
pc
n
1-
K1
64
R
u
bp
16
∆:
:n
at
1 
di
pl
oi
d
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
26
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
28
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
34
w
ild
-
ty
pe
pc
n
1-
K1
64
R
u
bp
16
∆:
:n
at
1 
di
pl
oi
d
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
26
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
28
u
bp
16
∆:
:n
at
1 
ha
pl
oi
d 
n
o.
34
0120
40
80
160
200
0
240
80
160
320
400
0
60
20
40
80
100
Jm-2Jm-2
Jm-2
Figure 4.31. Drop Test Assays Measuring the Relative Sensitivities to 
Different Doses of UVC of Different S. pombe ubp16∆::nat1 Haploid 
Clones Compared to wild-type, ubp16∆::nat1 Diploid and pcn1-
K164R. This experiment was carried out as described in figure 4.30.
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Figure 4.32. Colony Forming Assay Measuring the Percentage 
Survival Following UVC Irradiation. Haploids 26, 28 and 34 with the 
genotype ubp16∆::nat1 were compared with wild-type and pcn1-K164R. 
Exponentially growing cultures were plated onto YEA agar, which were 
exposed to the UVC doses indicated. Plates were grown for three days at 
30ºC before counting. The results represent the mean of replicates and the 
error bars represent the standard deviation. 
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Figure 4.33. Colony Forming Assay Measuring the Percentage 
Survival Following UVC Irradiation. Haploids 39, 42 and 43 with the 
genotype ubp16∆::nat1 were compared with wild-type and pcn1-K164R. 
This experiment was carried out as described in figure 4.32.
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Figure 4.34. PCR Amplification of the ubp16 Locus Utilising Primers 
that Anneal to Flanking DNA. Using genomic DNA from of the S. pombe 
strains wild-type, ubp16∆::nat1 diploid, ubp16∆::nat1 haploid clones 26, 
28 and 43, and ubp16∆::kan. Amplification of the ubp16 locus in clones 
26, 28 and 43 results in DNA with higher mobility than wild-type and 
ubp16∆::kan. The lower diagram shows the PCR strategy in wild-type 
gDNA and dub-deleted gDNA. Primers that flank the DUb gene locus are 
depicted by arrows.
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Figure 5.1. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, ubp21∆, ubp22∆, ubp21∆ ubp22∆, and
pcn1-K164R to Different Doses of UVC. Exponentially growing cultures 
were normalised by cell concentration and dropped down YEA plates, 
which were subsequently exposed to a UVC dose gradient as indicated. 
Plates were grown for three days at 30ºC before photographing. The “Not 
Treated” experiment was performed by a summer research student 
Sonoko Oshima. 
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Figure 5.2. Levels of SpPCNA Ubiquitination in the S. pombe Strains wild-
type, ubp21∆::ura4, ubp22∆::ura4, ubp21∆::ura4 ubp22∆::ura4 and pcn1-
K164R Without Treatment (-) or Following Hydroxyurea Treatment (+). The 
same number of cells of exponentially growing cultures were left untreated or 
treated with 10 mM HU, then size fractionated whole cell extracts were probed 
with anti-SpPCNA antibodies. A percentage value under a lane indicates the 
relative level of ubiquitinated SpPCNA when unmodified PCNA is set to 100%, 
which was measured by quantification of bands on a low exposure using 
ImageJ (http://rsb.info.nih.gov/ij/). The lower panel indicates a lower exposure 
of the unmodifed SpPCNA band to indicate relative sample loading levels 
between lanes.
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Figure 5.3. Levels of SpPCNA Ubiquitination Prior to and Following Cell 
Cycle Block in S-phase in the S. pombe Strains wild-type, ubp21∆::ura4,
ubp22∆::ura4, ubp21∆::ura4 ubp22∆::ura4, and pcn1-K164R. The same 
number of cells of exponentially growing cultures were treated with 10 mM
hydroxyurea for 2.5 hrs and then released into fresh media. Samples were taken 
prior to treatment (NT) and every 15 mins following release from HU. Size 
fractionated whole cell extracts were probed with anti-SpPCNA antibodies. A 
percentage value under a lane indicates the relative level of ubiquitinated 
SpPCNA when unmodified PCNA is set to 100%, which was measured by 
quantification of bands on a low exposure using ImageJ
(http://rsb.info.nih.gov/ij/). The lower panel indicates a lower exposure of the 
unmodifed SpPCNA band to indicate relative sample loading levels between 
lanes.
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Figure 5.4. Domain Structures of the S. pombe DUbs (A) SpUbp21 and 
(B) SpUbp22. The green box depicts the position of the MATH domain and 
the red box shows the UBP/USP catalytic domain. 
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Figure 5.5. EBI-CLUSTALW Alignment of the Amino Acid Sequence S. 
pombe DUbs SpUbp22 and SpUbp21. Amino acids 1-518 of SpUbp22 and 1-535 of 
SpUbp21are shown. The second half of this alignment, depicting the C-terminal 
amino acids are shown in figure 5.6. The region boxed in light green shows the 
MATH domain and the region boxed in red shows the UBP/USP catalytic domain. 
Residues highlighted in yellow are conserved in the catalytic Cys and His boxes of 
UBP/USP DUbs, and those that function in the catalytic triad, in blue. Residues 
letters are coloured according to type. Acidic residues, Asp and Glu, are typed in 
blue; basic residues, Arg and Lys, pink; green residues, His, Asn, Gly, Tyr, Ser, 
Gln, Thr, are hydrophilic; and hydrophobic residues, Phe, Met, Ala, Leu, Iso, Pro, 
Trp, are typed in red. An asterisk indicates homologous residues; a colon indicates 
conservation with a highly similar residue; a dot, conservation with less similar 
residues; and no symbol indicates no conservation.
Figure 5.6. EBI-CLUSTALW Alignment of the Amino Acid Sequence 
S. pombe DUbs SpUbp22 and SpUbp21. Amino acids 519-1108 of 
SpUbp22 and 535-1129 of SpUbp21 are shown. The first half of this 
alignment, depicting the N-terminal amino acids are shown in figure 5.5. 
The region boxed in red shows the C-terminus of the UBP/USP catalytic 
domain. The residue colouring and conservation symbols utilised in this 
alignment are described in figure 5.5.
Figure 5.7. Oligomerisation of α and β Subunits to Form Rat Meprins.
The MATH and MAM domains of meprin subunits are important for 
oligomerisation. Adapted from Bertenshaw et al, 2003. 
Figure 5.8. EBI-CLUSTALW Alignment of the Amino Acid Sequence SpUbp22 
and SpUbp21 with HsHAUSPUSP7. Amino acids 1-445 of SpUbp22, 1-462 of SpUbp21, 
and 1-445 of HAUSPUSP7 are shown. The second portion of this alignment, depicting 
the C-terminal amino acids, is shown in figure 5.9. The residue colouring, boxed 
regions and conservation symbols utilised in this alignment are described in figure 
5.4. In addition, blue squares indicate residues that, when mutated, were shown to 
abolish DUb activity on K48-linked di-ubiquitin (Hu et al, 2002). The table underneath 
shows the percentage identity (score) of pairwise comparisons.
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Figure 5.9. EBI-CLUSTALW Alignment of the Amino Acid Sequence SpUbp22
and SpUbp21 with HsHAUSPUSP7. Amino acids 446-1108 of SpUbp22, 463-1129 of 
SpUbp21, and 446-1102 of HsHAUSPUSP7 are shown. The first portion of this 
alignment, depicting the N-terminal amino acids, are shown in figure 5.8. The 
residue colouring, boxed regions and conservation symbols utilised in this alignment 
are as described in figure 5.4. 
Figure 5.10. Association of HsMDM2 with HsDAXX, HsHAUSPUSP7 and HsMDMX to 
induce HsMDM2 destabilisation of Hsp53. In unstressed cells, HsDAXX, 
HsHAUSPUSP7 and HsMDMX prevent HsMDM2 from ubiquitinating itself and direct it to 
ubiquitinate Hsp53 instead, which results in Hsp53 degradation. Following DNA 
damage and possibly HsATM-mediated phosphorylation, the complex breaks apart. 
HsMDM2 and HsMDMX switch to auto-ubiquitination mode. Hsp53 may or may not 
associate with HsDAXX or may be stabilised by the deubiquitinating activity of 
HsHAUSPUSP7. Adapted from Ronai, 2006. 
Figure 5.11. Crystal Structure of HsHAUSPUSP7 Catalytic Core. Overall 
structure shown as a ribbon diagram (top left) and space-filling diagram with the 
surface coloured according to electrostatic potential (top right). In the ribbon 
diagram, the thumb domain is shown in orange, the fingers in green and palm in 
blue. The active site found in the catalytic cleft is made from Cys box residues 
(the secondary structure is shaded in cyan) and His box residues (the 
secondary structure is shaded in pink). In the space-filling diagram, the concave 
site made by the ‘hand’ of this DUb binds ubiquitin, and the tapered C-terminus 
of ubiquitin falls into the catalytic cleft. The lower diagram shaded in black 
depicts the structure of the catalytic core of this DUb in complex with ubiquitin 
(green). Adapted from Hu et al., 2002. 
Figure 5.12. Ubiquitin Binding by DUbs. The DUb (purple) deubiquitinates a 
poly-ubiquitinated “modified protein” (burgundy) by binding a ubiquitin monomer 
(gold) in its concave “hand”. The poly-ubiquitin linkage is via lysines on ubiquitin 
found at positions “a”. The diagram depicts the DUb binding Ub-2, wherein the C-
terminus is covalently linked to another ubiquitin monomer, Ub-1. The DUb active 
site is highlighted with hatching. If the poly-ubiquitin linkage was via lysines at 
position “b”, then the DUb pictured would only be able to bind Ub-3, not Ub-2 or -
1.For example, if Ub-3 was linked to Ub-2 via position “b” on Ub-2, then Ub-3 
would be sterically hindered by the DUb “fingers”, hence Ub-2 would not be bound 
properly in the DUb active site and the Ub-2—Ub-1 linkage would not be cleaved. 
However, the most distal ubiquitin (Ub-3 in this case) in a lysine “b”-linked poly-
ubiquitin chain could be accommodated in the DUb active site. Hence it could be 
concluded that this DUb can deubiquitinate lysine “a” linked poly-ubiquitin chains 
with exo- or endo-deubiquitinating functionality, and lysine “b” linked poly-ubiquitin 
in only an exo-deubiquitinating manner. 
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Figure 5.13. Crystal Structure of the MATH domain of HsHAUSPUSP7 in 
Complex with a Hsp53 Peptide. Left, space-filling surface representation 
of the MATH domain – the Hsp53 peptide (pink) binding position is also 
shown. Centre and right, ribbon diagram of the MATH domain. Right, 
binding to Hsp53 does not induce any significant conformational change in 
the domain. Adapted from Hu et al., 2006. 
Figure 5.14. Colony Forming Assay Measuring the Percentage 
Survival Following UVC Irradiation. Strains ubp21∆, ubp22∆ and ubp21∆
ubp22∆ were compared with wild-type and pcn1-K164R. Exponentially 
growing cultures were plated onto agar, which were exposed to the UVC 
doses indicated. Plates were grown for five days at 30ºC before counting. 
The results represent the mean of two independent experiments and the 
error bars represent the standard deviation. 
wild-type
ubp21∆::ura4
ubp22∆::ura4
ubp21∆::ura4 ubp22∆::ura4
pcn1-K164R
Figure 5.15. Growth Curve Comparing Mid-log Growth Rates Between 
Strains. Strains ubp21∆, ubp22∆ and ubp21∆ ubp22∆ were compared with 
wild-type and pcn1-K164R. Exponentially growing cultures were grown at 
30°C. Samples were taken at the indicated times and the absorbance was 
measured at 600 nm.
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Figure 5.16. Growth Curve Comparing Recovery of Strains Following 
Release From Stationary Phase. Strains ubp21∆, ubp22∆ and ubp21∆
ubp22∆ were compared with wild-type and pcn1-K164R. Cultures were 
grown to stationary phase and then released into fresh media normalising 
to approximately the same absorbance. Samples were taken at the 
indicated times and the optical density measured at 600 nm.
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Figure 5.17. Drop Test Assays Measuring the Relative Sensitivities of 
S. pombe Strains wild-type, ubp13∆, ubp7∆, ubp22∆, ubp8∆, and
pcn1-K164R to Different Doses of UVC. Exponentially growing cultures 
were normalised by cell concentration and dropped down YEA plates, 
which were subsequently exposed to a UVC dose gradient as indicated. 
Plates were grown for three days at 30ºC before photographing.
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Figure 5.18. Levels of SpPCNA Ubiquitination Following Cell Cycle 
Block in S-phase in the S. pombe Strains Wild-type, ubp13∆::nat1,
ubp22∆::nat1, ubp8∆::nat1, and pcn1-K164R. The same number of 
cells of exponentially growing cultures were treated with 10 mM HU for 2.5 
hrs and then released into fresh media. Samples were taken after
treatment (HU) and every 15 mins following release from HU. Size 
fractionated whole cell extracts were probed with anti-SpPCNA antibodies. 
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Figure 5.19. Drop Test Assays Measuring the Relative Sensitivities to 
Different Doses of UVC of Different S. pombe ubp22∆::nat1 Clones 
Compared to wild-type, ubp22∆::ura4 and pcn1-K164R. Exponentially 
growing cultures were normalised by cell concentration and dropped down 
YEA plates, which were subsequently exposed to a UVC dose gradient as 
indicated. Plates were grown for three days at 30ºC before photographing. 
Clone number 21 is that utilised previously.
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Figure 5.20. PCR Amplification of the ubp22 Locus Utilising Primers 
that Anneal to Flanking DNA and Genomic DNA from the S. pombe 
Strains wild-type, and ubp22∆::hph. The lower diagram shows the PCR 
strategy in wild-type gDNA and dub-deleted gDNA. Primers that flank the 
DUb gene locus are depicted by arrows.
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Figure 5.21. Colony Forming Assay Measuring the Percentage 
Survival Following UVC Irradiation. Strains ubp21∆, ubp22∆ and ubp21∆
ubp22∆ were compared with wild-type and pcn1-K164R. Exponentially 
growing cultures were plated onto agar, which were exposed to the UVC 
doses indicated. Plates were grown for six days at 30ºC before counting. 
The results represent the mean of two independent experiments and the 
error bars represent the standard error of the mean. 
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Figure 5.22. Colony Forming Assay Measuring the Percentage 
Survival Following UVC Irradiation. As Figure 5.21.
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Figure 5.23. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R Following 
Mock (-) or UVC Treatment (+). The same number of cells of 
exponentially growing cultures were mock treated or treated with UVC. 
Samples were taken before treatment (NT) and at the indicated times 
following mock or UVC treatment. Size fractionated whole cell extracts 
were probed with anti-SpPCNA antibodies. A percentage value under a 
lane indicates the relative level of ubiquitinated SpPCNA when unmodified 
PCNA is set to 100%, which was measured by quantification of bands on 
a low exposure using ImageJ (http://rsb.info.nih.gov/ij/). 
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Figure 5.24. Levels of SpPCNA Ubiquitination in the S. pombe Strains 
wild-type, ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R Following 
Mock (-) or UVC Treatment (+). The same number of cells of 
exponentially growing cultures were mock treated or treated with UVC. 
Samples were taken before treatment (NT) and at the indicated times 
following mock or UVC treatment. Size fractionated whole cell extracts 
were probed with anti-SpPCNA antibodies. A percentage value under a 
lane indicates the relative level of ubiquitinated SpPCNA when unmodified 
PCNA is set to 100%, which was measured by quantification of bands on 
a low exposure using ImageJ (http://rsb.info.nih.gov/ij/). 
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Figure 5.25. Levels of SpPCNA Ubiquitination Following Cell Cycle 
Block in S-phase in the S. pombe Strains wild-type and 
ubp21∆::ura4, ubp22∆::ura4. The same number of cells of exponentially 
growing cultures were treated with 10 mM hydroxyurea for 2.5 hrs and 
then released into fresh media. Samples were taken before (NT) and after 
treatment (HU), in addition to every 15 mins following release from HU. 
Size fractionated whole cell extracts were probed with anti-SpPCNA 
antibodies. Samples at the aforementioned times were taken concurrently 
for analysis of DNA content, the results of which are shown in figure 5.25.
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Figure 5.26. DNA Content Analysis Following Cell Cycle Block in S-
phase in the S. pombe Strains wild-type and ubp21∆::ura4
ubp22∆::ura4. The same number of cells of exponentially growing 
cultures were treated with 10 mM hydroxyurea for 2.5 hrs and then 
released into fresh media. Samples were taken before (NT) and after 
treatment (HU), in addition to every 15 mins following release from 
hydroxyurea. DNA content was assayed using DAPI staining followed by 
analysis by FACS. Additional samples were taken concurrently at the 
aforementioned times for analysis of PCNA ubiquitination, the results of 
which are shown in Figure 5.25.
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Figure 5.27. Growth Analysis on Agar Containing 4-Nitroquinoline-1-
oxide (4NQO) of the S. pombe Strains wild-type, ubp21∆::ura4,
ubp22∆::ura4, ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The same 
number of cells of exponentially growing cultures were normalised by cell 
number, and six 1 in 6 serial dilutions were carried out. Cells were spotted 
onto agar containing 4NQO diluted in 0.2% DMSO and colonies were grown 
for two days at 30°C. 
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Figure 5.28. Growth Analysis on Agar Containing Dimethylsulfoxide 
(DMSO) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was carried as 
described in figure 5.26. 
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Figure 5.29. Temperature Sensitivity of Strains ubp21∆, ubp22∆ and 
ubp21∆ ubp22∆. Each plate was streaked with the strains ubp21∆ ::ura4 
(lower quadrant), ubp22∆ ::ura4 (left quadrant) and ubp21∆::ura4 ubp22∆ 
::ura4 (right quadrant). Growth of these strains were compared with wild-
type (top quadrant) after three days at the temperatures depicted. RT 
stands for room temperature, which was about 23°C.
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Figure 5.30. Growth Analysis on Agar Containing Hydroxyurea (HU)
of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
carried as described in figure 5.26 except the HU was dissolved in water.
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Figure 5.31. Growth Analysis on Agar Containing Methyl Methanesulfonate 
(MMS) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was carried as 
described in figure 5.26 except the MMS was dissolved in water.
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Figure 5.32. Growth Analysis on Agar Containing Camptothecin
(CPT) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
carried as described in figure 5.26. 
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Figure 5.33. Growth Analysis on Agar Containing cisplatin (cisPt) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
carried as described in figure 5.26 except cisPt was added to the agar as 
neat powder.
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Figure 5.34. Growth Analysis on Agar Containing Dimethylformamide
(DMF) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was carried as 
described in figure 5.26. 
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Figure 5.35. Growth Analysis on Agar Containing Hydrogen Peroxide 
(H2O2) of the S. pombe Strains wild-type, ubp21∆::ura4,
ubp22∆::ura4, ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The 
experiment was carried as described in figure 5.26 except the H2O2 was 
dissolved in water. 
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Figure 5.36. Growth Analysis on Agar Containing Bleomycin (Bleo) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was carried 
as described in figure 5.26 except the diluant was water. 
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Figure 5.37. Growth Analysis on Agar Containing Phleomycin (Phleo) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, ubp21∆::ura4
ubp22∆::ura4 and pcn1-K164R. The experiment was carried as described in 
figure 5.26 except the diluant was water.
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Figure 5.38. Growth Analysis Following γ Irradiation of the S. pombe 
Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, ubp21∆::ura4
ubp22∆::ura4 and pcn1-K164R. The same number of cells of exponentially 
growing cultures were normalised by cell number, and six 1 in 6 serial dilutions 
were carried out. Cells were spotted onto agar, irradiated at different doses and 
colonies were grown for two days at  30°C. 
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Figure 5.39. Growth Analysis on Agar Containing Thiabendazole 
(TBZ) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
carried out as described in figure 5.26. 
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Figure 5.40. Growth Analysis on Agar Containing Carbendazim (CBZ) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was carried 
as described in figure 5.26. . 
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Figure 5.41. Growth Analysis on Agar Containing 4-Nitroquinoline-1-oxide 
(4NQO) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The same number of cells of 
exponentially growing cultures were normalised by cell number, and six 1 in 6 
serial dilutions were carried out. Cells were spotted onto agar containing different 
concentrations of 4NQO and colonies were grown for one week at 30°C. 
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Figure 5.42. Growth Analysis on Agar Containing Dimethylsulfoxide 
(DMSO) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was performed 
as in figure 5.41. 
YEA
wild-type
ubp21∆::ura4
ubp22∆::ura4
ubp21∆::ura4 ubp22∆::ura4
pcn1-K164R
30 µg/ml cisPt
wild-type
ubp21∆::ura4
ubp22∆::ura4
ubp21∆::ura4 ubp22∆::ura4
pcn1-K164R
wild-type
ubp21∆::ura4
ubp22∆::ura4
ubp21∆::ura4 ubp22∆::ura4
pcn1-K164R
wild-type
ubp21∆::ura4
ubp22∆::ura4
ubp21∆::ura4 ubp22∆::ura4
pcn1-K164R
wild-type
ubp21∆::ura4
ubp22∆::ura4
ubp21∆::ura4 ubp22∆::ura4
pcn1-K164R
Figure 5.43. Growth Analysis on Agar Containing cisplatin (cisPt) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
performed as in figure 5.41.
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Figure 5.44. Growth Analysis on Agar Containing Dimethylformamide
(DMF) of the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was performed 
as in figure 5.41.
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Figure 5.45. Growth Analysis on Agar Containing Bleomycin (Bleo) of the 
S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, ubp21∆::ura4
ubp22∆::ura4 and pcn1-K164R. The experiment was performed as in figure 
5.41.
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Figure 5.46. Growth Analysis on Agar Containing Phleomycin (Phleo) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
performed as in figure 5.41.
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Figure 5.47. Growth Analysis on Agar Containing Carbendazim (CBZ) of 
the S. pombe Strains wild-type, ubp21∆::ura4, ubp22∆::ura4, 
ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R. The experiment was 
performed as in figure 5.41.
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Table 5.1. Sensitivity of ubp21∆::ura4 ubp22∆::ura4 and pcn1-K164R
To Genotoxins. Table summarises the relative sensitivities of these 
strains to the genotoxins tested. Key: ++++ extremely high sensitivity; +++ 
relatively high sensitivity; ++ intermediate; + low; 0 none; - not tested.
S. cerevisiae Deubiquitinating EnzymeAdditional Domains
UBP/USP Superfamily DUbs
ScPan2
-1115 a.a.
-WD-40 repeat.
-Exonuclease domain.
-Ribonuclease H fold
-YGL094C
-Likely orthologues are SpUbp13Pan2, HsUSP52.
Exonuclease Domain
ScUbp1
-809 a.a.
-Probable trans-membrane helix.
-YDL122W
-Likely orthologue is SpUbp11.
Trans-membrane 
Helix
ScUbp6
-499 a.a.
-Ubiquitin domain.
-YFR010W
-Likely orthologues are SpUbp6, HsUSP14.
Ubiquitin Domain
ScUbp14
-803 a.a.
-UBP-type zinc finger domain
-PHD-type zinc finger domain
-Two UBA domains within UBP/USP domain.
-YBR058C
-Likely orthologues are SpUbp14Ucp2, HsUSP5IsoT1, HsUSP13IsoT2.
ScSad1
-448 a.a.
-UBP-type zinc finger domain
-YFR005C
-Likely orthologues are SpUbp10, HsUSP39SNUT2*.
ScUbp8
-471 a.a.
-UBP-type zinc finger domain
-YMR223W
-Likely orthologues are SpUbp8, HsUSP22, HsUSP27*, HsUSP51*.
Zinc Finger Domain
ScUbp12
-1254 a.a.
-DUSP domain
-YJL197W
-Likely orthologues are SpUbp1, SpUbp12. HsUSP4, HsUSP11, 
HsUSP15.
DUSP domain
Table 6.1. DUbs in S. cerevisiae. Important facts for each S. cerevisiae 
DUb is provided. USP/UBP DUbs are shown in green, UCHs in blue, 
OTUs in pink, and JAMMs in beige. USP/UBPs are further divided by 
additional domains. A single asterisk indicates that the enzyme is unlikely 
to possess DUb activity.
ScUbp11
-717 a.a.
-YKR098C
ScUbp13
-688 a.a.
-YBL067C
-Paralogue is ScUbp9
-Likely orthologues are SpUbp9, HsUSP12, HsUSP46.
ScUbp9
-754 a.a.
-YER098W
-Paralogue is ScUbp13
-Likely orthologues are SpUbp9, HsUSP12, HsUSP46.
ScUbp3
-912 a.a.
-YER151C
-Likely orthologues are ScUbp3, HsUSP10.
ScUbp2
-1272 a.a
-YOR124C
-Likely orthologues are ScUbp2, HsUSP25, HsUSP28.
No additional 
domains
ScUbp7
-1071 a.a.
-Rhodanese domain.
-YIL156W
-Paralogues are ScDoa4Ubp4 and ScUbp7
-Likely orthologues are SpDoa4, HsUSP8UBPY.
ScUbp5
-805 a.a.
-Rhodanese domain.
-YER144C
-Paralogues are ScDoa4Ubp4 and ScUbp7
-Likely orthologues are SpDoa4, HsUSP8UBPY.
ScDoa4Ubp4
-926 a.a.
-Rhodanese domain.
-YDR069C
-Paralogues are ScUbp5 and ScUbp7
-Likely orthologues are SpDoa4, HsUSP8UBPY.
Rhodanese domain
ScUbp15
-1230 a.a.
-MATH domain.
-YMR304W
-Likely orthologues are SpUbp21, SpUbp22, HsHAUSPUSP7.
MATH domain
Table 6.2. DUbs in S. cerevisiae. Legend as Table 6.1.
UCH Superfamily DUbs
ScYuh1
-236 a.a.
-YJR099W
-Likely orthologues are SpUch1, HsUCH-L1, HsUCH-L3.
OTU Superfamily DUbs
ScOtu2
-307 a.a.
-YHL013C
-Likely orthologues are ScOtu2, HsOTUD6B and HsOTUD6A.
ScOtu1
-301 a.a.
-C2H2 zinc finger
-YFL044C
-Likely orthologues are SpOtu1, HsOTU1YOD1.
JAMM Superfamily DUbs
ScRri1Csn5/Jab1
-455 a.a.
-YDL216C 
-Likely orthologues are SpCsn5, HsCSN5.
ScRpn11
-306 a.a.
-YFR004W
-Likely orthologues are SpRpn11Pad1, HsRPN11.
Table 6.3. DUbs in S. cerevisiae. Legend as Table 6.1.
ScUbp16
-499 a.a.
-YPL072W
ScUbp10Dot4
-792 a.a.
-Three poly-Glu tracts
-Two poly-Ser tracts
-YNL186W
Figure 6.1. EBI-CLUSTALW Alignment of the Amino Acid Sequence SpUbp21, 
SpUbp22, ScUbp15 and HsHAUSPUSP7. N-terminal amino acids are shown. The 
second portion of this alignment, depicting the central amino acids, is shown in 
figure 6.2 and the third portion, depicting the C-terminal amino acids, is shown in 
figure 6.3. The residue colouring, boxed regions and conservation symbols utilised 
in this alignment are as described in Figures 5.5 and 5.8. Additionally, the circularly 
permuted zinc finger residues are boxed in black (Krishna and Grishin, 2004).
Figure 6.2. EBI-CLUSTALW Alignment of the Amino Acid Sequence SpUbp21, 
SpUbp22, ScUbp15 and HsHAUSPUSP7. Central amino acids are shown. The first 
portion of this alignment, depicting the N-terminal amino acids, is shown in figure 
6.1 and the third portion, depicting the C-terminal amino acids, is shown in figure 
6.3. The residue colouring, boxed regions and conservation symbols utilised in this 
alignment are as described in Figures 5.5 and 5.8. 
Figure 6.3. EBI-CLUSTALW Alignment of the Amino Acid Sequence SpUbp21, 
SpUbp22, ScUbp15 and HsHAUSPUSP7. C-terminal amino acids are shown. The first 
portion of this alignment, depicting the N-terminal amino acids, is shown in figure 
6.1 and the second portion, depicting the central amino acids, is shown in figure 6.2. 
The residue colouring, boxed regions and conservation symbols utilised in this 
alignment are as described in Figures 5.5 and 5.8. The table underneath shows the 
percentage identity (score) of pairwise comparisons.
29HsHAUSPUSP7SpUbp22
31HsHAUSPUSP7SpUbp21
40SpUbp22SpUbp21
29
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SpUbp22ScUbp15
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DUb 2DUb 1
Figure 6.4. PCR Amplification of the rad5 and ubp15 Loci Utilising 
Primers that Anneal to Flanking DNA and Genomic DNA. From of the
S. cerevisiae Strains wild-type, rad5∆::kan, and ubp15∆::kan. The 
lower diagram shows the PCR strategy in wild-type gDNA and deleted 
gDNA. Primers that flank the gene locus are depicted by arrows.
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Figure 6.5. Drop Test Assays Measuring the Relative Sensitivities of 
S. cerevisiae Strains wild-type, ubp15∆ and rad5∆ to Different Doses 
of UVC. Exponentially growing cultures were normalised by cell 
concentration and dropped down YPD agar plates, which were 
subsequently exposed to a UVC dose gradient as indicated. Plates were 
grown for three days at 25ºC before photographing.
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Figure 6.6. Growth Analysis on Agar Containing Hydrogen Peroxide
of the S. cerevisiae Strains wild-type, ubp15∆ and rad5∆. The same 
number of cells of exponentially growing cultures were normalised by cell 
number, and six 1 in 6 serial dilutions were carried out. Cells were spotted 
onto agar containing H2O2 and colonies were grown for two days at 25°C. 
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Figure 6.7. Growth Analysis on Agar Containing Phleomycin of the S. 
cerevisiae Strains wild-type, ubp15∆ and rad5∆. As Figure 6.6.
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Figure 6.8. Growth Analysis on Agar Containing Hydrogen Peroxide
of the S. cerevisiae Strains wild-type, ubp15∆::kan and rad5∆::kan.
As Figure 6.6.. 
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Figure 6.9. Growth Analysis on Agar Containing Thiabendazole (TBZ) of the 
S. cerevisiae Strains wild-type, ubp15∆ and rad5∆. As Figure 6.6.
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Figure 6.10. Growth Analysis on Agar Containing Thiabendazole of the 
S. cerevisiae Strains wild-type, ubp15∆::kan and rad5∆::kan. The same 
number of cells of exponentially growing cultures were normalised by cell 
number, and six 1 in 6 serial dilutions were carried out. Cells were spotted 
onto agar containing TBZ and colonies were grown for one week at 25°C. 
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Figure 7.1. Exogenously Expressed SpUbp21 and SpUbp22 Protein Constructs.
From top to bottom: vector only control, untagged, N-terminally tagged, C-terminally 
tagged. 
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Figure 7.2. SpPCNA Ubiquitination Following Exogenous Expression of 
SpUbp21. Wild-type cells transformed with the ubp21 contructs (as indicated) 
maintained on minimal media with or without thiamine (as indicated) were treated 
with 10 mM HU or left untreated (as indicated) for 3 hours. Whole cell extracts 
were then fractionated and probed with the indicated antibodies. Sizes of mono-
ubiquitinated (*), di-ubiquitinated (**) and tri-ubiquitinated (***) forms of SpPCNA 
are labelled.
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Figure 7.3. SpPCNA Ubiquitination Following Exogenous Expression of 
SpUbp22. Wild-type cells transformed with the ubp22 contructs (as indicated) 
maintained on minimal media with or without thiamine (as indicated) were treated 
with 10 mM HU or left untreated (as indicated) for 3 hours. Whole cell extracts were 
then fractionated and probed with the indicated antibodies. Sizes of mono-
ubiquitinated (*), di-ubiquitinated (**) and tri-ubiquitinated (***) forms of SpPCNA are 
labelled.
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Figure 7.4. Status of Ubiquitinated Species of Cellular Proteins Following the 
Exogenous Expression of SpUbp22. Legend as previous figure.
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Figure 7.5. PCR Amplification of the ubp21 and ubp22 Loci Utilising 
Primers that Anneal to Flanking DNA and Genomic DNA. From of 
the S. pombe Strains: Wild-type, ubp21∆::kan, ubp22∆::nat1 and 
ubp21∆::kan ubp22∆::nat1. The lower diagram shows the PCR strategy 
in wild-type gDNA and dub-deleted gDNA. Primers that flank the DUb
gene locus are depicted by arrows.
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Figure 7.6. ubp21∆::kan ubp22∆::nat1 Cells have the Same Sensitivity to UVC 
as ubp21∆::ura4 ubp22∆::ura4 Cells. Lanes: (1) Wild-type, (2) ubp21∆::kan, (3) 
ubp22∆::nat1, (4-6) three different clones of ubp21∆::kan ubp22∆::nat1, (7) 
ubp21∆::ura4 ubp22∆::ura4, (8) pcn1-K164R::ura4. Plates were photographed after 
6 days growth at 30°C. 
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Figure 7.7. ubp21∆::kan ubp22∆::nat1 Cells are Temperature Sensitive. Each 
plate was streaked with the strains ubp22∆::nat1 (lower quadrant), ubp21∆::kan 
ubp22∆::nat1 (left quadrant) and ubp22∆::nat1 (right quadrant). Growth of these 
strains were compared with wild-type (top quadrant) after six days at the 
temperatures indicated. 
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Figure 7.8. Rescue of UVC sensitivity by the Exogenous Expression of 
SpUbp21 Protein Constructs in ubp21∆::kan ubp22∆::nat1 Cells. Lanes: (1) 
Wild-type cells + vector only, (2) double delete cells + vector only, (3) double 
delete cells + untagged SpUbp21, (4) double delete cells + N-terminally tagged 
SpUbp21, (5) double delete cells + C-terminally tagged SpUbp21. Plates were 
photographed after 6 days growth at 30°C. 
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Figure 7.9. Rescue of UVC sensitivity by the Exogenous Expression of 
SpUbp22 Protein Constructs in ubp21∆::kan ubp22∆::nat1 Cells. Lanes: 
(1) Wild-type cells + vector only, (2) double delete cells + vector only, (3) 
double delete cells + untagged SpUbp22, (4) double delete cells + N-terminally 
tagged SpUbp22, (5) double delete cells + C-terminally tagged SpUbp22. Plates 
were photographed after 6 days growth at 30°C. 
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Figure 7.10. Alignment of the MATH Domain in MATH-USP/UBP DUbs from 23 
Different Species. The entirely conserved DWGF motif is boxed.
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Figure 7.11. Structure of the MATH Domain of HsHAUSPUSP7 in Complex with an
HsMDM2 peptide. Left: Ribbon structure in turquoise. Phenylalanines (F) highlighted 
in red, aspartic acids (D) in brown, tryptophans (W) in purple, and glycines (G) in 
pink. Highly conserved residues labelled with the HsHAUSPUSP amino acid number. 
HsMDM2 peptide shown stick form in magenta. Right: Space fill model. Structures 
from PDB ID: 2FOJ (Sheng et al, 2006).
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Figure 7.12. Rescue of UV Sensitivity of Double Delete Via Exogenous 
Expression of SpUbp22-DWGF-AAAA. Lanes: (1) Vector only, (2) untagged 
Ubp22, (3) untagged Ubp22-DWGF-AAAA, (4) pcn1-K164R::ura4. Plates were 
photographed after 4 days growth at 30°C. 
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Figure 7.13. EBI-CLUSTALW Alignment of the Amino Acid Sequence SpUbp21, 
SpUbp22, ScUbp15 and HsHAUSPUSP7. The residue colouring and conservation 
symbols utilised in this alignment are as described in Figures 5.5. Potential PIP 
boxes, designated (A) and (B), are boxed in dark red. 
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Figure 7.14. Secondary Structure Prediction of the Potential PIP Boxes of 
SpUbp21 and SpUbp22 Using the PHYRE Program. (A) and (B) as previous 
figure and in the text. For each query amino acid sequence, the program predicted 
the likelihood of an α-helix (h) or β-sheet (e), using different algorithms. The 
consensus probability (Cons_prob) rates the likelihood of secondary structure 
being present – high rating equates to high likelihood. The potential for disorder 
(d) and order (o) is also predicted and rated (Diso_prob).
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Figure 8.1. PCR Amplification of the pcn1, rad8 and rhp18 Loci 
Utilising ura4 Gene Primers, and Genomic DNA. From of the S. pombe 
Strains wild-type, pcn1-K164R::ura4 ubp21∆::kan ubp22∆::nat1,
rad8∆::ura4 ubp21∆::kan ubp22∆::nat1, and rhp18∆::ura4 ubp21∆::kan
ubp22∆::nat1. For the rad8 and rhp18 PCRs, the ura4 primer was coupled 
with a primer that anneals to flanking DNA. The lower diagram shows the 
PCR strategy in wild-type gDNA and deleted gDNA. Primers that flank the 
gene locus are depicted by arrows. For the pcn1 PCRs, the ura4 primer 
was coupled with a primer that anneals within the pcn1 gene (diagram not 
shown). 
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Figure 8.2. PCR Amplification of the ubp21 Locus Utilising Primers 
that Anneal to Flanking DNA and Genomic DNA. From of the S. pombe 
Strains wild-type, pcn1-K164R::ura4 ubp21∆::kan ubp22∆::nat1,
rad8∆::ura4 ubp21∆::kan ubp22∆::nat1, and rhp18∆::ura4 ubp21∆::kan
ubp22∆::nat1. Diagram as previous figure.
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Figure 8.3. PCR Amplification of the ubp21 Locus Utilising Primers 
that Anneal to Flanking DNA and Genomic DNA. From the S. pombe 
Strains wild-type, pcn1-K164R::ura4 ubp21∆::kan ubp22∆::nat1,
rad8∆::ura4 ubp21∆::kan ubp22∆::nat1, and rhp18∆::ura4 ubp21∆::kan
ubp22∆::nat1. Diagram as Figure 8.1.
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Figure 8.4. UV Epistasis Analysis with pcn1-K164R. S. pombe strains 
wild-type (blue diamonds), ubp21∆::kan ubp22∆::nat1 (teal squares), 
ubp21∆::kan ubp22∆::nat1 pcn1-K164R::ura4 (red triangles) and pcn1-
K164R::ura4 (purple, open circles). Colonies were counted following 6 
days growth at 30°C. Error bars indicate the standard error of the mean of 
three independent experiments.
Figure 8.5. UV Epistasis Analysis with rad8∆. S. pombe strains wild-
type (blue diamonds), ubp21∆::kan ubp22∆::nat1 (teal, open triangles), 
ubp21∆::kan ubp22∆::nat1 rad8∆::ura4 (red, open squares) and 
rad8∆::ura4 (purple circles). Colonies were counted following 6 days 
growth at 30°C. Error bars indicate the standard deviation of two 
independent experiments.
Figure 8.6. UV Epistasis Analysis with rhp18∆. S. pombe strains wild-
type (blue diamonds), ubp21∆::kan ubp22∆::nat1 (teal, open triangles), 
ubp21∆::kan ubp22∆::nat1 rhp18∆::ura4 (red circles) and rhp18∆::ura4 
(purple triangles). Colonies were counted following 6 days growth at 30°C. 
Error bars indicate the standard deviation of two independent 
experiments.
